Unnamed: 0
stringlengths 3
8
| Date
stringlengths 23
23
| Article_title
stringlengths 1
250
| Stock_symbol
stringlengths 1
5
| Url
stringlengths 44
135
| Publisher
stringclasses 1
value | Author
stringclasses 1
value | Article
stringlengths 1
343k
| Lsa_summary
stringlengths 3
53.9k
| Luhn_summary
stringlengths 1
53.9k
| Textrank_summary
stringlengths 1
53.9k
| Lexrank_summary
stringlengths 1
53.9k
| uuid
stringlengths 36
36
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
713600.0
|
2023-12-11 00:00:00 UTC
|
The 7 Top Cryptocurrencies for Long-Term Investors
|
DCOMP
|
https://www.nasdaq.com/articles/the-7-top-cryptocurrencies-for-long-term-investors
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
The cryptocurrency market has experienced a remarkable rebound in 2023, with Bitcoin’s (BTC-USD) surge past $40,000, highlighting a renewed interest in cryptos to buy.
Substantial inflows into crypto funds bolster this rally, reaching $1.76 billion according to CoinShares, sparking a massive wave of optimism among investors. This optimism is further fueled by the growing excitement surrounding spot bitcoin ETFs and the upcoming Bitcoin halving in May 2024.
Hence, as the market gears up for a potentially exhilarating growth phase, investors are keenly searching for the best cryptos to buy. This environment creates an ideal backdrop for a selection of top cryptos to buy, particularly for those aiming for long-term gains.
Bitcoin (BTC)
Source: Shutterstock
Bitcoin’s (BTC-USD) remarkable ascent in 2023 has silenced its doubters over its positioning in the cryptocurrency market, climbing a remarkable 147% year-to-date. It also has positioned it as one of the to cryptos to buy.
Starting the year at around $16,000, Bitcoin has shown an impressive upward trajectory, currently trading above $40,000. Analysts at Standard Chartered have projected a bullish future, predicting Bitcoin could soar to $120,000 by the end of 2024, almost a threefold increase from its current level.
The narrative about Bitcoin continues to grow in the ETFs sector. A recent report revealed a staggering $17.7 trillion of institutional wealth poised to flow into Bitcoin ETFs. This is apparent, given Bitcoin’s history of delivering over 35% average returns in the fourth quarter over a nine-year period.
Capital inflows into Bitcoin reflect escalating investor confidence. If the SEC green-lights pending Bitcoin ETF applications, the cryptocurrency’s value could surge past $50,000. This potential growth underscores Bitcoin’s strong market presence, attracting both retail and institutional investors.
Ethereum (ETH)
Source: Thaninee Chuensomchit / Shutterstock.com
Ethereum (ETH-USD), the second-largest crypto by market cap, plays a critical role in smart contracts and in the Web 3.0 arena. It’s one of the perennial cryptos to buy, because of its versatility in supporting decentralized computing has positioned it as a leader in the crypto sphere.
The Ethereum Virtual Machine further sets it apart, enabling a diverse range of decentralized applications.
Ethereum’s central role in decentralized applications underscores its long-term potential in the crypto sphere. With increasing on-chain adoption, Ethereum’s prospects for continued expansion and influence in the cryptocurrency world appear more promising than ever.
Reflecting broader crypto market trends, Ethereum has seen a 26% price surge in the past six months. Analysts, including those from Standard Chartered, predict a significant bump in its value, forecasting a potential five-fold increase to about $8,000 by 2026.
This optimism is attributed to Ethereum’s growing use in blockchain smart contracts and gaming.
Solana (SOL)
Source: Shutterstock
Solana (SOL-USD) has rapidly emerged in the cryptocurrency landscape and leads the charge in decentralizing finance and decentralized applications because of its exceptional throughput and low transaction costs.
This combination of high efficiency and cost-effectiveness positions Solana as one of the best cryptos to buy in the realm of digital currencies.
Solana’s recent foray into a bullish market, breaking past its earlier lower highs, further highlights its robustness. The launch of the Saga phone, marking Solana’s entry into the mobile crypto market, represents a major milestone, broadening its decentralized impact.
The Render Network’s migration to Solana highlights its efficient and fast transaction processing, notably in AI and crypto operations.
Despite previous challenges linked to the FTX debacle, Solana’s stock surge of an astounding 498% year-to-date, with market capitalization reaching a remarkable $30.39 billion, is a testament to its resilience and growth potential.
Currently priced at a robust $71.26, Solana keeps attracting significant investor and user interest.
Avalanche (AVAX)
Source: Shutterstock
Avalanche (AVAX-USD) is rapidly establishing itself as a formidable player in the smart contract arena, known for its remarkable processing capability of up to 6,500 transactions per second.
This impressive performance is bolstered by its unique architecture, which includes three specialized chains, each tailored for specific tasks.
Avalanche’s partnership with Amazon’s (NASDAQ: AMZN) cloud computing division is a game-changing move. This collaboration expands Avalanche’s reach, bringing its technology to various clients including businesses, institutions, and governments. Such a move shows Avalanche’s versatility and capacity to adapt to a dynamic market.
Furthermore, 2023 has been a year of remarkable resurgence for Avalanche, as evidenced by its price soaring to $40, a robust 234% year-to-date.
This growth trajectory has propelled its market capitalization to an impressive $14.51 billion, reinforcing Avalanche’s growing clout and affirming its position as a key competitor in the cryptocurrency landscape.
Zilliqa (ZIL)
Source: Shutterstock
Zilliqa (ZIL-USD) has carved a niche in the crypto space as the pioneer in sharding technology, partitioning transactions for parallel processing.
This innovation results in faster, more cost-effective transactions, setting it apart from heavyweights like Bitcoin and Ethereum. Coupled with an attractive 13.23% Annual Percentage Rate in staking rewards, Zilliqa positions itself as an alluring long-term investment for crypto enthusiasts.
The network’s bold move into the metaverse, relaunching as MetaMinds, taps into the escalating interest in AR/VR and gaming. Zilliqa’s significant partnership with Google Cloud, a collaboration that promises to enhance the Zilliqa blockchain’s data availability and resilience amplifies this strategic pivot, further elevating its market appeal.
Zilliqa’s recent recognition as a verified Microsoft Partner Center member solidifies its reputation in the Web3 gaming sector, setting the stage for the FUS1ON Gaming Hub debut on the Microsoft Store. Coupled with a notable 42% year-to-date price increase, Zilliqa distinguishes itself as a compelling investment choice.
Uniswap (UNI)
Source: Shutterstock
Uniswap (UNI-USD), dipping into decentralized finance, recently achieved a remarkable milestone, recording an all-time high trading volume exceeding $100 billion in October.
This feat underscores its edge over traditional centralized exchanges like Coinbase. The platform’s allure lies in facilitating direct cryptocurrency exchanges, bypassing conventional banking systems, a critical attribute in the rapidly evolving decentralized financial landscape.
Uniswap’s Version 4 upgrade marks a significant step in enhancing user experience. The standout feature, “Hooks,” transforms automated market maker exchanges, granting developers more flexibility in interacting with asset pools. This advancement boosts the platform’s capabilities and its overall appeal.
Uniswap Labs remains true to its decentralized roots, emphasizing community-driven development. This approach ensures Uniswap’s platform grows with users’ interests, solidifying its position in decentralized finance. With a year-to-date increase of a robust 16% in its price, Uniswap has become an attractive choice for investors.
XRP (XRP)
Source: Shutterstock
XRP (XRP-USD) stands out in the cryptocurrency market as a streamlined solution for international transactions, offering a cost-effective alternative to traditional financial methods.
Its capability for ultra-fast transactions particularly suits micro-payment scenarios. A recent legal win against the U.S. Securities and Exchange Commission has reinforced investor confidence in XRP despite a price dip in early November.
XRP has showed resilience, achieving a 17% increase over the last six months and a significant 76% bump year-to-date. This growth has elevated its market capitalization to a robust $32.97 billion, reflecting the cryptocurrency’s lasting appeal and growing investor trust.
Ripple Labs’ recent initiative to incorporate Automated Market Makers into the XRP Ledger marks a significant step toward boosting liquidity and efficiency in its trading ecosystem. This move will improve the platform and strengthen XRP’s position in the cryptocurrency landscape.
On the date of publication, Muslim Farooque did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Muslim Farooque is a keen investor and an optimist at heart. A life-long gamer and tech enthusiast, he has a particular affinity for analyzing technology stocks. Muslim holds a bachelor’s of science degree in applied accounting from Oxford Brookes University.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post The 7 Top Cryptocurrencies for Long-Term Investors appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Despite previous challenges linked to the FTX debacle, Solana’s stock surge of an astounding 498% year-to-date, with market capitalization reaching a remarkable $30.39 billion, is a testament to its resilience and growth potential. The platform’s allure lies in facilitating direct cryptocurrency exchanges, bypassing conventional banking systems, a critical attribute in the rapidly evolving decentralized financial landscape. Ripple Labs’ recent initiative to incorporate Automated Market Makers into the XRP Ledger marks a significant step toward boosting liquidity and efficiency in its trading ecosystem.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The cryptocurrency market has experienced a remarkable rebound in 2023, with Bitcoin’s (BTC-USD) surge past $40,000, highlighting a renewed interest in cryptos to buy. Ethereum’s central role in decentralized applications underscores its long-term potential in the crypto sphere. Uniswap (UNI) Source: Shutterstock Uniswap (UNI-USD), dipping into decentralized finance, recently achieved a remarkable milestone, recording an all-time high trading volume exceeding $100 billion in October.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The cryptocurrency market has experienced a remarkable rebound in 2023, with Bitcoin’s (BTC-USD) surge past $40,000, highlighting a renewed interest in cryptos to buy. Bitcoin (BTC) Source: Shutterstock Bitcoin’s (BTC-USD) remarkable ascent in 2023 has silenced its doubters over its positioning in the cryptocurrency market, climbing a remarkable 147% year-to-date. Solana (SOL) Source: Shutterstock Solana (SOL-USD) has rapidly emerged in the cryptocurrency landscape and leads the charge in decentralizing finance and decentralized applications because of its exceptional throughput and low transaction costs.
|
It also has positioned it as one of the to cryptos to buy. Ethereum’s central role in decentralized applications underscores its long-term potential in the crypto sphere. Solana (SOL) Source: Shutterstock Solana (SOL-USD) has rapidly emerged in the cryptocurrency landscape and leads the charge in decentralizing finance and decentralized applications because of its exceptional throughput and low transaction costs.
|
84cace7a-d1de-4145-8622-3d3e9e0e1ad5
|
713601.0
|
2023-12-11 00:00:00 UTC
|
TotalEnergies (TTE) Inks a Joint Deal to Develop 1,500-MW MNK
|
DCOMP
|
https://www.nasdaq.com/articles/totalenergies-tte-inks-a-joint-deal-to-develop-1500-mw-mnk
|
nan
|
nan
|
TotalEnergies SE TTE, along with partners EDF and Sumitomo Corporation SSUMY, announced that they have been selected as strategic partners by the government of Mozambique. The companies entered into a joint agreement for the development of the Mphanda Nkuwa hydropower project (MNK).
MNK is a 1,500 megawatt (MW) run-of-river hydropower plant, situated on the Zambezi River, around 37 miles (60 Kms) downstream from Cahora Bassa and 37 miles (60 Kms) from Tete City.
The consortium will make use of TotalEnergies' vast experience in developing large-scale integrated energy projects globally, particularly in Africa, EDF's extensive hydropower experience and reputable technical expertise, and Sumitomo's global experience in financing strategic IPP projects, including Sub-Saharan Africa, for the development of the MNK project.
The consortium signed a cooperative development agreement with the Hidroeléctrica de Cahora Bassa (HCB), Electricidade de Moçambique (EDM) and Gabinete de Implementação do Projecto Hidroeléctrico de Mphanda Nkuwa (GMNK). It will hold 70% of the project, while EDM and HCB will own the remaining 30%.
More than 50% of Mozambique's available power generation capacity would be generated by the MNK project, which could provide clean electricity to more than 3 million households in and around Mozambique and South Africa. The MNK project would play an important role in the region's energy transition by providing reliable renewable electricity.
TTE’s Focus on Renewable Energy
Multi-energy focused TotalEnergies extends its reach beyond the scope of the Mozambique Liquefied Natural Gas project by making a significant investment in renewable energy for the benefit of the people of Mozambique. This is a new phase in TotalEnergies' multi-faceted strategy to support oil and gas countries in their energy transition.
TotalEnergies strives to be a net-zero carbon emission company by 2050 and has taken the necessary steps to achieve the target. TotalEnergies aims to achieve cost-competitive portfolio combining renewables and flexible assets to deliver clean firm power to its customers. At the end of 2023, TotalEnergies’ gross renewable electricity generation installed capacity was 22 gigawatt (GW). TotalEnergies will continue to expand this business to reach 35 GW in 2025 and more than 100 TWh of net electricity production by 2030.
Growth Prospects
According to Precedence Research report, the global renewable energy market size was estimated at $970 billion in 2022 and is expected to hit over $2182.99 billion by 2032 with a registered CAGR of 8.5% from 2023 to 2032.
The hydroelectric power was the leading segment in the global renewable energy market in 2022. The increasing government initiatives to promote the generation and adoption of the hydropower are fueling the growth of the hydroelectric power segment in the global renewable energy market. According to the same report mentioned above, the global hydroelectric power segment is growing at a CAGR of 6.6% from 2023 to 2032.
Along with TTE, other oil and gas companies like BP plc BP and ExxonMobil Corporation XOM are also focused on renewable energy and adopting measures to reduce emissions from operations.
BP has set an aggressive energy transition plan to capitalize on the mounting clean energy demand. By 2030, it plans to reduce emissions from operations by 30-35%. In a decade, BP has set an ambitious goal of developing 50 GW of net renewable energy generating capacity.
BP’s long-term (three- to five-year) earnings growth rate is 6.51%. The Zacks Consensus Estimate for 2023 earnings is pegged at $5.05 per share.
ExxonMobil has been working to reduce emissions by developing more efficient fuels. The company intends to make large investments in emission-reduction projects over the next few years. XOM has developed an ambitious roadmap to achieve net-zero Scope 1 and net-zero Scope 2 GHG emissions by 2030 for unconventionally operated assets.
XOM’s long-term earnings growth rate is 3%. It delivered an average earnings surprise of 0.6% in the last four quarters.
Price Performance
In the past six months, shares of TotalEnergies have risen 14.2% compared with the industry’s 10.5% growth.
Image Source: Zacks Investment Research
Zacks Rank
TotalEnergies currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
BP p.l.c. (BP) : Free Stock Analysis Report
Exxon Mobil Corporation (XOM) : Free Stock Analysis Report
Sumitomo Corp. (SSUMY) : Free Stock Analysis Report
TotalEnergies SE Sponsored ADR (TTE) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
TotalEnergies aims to achieve cost-competitive portfolio combining renewables and flexible assets to deliver clean firm power to its customers. The increasing government initiatives to promote the generation and adoption of the hydropower are fueling the growth of the hydroelectric power segment in the global renewable energy market. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
TTE’s Focus on Renewable Energy Multi-energy focused TotalEnergies extends its reach beyond the scope of the Mozambique Liquefied Natural Gas project by making a significant investment in renewable energy for the benefit of the people of Mozambique. Along with TTE, other oil and gas companies like BP plc BP and ExxonMobil Corporation XOM are also focused on renewable energy and adopting measures to reduce emissions from operations. (BP) : Free Stock Analysis Report Exxon Mobil Corporation (XOM) : Free Stock Analysis Report Sumitomo Corp. (SSUMY) : Free Stock Analysis Report TotalEnergies SE Sponsored ADR (TTE) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The consortium will make use of TotalEnergies' vast experience in developing large-scale integrated energy projects globally, particularly in Africa, EDF's extensive hydropower experience and reputable technical expertise, and Sumitomo's global experience in financing strategic IPP projects, including Sub-Saharan Africa, for the development of the MNK project. TTE’s Focus on Renewable Energy Multi-energy focused TotalEnergies extends its reach beyond the scope of the Mozambique Liquefied Natural Gas project by making a significant investment in renewable energy for the benefit of the people of Mozambique. (BP) : Free Stock Analysis Report Exxon Mobil Corporation (XOM) : Free Stock Analysis Report Sumitomo Corp. (SSUMY) : Free Stock Analysis Report TotalEnergies SE Sponsored ADR (TTE) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The increasing government initiatives to promote the generation and adoption of the hydropower are fueling the growth of the hydroelectric power segment in the global renewable energy market. Along with TTE, other oil and gas companies like BP plc BP and ExxonMobil Corporation XOM are also focused on renewable energy and adopting measures to reduce emissions from operations. The Zacks Consensus Estimate for 2023 earnings is pegged at $5.05 per share.
|
62c035c9-f0e4-4aa3-8f37-45e7b795f9ae
|
713602.0
|
2023-12-11 00:00:00 UTC
|
Pembina (PBA) to Buy Enbridge's Assets in a C$3.1-Billion Deal
|
DCOMP
|
https://www.nasdaq.com/articles/pembina-pba-to-buy-enbridges-assets-in-a-c%243.1-billion-deal
|
nan
|
nan
|
Pembina Pipeline Corporation PBA, a leading Canadian midstream company, announced that it will purchase Enbridge Inc.'s ENB remaining interests in the Alliance Pipeline, Aux Sable pipelines and NRGreen joint ventures for C$3.1 billion.
This deal will see Pembina take full ownership of its critical assets, strengthening its position as a leader in transporting natural gas across North America. This strategic move is also expected to significantly boost Pembina's growth and profitability in the years to come.
Let's delve into the details of this expansive acquisition and its potential impacts.
Background
The Alliance Pipeline is a critical natural gas transportation system that operates across Canada and the United States. Spanning approximately 3,888 kilometers (2,414 miles), it carries natural gas from western Canada to the Chicago market. The Aux Sable processing plant, located in Illinois, is strategically connected to the Alliance Pipeline and is responsible for processing natural gas liquids (NGL) from the pipeline.
The Acquisition
Per the terms of the agreement, Pembina is set to purchase Enbridge's 50% interest in Alliance, Aux Sable (42.7% interest) and NRGreen joint ventures. Additionally, PBA will assume C$327 million of Enbridge's debt in the Alliance venture. This acquisition will enable Pembina to take full ownership of these pivotal assets, providing enhanced control and operational flexibility.
Significance and Benefits
Increased Stake in Gas Transportation: By acquiring Enbridge's interests, PBA will expand its footprint in the natural gas transportation sector. This transaction will significantly bolster the company's overall gas logistics capabilities and extend its reach into key markets.
Streamlined Operations: Combining ownership of the Alliance Pipeline and Aux Sable processing plant will allow Pembina to streamline operations, leading to improved efficiency, cost optimization, and better integration of the gas transportation and processing value chain.
Diversification and Revenue Growth: The acquisition aligns with Pembina's long-term growth strategy, enabling diversification of revenue streams and reduced exposure to any single commodity. It positions the company as a strong player in serving North American energy markets, driving potential revenue growth and stable cash flow.
Enhanced Infrastructure for Energy Transition: As the world transitions toward cleaner energy sources, natural gas and NGLs continue to play a crucial role. Pembina's expanded ownership of vital infrastructure, such as the Alliance Pipeline, positions the company to support the efficient transportation and processing of natural gas and NGLs, contributing to the energy transition efforts.
Regulatory Approvals and Closing
The acquisition is subject to customary closing conditions, along with necessary regulatory approvals. Pembina expects the transaction to close in the first half of 2024.
Conclusion
PBA’s acquisition of Enbridge's interests in the Alliance Pipeline and Aux Sable processing plant marks a milestone in the energy sector. This deal not only strengthens Pembina's position as a key player in gas transportation and processing but also supports its long-term growth strategy and provides infrastructure for the evolving energy landscape.
Zacks Rank and Key Picks
Currently, both PBA and ENB carry a Zacks Rank #3 (Hold).
Investors interested in the energy sector might look at some better-ranked stocks like The Williams Companies WMB, sporting a Zacks Rank #1 (Strong Buy), and Liberty Energy Inc. LBRT, carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Williams Companies is valued at $41.86 billion. The company currently pays a dividend of $1.79 per share, or 5.20%, on an annual basis.
WMB, the U.S.-based energy infrastructure company, operates through Transmission & Gulf of Mexico, Northeast G&P, West and Gas & NGL Marketing Services segments.
Liberty Energy is valued at $2.99 billion. LBRT currently pays a dividend of 28 cents per share, or 1.58%, on an annual basis.
LBRT is a leading provider of hydraulic fracturing and other auxiliary services to the North American onshore exploration and production companies.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Williams Companies, Inc. (The) (WMB) : Free Stock Analysis Report
Enbridge Inc (ENB) : Free Stock Analysis Report
Pembina Pipeline Corp. (PBA) : Free Stock Analysis Report
Liberty Energy Inc. (LBRT) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
It positions the company as a strong player in serving North American energy markets, driving potential revenue growth and stable cash flow. Pembina's expanded ownership of vital infrastructure, such as the Alliance Pipeline, positions the company to support the efficient transportation and processing of natural gas and NGLs, contributing to the energy transition efforts. This deal not only strengthens Pembina's position as a key player in gas transportation and processing but also supports its long-term growth strategy and provides infrastructure for the evolving energy landscape.
|
Pembina's expanded ownership of vital infrastructure, such as the Alliance Pipeline, positions the company to support the efficient transportation and processing of natural gas and NGLs, contributing to the energy transition efforts. Investors interested in the energy sector might look at some better-ranked stocks like The Williams Companies WMB, sporting a Zacks Rank #1 (Strong Buy), and Liberty Energy Inc. LBRT, carrying a Zacks Rank #2 (Buy) at present. Click to get this free report Williams Companies, Inc. (The) (WMB) : Free Stock Analysis Report Enbridge Inc (ENB) : Free Stock Analysis Report Pembina Pipeline Corp. (PBA) : Free Stock Analysis Report Liberty Energy Inc. (LBRT) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Pembina's expanded ownership of vital infrastructure, such as the Alliance Pipeline, positions the company to support the efficient transportation and processing of natural gas and NGLs, contributing to the energy transition efforts. Investors interested in the energy sector might look at some better-ranked stocks like The Williams Companies WMB, sporting a Zacks Rank #1 (Strong Buy), and Liberty Energy Inc. LBRT, carrying a Zacks Rank #2 (Buy) at present. Click to get this free report Williams Companies, Inc. (The) (WMB) : Free Stock Analysis Report Enbridge Inc (ENB) : Free Stock Analysis Report Pembina Pipeline Corp. (PBA) : Free Stock Analysis Report Liberty Energy Inc. (LBRT) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Pembina Pipeline Corporation PBA, a leading Canadian midstream company, announced that it will purchase Enbridge Inc.'s ENB remaining interests in the Alliance Pipeline, Aux Sable pipelines and NRGreen joint ventures for C$3.1 billion. Pembina's expanded ownership of vital infrastructure, such as the Alliance Pipeline, positions the company to support the efficient transportation and processing of natural gas and NGLs, contributing to the energy transition efforts. Pembina expects the transaction to close in the first half of 2024.
|
54a2e520-9097-444d-b2b5-8b89464f8648
|
713603.0
|
2023-12-11 00:00:00 UTC
|
3 Lithium Stocks to Turn $5,000 Into $1 Million: December 2023
|
DCOMP
|
https://www.nasdaq.com/articles/3-lithium-stocks-to-turn-%245000-into-%241-million%3A-december-2023
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Supply issues crushed lithium stocks. However, as I noted on Dec. 5, “the fear is creating a massive opportunity for patient investors.” I also said, “I’d use the temporary, excessive fear as an opportunity.” That’s because the pullback was ridiculously overdone. Sure, supply issues still exist. But down the line, we won’t have enough supply to meet growing demand.
Remember, as noted by Morningstar, “rising electric vehicle adoption and the increasing buildout of energy storage systems will keep lithium demand growing to surpass 1 million metric tons in 2024, from 800,000 in 2022, eventually hitting 2.5 million metric tons by 2030. While we see rising supply, we think enough projects will face delays to maintain a market deficit as demand grows.”
Plus, the biggest lithium producers in the world are still bullish on lithium. In fact, as noted by Reuters, “In calls with investors and analysts in recent days, lithium producers said they saw the market volatility as short term, adding that they expect electrification to keep growing.”
That said, I’d still buy lithium stocks on weakness.
Albemarle (ALB)
Source: IgorGolovniov/Shutterstock.com
The last time I mentioned Albemarle (NYSE:ALB), the industry’s 800 lb. gorilla had plunged to a low of $123.38 on Nov. 29. It was also trading at six times earnings at the time, I noted, and at less than half of growth. None of which was sustainable.
Since then, ALB bounced back to about $128 and could refill its bearish gap around $170. Helping, Bank of America (NYSE:BAC) just upgraded ALB to a Neutral rating, noting the stock is undervalued. I’m not sure what took them so long, but it’s good to see they’re waking up. I also expect other firms to start jumping on the bullish ALB bandwagon again shortly.
Better, while we wait for ALB to recover lost ground, we can collect its 1.2% yield.
Livent (LTHM)
Source: Ralf Liebhold / Shutterstock
I also mentioned Livent (NYSE:LTHM) on Nov. 29, noting, “it’s wildly over-extended on relative strength (RSI), MACD and Williams’ %R. [Plus], according to the company, it still expects to see ‘significantly improved performance versus 2022.’”
At the time, LTHM just slipped to $13.54. It’s now up to $14.69. From here, I’d like to see it initially retest prior resistance around $19.
While JPMorgan (NYSE:JPM) and Piper Sandler lowered their ratings on the LTHM stock in recent days, that’s a bad call, in my opinion. With the lithium price pullback being a temporary event, investors should take full advantage of the weakness here and with other beaten-down lithium stocks. We also have to consider LTHM trades at 20% growth at the moment, too.
American Lithium (AMLI)
Source: Shutterstock
There’s also American Lithium (NASDAQ:AMLI), which plunged to a low of $1. Now up to $1.10, I still believe there’s good potential here. For one, it recently submitted an environmental impact assessment study for its Falchani lithium project in Peru, hoping for near-term approval.
Even better, AMLI “raised its estimates for the Falchani project by 476% from 2019, saying it could hold 5.53M metric tons of lithium carbonate equivalent, which would make it one of the world’s largest hard-rock lithium projects,” as noted by Seeking Alpha.
While its chart is nothing to write home about, this potentially lucrative Peru project could provide a massive upside catalyst.
On the date of publication, Ian Cooper did not hold (either directly or indirectly) any positions in the securities mentioned. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Ian Cooper, a contributor to InvestorPlace.com, has been analyzing stocks and options for web-based advisories since 1999.
More From InvestorPlace
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The #1 AI Investment Might Be This Company You’ve Never Heard Of
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post 3 Lithium Stocks to Turn $5,000 Into $1 Million: December 2023 appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
While JPMorgan (NYSE:JPM) and Piper Sandler lowered their ratings on the LTHM stock in recent days, that’s a bad call, in my opinion. For one, it recently submitted an environmental impact assessment study for its Falchani lithium project in Peru, hoping for near-term approval. The #1 AI Investment Might Be This Company You’ve Never Heard Of The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post 3 Lithium Stocks to Turn $5,000 Into $1 Million: December 2023 appeared first on InvestorPlace.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Supply issues crushed lithium stocks. Albemarle (ALB) Source: IgorGolovniov/Shutterstock.com The last time I mentioned Albemarle (NYSE:ALB), the industry’s 800 lb. American Lithium (AMLI) Source: Shutterstock There’s also American Lithium (NASDAQ:AMLI), which plunged to a low of $1.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Supply issues crushed lithium stocks. In fact, as noted by Reuters, “In calls with investors and analysts in recent days, lithium producers said they saw the market volatility as short term, adding that they expect electrification to keep growing.” That said, I’d still buy lithium stocks on weakness. Even better, AMLI “raised its estimates for the Falchani project by 476% from 2019, saying it could hold 5.53M metric tons of lithium carbonate equivalent, which would make it one of the world’s largest hard-rock lithium projects,” as noted by Seeking Alpha.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Supply issues crushed lithium stocks. In fact, as noted by Reuters, “In calls with investors and analysts in recent days, lithium producers said they saw the market volatility as short term, adding that they expect electrification to keep growing.” That said, I’d still buy lithium stocks on weakness. Albemarle (ALB) Source: IgorGolovniov/Shutterstock.com The last time I mentioned Albemarle (NYSE:ALB), the industry’s 800 lb.
|
8374c3d5-2611-4473-a8fc-087598011797
|
713604.0
|
2023-12-11 00:00:00 UTC
|
Core & Main Inc Class A Shares Approach 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/core-main-inc-class-a-shares-approach-52-week-high-market-mover
|
nan
|
nan
|
Core & Main Inc Class A (CNM) shares closed today at 0.9% below its 52 week high of $39.12, giving the company a market cap of $6B. The stock is currently up 101.5% year-to-date, up 85.9% over the past 12 months, and up 64.1% over the past five years. This week, the Dow Jones Industrial Average rose 2.9%, and the S&P 500 rose 3.5%.
Trading Activity
Trading volume this week was 12.1% lower than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.1.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 2427.4%
The company's stock price performance over the past 12 months beats the peer average by 1806.1%
The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -6.3% lower than the average peer.
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Core & Main Inc Class A (CNM) shares closed today at 0.9% below its 52 week high of $39.12, giving the company a market cap of $6B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.1. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 2427.4% The company's stock price performance over the past 12 months beats the peer average by 1806.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -6.3% lower than the average peer.
|
This week, the Dow Jones Industrial Average rose 2.9%, and the S&P 500 rose 3.5%. Trading Activity Trading volume this week was 12.1% lower than the 20-day average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 2427.4% The company's stock price performance over the past 12 months beats the peer average by 1806.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -6.3% lower than the average peer.
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 2427.4% The company's stock price performance over the past 12 months beats the peer average by 1806.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -6.3% lower than the average peer. This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 2.9%, and the S&P 500 rose 3.5%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 2427.4% The company's stock price performance over the past 12 months beats the peer average by 1806.1% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is -6.3% lower than the average peer.
|
6b9a0d96-b439-450b-aa56-6f247b27575d
|
713605.0
|
2023-12-11 00:00:00 UTC
|
JOBY Stock: Ready for Liftoff or Grounded Indefinitely?
|
DCOMP
|
https://www.nasdaq.com/articles/joby-stock%3A-ready-for-liftoff-or-grounded-indefinitely
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
The risk with a lot of future-tech stocks is they are all story and no substance. In Texas, you might say they are all hat, no cattle. That’s not Joby Aviation (NYSE:JOBY).
It’s a speculative stock to be sure and has a story to tell but there is substance to what it’s building.
A leader in the rising class of electric vertical takeoff and landing aircraft, Joby is poised to become a real-world, commercial robotaxi company.
It’s building prototypes, delivering them to partners for testing, building factories to produce vehicles, and working towards the certifications needed to fly. So there’s a lot of potential, but also substantial risk.
We’ve seen similar stories flameout in the electric vehicle industry. Lordstown Motors, Mullen Automotive (NASDAQ:MULN), and Nikola (NASDAQ:NKLA) all promised to upend their industries. The only thing they lit on fire was investor cash.
So investor caution is warranted. But from all existing information, Joby Aviation stock looks ready to take flight.
So let’s see whether it is worthy of your investment dollars.
Taxiing for takeoff
Even if Joby had a hangar full of robotaxis ready for liftoff today, its stock would remain grounded without Federal Aviation Administration certification. The regulatory body has a multi-phase process for earning your wings, including proving airworthiness, pilot training, safety, and more.
Joby Aviation was the first eVTOL aircraft developer to receive a signed, stage 4 G-1 certification, which covers specific FAA airworthiness and environmental standards required for full certification. It maintains it will be the first eVTOL manufacturer to earn full airworthiness certification.
It’s a good way along the path. Joby devised a five-stage plan to help investors follow its progress. It completed Stage 1, is almost all the way through Stage 2, and the FAA has accepted 84% of its Stage 3 plans. There is still a lot more to go. The real challenge, and what Joby is really focused on is Stage 4, Testing and Analysis, which it’s only just starting.
It delivered its first aircraft for initial service operations with the Defense Dept. as part of a $131 million contract to test electric air taxis. It says as far as it knows, it is also the first company to receive airworthiness approval for an eVTOL aircraft from the U.S. Air Force.
Joby remains confident it will begin commercial passenger operations in 2025. That will come as part of the manufacturing facility it will build in Ohio with the capacity to produce up to 500 aircraft. That’s not a large number, but you have to walk before you can run. Financial backer Toyota Motors (NYSE:TM) is advising Joby as it prepares to scale production.
A story worth listening to
Joby Aviation has a good story going. But that’s not enough to justify an investment. Its financials look OK on the surface. Of course, it has no revenue, but it managed to report a $1.5 million profit in the third quarter. However, that happened because of changes in the fair value of warrants and earn-out shares and an increase in interest income because of higher interest rates on invested funds.
So investors shouldn’t put any credence in Joby being in better financial shape. These were non-operational gains unrelated to the business. The realized gains can (and likely will) turn negative in the ensuing quarters.
Joby saw a 36% increase in research and development expenses and a 19% increase in selling, general, and administrative expenses. This is not unexpected as Joby marches forward on its path to be commercial robotaxi operator. And that’s key to remember.
Joby Aviation doesn’t plan on selling its eVTOL craft to third parties but use them itself to run an air taxi company. It wants to be the “Uber of the Sky.” A vertically integrated business carries its own set of risks. It’s as if Uber Technologies (NYSE:UBER) was also manufacturing its own rideshare cars. It’s a more complicated business model and involves greater expense. Joby may find picking a lane and sticking to it is the best option. Be a manufacturer or a robotaxi company, but not both.
Worth the risk?
The robotaxi stock seems as though it’s doing all the right things and moving in the right direction. Investors who want to tap into this future-tech company should feel confident doing so, as long as they understand it is only a “story stock” right now.
Just don’t get lulled by it. There are still many chapters to come. You shouldn’t be backing up the truck to invest in Joby Aviation stock.
On the date of publication, Rich Duprey did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Rich Duprey has written about stocks and investing for the past 20 years. His articles have appeared on Nasdaq.com, The Motley Fool, and Yahoo! Finance, and he has been referenced by U.S. and international publications, including MarketWatch, Financial Times, Forbes, Fast Company, USA Today, Milwaukee Journal Sentinel, Cheddar News, The Boston Globe, L’Express, and numerous other news outlets.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post JOBY Stock: Ready for Liftoff or Grounded Indefinitely? appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
A leader in the rising class of electric vertical takeoff and landing aircraft, Joby is poised to become a real-world, commercial robotaxi company. Taxiing for takeoff Even if Joby had a hangar full of robotaxis ready for liftoff today, its stock would remain grounded without Federal Aviation Administration certification. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires.
|
Taxiing for takeoff Even if Joby had a hangar full of robotaxis ready for liftoff today, its stock would remain grounded without Federal Aviation Administration certification. Joby Aviation was the first eVTOL aircraft developer to receive a signed, stage 4 G-1 certification, which covers specific FAA airworthiness and environmental standards required for full certification. It maintains it will be the first eVTOL manufacturer to earn full airworthiness certification.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The risk with a lot of future-tech stocks is they are all story and no substance. Taxiing for takeoff Even if Joby had a hangar full of robotaxis ready for liftoff today, its stock would remain grounded without Federal Aviation Administration certification. Joby Aviation was the first eVTOL aircraft developer to receive a signed, stage 4 G-1 certification, which covers specific FAA airworthiness and environmental standards required for full certification.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The risk with a lot of future-tech stocks is they are all story and no substance. Taxiing for takeoff Even if Joby had a hangar full of robotaxis ready for liftoff today, its stock would remain grounded without Federal Aviation Administration certification. A story worth listening to Joby Aviation has a good story going.
|
41c60be6-6b70-4004-bb10-6d7671da57f3
|
713606.0
|
2023-12-11 00:00:00 UTC
|
US STOCKS-Futures rise after Fed's dovish pivot
|
DCOMP
|
https://www.nasdaq.com/articles/us-stocks-futures-rise-after-feds-dovish-pivot
|
nan
|
nan
|
For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window.
Futures up: Dow 0.22%, S&P 0.29%, Nasdaq 0.41%
Dec 14 (Reuters) - U.S. stock index futures gained on Thursday, a day after the Federal Reserve hinted an end to its recent aggressive rate hikes and signaled that borrowing costs would be lower next year.
The Fed left interest rates unchanged on Wednesday, as expected, with Chair Jerome Powell saying the historic tightening of monetary policy was likely over, as inflation falls faster than expected, and discussions on cuts in borrowing costs were coming "into view".
The Fed had raised its policy rate by a market-punishing 525 basis points since March 2022 in an effort to curb decades-high inflation. On Wednesday, 17 of 19 Fed officials projected the policy rate would be lower by end-2024.
The dovish pivot in the central bank's statement triggered a rally in equities on Wednesday and sent the Dow Jones Industrial Average Index .DJI to a record closing high.
"Continuing disinflationary pressures has offered the Fed room to maneuver. Further, there are signs that rate hikes are loosening the labor market," said Emin Hajiyev, senior economist at Insight Investment.
"If the Fed can bring inflation down without these measures deteriorating much further, it strongly improves the central bank’s prospect of achieving a “soft landing” and avoiding a recession."
Money markets now see a 95.2% chance of at least a 25-basis-point rate cut in March 2024, up from about 50% before the policy decision, while fully pricing in another cut in May, according to CME Group's FedWatch tool.
Treasury yields also fell to multi-month lows following Wednesday's events, with the yield on the benchmark 10-year Treasury note US10YT=RR last standing at 3.95%. US/
The falling yields further cushioned equities, with megacap stocks like Alphabet GOOGL.O, Tesla TSLA.O and Nvidia NVDA.O inching up between 0.8% and 1% before the bell.
Investors will now parse the retail sales data for November and the weekly jobless claims number, both due at 8:30 a.m. ET, for more clues on softening inflation.
At 5:30 a.m. ET, Dow e-minis 1YMcv1 were up 81 points, or 0.22%, S&P 500 e-minis EScv1 were up 14 points, or 0.29%, and Nasdaq 100 e-minis NQcv1 were up 69.5 points, or 0.41%.
Among single stocks, Occidental PetroleumOXY.N added 1.7% premarket after Warren Buffett's Berkshire Hathaway BRKa.N acquired nearly 10.5 million shares of the oil giant for about $588.7 million.
AdobeADBE.O shed 6.0% after the Photoshop maker forecast annual and quarterly revenue below estimates.
Foot Locker FL.N rose 3.6% after Piper Sandler upgraded the sportswear retailer to "overweight" from "neutral".
Stocks love the Fed again https://tmsnrt.rs/3v4nD2u
(Reporting by Shristi Achar A in Bengaluru; Editing by Pooja Desai)
((Shristi.AcharA@thomsonreuters.com https://twitter.com/ShristiAchar;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The dovish pivot in the central bank's statement triggered a rally in equities on Wednesday and sent the Dow Jones Industrial Average Index .DJI to a record closing high. Further, there are signs that rate hikes are loosening the labor market," said Emin Hajiyev, senior economist at Insight Investment. "If the Fed can bring inflation down without these measures deteriorating much further, it strongly improves the central bank’s prospect of achieving a “soft landing” and avoiding a recession."
|
Futures up: Dow 0.22%, S&P 0.29%, Nasdaq 0.41% Dec 14 (Reuters) - U.S. stock index futures gained on Thursday, a day after the Federal Reserve hinted an end to its recent aggressive rate hikes and signaled that borrowing costs would be lower next year. The Fed left interest rates unchanged on Wednesday, as expected, with Chair Jerome Powell saying the historic tightening of monetary policy was likely over, as inflation falls faster than expected, and discussions on cuts in borrowing costs were coming "into view". ET, Dow e-minis 1YMcv1 were up 81 points, or 0.22%, S&P 500 e-minis EScv1 were up 14 points, or 0.29%, and Nasdaq 100 e-minis NQcv1 were up 69.5 points, or 0.41%.
|
Futures up: Dow 0.22%, S&P 0.29%, Nasdaq 0.41% Dec 14 (Reuters) - U.S. stock index futures gained on Thursday, a day after the Federal Reserve hinted an end to its recent aggressive rate hikes and signaled that borrowing costs would be lower next year. The Fed left interest rates unchanged on Wednesday, as expected, with Chair Jerome Powell saying the historic tightening of monetary policy was likely over, as inflation falls faster than expected, and discussions on cuts in borrowing costs were coming "into view". Stocks love the Fed again https://tmsnrt.rs/3v4nD2u (Reporting by Shristi Achar A in Bengaluru; Editing by Pooja Desai) ((Shristi.AcharA@thomsonreuters.com https://twitter.com/ShristiAchar;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Futures up: Dow 0.22%, S&P 0.29%, Nasdaq 0.41% Dec 14 (Reuters) - U.S. stock index futures gained on Thursday, a day after the Federal Reserve hinted an end to its recent aggressive rate hikes and signaled that borrowing costs would be lower next year. The Fed had raised its policy rate by a market-punishing 525 basis points since March 2022 in an effort to curb decades-high inflation.
|
302634d7-4da3-492f-bb8e-13471a47ec8f
|
713607.0
|
2023-12-11 00:00:00 UTC
|
Strength Seen in Cadence (CADE): Can Its 6.0% Jump Turn into More Strength?
|
DCOMP
|
https://www.nasdaq.com/articles/strength-seen-in-cadence-cade%3A-can-its-6.0-jump-turn-into-more-strength
|
nan
|
nan
|
Cadence (CADE) shares ended the last trading session 6% higher at $29.54. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 14.3% gain over the past four weeks.
Shares of Cadence rallied for the fourth consecutive trading day. The Federal Reserve signaled end of the current rate cycle and kept the interest rates unchanged at 22-year high of 5.25-5.5% at the end of two-day FOMC meeting. Further, the central bank indicated three interest rate cuts by 2024-end. These developments turned investor sentiments bullish on bank stocks as high funding costs being faced by the industry players will somewhat come down next year, thus supporting net interest income and margin. Thus, the CADE stock moved higher.
This bank is expected to post quarterly earnings of $0.53 per share in its upcoming report, which represents a year-over-year change of -32.1%. Revenues are expected to be $445.94 million, down 6% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Cadence, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on CADE going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Cadence is part of the Zacks Banks - Southeast industry. South Plains Financial (SPFI), another stock in the same industry, closed the last trading session 5.3% higher at $29.67. SPFI has returned 3.3% in the past month.
For South Plains Financial, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.65. This represents a change of -8.5% from what the company reported a year ago. South Plains Financial currently has a Zacks Rank of #2 (Buy).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Cadence Bank (CADE) : Free Stock Analysis Report
South Plains Financial, Inc. (SPFI) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiments bullish on bank stocks as high funding costs being faced by the industry players will somewhat come down next year, thus supporting net interest income and margin. For South Plains Financial, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.65. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Cadence is part of the Zacks Banks - Southeast industry. For South Plains Financial, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.65. Click to get this free report Cadence Bank (CADE) : Free Stock Analysis Report South Plains Financial, Inc. (SPFI) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Cadence is part of the Zacks Banks - Southeast industry. Click to get this free report Cadence Bank (CADE) : Free Stock Analysis Report South Plains Financial, Inc. (SPFI) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Thus, the CADE stock moved higher. This bank is expected to post quarterly earnings of $0.53 per share in its upcoming report, which represents a year-over-year change of -32.1%. Click to get this free report Cadence Bank (CADE) : Free Stock Analysis Report South Plains Financial, Inc. (SPFI) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
66a50351-8556-433c-a115-3cafccbaceb8
|
713608.0
|
2023-12-11 00:00:00 UTC
|
New Strong Buy Stocks for December 14th
|
DCOMP
|
https://www.nasdaq.com/articles/new-strong-buy-stocks-for-december-14th-1
|
nan
|
nan
|
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Murphy USA Inc. MUSA: This retailer of motor fuel products and convenience merchandise has seen the Zacks Consensus Estimate for its current year earnings increasing 12.5% over the last 60 days.
Murphy USA Inc. Price and Consensus
Murphy USA Inc. price-consensus-chart | Murphy USA Inc. Quote
Avalo Therapeutics, Inc. AVTX: This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 90.3% over the last 60 days.
Avalo Therapeutics, Inc. Price and Consensus
Avalo Therapeutics, Inc. price-consensus-chart | Avalo Therapeutics, Inc. Quote
Anika Therapeutics, Inc. ANIK: This joint preservation company has seen the Zacks Consensus Estimate for its current year earnings increasing 14.5% over the last 60 days.
Anika Therapeutics Inc. Price and Consensus
Anika Therapeutics Inc. price-consensus-chart | Anika Therapeutics Inc. Quote
CarGurus, Inc. CARG: This online automotive marketplace has seen the Zacks Consensus Estimate for its current year earnings increasing 9.8% over the last 60 days.
CarGurus, Inc. Price and Consensus
CarGurus, Inc. price-consensus-chart | CarGurus, Inc. Quote
Western Midstream Partners, LP WES: This midstream energy company has seen the Zacks Consensus Estimate for its current year earnings increasing 4.4% over the last 60 days.
Western Midstream Partners, LP Price and Consensus
Western Midstream Partners, LP price-consensus-chart | Western Midstream Partners, LP Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Western Midstream Partners, LP (WES) : Free Stock Analysis Report
Murphy USA Inc. (MUSA) : Free Stock Analysis Report
Anika Therapeutics Inc. (ANIK) : Free Stock Analysis Report
CarGurus, Inc. (CARG) : Free Stock Analysis Report
Avalo Therapeutics, Inc. (AVTX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today: Murphy USA Inc. MUSA: This retailer of motor fuel products and convenience merchandise has seen the Zacks Consensus Estimate for its current year earnings increasing 12.5% over the last 60 days. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains. Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
|
Murphy USA Inc. Price and Consensus Murphy USA Inc. price-consensus-chart | Murphy USA Inc. Quote Avalo Therapeutics, Inc. AVTX: This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 90.3% over the last 60 days. Western Midstream Partners, LP Price and Consensus Western Midstream Partners, LP price-consensus-chart | Western Midstream Partners, LP Quote You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Click to get this free report Western Midstream Partners, LP (WES) : Free Stock Analysis Report Murphy USA Inc. (MUSA) : Free Stock Analysis Report Anika Therapeutics Inc. (ANIK) : Free Stock Analysis Report CarGurus, Inc. (CARG) : Free Stock Analysis Report Avalo Therapeutics, Inc. (AVTX) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Avalo Therapeutics, Inc. Price and Consensus Avalo Therapeutics, Inc. price-consensus-chart | Avalo Therapeutics, Inc. Quote Anika Therapeutics, Inc. ANIK: This joint preservation company has seen the Zacks Consensus Estimate for its current year earnings increasing 14.5% over the last 60 days. Anika Therapeutics Inc. Price and Consensus Anika Therapeutics Inc. price-consensus-chart | Anika Therapeutics Inc. Quote CarGurus, Inc. CARG: This online automotive marketplace has seen the Zacks Consensus Estimate for its current year earnings increasing 9.8% over the last 60 days. Click to get this free report Western Midstream Partners, LP (WES) : Free Stock Analysis Report Murphy USA Inc. (MUSA) : Free Stock Analysis Report Anika Therapeutics Inc. (ANIK) : Free Stock Analysis Report CarGurus, Inc. (CARG) : Free Stock Analysis Report Avalo Therapeutics, Inc. (AVTX) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Murphy USA Inc. Price and Consensus Murphy USA Inc. price-consensus-chart | Murphy USA Inc. Quote Avalo Therapeutics, Inc. AVTX: This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 90.3% over the last 60 days. CarGurus, Inc. Price and Consensus CarGurus, Inc. price-consensus-chart | CarGurus, Inc. Quote Western Midstream Partners, LP WES: This midstream energy company has seen the Zacks Consensus Estimate for its current year earnings increasing 4.4% over the last 60 days. Click to get this free report Western Midstream Partners, LP (WES) : Free Stock Analysis Report Murphy USA Inc. (MUSA) : Free Stock Analysis Report Anika Therapeutics Inc. (ANIK) : Free Stock Analysis Report CarGurus, Inc. (CARG) : Free Stock Analysis Report Avalo Therapeutics, Inc. (AVTX) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
14bf4eea-30bb-47ef-bd70-94d00ab049a8
|
713609.0
|
2023-12-11 00:00:00 UTC
|
3 Smart Stock Picks in the Wake of Platform X’s Ad Exodus
|
DCOMP
|
https://www.nasdaq.com/articles/3-smart-stock-picks-in-the-wake-of-platform-xs-ad-exodus
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
The list of companies that have stopped advertising on platform X (formerly known as Twitter) because Elon Musk endorsed an antisemitic post continues to grow. It’s become so long that you could construct an excellent portfolio from all the names abandoning the social media platform and its volatile billionaire owner.
Interestingly, most companies that have dropped ads from X use corporate speak to avoid calling Musk an outright racist, which remains debatable. I think he enjoys stirring the pot, much like Donald Trump. What these two men actually believe, I doubt anyone will ever know.
The latest large-cap stock to drop X was Walmart (NYSE:WMT), which dropped the platform from its advertising plan on Dec. 1.
“We aren’t advertising on X as we’ve found other platforms to better reach our customers,” a Walmart spokesperson said.
According to media reports, the number of brands bailing on X is more than 100. Here are three smart stock picks from the carnage Musk created by his lonesome.
Microsoft (MSFT)
Source: The Art of Pics / Shutterstock.com
According to The New York Times, Microsoft (NASDAQ:MSFT) pulling its ads from X could be worth more than $4 million in lost revenue to Musk. That might not seem like a lot, given the billionaire paid $44 billion for the platform formerly known as Twitter.
However, in 2022, X generated $4.4 billion in revenue, most of it from ads. At the end of November, the Times said the number of brands leaving the platform was more than 200. $2 million per advertiser is $400 million in lost revenue or about 10% of its annual sales.
X CEO Linda Yaccarino tried to convince customers Musk’s views on free speech were something to get behind. After what happened to Bud Light this past summer, there is no way any CEO is going anywhere near X. That would be career suicide.
“It doesn’t resonate at all,” Ruben Schreurs, the chief strategy officer at Ebiquity, a marketing and media consulting firm said, The Times reported. Schreurs added that the spending pauses seemed to be “turning into a termination of advertising on X.”
Only Musk’s sale of the platform will get these brands back.
As for Microsoft, there is no way it has any appetite for mixing it up with Elon Musk. After going through a stressful couple of weeks with OpenAI, it can find plenty of places to spend $4 million in ad revenue.
Netflix (NFLX)
Source: TY Lim / Shutterstock.com
According to The Times, Netflix (NASDAQ:NFLX), pulled $3 million in ads. The paper doesn’t specify over what period. However, assuming 90% of X’s $4.4 billion in 2022 revenue was for ads, daily ad spending on the platform exceeds an estimated $10.8 million.
The revenue damage becomes far more real annualized over a year. According to Statista, Netflix spent $1.59 billion in 2022 on advertising expenses. That was down slightly from $1.67 billion a year earlier. Since 2014, the most it’s ever spent was in 2019, when it dished out $1.88 billion.
If Netflix spent $3 million per week on X, which is hard to imagine, Elon Musk’s proverbial goose is undoubtedly cooked.
Even if $3 million per week were accurate, Netflix has ad-supported plans to grow. It can use the money not spent on X to reinvest in its ad business. To me, and probably to Netflix shareholders, that is a much better return on investment.
Elon’s loss is Netflix’s gain.
Airbnb (ABNB)
Source: Kaspars Grinvalds / Shutterstock
The last of the three is Airbnb (NASDAQ:ABNB). It’s reported to have pulled $1 million in ads from X.
The optics of a service such as Airbnb supporting the rantings of a madman would upset not only its users but also its hosts, which drive the company’s revenues. Airbnb doesn’t exist without its hosts. CEO and co-founder Brian Chesky knows this firsthand because he was the company’s first host.
Today, more than four million hosts provide over seven million listings in 220+ countries. Sure, you also have to have guests, but if they didn’t stay at an Airbnb, they’d stay at a hotel or resort or sleep in a tent at a campground. Inventory is critical to the business.
Interestingly, co-founder Joe Gebbia serves on Tesla’s (NASDAQ:TSLA) board, which he joined in 2022. That would be an awkward conversation at the next Tesla board meeting. Hopefully, Musk doesn’t use the exact words he did with Walt Disney (NYSE:DIS) CEO Bob Iger. At least, in Iger’s case, he wasn’t in the room.
Of these three names, Airbnb had the biggest reason to pull their ads. It isn’t an excellent look to support an alleged racist when you’re selling an inclusive type of experience.
I continue to like ABNB stock.
On the date of publication, Will Ashworth did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Will Ashworth has written about investments full-time since 2008. Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He particularly enjoys creating model portfolios that stand the test of time. He lives in Halifax, Nova Scotia.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post 3 Smart Stock Picks in the Wake of Platform X’s Ad Exodus appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
“It doesn’t resonate at all,” Ruben Schreurs, the chief strategy officer at Ebiquity, a marketing and media consulting firm said, The Times reported. More From InvestorPlace ChatGPT IPO Could Shock the World, Make This Move Before the Announcement Musk’s “Project Omega” May Be Set to Mint New Millionaires. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post 3 Smart Stock Picks in the Wake of Platform X’s Ad Exodus appeared first on InvestorPlace.
|
The latest large-cap stock to drop X was Walmart (NYSE:WMT), which dropped the platform from its advertising plan on Dec. 1. Microsoft (MSFT) Source: The Art of Pics / Shutterstock.com According to The New York Times, Microsoft (NASDAQ:MSFT) pulling its ads from X could be worth more than $4 million in lost revenue to Musk. Netflix (NFLX) Source: TY Lim / Shutterstock.com According to The Times, Netflix (NASDAQ:NFLX), pulled $3 million in ads.
|
Microsoft (MSFT) Source: The Art of Pics / Shutterstock.com According to The New York Times, Microsoft (NASDAQ:MSFT) pulling its ads from X could be worth more than $4 million in lost revenue to Musk. Netflix (NFLX) Source: TY Lim / Shutterstock.com According to The Times, Netflix (NASDAQ:NFLX), pulled $3 million in ads. However, assuming 90% of X’s $4.4 billion in 2022 revenue was for ads, daily ad spending on the platform exceeds an estimated $10.8 million.
|
$2 million per advertiser is $400 million in lost revenue or about 10% of its annual sales. It’s reported to have pulled $1 million in ads from X. Airbnb doesn’t exist without its hosts.
|
3135940d-d118-4dd3-9bce-de89bab9c0c9
|
713610.0
|
2023-12-11 00:00:00 UTC
|
Assessing BlackRock Stock: The Pros and Cons of BLK for 2024 Investors
|
DCOMP
|
https://www.nasdaq.com/articles/assessing-blackrock-stock%3A-the-pros-and-cons-of-blk-for-2024-investors
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Of 13 analysts following Blackrock (NYSE:BLK) stock at Tipranks, 12 say buy it. This despite their own prediction of a meager 3.5% gain in BLK stock next year. They remain true even though, until very recently, Blackrock was going precisely nowhere on the year.
BLK stock is now up 6% for 2023 but was down 15% as recently as Oct. 27. The surge has everyone, including chart watchers, bullish for 2024. But Blackrock is not a stock for everyone.
Inside BLK Stock
Blackrock is America’s largest asset manager, with almost $9.5 trillion under its control. About 16% of that comes from holdings in the Cloud Czars themselves, and Nvidia (NASDAQ:NVDA). Its 13F filing is scrutinized like that of Berkshire-Hathaway (NYSE:BRK-A) (NYSE:BRK-B), but it also runs real estate and other assets for institutions.
Despite all this wealth going through its fingers, Blackrock’s market cap is under $112 billion.
That’s because Blackrock is mainly a passive investor, its profits flow through to others. Its own income is from investment advisory fees. In the September quarter, this came to about $3.5 billion. Net income came to $1.6 billion, $10.66 per share, and about half that or $5/share went out as dividends.
That dividend is the main reason to buy BLK stock. It’s $20 in cash each year, and up 50% in the last five years. The equity has risen less than 20% per year, but the stock is volatile, rising and falling with the market.
The Punching Bag
Most of what you read about Blackrock has nothing to do with this.
Because it holds a lot of everything for clients, Blackrock is a target for everyone’s political points. It owned gun manufacturers and oil companies. At one time it owned more coal power plants than anyone else. Blackrock has a billion-dollar mutual fund in China.
But when CEO Larry Fink tried to reverse some policies, committing the company to Environmental, Social, and Governance standards, the other side pounced.
The biggest risk to Blackrock may be Fink’s retirement. He’s 70 and says he’s grooming successors. But every new CEO wants to do things their own way. Will their way prove to be as profitable?
The Bottom Line
Fink himself offers the best reason not to buy Blackrock for 2024. He says next year will be a stock picker’s market.
Blackrock is too big to be a stock picker. In its various funds and management operations, it picks everything.
I’m left where I started. Blackrock is a solid dividend stock. It’s a good bet in a rising stock market. It’s no protection in a panic, and it won’t make you Blackrock rich. But it’s a good place to put some retirement money, either directly or in one of its iShares funds.
As of this writing, Dana Blankenhorn had LONG positions in MSFT and NVDA. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Dana Blankenhorn has been a financial and technology journalist since 1978. He is the author of Technology’s Big Bang: Yesterday, Today and Tomorrow with Moore’s Law, available at the Amazon Kindle store. Tweet him at @danablankenhorn, connect with him on Mastodon or subscribe to his Substack.
More From InvestorPlace
The #1 AI Investment Might Be This Company You’ve Never Heard Of
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post Assessing BlackRock Stock: The Pros and Cons of BLK for 2024 Investors appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
But when CEO Larry Fink tried to reverse some policies, committing the company to Environmental, Social, and Governance standards, the other side pounced. He is the author of Technology’s Big Bang: Yesterday, Today and Tomorrow with Moore’s Law, available at the Amazon Kindle store. More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Of 13 analysts following Blackrock (NYSE:BLK) stock at Tipranks, 12 say buy it. Inside BLK Stock Blackrock is America’s largest asset manager, with almost $9.5 trillion under its control. That dividend is the main reason to buy BLK stock.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Of 13 analysts following Blackrock (NYSE:BLK) stock at Tipranks, 12 say buy it. But Blackrock is not a stock for everyone. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post Assessing BlackRock Stock: The Pros and Cons of BLK for 2024 Investors appeared first on InvestorPlace.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Of 13 analysts following Blackrock (NYSE:BLK) stock at Tipranks, 12 say buy it. But Blackrock is not a stock for everyone. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post Assessing BlackRock Stock: The Pros and Cons of BLK for 2024 Investors appeared first on InvestorPlace.
|
18a6b1cb-b32c-43f9-aca8-8c7a69bddd3e
|
713611.0
|
2023-12-11 00:00:00 UTC
|
Will Berkshire Hathaway Finally Make a Massive Acquisition in 2024?
|
DCOMP
|
https://www.nasdaq.com/articles/will-berkshire-hathaway-finally-make-a-massive-acquisition-in-2024
|
nan
|
nan
|
Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) finished the third quarter of 2023 with $157.2 billion in cash and short-term investments (mostly Treasury securities). Buffett is known for keeping large stockpiles of cash on the sidelines, but this is the most the conglomerate has ever had. Even excluding the $30 billion Buffett insists on keeping at all times, there's $127.2 billion in ammo for the company to go shopping.
Realistically, Berkshire's budget is even higher. The company has top-notch credit and massive borrowing capacity, so if the right opportunity came along, there's no reason Berkshire couldn't make a purchase for, say, $150 billion.
Plus, it's likely we'll find that Berkshire's cash hoard has increased, once again, in the fourth quarter. We recently learned Berkshire sold a significant amount of its HP stock, and there's no indicators that Buffett and his team are doing a ton of buying in the stock market.
What could Berkshire buy?
Just looking at the company's actual cash on hand minus the $30 billion cushion, there are only about 80 companies Berkshire couldn't theoretically afford to buy with the cash it has on hand. Just to put things into perspective, Lowe's, AT&T, Starbucks, and Lockheed Martin all have market caps lower than Berkshire's available cash.
When an acquisition is made, the acquirer typically pays a premium over the market value. However, the point is that Berkshire has the capacity to make a big acquisition -- if it wants to.
Plus, with many experts still expecting a recession in 2024, there's a solid possibility that business valuations could come down. Buffett has said that he wants to be a provider of liquidity to the system during tough times. It was this exact mentality that allowed Berkshire to invest in Bank of America and Goldman Sachs at fire-sale valuations around the time of the financial crisis.
Why Berkshire might want to sit on its capital
Although Berkshire's cash stockpile is at an all-time high, there's an argument to be made that Buffett could be less eager to make a big acquisition than he was a few years ago. In short, with the rising interest-rate environment, Berkshire is getting paid very well for its idle cash right now. Just as one example, the three-month U.S. Treasury yield was about 0.06% at the beginning of 2022. It's about 5.42% as of this writing.
While Berkshire doesn't have all of its money in any one specific maturity of Treasuries, this implies that the company could earn about $8.5 billion per year from its cash. Just a couple of years ago, Berkshire's cash was earning virtually nothing.
In other words, in order to appeal to Buffett, any potential acquisition target would likely need to have a strong possibility of generating more cash flow than could reasonably be achieved from simply keeping its cash as is.
Will we finally see a big acquisition in 2024?
Of course, nobody has a crystal ball, and there's a lot that can happen in one year regarding market conditions, interest rates, and other factors. As long as interest rates stay elevated, we might see some smaller acquisitions, but the chances of a massive deal taking place appear to be rather low, given Berkshire's risk-free rate of return from its cash.
Should you invest $1,000 in Berkshire Hathaway right now?
Before you buy stock in Berkshire Hathaway, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Berkshire Hathaway wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Bank of America is an advertising partner of The Ascent, a Motley Fool company. Matthew Frankel, CFP® has positions in Bank of America, Berkshire Hathaway, and Goldman Sachs Group. The Motley Fool has positions in and recommends Bank of America, Berkshire Hathaway, Goldman Sachs Group, and Starbucks. The Motley Fool recommends Helmerich & Payne, Lockheed Martin, and Lowe's Companies. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The company has top-notch credit and massive borrowing capacity, so if the right opportunity came along, there's no reason Berkshire couldn't make a purchase for, say, $150 billion. It was this exact mentality that allowed Berkshire to invest in Bank of America and Goldman Sachs at fire-sale valuations around the time of the financial crisis. While Berkshire doesn't have all of its money in any one specific maturity of Treasuries, this implies that the company could earn about $8.5 billion per year from its cash.
|
Before you buy stock in Berkshire Hathaway, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Berkshire Hathaway wasn't one of them. Matthew Frankel, CFP® has positions in Bank of America, Berkshire Hathaway, and Goldman Sachs Group. The Motley Fool has positions in and recommends Bank of America, Berkshire Hathaway, Goldman Sachs Group, and Starbucks.
|
Just looking at the company's actual cash on hand minus the $30 billion cushion, there are only about 80 companies Berkshire couldn't theoretically afford to buy with the cash it has on hand. Why Berkshire might want to sit on its capital Although Berkshire's cash stockpile is at an all-time high, there's an argument to be made that Buffett could be less eager to make a big acquisition than he was a few years ago. Before you buy stock in Berkshire Hathaway, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Berkshire Hathaway wasn't one of them.
|
While Berkshire doesn't have all of its money in any one specific maturity of Treasuries, this implies that the company could earn about $8.5 billion per year from its cash. Before you buy stock in Berkshire Hathaway, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Berkshire Hathaway wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Bank of America is an advertising partner of The Ascent, a Motley Fool company.
|
bc34fa88-d314-4702-b3fa-cf636d643d57
|
713612.0
|
2023-12-11 00:00:00 UTC
|
3 Growth Stocks to Buy Hand Over Fist in 2024
|
DCOMP
|
https://www.nasdaq.com/articles/3-growth-stocks-to-buy-hand-over-fist-in-2024
|
nan
|
nan
|
The U.S. economy ended the third quarter (ending Sep. 30, 2023) with stronger-than-expected growth due to robust consumer spending. While real gross domestic product (GDP) grew year over year by 4.9% in Q3 (the fastest in the past two years), inflation cooled down significantly in October 2023.
Many analysts now believe that the Federal Reserve's interest rate hikes may now pause. With Wall Street seemingly gearing up for a bull rally in the coming months, investors stand to benefit by picking up stakes in attractive growth stocks such as Microsoft (NASDAQ: MSFT), Roblox (NYSE: RBLX), and Zscaler (NASDAQ: ZS).
Let's assess these stocks in detail.
Microsoft
Technology titan Microsoft's nearly $13 billion investment in OpenAI, the developer of ultrafamous chatbot ChatGPT, has been a game-changer, enabling the company to infuse its core offerings, such as the Azure cloud-computing platform, Bing search engine, and Microsoft 365 productivity suite, with OpenAI's technology. Microsoft also strategically handled the ouster and return of OpenAI's CEO Sam Altman. Subsequently, the company has now taken a non-voting, observer position on OpenAI's board, giving it access to the latter's confidential information. All this bodes well for Microsoft's future interests in the AI space.
Microsoft is committed to the growth of Azure, which is the largest revenue driver for the company. Demand for Azure has rebounded, as customers have started bringing new workloads to the cloud. More than 18,000 organizations are also using the Azure OpenAI service (a cloud-based AI service provided atop Microsoft Azure) to build customized generative AI applications.
Microsoft also stands to benefit significantly from Microsoft 365 Copilot, an AI assistant integrated into Microsoft 365 applications to improve their productivity and creativity. Starting Nov. 1, 2023, Microsoft 365 Copilot has been available to enterprise customers at $30 per user per month. With 345 million paid members (paid seats) of Microsoft 365, there is a huge monetization scope in this AI offering.
Microsoft is also making its presence felt in the AI hardware space by introducing two AI and enterprise-workload optimized chips: Microsoft Azure Maia and Microsoft Azure Cobalt. This move will reduce the company's dependence on external chip players, further strengthening its growth prospects in the AI space.
Roblox
A leading online-entertainment platform, Roblox enables its users to develop and host games in virtual worlds and play them with other gamers across various devices. The platform doubles as a social-media application, allowing players to interact with each other. Roblox can also be considered a major contender for the metaverse opportunity. This is evident since all players in its games use avatars to play and interact with each other. Furthermore, players can also use the virtual currency Robux for in-game purchases or avatar upgrades.
After a difficult 2021 and 2022, Roblox seems to be finally making a recovery with Q3 (ending Sep. 30, 2023) revenues and earnings surpassing consensus estimates. The company also posted a solid improvement in engagement trends, with average daily active users (DAUs) jumping 20% year over year to 70.2 million, while total hours of engagement also rose year over year by 20% to over 16 billion in Q3.
Roblox currently earns a major chunk of its revenues from selling Robux currency. However, the company has also partnered with Gucci brand owner Kering, Vans brand owner VF Corporation, Nike, and other such prominent brands to help bring traffic to their 3D virtual destinations to interact with brands, learn more about the products through videos, try stuff virtually, and finally purchase goods. Hence, Roblox's focus on providing users with a more interactive and immersive experience with the brands coupled with a large and engaged customer base can help establish advertising and sponsorships as a significant revenue source in the coming years.
Roblox also earns some revenue from selling its premium subscription service, Roblox Premium. Since only 20% of its users are paying subscribers, this area also has huge growth potential.
All these tailwinds make Roblox a compelling pick in 2024.
Zscaler
Cybersecurity player Zscaler came out with an impressive first quarter of fiscal 2024 (ending Oct. 31, 2023) performance, with revenues and earnings surpassing consensus estimates. This is an impressive feat considering that companies have been increasingly scrutinizing their cybersecurity budgets for large deals in the current difficult macroeconomic environment. The company also released stronger-than-anticipated revenue and margin guidance for Q2 and full-year fiscal 2024. While the weak fiscal 2024 billings outlook seems to have muted investor enthusiasm for the stock, there are still several things to like in this company.
With enterprises increasingly shifting complex AI-driven workloads to the public cloud, cybersecurity has become a mission-critical part of organizations' IT infrastructure. Furthermore, increased frequency of high-profile cyberattacks coupled with rising Securities and Exchange Commission (SEC) disclosure requirements have further spurred demand for the company's Zero Trust security solutions (a cybersecurity framework that requires all users and devices to be continuously verified and validated before they are given access to devices, data, and applications).
A critical aspect of Zscaler's success is its achievement in acquiring high-value clients who are entering into larger, multiyear, and multiproduct deals. Thanks to customers opting for Zscaler's broad platform over point products from multiple vendors, the company witnessed a 34% year-over-year jump in the number of customers spending over $1 million in annual recurring revenues (ARR) to 468 customers in Q1. Plus, the company's impressive dollar-based net-retention rate of 120% also underlines a robust upsell strategy wherein existing customers are not only staying with the company but also increasing their spending.
Hence, as the leader in the cloud-native zero-trust security market with improving operational and financial metrics, Zscaler still has plenty of growth potential in its $72 billion total addressable market.
Should you invest $1,000 in Microsoft right now?
Before you buy stock in Microsoft, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Microsoft wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 7, 2023
Manali Bhade has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Microsoft, Nike, Roblox, and Zscaler. The Motley Fool recommends the following options: long January 2025 $47.50 calls on Nike. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Hence, Roblox's focus on providing users with a more interactive and immersive experience with the brands coupled with a large and engaged customer base can help establish advertising and sponsorships as a significant revenue source in the coming years. This is an impressive feat considering that companies have been increasingly scrutinizing their cybersecurity budgets for large deals in the current difficult macroeconomic environment. With enterprises increasingly shifting complex AI-driven workloads to the public cloud, cybersecurity has become a mission-critical part of organizations' IT infrastructure.
|
More than 18,000 organizations are also using the Azure OpenAI service (a cloud-based AI service provided atop Microsoft Azure) to build customized generative AI applications. Microsoft also stands to benefit significantly from Microsoft 365 Copilot, an AI assistant integrated into Microsoft 365 applications to improve their productivity and creativity. Zscaler Cybersecurity player Zscaler came out with an impressive first quarter of fiscal 2024 (ending Oct. 31, 2023) performance, with revenues and earnings surpassing consensus estimates.
|
Microsoft Technology titan Microsoft's nearly $13 billion investment in OpenAI, the developer of ultrafamous chatbot ChatGPT, has been a game-changer, enabling the company to infuse its core offerings, such as the Azure cloud-computing platform, Bing search engine, and Microsoft 365 productivity suite, with OpenAI's technology. Microsoft is also making its presence felt in the AI hardware space by introducing two AI and enterprise-workload optimized chips: Microsoft Azure Maia and Microsoft Azure Cobalt. Before you buy stock in Microsoft, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Microsoft wasn't one of them.
|
Microsoft Technology titan Microsoft's nearly $13 billion investment in OpenAI, the developer of ultrafamous chatbot ChatGPT, has been a game-changer, enabling the company to infuse its core offerings, such as the Azure cloud-computing platform, Bing search engine, and Microsoft 365 productivity suite, with OpenAI's technology. Zscaler Cybersecurity player Zscaler came out with an impressive first quarter of fiscal 2024 (ending Oct. 31, 2023) performance, with revenues and earnings surpassing consensus estimates. Before you buy stock in Microsoft, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Microsoft wasn't one of them.
|
f897dcee-714a-4cf8-8c10-abc2462c009e
|
713613.0
|
2023-12-11 00:00:00 UTC
|
Prediction: This Will Be the Best Artificial Intelligence (AI) Stock to Own in 2024
|
DCOMP
|
https://www.nasdaq.com/articles/prediction%3A-this-will-be-the-best-artificial-intelligence-ai-stock-to-own-in-2024
|
nan
|
nan
|
Although 2023 has marked the rise of many artificial intelligence (AI) stocks, 2024 will be an even bigger year. 2023 was filled with product announcements, but we haven't come close to seeing what these innovations can do. It will also expose many AI-related investments propped up on a lot of hype. Those are stocks to avoid.
However, one stock that I'm confident will have a strong 2024 (and perhaps the best of all companies) is Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL). It is just starting to hit its stride in the AI space, and its primary business is also starting to turn around after a weak 2022 and 2023.
Alphabet has multiple strong products
Alphabet is the parent company of many well-known brands like Google, YouTube, and the Android operating system. While CEO Sundar Pichai has long declared Alphabet an AI-first company, its primary revenue stream is advertising.
In the third quarter, 78% of revenue came from advertising. Advertising wasn't at its peak over the past few years, as many businesses were preparing for a recession and dialed back spending. But for the first time in several quarters, Alphabet's advertising wing had a solid quarter, growing revenue by 9%. This bodes well for 2024, as advertising still steers Alphabet.
In addition to advertising is Alphabet's Google Cloud, its cloud computing wing. Cloud computing is also set up to have a strong 2024, as the computing capability combined with data storage that cloud computing provides will become critical as companies roll out their in-house AI solutions.
Mentioning AI, Alphabet's Gemini was recently released and is the first model to surpass human experts in the massive multitask language understanding test, a popular way to measure an AI model's effectiveness. With its best-in-class performance (it beat OpenAI's GPT-4 model in many head-to-head competitions), Gemini should be a huge revenue boost for Alphabet as it's adopted.
Heading into 2024, Alphabet is well positioned to succeed. But just how much performance can Alphabet shareholders expect?
The stock may be undervalued
Another component in my prediction that Alphabet will have a great year is rooted in its current valuation. Over the past decade, Alphabet's price-to-earnings (P/E) ratio was about 30. This isn't out of line with what other big tech stocks trade at, as Apple and Microsoft each trade at around 30 times earnings or greater.
GOOGL PE Ratio data by YCharts
However, Alphabet doesn't have that same premium, as it only trades for 25.5 times earnings, which is about the same as the S&P 500's 24.6 times earnings. Essentially, the market values Alphabet like it's an average business, which is a huge mistake considering the potential upside.
If you value Alphabet using 2024 earnings, it looks even cheaper at 20 times earnings.
In 2024, if Alphabet delivers the earnings that analysts project and the stock reaches its average historical valuation of 30 times earnings, that would represent a 50% upside in the stock. But even if it remains at its current 25.5 times earnings valuation, Alphabet's stock will gain about 28% if it hits projections.
However, the tailwinds blowing in Alphabet's favor are just starting, and they will last beyond 2024. So, even though Alphabet is slated to have a strong 2024, I'm still excited to be a long-term shareholder.
While other AI stocks may have greater upside than Alphabet, few have the almost guaranteed positive return promise that Alphabet can provide shareholders in 2024. As a result, it's my top AI stock pick for 2024.
Should you invest $1,000 in Alphabet right now?
Before you buy stock in Alphabet, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Alphabet wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Keithen Drury has positions in Alphabet. The Motley Fool has positions in and recommends Alphabet, Apple, and Microsoft. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
While CEO Sundar Pichai has long declared Alphabet an AI-first company, its primary revenue stream is advertising. Advertising wasn't at its peak over the past few years, as many businesses were preparing for a recession and dialed back spending. With its best-in-class performance (it beat OpenAI's GPT-4 model in many head-to-head competitions), Gemini should be a huge revenue boost for Alphabet as it's adopted.
|
In addition to advertising is Alphabet's Google Cloud, its cloud computing wing. But even if it remains at its current 25.5 times earnings valuation, Alphabet's stock will gain about 28% if it hits projections. Before you buy stock in Alphabet, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Alphabet wasn't one of them.
|
In 2024, if Alphabet delivers the earnings that analysts project and the stock reaches its average historical valuation of 30 times earnings, that would represent a 50% upside in the stock. While other AI stocks may have greater upside than Alphabet, few have the almost guaranteed positive return promise that Alphabet can provide shareholders in 2024. Before you buy stock in Alphabet, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Alphabet wasn't one of them.
|
In the third quarter, 78% of revenue came from advertising. In 2024, if Alphabet delivers the earnings that analysts project and the stock reaches its average historical valuation of 30 times earnings, that would represent a 50% upside in the stock. While other AI stocks may have greater upside than Alphabet, few have the almost guaranteed positive return promise that Alphabet can provide shareholders in 2024.
|
dbc570e1-37e5-468d-9f93-b0ab595dc7c0
|
713614.0
|
2023-12-11 00:00:00 UTC
|
Pfizer's 2024 Outlook Disappointed Wall Street, But Where Will the Stock Be in 5 Years?
|
DCOMP
|
https://www.nasdaq.com/articles/pfizers-2024-outlook-disappointed-wall-street-but-where-will-the-stock-be-in-5-years
|
nan
|
nan
|
Pfizer (NYSE: PFE) was a top performer when the U.S. government was shoveling COVID-related revenue in its direction. Unfortunately, the past year hasn't been nearly as kind. The former high-flying stock has fallen by about 41% in 2023, and the year ahead isn't shaping up to be its best.
Pfizer's stock price fell sharply on Wednesday, Dec. 13, after management issued guidance for 2024 that wasn't nearly as good as Wall Street expected.
Why Pfizer stock fell
Pfizer stock fell about 8% when the market opened on Dec. 13 in a knee-jerk reaction to forward-looking estimates that didn't align with Wall Street's predictions.
The average analyst who follows Pfizer was expecting the company to predict $63.2 billion in annual revenue and $3.16 in earnings per share. Instead, the pharmaceutical giant disappointed Wall Street with a guided revenue range between $58.5 billion and $61.5 billion. On the bottom line, earnings are only expected to land somewhere between $2.05 and $2.25 per share.
Rapidly eroding sales of Pfizer's COVID-19 vaccine, Comirnaty, and Paxlovid, its antiviral COVID-19 treatment, are a big reason Pfizer caught Wall Street by surprise. The company expects just $8 billion in sales from the pair next year, down from a whopping $56.7 billion in 2022.
The long-awaited Seagen merger is on
This May, Pfizer offered to buy Seagen (NASDAQ: SGEN), a successful cancer drug developer, for $43 billion in cash. On Tuesday, Dec. 12, Pfizer announced that it had received regulatory approval to complete the acquisition, and it expects to wrap things up on Thursday, Dec. 14.
Seagen's drugs are made from antibodies that target tumor cells and unleash lethal chemotherapy payloads only after they reach their target. Padcev, a bladder cancer treatment that earned its first approval from the U.S. Food and Drug Administration (FDA) in 2019, is quickly becoming a top seller. Third-quarter Padcev sales jumped 89% year over year to $200 million.
Padcev's sales jump is the result of a recent label expansion to treat newly diagnosed bladder cancer patients, in combination with Keytruda from Merck. Currently, patients must be ineligible for treatment with standard chemotherapy to receive Padcev plus Keytruda.
Image source: Getty Images.
In September, Seagen announced success in a trial with chemo-eligible patients that will most likely result in Padcev plus Keytruda becoming the first chemo-free treatment option for new bladder cancer patients, regardless of their chemotherapy eligibility. We should find out on or before the FDA's proposed action date scheduled for May 9, 2024.
Seagen's therapies are expected to contribute $3.1 billion in sales for Pfizer next year. With a first-line label expansion, though, Padcev sales alone could exceed this figure in 2025. Five years from now, I expect annual contributions from Seagen to equal roughly one-fifth of its purchase price. That's not a bad deal.
Is Pfizer a buy, sell, or hold now?
There aren't many companies with a global salesforce that can make the most of a merger with Seagen. Even fewer can scrape together $43 billion in cash to make it happen. Assuming the FDA expands Padcev plus Keytruda's approved indications to include all first-line bladder cancer patients, the deal should work out well for investors over the long run.
Moreover, Pfizer doesn't necessarily need to merge with Seagen to achieve growth. It has several growth drivers right now, including Vyndaqel, a rare disease drug with sales that jumped 47% year over year to an annualized $3.6 billion in the third quarter.
Soaring COVID-related sales caused Pfizer stock to rise too far ahead of itself in 2022. After its recent drop, though, it's been trading at a very reasonable valuation. At recent prices, the stock is trading for just 12.2 times the midpoint of management's adjusted earnings guidance range for next year.
Selling Pfizer following its recent beating looks like the wrong move. Holding shares already in your portfolio and averaging down by buying some more on the dip is probably the right move. Significant earnings growth on the back of Vyndaqel and Padcev should keep its bottom line moving in the right direction for the foreseeable future. Plus, the stock offers a 6.3% dividend yield that you get to keep even if its price unexpectedly tanks.
Should you invest $1,000 in Pfizer right now?
Before you buy stock in Pfizer, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Pfizer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of the S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Merck and Pfizer. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Pfizer's stock price fell sharply on Wednesday, Dec. 13, after management issued guidance for 2024 that wasn't nearly as good as Wall Street expected. Padcev's sales jump is the result of a recent label expansion to treat newly diagnosed bladder cancer patients, in combination with Keytruda from Merck. Assuming the FDA expands Padcev plus Keytruda's approved indications to include all first-line bladder cancer patients, the deal should work out well for investors over the long run.
|
The average analyst who follows Pfizer was expecting the company to predict $63.2 billion in annual revenue and $3.16 in earnings per share. The long-awaited Seagen merger is on This May, Pfizer offered to buy Seagen (NASDAQ: SGEN), a successful cancer drug developer, for $43 billion in cash. Assuming the FDA expands Padcev plus Keytruda's approved indications to include all first-line bladder cancer patients, the deal should work out well for investors over the long run.
|
Why Pfizer stock fell Pfizer stock fell about 8% when the market opened on Dec. 13 in a knee-jerk reaction to forward-looking estimates that didn't align with Wall Street's predictions. Seagen's therapies are expected to contribute $3.1 billion in sales for Pfizer next year. Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Pfizer wasn't one of them.
|
The average analyst who follows Pfizer was expecting the company to predict $63.2 billion in annual revenue and $3.16 in earnings per share. Assuming the FDA expands Padcev plus Keytruda's approved indications to include all first-line bladder cancer patients, the deal should work out well for investors over the long run. Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Pfizer wasn't one of them.
|
b7a4009e-7db9-402d-9bdc-023bc0b81dc0
|
713615.0
|
2023-12-11 00:00:00 UTC
|
BP Claws Back $41M From Ex-CEO Amid Misconduct Allegations
|
DCOMP
|
https://www.nasdaq.com/articles/bp-claws-back-%2441m-from-ex-ceo-amid-misconduct-allegations
|
nan
|
nan
|
BP plc BP announced on Wednesday that it will claw back up to $41 million from its former chief executive Bernard Looney, following allegations of serious misconduct related to past relationship with colleagues. This decision came in the wake of Looney's abrupt resignation in September, prompting the energy giant to thoroughly review the circumstances surrounding his departure.
According to a statement released by BP, the total maximum value of the potential remuneration that has been forfeited or clawed back is a staggering £32,426,000 (approximately $41 million), including the maximum potential value of his salary, pension payments, deferred bonuses and other compensations, which he might have received before taxes. This sum was based on estimates of share prices, subject to changes dependent on the company's performance.
BP contends that Looney provided the company with "inaccurate and incomplete" information dating back to July 2022, accusing him of knowingly misleading the board. The company deems this behavior as serious misconduct, causing the board to dismiss Looney without notice, effective Dec 13.
In light of this decision, Looney will not receive any further salary or benefits from the dismissal date; he will also be denied an annual bonus for fiscal 2023. He will also need to repay 50% of the cash portion of the annual bonus paid for fiscal 2022.
The company is now tasked with the challenge of finding a suitable replacement for the vacant CEO position.
Zacks Rank & Key Picks
BP currently carries a Zack Rank #3 (Hold).
Some better-ranked stocks in the energy sector are The Williams Companies, Inc. WMB, Matador Resources Company MTDR and Liberty Energy Inc. LBRT. While Williams Companies sports a Zacks Rank #1 (Strong Buy), both Matador Resources and Liberty Energy carry a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Williams Companies is well-positioned to capitalize on the anticipated substantial long-term growth in U.S. natural gas demand, thanks to its impressive portfolio of large-scale projects that create significant value. The company’s debt maturity profile is in good shape with its $4.5 billion revolver maturing in fiscal 2023.
WMB’s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 13.68%.
Matador Resources is among the leading oil and gas explorers in the shale and unconventional resources in the United States. The company’s prime intention is to create more value for shareholders and generate lucrative returns from the capital invested in unconventional plays.
MTDR’s earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 13.89%.
Liberty Energy is a North American provider of hydraulic fracturing services to upstream energy operators. The company’s multi-basin presence offers an attractive upside opportunity compared with most of its peers. Its strong relationship with high-quality customers provides revenue visibility and business certainty.
LBRT’s earnings beat estimates in three of the trailing four quarters and missed once, delivering an average surprise of 9.88%.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Williams Companies, Inc. (The) (WMB) : Free Stock Analysis Report
BP p.l.c. (BP) : Free Stock Analysis Report
Matador Resources Company (MTDR) : Free Stock Analysis Report
Liberty Energy Inc. (LBRT) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
BP contends that Looney provided the company with "inaccurate and incomplete" information dating back to July 2022, accusing him of knowingly misleading the board. The Williams Companies is well-positioned to capitalize on the anticipated substantial long-term growth in U.S. natural gas demand, thanks to its impressive portfolio of large-scale projects that create significant value. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
While Williams Companies sports a Zacks Rank #1 (Strong Buy), both Matador Resources and Liberty Energy carry a Zacks Rank #2 (Buy) at present. Click to get this free report Williams Companies, Inc. (The) (WMB) : Free Stock Analysis Report BP p.l.c. (BP) : Free Stock Analysis Report Matador Resources Company (MTDR) : Free Stock Analysis Report Liberty Energy Inc. (LBRT) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Some better-ranked stocks in the energy sector are The Williams Companies, Inc. WMB, Matador Resources Company MTDR and Liberty Energy Inc. LBRT. While Williams Companies sports a Zacks Rank #1 (Strong Buy), both Matador Resources and Liberty Energy carry a Zacks Rank #2 (Buy) at present. (BP) : Free Stock Analysis Report Matador Resources Company (MTDR) : Free Stock Analysis Report Liberty Energy Inc. (LBRT) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
In light of this decision, Looney will not receive any further salary or benefits from the dismissal date; he will also be denied an annual bonus for fiscal 2023. Some better-ranked stocks in the energy sector are The Williams Companies, Inc. WMB, Matador Resources Company MTDR and Liberty Energy Inc. LBRT. While Williams Companies sports a Zacks Rank #1 (Strong Buy), both Matador Resources and Liberty Energy carry a Zacks Rank #2 (Buy) at present.
|
845c1f95-356e-4387-bdcd-046f2681b5c5
|
713616.0
|
2023-12-11 00:00:00 UTC
|
RTX Secures a Contract to Support Rolling Airframe Missile
|
DCOMP
|
https://www.nasdaq.com/articles/rtx-secures-a-contract-to-support-rolling-airframe-missile
|
nan
|
nan
|
RTX Corp. RTX recently clinched a modification contract involving the Rolling Airframe Missile (RAM). The award has been offered by the Naval Sea Systems Command, Washington, D.C.
Details of the Deal
Valued at $34.3 million, the contract is projected to be completed by March 2028. This latest modification includes options to provide design agent and engineering support services for the Rolling Airframe Missile.
Work related to this contract will be executed in Tucson, AZ.
How Will the Deal Favor RTX?
Increasing geopolitical tensions worldwide have prompted nations to strengthen their defense systems manifold. With rapid technological upgrades, missile defense has steadily become pivotal in a nation’s defense strategy. With the United States being the world’s largest weapon supplier and RTX a prominent U.S. missile maker, the increased missile defense adoption by nations provides the company with solid growth opportunities.
RTX’s RAM guided missile weapon system is the world's most modern ship self-defense weapon and is designed to provide exceptional protection for ships of all sizes. RAM is currently deployed on more than 165 ships in 11 countries, ranging from 500-ton fast-attack crafts to 95,000-ton aircraft carriers.
Further, RAM’s latest version, the Block 2 variant, has a larger rocket motor, an advanced control section and an enhanced RF receiver capable of detecting the quietest of threat emitters. These improvements have made RAM two and a half times more maneuverable, with one and a half times the effective intercept range.
As far as this program’s latest development is concerned, licensed production of the RAM system's guided missile round pack is currently underway in Korea. In 2018, RTX delivered a RAM launcher to the Mexican Navy as part of the long-range, off-shore patrol vessel program. It was the first delivery of a RAM product to a Latin American country.
The aforementioned discussion reflects the solid demand that RTX’s RAM enjoys in the missile defense space. The latest contract win is a further testament to that and is expected to bolster RTX’s revenues in the coming quarters.
Growth Prospects
Per a report by the Markets and Markets firm, the global rocket and missile market is projected to witness a CAGR of 6.1% during the 2023-2028 period to reach $77.4 million by 2028. Such massive growth projections indicate solid opportunities for RTX and other major defense primes like Northrop Grumman NOC, Lockheed Martin LMT and Boeing BA, which specialize in developing technologically advanced missiles.
Northrop Grumman’s missile defense program includes AGM-88E advanced anti-radiation guided missiles, the Ground Based Strategic Deterrent weapon system and rocket propulsion systems. In August 2022, the company had been chosen by the U.S. Missile Defense Agency to lead the Homeland Missile Defense Program.
Northrop currently boasts a long-term earnings growth rate of 2.4%. The Zacks Consensus Estimate for NOC’s 2023 sales implies an improvement of 6.6% from the 2022 reported figure.
Lockheed Martin’s missile defense program includes the Patriot Advanced Capability-3 (PAC-3) and Terminal High-Altitude Area Defense air and missile defense programs. It also manufactures the Multiple Launch Rocket System, the Joint Air-to-Surface Standoff Missile and Javelin tactical missile programs alongside other tactical missiles.
Lockheed has a long-term earnings growth rate of 8.6%. The stock has gained 6% in the past three months.
Likewise, Boeing-built and supported air and missile defense systems have protected the nation, warfighters, allies and international partners against threats ranging from intercontinental ballistic missiles to hostile aircraft for almost 25 years. Its missile and missile portfolio includes Aegis Ballistic Missile Defense, Avenger, Ground-Based Midcourse Defense and PAC-3 Missile Seeker.
The Zacks Consensus Estimate for Boeing’s 2023 sales implies an improvement of 15.4% from the 2022 reported figure. The stock has a long-term earnings growth rate of 4%.
Price Performance
In the past three months, RTX’s shares have rallied 10.2% compared with the industry’s 6.4% growth.
Image Source: Zacks Investment Research
Zacks Rank
RTX currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The Boeing Company (BA) : Free Stock Analysis Report
Lockheed Martin Corporation (LMT) : Free Stock Analysis Report
Northrop Grumman Corporation (NOC) : Free Stock Analysis Report
RTX Corporation (RTX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Further, RAM’s latest version, the Block 2 variant, has a larger rocket motor, an advanced control section and an enhanced RF receiver capable of detecting the quietest of threat emitters. Such massive growth projections indicate solid opportunities for RTX and other major defense primes like Northrop Grumman NOC, Lockheed Martin LMT and Boeing BA, which specialize in developing technologically advanced missiles. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Such massive growth projections indicate solid opportunities for RTX and other major defense primes like Northrop Grumman NOC, Lockheed Martin LMT and Boeing BA, which specialize in developing technologically advanced missiles. Northrop Grumman’s missile defense program includes AGM-88E advanced anti-radiation guided missiles, the Ground Based Strategic Deterrent weapon system and rocket propulsion systems. Click to get this free report The Boeing Company (BA) : Free Stock Analysis Report Lockheed Martin Corporation (LMT) : Free Stock Analysis Report Northrop Grumman Corporation (NOC) : Free Stock Analysis Report RTX Corporation (RTX) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Lockheed Martin’s missile defense program includes the Patriot Advanced Capability-3 (PAC-3) and Terminal High-Altitude Area Defense air and missile defense programs. Its missile and missile portfolio includes Aegis Ballistic Missile Defense, Avenger, Ground-Based Midcourse Defense and PAC-3 Missile Seeker. Click to get this free report The Boeing Company (BA) : Free Stock Analysis Report Lockheed Martin Corporation (LMT) : Free Stock Analysis Report Northrop Grumman Corporation (NOC) : Free Stock Analysis Report RTX Corporation (RTX) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Details of the Deal Valued at $34.3 million, the contract is projected to be completed by March 2028. The stock has gained 6% in the past three months. Image Source: Zacks Investment Research Zacks Rank RTX currently carries a Zacks Rank #3 (Hold).
|
3d6bb5b7-586e-4286-b7b6-10eb6206f77f
|
713617.0
|
2023-12-11 00:00:00 UTC
|
Lockheed (LMT) Wins $175M Contract to Aid F-35 Fighter Aircraft
|
DCOMP
|
https://www.nasdaq.com/articles/lockheed-lmt-wins-%24175m-contract-to-aid-f-35-fighter-aircraft
|
nan
|
nan
|
Lockheed Martin Corp.’s LMT Aeronautics business division recently clinched a modification contract involving its F-35 fighter jets. The award has been offered by the Naval Air Systems Command, Patuxent River, MD.
Details of the Deal
Valued at $174.6 million, the contract is projected to be completed by February 2028. Per the terms of the deal, Lockheed will procure helmet-mounted display requirements from the 17th lot to support the F-35 Joint Strike Fighter aircraft program.
The contract will cater to the U.S. Air Force, Marine Corps, Navy, F-35 Cooperative Program Partners, and Foreign Military Sales customers. Work related to this deal will be executed in Fort Worth, TX.
Importance of F-35 for LMT
Lockheed enjoys a dominant position in the global military aircraft space with its F-35 fleet. The stealth aircraft boasts features that make it an ideal choice for many nations. The company’s constant efforts to modernize and upgrade the aircraft using advanced technologies to meet current warfare needs boost demand significantly.
The F-35 program remained the largest revenue generator for the Aeronautics business unit. It also accounted for 66% of the segment’s net sales in 2022.
Lockheed has delivered 974 F-35 airplanes since the program's inception, with 391 jets in the backlog as of Sep 24, 2023. This, along with the latest contract win, boosts sales expectations for the segment.
Looking ahead, LMT expects to deliver 97 F-35 jets in 2023 and 147-153 aircraft in 2024. The jet deliveries for 2025 and beyond are still estimated to be 156. Successful delivery of the F-35 jets in due time, as expected by the company, should significantly bolster its revenues in the coming quarters.
Growth Prospects
Amid the widespread geopolitical tensions prevalent across the globe, nations are rapidly augmenting their defense purchase to strengthen their warfare capabilities. This has led to an increased demand for fighter jets, which form an integral part of a country’s defense products.
Looking ahead, per a report by the Mordor Intelligence firm, the global military aviation market is expected to witness a CAGR of 7.37% during 2023-2028. Such projections indicate immense opportunities for Lockheed to reap the benefits of military aviation market expansion, with its Aeronautics business segment engaged in the research, design, development, manufacture, integration, sustainment, support and upgrade of advanced military aircraft.
Notably, Aeronautics’ major programs include C-130 Hercules international tactical airlifter; F-16 Fighting Falcon jet; and the F-22 Raptor stealth fighter aircraft, in addition to F-35 jets.
Peer Opportunities
Some other prominent defense majors involved in the manufacturing of military aircraft that are expected to gain from the military aviation market’s growth opportunities are Northrop Grumman NOC, Airbus Group EADSY and Textron TXT.
Since its inception, Northrop Grumman has been a pioneer in the development of manned aircraft. From fighter jets and stealth bombers to surveillance and electronic warfare, it has been providing manned solutions to customers worldwide. The company has built some of the world’s most advanced aircraft, ranging from the innovative B-2 Spirit stealth bomber to the game-changing E-2D Advanced Hawkeye.
NOC’s Aeronautics Systems unit is engaged in the design, development, production, integration, sustainment and modernization of advanced aircraft systems. Meanwhile, the Mission Systems segment offers advanced mission solutions and multifunction systems like Airborne Early Warning & Control, the LONGBOW Fire Control Radar and the Scalable Agile Beam Radar.
Airbus Group’s military aircraft consists of the A400M, the C295 tactical transporter, the new-generation A330 Multi Role Tanker Transport and the Eurofighter, the most advanced swing-role fighter ever conceived.
The company has been providing its aircraft customers with an extended portfolio of services for more than 40 years, ranging from the training of flight and ground staff to live firing exercises anywhere worldwide.
Textron’s military aircraft includes the Beechcraft T-6 training aircraft and the Beechcraft AT-6 light-attack aircraft. The company also manufactures the Beechcraft Model 18 light bomber, the T-44 and T-34 training aircraft, and the T-1A jet trainer.
TXT’s subsidiary, Able Aerospace Services, provides component and maintenance, repair and overhaul services in support of commercial and military fixed and rotor-wing aircraft.
Price Movement
Shares of Lockheed have lost 7% in the past 12 months compared with the industry’s 9.5% decline.
Image Source: Zacks Investment Research
Zacks Rank
Lockheed currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Lockheed Martin Corporation (LMT) : Free Stock Analysis Report
Northrop Grumman Corporation (NOC) : Free Stock Analysis Report
Textron Inc. (TXT) : Free Stock Analysis Report
Airbus Group (EADSY) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Growth Prospects Amid the widespread geopolitical tensions prevalent across the globe, nations are rapidly augmenting their defense purchase to strengthen their warfare capabilities. The company has been providing its aircraft customers with an extended portfolio of services for more than 40 years, ranging from the training of flight and ground staff to live firing exercises anywhere worldwide. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Such projections indicate immense opportunities for Lockheed to reap the benefits of military aviation market expansion, with its Aeronautics business segment engaged in the research, design, development, manufacture, integration, sustainment, support and upgrade of advanced military aircraft. Peer Opportunities Some other prominent defense majors involved in the manufacturing of military aircraft that are expected to gain from the military aviation market’s growth opportunities are Northrop Grumman NOC, Airbus Group EADSY and Textron TXT. Click to get this free report Lockheed Martin Corporation (LMT) : Free Stock Analysis Report Northrop Grumman Corporation (NOC) : Free Stock Analysis Report Textron Inc. (TXT) : Free Stock Analysis Report Airbus Group (EADSY) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Such projections indicate immense opportunities for Lockheed to reap the benefits of military aviation market expansion, with its Aeronautics business segment engaged in the research, design, development, manufacture, integration, sustainment, support and upgrade of advanced military aircraft. Textron’s military aircraft includes the Beechcraft T-6 training aircraft and the Beechcraft AT-6 light-attack aircraft. Click to get this free report Lockheed Martin Corporation (LMT) : Free Stock Analysis Report Northrop Grumman Corporation (NOC) : Free Stock Analysis Report Textron Inc. (TXT) : Free Stock Analysis Report Airbus Group (EADSY) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Looking ahead, LMT expects to deliver 97 F-35 jets in 2023 and 147-153 aircraft in 2024. Peer Opportunities Some other prominent defense majors involved in the manufacturing of military aircraft that are expected to gain from the military aviation market’s growth opportunities are Northrop Grumman NOC, Airbus Group EADSY and Textron TXT. NOC’s Aeronautics Systems unit is engaged in the design, development, production, integration, sustainment and modernization of advanced aircraft systems.
|
50d0b306-3721-4925-8425-c0bce2535962
|
713618.0
|
2023-12-11 00:00:00 UTC
|
What ASML, Nvidia, and TSMC Stock Investors Should Know About Recent Semiconductor Updates
|
DCOMP
|
https://www.nasdaq.com/articles/what-asml-nvidia-and-tsmc-stock-investors-should-know-about-recent-semiconductor-updates
|
nan
|
nan
|
In today's video, I discuss recent semiconductor updates impacting ASML (NASDAQ: ASML), Nvidia (NASDAQ: NVDA), and Taiwan Semiconductor Manufacturing (NYSE: TSM). Check out the short video to learn more, consider subscribing, and click the special offer link below.
*Stock prices used were the market prices of Dec. 13, 2023. The video was published on Dec. 13, 2023.
Should you invest $1,000 in ASML right now?
Before you buy stock in ASML, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and ASML wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Jose Najarro has positions in Applied Materials, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool has positions in and recommends ASML, Applied Materials, Lam Research, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool has a disclosure policy. Jose Najarro is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Check out the short video to learn more, consider subscribing, and click the special offer link below. The Motley Fool has positions in and recommends ASML, Applied Materials, Lam Research, Nvidia, and Taiwan Semiconductor Manufacturing. Jose Najarro is an affiliate of The Motley Fool and may be compensated for promoting its services.
|
In today's video, I discuss recent semiconductor updates impacting ASML (NASDAQ: ASML), Nvidia (NASDAQ: NVDA), and Taiwan Semiconductor Manufacturing (NYSE: TSM). See the 10 stocks *Stock Advisor returns as of December 11, 2023 Jose Najarro has positions in Applied Materials, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool has positions in and recommends ASML, Applied Materials, Lam Research, Nvidia, and Taiwan Semiconductor Manufacturing.
|
In today's video, I discuss recent semiconductor updates impacting ASML (NASDAQ: ASML), Nvidia (NASDAQ: NVDA), and Taiwan Semiconductor Manufacturing (NYSE: TSM). Before you buy stock in ASML, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and ASML wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Jose Najarro has positions in Applied Materials, Nvidia, and Taiwan Semiconductor Manufacturing.
|
Before you buy stock in ASML, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and ASML wasn't one of them. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Jose Najarro has positions in Applied Materials, Nvidia, and Taiwan Semiconductor Manufacturing.
|
af5d7f8a-fcbe-4b3d-88c4-5e5e53d03557
|
713619.0
|
2023-12-11 00:00:00 UTC
|
Elon Musk and SEC to face off in court over Twitter testimony
|
DCOMP
|
https://www.nasdaq.com/articles/elon-musk-and-sec-to-face-off-in-court-over-twitter-testimony
|
nan
|
nan
|
By Chris Prentice
Dec 14 (Reuters) - The U.S. Securities and Exchange Commission will face off with lawyers for Elon Musk in a San Francisco court on Thursday as it tries to force the billionaire to testify again for its probe of his $44 billion takeover of Twitter.
The SEC sued Musk in October to compel him to testify as part of an investigation into his 2022 purchase of social media giant Twitter, which he subsequently renamed X. Musk refused to attend a September interview for the probe, the SEC said.
The agency is examining whether Musk, the world's richest person, followed the law when filing the required paperwork with the agency about his purchases in Twitter stock, and whether his statements in relation to the deal were misleading.
The court hearing is the latest spat in a years-long feud between Musk and the top U.S. markets regulator, dating back to 2018 when he tweeted that he had "funding secured" to take the electric carmaker private.
The SEC has been probing Musk's Twitter takeover since April 2022, when he first disclosed he had purchased stock in the company. Musk gave the SEC documents for its probe and testified via videoconference for two half-day sessions that July, the SEC said in its filing. SEC attorneys said they have more questions for Musk after receiving new documents, and had sought additional testimony in September, but Musk would not comply.
In response to the SEC's October lawsuit, Musk's lawyers urged U.S. Magistrate Judge Laurel Beeler to deny the SEC's request, calling the probe misguided. "The SEC's pursuit of Mr. Musk has crossed the line into harassment," they wrote in a filing last month. They argued that individual SEC attorneys do not have the legal authority to issue subpoenas for testimony.
The SEC rejected those claims, saying agency officials have legal authority to seek additional testimony as probes evolve.
On Thursday, the judge is expected to hear arguments from both sides in a hearing scheduled for 9:30 a.m. PST (1730 GMT). The SEC will need to show that the probe falls within its authority, that it has followed procedural requirements, and that the evidence it is seeking is relevant and material.
Legal experts have said they think the judge is likely to side with the SEC, although she could impose some conditions.
TWITTER TAKEOVER
Musk and the SEC have been sparring since his "funding secured" tweet in 2018. The SEC settled that case but the commission sued Musk again in 2019 for allegedly breaching a that settlement. The tweets also prompted a shareholder lawsuit. A jury in February found Musk was not liable for misleading investors.
Over the years, the agency has opened multiple other probes into Musk and Tesla.
On April 4, 2022, Musk disclosed he had acquired a 9.2% stake in Twitter. It was 11 days after the SEC's deadline for such disclosures. Musk initially indicated via that regulatory filing that he planned to be a passive stakeholder, meaning he did not plan to take over the company.
Later that month, however, he announced plans to buy Twitter for $44 billion. He subsequently tried to get out of the deal, alleging Twitter was not disclosing the full extent of bot activity on its platform.
After being sued to complete the deal, Musk closed his acquisition of Twitter in late October 2022.
(Reporting by Chris Prentice; Additional reporting by Jody Godoy in New York; Editing by Michelle Price and David Gregorio)
((christine.prentice@thomsonreuters.com; +1 (202) 843-6464;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By Chris Prentice Dec 14 (Reuters) - The U.S. Securities and Exchange Commission will face off with lawyers for Elon Musk in a San Francisco court on Thursday as it tries to force the billionaire to testify again for its probe of his $44 billion takeover of Twitter. The court hearing is the latest spat in a years-long feud between Musk and the top U.S. markets regulator, dating back to 2018 when he tweeted that he had "funding secured" to take the electric carmaker private. The SEC rejected those claims, saying agency officials have legal authority to seek additional testimony as probes evolve.
|
The SEC has been probing Musk's Twitter takeover since April 2022, when he first disclosed he had purchased stock in the company. In response to the SEC's October lawsuit, Musk's lawyers urged U.S. Magistrate Judge Laurel Beeler to deny the SEC's request, calling the probe misguided. The SEC rejected those claims, saying agency officials have legal authority to seek additional testimony as probes evolve.
|
The SEC sued Musk in October to compel him to testify as part of an investigation into his 2022 purchase of social media giant Twitter, which he subsequently renamed X. Musk refused to attend a September interview for the probe, the SEC said. Musk gave the SEC documents for its probe and testified via videoconference for two half-day sessions that July, the SEC said in its filing. In response to the SEC's October lawsuit, Musk's lawyers urged U.S. Magistrate Judge Laurel Beeler to deny the SEC's request, calling the probe misguided.
|
The SEC has been probing Musk's Twitter takeover since April 2022, when he first disclosed he had purchased stock in the company. The SEC rejected those claims, saying agency officials have legal authority to seek additional testimony as probes evolve. He subsequently tried to get out of the deal, alleging Twitter was not disclosing the full extent of bot activity on its platform.
|
027cc150-12d7-40a1-b799-5c4f07e4bbee
|
713620.0
|
2023-12-11 00:00:00 UTC
|
From Outcast to Outperformer: Finish 2023 in Style With Intel Stock
|
DCOMP
|
https://www.nasdaq.com/articles/from-outcast-to-outperformer%3A-finish-2023-in-style-with-intel-stock
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
It’s amazing to witness a the resurgence of interest in Intel (NASDAQ:INTC) in late 2023. Earlier this year, INTC stock hit rock bottom as financial traders mocked Intel. They relentlessly talked about Advanced Micro Devices (NASDAQ:AMD) eating Intel’s lunch. But now, Intel’s loyal investors are having the last laugh, and in 2024 I expect that they’ll be laughing all the way to the bank.
It’s not too late to buy Intel stock this year if you don’t already have a position. After all, Intel’s turnaround tale is still in its beginning stages. There’s plenty of room to run, both in December and in the coming year, as Intel potentially goes from most hated to most celebrated.
AI PC Market Growth Could Power an INTC Stock Rally
Besides Advanced Micro Devices taking market share from the company, another problem for Intel this year was the persistently soft demand for personal computers. However, the prospects of a revival look surprisingly good as AI-embedded PCs could bring the PC market back to life in 2024.
The outlook seems fairly positive now, as Intel Chief Commercial Officer Christoph Schell envisions a “significant” refresh opportunity with AI-capable PCs. Investors should be patient, though. As Schell clarifies, he doesn’t anticipate moonshot growth.
“I also know this is a question where a lot of people hope for a hockey stick,” he said. “I don’t think it will be a hockey stick. I think it will take a little bit of time for people to actually understand the use cases.”
It still makes sense to invest today in anticipation of AI PC industry acceleration next year, however. Schell predicts that growth in this field could occur later in 2024.
“If we meet a year from now, the amount of [request-for-quotes] that we would have seen, particularly the second half of next calendar year, in the client commercial space that will have [requested] AI features will be a significant number. That’s my bet,” he said.
It’s a bold bet to make, but if it turns out to be true, then get ready for INTC stock to head higher. I actually wouldn’t rule out the “hockey stick” scenario, even if Schell doesn’t want people to assume it will happen.
What Would Happen if Nvidia Announces a Deal With Intel?
One aspect of Intel’s business model that could generate substantial revenue for the company is its foundry (i.e., microchip manufacturing) division.
As Barron’s pointed out, “Intel announced plans to separate its manufacturing from its design business, with each group getting its own accounting.”
Having a separate, dedicated chip-manufacturing unit could make Intel an attractive target for mutually beneficial collaborations. Indeed, earlier this year, Nvidia (NASDAQ:NVDA) CEO Jensen Huang stated outright that Nvidia was “open to manufacturing with Intel.”
This collaboration hasn’t actually happened yet, but it could be in the works soon. Recently, Nvidia Chief Financial Officer Colette Kress teased the possibility of adding “potentially adding another foundry” company as a partner.
Kress didn’t mention Intel by name in that quote. Still, given Huang’s aforementioned quote, it’s easy to imagine Nvidia announcing a strategic partnership with Intel in the coming months.
This would be a win-win for both companies, but of course, the greater beneficiary would be Intel. Nvidia is the golden child of 2023, and anything it touches will also turn to gold. In that context, just consider how high INTC stock would run if an Nvidia-Intel were to be announced.
Intel Stock’s Upcoming Rally: Are You Ready for It?
Intel stock jumped in November, but the tale of December is still being written. There’s no way to predict what will happen in the coming year.
The coming months could be very exciting, however, if you’re invested in Intel. Soon enough, the days of commentators mocking Intel could be nothing more than a distant memory.
So, what will drive INTC stock higher in 2024? Will it be an AI-powered revival of the PC market? Or, will it be a partnership between Intel and Nvidia? Maybe it will be all of the above. Therefore, I invite you to consider taking a share position in Intel before it goes into “hockey stick” mode.
On the date of publication, David Moadel did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
David Moadel has provided compelling content – and crossed the occasional line – on behalf of Motley Fool, Crush the Street, Market Realist, TalkMarkets, TipRanks, Benzinga, and (of course) InvestorPlace.com. He also serves as the chief analyst and market researcher for Portfolio Wealth Global and hosts the popular financial YouTube channel Looking at the Markets.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post From Outcast to Outperformer: Finish 2023 in Style With Intel Stock appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The outlook seems fairly positive now, as Intel Chief Commercial Officer Christoph Schell envisions a “significant” refresh opportunity with AI-capable PCs. I think it will take a little bit of time for people to actually understand the use cases.” It still makes sense to invest today in anticipation of AI PC industry acceleration next year, however. David Moadel has provided compelling content – and crossed the occasional line – on behalf of Motley Fool, Crush the Street, Market Realist, TalkMarkets, TipRanks, Benzinga, and (of course) InvestorPlace.com.
|
AI PC Market Growth Could Power an INTC Stock Rally Besides Advanced Micro Devices taking market share from the company, another problem for Intel this year was the persistently soft demand for personal computers. The outlook seems fairly positive now, as Intel Chief Commercial Officer Christoph Schell envisions a “significant” refresh opportunity with AI-capable PCs. Recently, Nvidia Chief Financial Officer Colette Kress teased the possibility of adding “potentially adding another foundry” company as a partner.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s amazing to witness a the resurgence of interest in Intel (NASDAQ:INTC) in late 2023. AI PC Market Growth Could Power an INTC Stock Rally Besides Advanced Micro Devices taking market share from the company, another problem for Intel this year was the persistently soft demand for personal computers. As Barron’s pointed out, “Intel announced plans to separate its manufacturing from its design business, with each group getting its own accounting.” Having a separate, dedicated chip-manufacturing unit could make Intel an attractive target for mutually beneficial collaborations.
|
AI PC Market Growth Could Power an INTC Stock Rally Besides Advanced Micro Devices taking market share from the company, another problem for Intel this year was the persistently soft demand for personal computers. It’s a bold bet to make, but if it turns out to be true, then get ready for INTC stock to head higher. There’s no way to predict what will happen in the coming year.
|
7067b370-6f2f-46bf-970b-450b9afb553c
|
713621.0
|
2023-12-11 00:00:00 UTC
|
Atlassian (TEAM) Soars 6.5%: Is Further Upside Left in the Stock?
|
DCOMP
|
https://www.nasdaq.com/articles/atlassian-team-soars-6.5%3A-is-further-upside-left-in-the-stock
|
nan
|
nan
|
Atlassian TEAM shares rallied 6.5% in the last trading session to close at $215.14. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 8.5% gain over the past four weeks.
The upswing came after the U.S. Federal Reserve kept benchmark interest rates unchanged for the third consecutive time due to easing inflation. Furthermore, the central bank hinted a dovish stance and expect three rate cuts in 2024. A decline in interest rates would boost IT spending, thereby increasing demand for Atlassian’s solutions.
This company is expected to post quarterly earnings of $0.61 per share in its upcoming report, which represents a year-over-year change of +35.6%. Revenues are expected to be $1.02 billion, up 16.8% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Atlassian, the consensus EPS estimate for the quarter has been revised 1.9% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on TEAM going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Atlassian belongs to the Zacks Internet - Software industry. Another stock from the same industry, Freshworks Inc. FRSH, closed the last trading session 4.5% higher at $22.19. Over the past month, FRSH has returned 15.9%.
Freshworks Inc.'s consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.05. Compared to the company's year-ago EPS, this represents a change of +400%. Freshworks Inc. currently boasts a Zacks Rank of #3 (Hold).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Atlassian Corporation PLC (TEAM) : Free Stock Analysis Report
Freshworks Inc. (FRSH) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The upswing came after the U.S. Federal Reserve kept benchmark interest rates unchanged for the third consecutive time due to easing inflation. This company is expected to post quarterly earnings of $0.61 per share in its upcoming report, which represents a year-over-year change of +35.6%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Freshworks Inc.'s consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.05. Click to get this free report Atlassian Corporation PLC (TEAM) : Free Stock Analysis Report Freshworks Inc. (FRSH) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Atlassian belongs to the Zacks Internet - Software industry. Click to get this free report Atlassian Corporation PLC (TEAM) : Free Stock Analysis Report Freshworks Inc. (FRSH) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
For Atlassian, the consensus EPS estimate for the quarter has been revised 1.9% higher over the last 30 days to the current level. Another stock from the same industry, Freshworks Inc. FRSH, closed the last trading session 4.5% higher at $22.19. Freshworks Inc.'s consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.05.
|
fe7f59e1-a23e-4fd2-a233-9f19a88642b7
|
713622.0
|
2023-12-11 00:00:00 UTC
|
If You Invested $15,000 in Aurora Cannabis in 2020, This Is How Much You Would Have Today
|
DCOMP
|
https://www.nasdaq.com/articles/if-you-invested-%2415000-in-aurora-cannabis-in-2020-this-is-how-much-you-would-have-today
|
nan
|
nan
|
Investing in Aurora Cannabis (NASDAQ: ACB) generally hasn't paid off for investors. But what if you waited until 2020, when the markets briefly crashed and valuations were incredibly low for many stocks? Would buying Aurora at the time have been a good move for investors? Here's a look at what it was trading at back then, and what an investment in the cannabis producer in March 2020 would be worth today.
How Aurora Cannabis stock has performed since March 2020
In March 2020, news of the coronavirus spreading sent the markets into a panic. Although the market plunge was short-lived, it temporarily sent stocks to lows that would allow opportunistic investors to cash in and and buy on the cheap.
Shares of Aurora Cannabis reached a low of $0.60 on March 18, 2020. If you invested $15,000 in the stock back then, you would have owned 25,000 shares of the cannabis company -- until its reverse split. Due to its low price and the need to maintain a share price of more than $1, Aurora consolidated its shares on a 1-for-12 basis a few months later. On May 11, those 25,000 shares would have been traded in for just 2,083 shares. Aurora's stock price, however, would go up as a result of the reverse split.
Today, the stock trades at around $0.48 per share. That means even though it consolidated shares, the stock price is still worth less than what it was back in March 2020. The value of those 2,083 shares today would be about $1,000, equaling a loss of 93%.
The company has been making progress
Although Aurora's stock has continued to fall in recent years, that doesn't mean the company hasn't been making progress in improving its financials. Next year, for instance, Aurora is expecting to achieve positive free cash flow. That's no small accomplishment for a cannabis business, where cash burn is typically the norm.
And in November, it posted an adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) profit for a fourth consecutive quarter. The company has diversified its operations by acquiring plant propagation business Bevo Farms, which now accounts for more than 11% of Aurora's net revenue, which totaled 63.4 million Canadian dollars ($50 million) for the period ended Sept. 30.
A poor industry outlook paired with Aurora's inconsistent revenue growth, particularly from its marijuana operations, are a couple of key reasons investors remain bearish on the stock today.
Data source: YCharts
Plus, poor macroeconomic conditions, including high interest rates, mean that investors have better and safer investment options to choose from (e.g., bonds). All that makes stocks, particularly risky ones like Aurora, less desirable.
If the market conditions were different, Aurora's stock could be performing better given its improved financials.
Is Aurora Cannabis stock a better buy today?
Aurora Cannabis hasn't been a good buy in recent years and it's hard to expect things will be better in the future. The company still faces plenty of competition in the marijuana industry, and while it financial results have improved, the lack of consistent growth is a problem. And without significant opportunities on the horizon, investors are better off pursuing safer growth stocks instead of Aurora.
Ultimately, there isn't a reason to be bullish on the stock right now. Without a compelling reason and a growth catalyst to suggest that it will be able to generate consistent revenue while also posting a strong bottom line, investors are better off steering clear of Aurora because even buying during a market crash hasn't proven to be a good strategy for investors.
Should you invest $1,000 in Aurora Cannabis right now?
Before you buy stock in Aurora Cannabis, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Aurora Cannabis wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
David Jagielski has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
And in November, it posted an adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) profit for a fourth consecutive quarter. A poor industry outlook paired with Aurora's inconsistent revenue growth, particularly from its marijuana operations, are a couple of key reasons investors remain bearish on the stock today. Data source: YCharts Plus, poor macroeconomic conditions, including high interest rates, mean that investors have better and safer investment options to choose from (e.g., bonds).
|
The company has been making progress Although Aurora's stock has continued to fall in recent years, that doesn't mean the company hasn't been making progress in improving its financials. Aurora Cannabis hasn't been a good buy in recent years and it's hard to expect things will be better in the future. Before you buy stock in Aurora Cannabis, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Aurora Cannabis wasn't one of them.
|
The company has been making progress Although Aurora's stock has continued to fall in recent years, that doesn't mean the company hasn't been making progress in improving its financials. Before you buy stock in Aurora Cannabis, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Aurora Cannabis wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 David Jagielski has no position in any of the stocks mentioned.
|
Shares of Aurora Cannabis reached a low of $0.60 on March 18, 2020. Is Aurora Cannabis stock a better buy today? Before you buy stock in Aurora Cannabis, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Aurora Cannabis wasn't one of them.
|
80f9f4d5-75fa-4c67-a206-842e004868ca
|
713623.0
|
2023-12-11 00:00:00 UTC
|
2 Stocks That Will Make You Richer in 2024
|
DCOMP
|
https://www.nasdaq.com/articles/2-stocks-that-will-make-you-richer-in-2024
|
nan
|
nan
|
There's no such thing as a surefire stock that can make you richer in 2024. However, a few stocks look set to have a strong 2024, making them excellent stocks to buy right now.
Two on my short list are Twilio (NYSE: TWLO) and MercadoLibre (NASDAQ: MELI), as both look like strong 2024 picks.
1. Twilio
Twilio has had a strong run in 2023, up around 40%. But that's just the start for this communications company.
Twilio's software is all about communicating with customers, and it offers products that make it easy to integrate text messaging systems, customize email marketing, and turn voice conversations into customer data. But this type of technology isn't in high demand when consumer sentiment dips and it's harder to attract customers.
This weighed on Twilio in 2023, and its revenue growth hasn't been spectacular. In Q3, revenue rose 5% to $1.03 billion and the company gave guidance of 1.5% growth in the fourth quarter. As a result of the slowing growth, Twilio has shed much of its workforce, going through three rounds of layoffs.
This is in an attempt to become more profitable, as Twilio has yet to turn a profit under generally accepted accounting principles (GAAP). But that sets the stage for what I think could be a great 2024.
Twilio has already achieved profitability when stock-based compensation (a noncash expense) is subtracted. With another round of layoffs plus revenue growth returning (Wall Street analysts project 7.4% growth in 2024), Twilio may be able to post its first round of true profits in history. All of this upside can be purchased for a dirt cheap 3.2 times sales.
TWLO PS Ratio data by YCharts
With many tech stocks trading for 10 to 20 times sales, Twilio's reasonable valuation is refreshing.
If consumer sentiment improves in 2024, Twilio's clients will be willing to spend more with them to capture an additional audience. Add in that it's nearing profitability and trading at a cheap valuation, and the stock looks poised for an excellent 2024.
2. MercadoLibre
MercadoLibre has often been characterized as the "Amazon of Latin America." But that's selling the company short. MercadoLibre is much more than that; it also has a consumer lending arm and a thriving fintech business, Mercado Pago.
This combines to create the dominant digital ecosystem in Latin America, and the company's growth backs up those claims.
In Q3, MercadoLibre's revenue rose a currency-neutral 69% to $3.76 billion, with commerce revenue up 76% to $2.13 billion and fintech revenue rising 61% to $1.63 billion. With growth coming from all sides of its business, MercadoLibre is in a great position.
Furthermore, its profit margins have steadily improved over the past few years.
MELI Profit Margin (Quarterly) data by YCharts
This growth has created an incredibly profitable business, and with Wall Street analysts projecting 23% revenue growth in 2024, its profits are set to explode higher.
You'll have to pay up to own MercadoLibre, as it trades for about 50 times 2024 earnings. However, MercadoLibre has consistently beaten expectations on both the top and bottom lines, so its forward PE is likely lower than that figure, making the stock cheaper than it appears
As a result, I think MercadoLibre is a stock that will make you richer not only in 2024, but also in the five years beyond it.
Should you invest $1,000 in Twilio right now?
Before you buy stock in Twilio, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Twilio wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Keithen Drury has positions in Amazon, MercadoLibre, and Twilio. The Motley Fool has positions in and recommends Amazon, MercadoLibre, and Twilio. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
But this type of technology isn't in high demand when consumer sentiment dips and it's harder to attract customers. TWLO PS Ratio data by YCharts With many tech stocks trading for 10 to 20 times sales, Twilio's reasonable valuation is refreshing. This combines to create the dominant digital ecosystem in Latin America, and the company's growth backs up those claims.
|
With another round of layoffs plus revenue growth returning (Wall Street analysts project 7.4% growth in 2024), Twilio may be able to post its first round of true profits in history. MELI Profit Margin (Quarterly) data by YCharts This growth has created an incredibly profitable business, and with Wall Street analysts projecting 23% revenue growth in 2024, its profits are set to explode higher. Before you buy stock in Twilio, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Twilio wasn't one of them.
|
MELI Profit Margin (Quarterly) data by YCharts This growth has created an incredibly profitable business, and with Wall Street analysts projecting 23% revenue growth in 2024, its profits are set to explode higher. However, MercadoLibre has consistently beaten expectations on both the top and bottom lines, so its forward PE is likely lower than that figure, making the stock cheaper than it appears As a result, I think MercadoLibre is a stock that will make you richer not only in 2024, but also in the five years beyond it. Before you buy stock in Twilio, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Twilio wasn't one of them.
|
However, a few stocks look set to have a strong 2024, making them excellent stocks to buy right now. With growth coming from all sides of its business, MercadoLibre is in a great position. MELI Profit Margin (Quarterly) data by YCharts This growth has created an incredibly profitable business, and with Wall Street analysts projecting 23% revenue growth in 2024, its profits are set to explode higher.
|
a647d72b-09ca-461a-9acb-d58ed81da6a6
|
713624.0
|
2023-12-11 00:00:00 UTC
|
EU asks Apple, Google to clarify app store risk management
|
DCOMP
|
https://www.nasdaq.com/articles/eu-asks-apple-google-to-clarify-app-store-risk-management
|
nan
|
nan
|
Adds more detail, background
PARIS, Dec 14 (Reuters) - The European Commission on Thursday said it had asked technology giants Apple AAPL.O and Google GOOGL.O to clarify their risk management regarding their online platforms for purchasing apps under new regulation known as the Digital Services Act (DSA).
"The Commission is requesting the providers of these services to provide more information on how they have diligently identified any systemic risks concerning the App Store and Google Play", the EU executive said in a statement.
The two firms were given a Jan. 15 deadline to reply.
They are part of a group of over a dozen of the world's biggest tech companies facing unprecedented legal scrutiny since the DSA came into force this year, including sweeping new obligations to tackle illegal content and online security risks.
The EU's list of questions also concerns transparency-related issues linked to recommender systems and online advertisements, the commission said, adding that potential next steps include the opening of formal proceedings.
(Reporting by Bart Meijer, Tassilo Hummel)
((tassilo.hummel@thomsonreuters.com ; Twitter handle: @tassilo_hummel;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Adds more detail, background PARIS, Dec 14 (Reuters) - The European Commission on Thursday said it had asked technology giants Apple AAPL.O and Google GOOGL.O to clarify their risk management regarding their online platforms for purchasing apps under new regulation known as the Digital Services Act (DSA). They are part of a group of over a dozen of the world's biggest tech companies facing unprecedented legal scrutiny since the DSA came into force this year, including sweeping new obligations to tackle illegal content and online security risks. The EU's list of questions also concerns transparency-related issues linked to recommender systems and online advertisements, the commission said, adding that potential next steps include the opening of formal proceedings.
|
Adds more detail, background PARIS, Dec 14 (Reuters) - The European Commission on Thursday said it had asked technology giants Apple AAPL.O and Google GOOGL.O to clarify their risk management regarding their online platforms for purchasing apps under new regulation known as the Digital Services Act (DSA). "The Commission is requesting the providers of these services to provide more information on how they have diligently identified any systemic risks concerning the App Store and Google Play", the EU executive said in a statement. The EU's list of questions also concerns transparency-related issues linked to recommender systems and online advertisements, the commission said, adding that potential next steps include the opening of formal proceedings.
|
Adds more detail, background PARIS, Dec 14 (Reuters) - The European Commission on Thursday said it had asked technology giants Apple AAPL.O and Google GOOGL.O to clarify their risk management regarding their online platforms for purchasing apps under new regulation known as the Digital Services Act (DSA). The two firms were given a Jan. 15 deadline to reply. (Reporting by Bart Meijer, Tassilo Hummel) ((tassilo.hummel@thomsonreuters.com ; Twitter handle: @tassilo_hummel;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Adds more detail, background PARIS, Dec 14 (Reuters) - The European Commission on Thursday said it had asked technology giants Apple AAPL.O and Google GOOGL.O to clarify their risk management regarding their online platforms for purchasing apps under new regulation known as the Digital Services Act (DSA). "The Commission is requesting the providers of these services to provide more information on how they have diligently identified any systemic risks concerning the App Store and Google Play", the EU executive said in a statement. The two firms were given a Jan. 15 deadline to reply.
|
fecf3617-e688-4066-8531-18937c69ac01
|
713625.0
|
2023-12-11 00:00:00 UTC
|
This Semiconductor Stock Is Benefiting From the Growth of Artificial Intelligence (AI) Chips
|
DCOMP
|
https://www.nasdaq.com/articles/this-semiconductor-stock-is-benefiting-from-the-growth-of-artificial-intelligence-ai-chips
|
nan
|
nan
|
In today's video, I discuss recent updates impacting Synopsys (NASDAQ: SNPS). Check out the short video to learn more, consider subscribing, and click the special offer link below.
*Stock prices used were the market prices of Dec. 13, 2023. The video was published on Dec. 13, 2023.
Should you invest $1,000 in Synopsys right now?
Before you buy stock in Synopsys, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Synopsys wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Jose Najarro has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Synopsys. The Motley Fool has a disclosure policy. Jose Najarro is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In today's video, I discuss recent updates impacting Synopsys (NASDAQ: SNPS). Check out the short video to learn more, consider subscribing, and click the special offer link below. If you choose to subscribe through their link they will earn some extra money that supports their channel.
|
Before you buy stock in Synopsys, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Synopsys wasn't one of them. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Jose Najarro has no position in any of the stocks mentioned.
|
Before you buy stock in Synopsys, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Synopsys wasn't one of them. Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Jose Najarro has no position in any of the stocks mentioned.
|
The Stock Advisor service has more than tripled the return of S&P 500 since 2002*. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Jose Najarro has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Synopsys.
|
116c97cb-45b8-4db5-8f26-dbf0c756e975
|
713626.0
|
2023-12-11 00:00:00 UTC
|
EXCLUSIVE-Guggenheim oil and gas bankers leave for Moelis after mega-deal miss -sources
|
DCOMP
|
https://www.nasdaq.com/articles/exclusive-guggenheim-oil-and-gas-bankers-leave-for-moelis-after-mega-deal-miss-sources
|
nan
|
nan
|
By David French
Dec 14 (Reuters) - Six U.S. oil and gas bankers who missed out on a wave of mega deals in the oil patch after leaving mergers and acquisitions powerhouse Citigroup C.N last year to join smaller firm Guggenheim Securities are now decamping to Moelis & Co MC.N, according to people familiar with the matter.
The merry-go-round underscores the restlessness of dealmakers who try to get hired on big, high-prestige deals while working for firms that let them keep more of the advisory fees they generate. Energy and power has been the most active sector for dealmaking this year, accounting for $460.3 billion worth of transactions globally, up 4% year-on-year, according to LSEG.
The six bankers which Moelis has hired from Guggenheim include Muhammad Laghari, Alexander Burpee, Benjamin Dubois, and Ryan Staha, said the sources, who requested anonymity because the moves have not yet been announced.
The bankers, who previously worked at Citigroup together, are on gardening leave and will start at Moelis in the next few weeks, the sources added.
While Citigroup advised Pioneer on its sale to Exxon, neither Guggenheim nor Moelis were on these deals.
Deal-focused investment banking boutiques like Moelis and Guggenheim typically allow their bankers to keep more of their client fees compared with big bulge-bracket banks like Citigroup, which run more diverse businesses they have to pay for.
Guggenheim ranks 19th in LSEG's league table for U.S. oil and gas deals this year with $5.8 billion of announced transactions, having been outside the top 25 advisers in 2022. Its largest mandate was helping Civitas Resources CIVI.N on its $4.7 billion purchase of energy producers from private equity firm NGP, which was announced in June.
Moelis has also been a minor U.S. player. It is currently 25th in the same league table this year, and was outside the top 25 in 2022. It has close ties, however, to a number of major international energy clients, including Saudi Aramco 2222.SE and Abu Dhabi National Oil Co.
(Reporting by David French in New York Editing by Matthew Lewis)
((davidj.french@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The six bankers which Moelis has hired from Guggenheim include Muhammad Laghari, Alexander Burpee, Benjamin Dubois, and Ryan Staha, said the sources, who requested anonymity because the moves have not yet been announced. Guggenheim ranks 19th in LSEG's league table for U.S. oil and gas deals this year with $5.8 billion of announced transactions, having been outside the top 25 advisers in 2022. Its largest mandate was helping Civitas Resources CIVI.N on its $4.7 billion purchase of energy producers from private equity firm NGP, which was announced in June.
|
The six bankers which Moelis has hired from Guggenheim include Muhammad Laghari, Alexander Burpee, Benjamin Dubois, and Ryan Staha, said the sources, who requested anonymity because the moves have not yet been announced. Guggenheim ranks 19th in LSEG's league table for U.S. oil and gas deals this year with $5.8 billion of announced transactions, having been outside the top 25 advisers in 2022. It has close ties, however, to a number of major international energy clients, including Saudi Aramco 2222.SE and Abu Dhabi National Oil Co. (Reporting by David French in New York Editing by Matthew Lewis) ((davidj.french@thomsonreuters.com;)) The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
By David French Dec 14 (Reuters) - Six U.S. oil and gas bankers who missed out on a wave of mega deals in the oil patch after leaving mergers and acquisitions powerhouse Citigroup C.N last year to join smaller firm Guggenheim Securities are now decamping to Moelis & Co MC.N, according to people familiar with the matter. Deal-focused investment banking boutiques like Moelis and Guggenheim typically allow their bankers to keep more of their client fees compared with big bulge-bracket banks like Citigroup, which run more diverse businesses they have to pay for. Guggenheim ranks 19th in LSEG's league table for U.S. oil and gas deals this year with $5.8 billion of announced transactions, having been outside the top 25 advisers in 2022.
|
The merry-go-round underscores the restlessness of dealmakers who try to get hired on big, high-prestige deals while working for firms that let them keep more of the advisory fees they generate. The six bankers which Moelis has hired from Guggenheim include Muhammad Laghari, Alexander Burpee, Benjamin Dubois, and Ryan Staha, said the sources, who requested anonymity because the moves have not yet been announced. Guggenheim ranks 19th in LSEG's league table for U.S. oil and gas deals this year with $5.8 billion of announced transactions, having been outside the top 25 advisers in 2022.
|
66744f4e-eda0-42e5-9ef7-8a487989883c
|
713627.0
|
2023-12-11 00:00:00 UTC
|
Tesla Stock Is Up 92% in 2023, but Here Are 2 Other Stocks Up Big I'd Buy First
|
DCOMP
|
https://www.nasdaq.com/articles/tesla-stock-is-up-92-in-2023-but-here-are-2-other-stocks-up-big-id-buy-first
|
nan
|
nan
|
It's been another wonderful year for Tesla (NASDAQ: TSLA) investors, with shares up almost double through early December. In this video, Motley Fool contributors Jason Hall and Jeff Santoro break down two other stocks up a lot this year they're ready to buy before Tesla. Stocks discussed include Trex (NYSE: TREX) and Meritage Homes (NYSE: MTH).
*Stock prices used were from the afternoon of Dec. 5, 2023. The video was published on Dec. 13, 2023.
Where to invest $1,000 right now
When our analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for two decades, Motley Fool Stock Advisor, has more than tripled the market.*
They just revealed what they believe are the ten best stocks for investors to buy right now... and Tesla made the list -- but there are 9 other stocks you may be overlooking.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Jason Hall has positions in Meritage Homes and Trex. Tyler Crowe has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Tesla and Trex. The Motley Fool recommends Meritage Homes. The Motley Fool has a disclosure policy. Jason Hall is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
It's been another wonderful year for Tesla (NASDAQ: TSLA) investors, with shares up almost double through early December. In this video, Motley Fool contributors Jason Hall and Jeff Santoro break down two other stocks up a lot this year they're ready to buy before Tesla. After all, the newsletter they have run for two decades, Motley Fool Stock Advisor, has more than tripled the market.
|
Stocks discussed include Trex (NYSE: TREX) and Meritage Homes (NYSE: MTH). See the 10 stocks *Stock Advisor returns as of December 11, 2023 Jason Hall has positions in Meritage Homes and Trex. The Motley Fool recommends Meritage Homes.
|
In this video, Motley Fool contributors Jason Hall and Jeff Santoro break down two other stocks up a lot this year they're ready to buy before Tesla. * They just revealed what they believe are the ten best stocks for investors to buy right now... and Tesla made the list -- but there are 9 other stocks you may be overlooking. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Jason Hall has positions in Meritage Homes and Trex.
|
In this video, Motley Fool contributors Jason Hall and Jeff Santoro break down two other stocks up a lot this year they're ready to buy before Tesla. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Jason Hall has positions in Meritage Homes and Trex. The Motley Fool has positions in and recommends Tesla and Trex.
|
aacb3232-b9d5-4ec2-a89f-5ec4df20960c
|
713628.0
|
2023-12-11 00:00:00 UTC
|
Keep a Cool Head as AMD Stock Runs Hot
|
DCOMP
|
https://www.nasdaq.com/articles/keep-a-cool-head-as-amd-stock-runs-hot
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
There’s no denying that Advanced Micro Devices (NASDAQ:AMD) is a strong competitor among artificial intelligence chip makers. On the other hand, the company’s future growth and success may already be factored into the AMD share price. Therefore, we’re assigning a “B” grade to AMD stock with a cautiously optimistic outlook.
If you’re seeking exposure to the high-conviction AI hardware market, investing in AMD isn’t a bad choice. Just monitor AMD’s financial and operational performance as the company has the challenging task of delivering on high expectations.
AMD’s Big AI Chip Industry Forecast
Not long ago, AMD announced the availability of its Instinct MI300X accelerators. These accelerators can handle the power-intensive requirements of AI workloads.
Without a doubt, AMD will make waves in the AI processor industry with the MI300X model. According to AMD President Victor Peng, the company’s “Instinct MI300 Series accelerators are designed with our most advanced technologies, delivering leadership performance.” In addition, Peng stated these accelerators will be used “in large scale cloud and enterprise deployments.”
AMD’s management is quite confident in the company’s growth prospects as an AI-compatible processor provider. Recently, per Bloobmerg, AMD CEO Lisa Su predicted the AI chip industry could exceed $400 billion “in the next four years.”
According to Reuters, Su assured that AMD has a “significant” supply of AI chips with a combined value “well above” $2 billion. Consequently, it’s fine to hold some AMD shares if you’re on board with AMD’s ambitious outlook for the AI-processor market.
Don’t Assume a Repeat Performance With AMD Stock
Momentum-focused traders might be glad to see AMD stock shooting higher in 2023. Impressively, the stock doubled from $64 at the beginning of the year to $128 in early December.
Investors are thinking ahead and have already factored their assumptions about AMD’s future growth prospects as as premier AI chip maker. If you believe that the market is highly efficient, then you might conclude that AMD is “fully priced.”
There’s already a lot of optimism in the market and some of it comes directly from AMD’s management. For example, AMD recently increased its total addressable market estimate for the company’s data center AI processors from $30 billion to $45 billion.
That’s a 50% increase, and again, it indicates AMD’s overwhelming confidence. Meanwhile, AMD seems unstoppable, but value-focused investors might be wary. After all, AMD’s trailing 12-month price-to-earnings ratio recently topped 1,000x. So, be sure to consider this if you’re deciding whether to jump into an investment in AMD.
Plan Your AMD Stock Strategy With Patience
Remember, you don’t have to invest in AMD all at once. If you’re concerned about a correction to the downside, you can just buy a few AMD shares now. You also could hold some cash to buy more shares later at a lower price.
This is the strategy of “scaling into” a stock, and it makes sense if you’re cautiously optimistic about AMD. But of course, you have to decide what you want to buy and when, based on your portfolio. AMD stock earns a “B” grade and should generally be appropriate for a moderately sized share position.
On the date of publication, neither Louis Navellier nor the InvestorPlace Research Staff member primarily responsible for this article held (either directly or indirectly) any positions in the securities mentioned in this article.
More From InvestorPlace
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The #1 AI Investment Might Be This Company You’ve Never Heard Of
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post Keep a Cool Head as AMD Stock Runs Hot appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
According to AMD President Victor Peng, the company’s “Instinct MI300 Series accelerators are designed with our most advanced technologies, delivering leadership performance.” In addition, Peng stated these accelerators will be used “in large scale cloud and enterprise deployments.” AMD’s management is quite confident in the company’s growth prospects as an AI-compatible processor provider. Investors are thinking ahead and have already factored their assumptions about AMD’s future growth prospects as as premier AI chip maker. The #1 AI Investment Might Be This Company You’ve Never Heard Of The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post Keep a Cool Head as AMD Stock Runs Hot appeared first on InvestorPlace.
|
Therefore, we’re assigning a “B” grade to AMD stock with a cautiously optimistic outlook. Investors are thinking ahead and have already factored their assumptions about AMD’s future growth prospects as as premier AI chip maker. For example, AMD recently increased its total addressable market estimate for the company’s data center AI processors from $30 billion to $45 billion.
|
According to AMD President Victor Peng, the company’s “Instinct MI300 Series accelerators are designed with our most advanced technologies, delivering leadership performance.” In addition, Peng stated these accelerators will be used “in large scale cloud and enterprise deployments.” AMD’s management is quite confident in the company’s growth prospects as an AI-compatible processor provider. Recently, per Bloobmerg, AMD CEO Lisa Su predicted the AI chip industry could exceed $400 billion “in the next four years.” According to Reuters, Su assured that AMD has a “significant” supply of AI chips with a combined value “well above” $2 billion. Don’t Assume a Repeat Performance With AMD Stock Momentum-focused traders might be glad to see AMD stock shooting higher in 2023.
|
AMD’s Big AI Chip Industry Forecast Not long ago, AMD announced the availability of its Instinct MI300X accelerators. Investors are thinking ahead and have already factored their assumptions about AMD’s future growth prospects as as premier AI chip maker. For example, AMD recently increased its total addressable market estimate for the company’s data center AI processors from $30 billion to $45 billion.
|
3261bda8-cc31-462e-a955-8712bddb65fc
|
713629.0
|
2023-12-11 00:00:00 UTC
|
AGNC's Dividend Isn't Worth the Headache. Buy This High-Yield Stock Instead.
|
DCOMP
|
https://www.nasdaq.com/articles/agncs-dividend-isnt-worth-the-headache.-buy-this-high-yield-stock-instead.
|
nan
|
nan
|
AGNC Investments (NASDAQ: AGNC) offers one whopper of a dividend. The mortgage-focused real estate investment trust (REIT) currently yields an eye-popping 16%. That's over 10x higher than the S&P 500's dividend yield.
While there's reason to be optimistic that the mortgage REIT can maintain its big-time payout in 2024, its long-term sustainability remains a big question mark, given its history. Because of that, it's probably not worth the headache of dealing with another dividend cut.
Instead, yield-hungry investors should consider buying Energy Transfer (NYSE: ET). The master limited partnership (MLP) offers a 9.5%-yielding distribution that it should be able to steadily increase in the future.
On shaky ground
AGNC Investments invests in residential mortgage-backed securities (MBS), which are guaranteed against credit losses by government agencies like Fannie Mae and Freddie Mac. The company's business model makes it more like a bank than a traditional REIT that owns income-producing commercial real estate.
The company uses shareholder capital that it leverages with short-term borrowings to buy MBS. The REIT makes money on the spread between where it borrows money and the interest income generated by its MBS investments. It uses those profits to pay a monthly dividend.
This business model can be very profitable. However, earnings can also be very volatile since changes in interest rates can affect the company's profit margin.
That volatility has forced AGNC Investments to cut its dividend several times over the years. Since it switched to paying monthly dividends in 2014, AGNC has cut its dividend four times, steadily reducing its monthly payment from $0.22 per share to the current rate of $0.12 per share.
The company's management team discussed the dividend's future on its third-quarter conference call. CEO Peter Federico stated: "We do not provide forward guidance for our dividends, but I do want to share some thoughts on the dividend in the current environment...one of the primary factors that we evaluate in setting our dividend is the economic return that we expect to earn on our portfolio at current MBS valuation levels."
He went on to point out that the company's dividend yield has increased considerably over the past couple of years, due to the decline in its share price. That's increasing its cost of capital.
The good news is that the company is currently earning a high enough return to maintain its dividend rate. However, the CEO noted, "We continuously evaluate our dividend as market conditions, expected returns, and risk management considerations are always changing." If any of those factors deteriorate, the company might need to reduce its dividend again.
Heading higher
Energy Transfer has a very different business model. The MLP owns and operates energy midstream assets, like pipelines, processing plants, and storage facilities. These assets generate very predictable and stable cash flow. The company gets about 90% of its earnings from long-term, fixed-rate contracts and government-regulated rate structures.
Meanwhile, despite its high yield, Energy Transfer distributes a conservative percentage of its cash flow to investors (a little over 50%). That enables it to retain money to fund expansion projects and maintain a strong balance sheet.
The company expects to invest about $2 billion to $3 billion on growth projects each year (27% to 40% of its cash flow), including around $2 billion in 2023. In addition to organic growth, the MLP has a long history of making value-enhancing acquisitions. This year, it made two meaningful deals -- the $1.5 billion acquisition of Lotus Midstream and its $7.1 billion merger with Crestwood Equity Partners -- which should boost its free cash flow.
The company's growing cash flow is giving it the fuel to increase its already massive cash distribution, and it plans to raise its payout by 3% to 5% annually. That visible dividend growth stands in stark contrast to AGNC Investments, which might need to cut its dividend again if market conditions deteriorate.
A more sustainable income stream
AGNC Investments' big-time dividend could see another cut in the future. The risk of another reduction is why it's not worth the headache for yield-seeking investors.
Instead, they should consider Energy Transfer's similarly massive payout, which the MLP expects to grow in the coming years. That more sustainable and steadily rising stream of cash is a better option for income-seeking investors.
Should you invest $1,000 in AGNC Investment Corp. right now?
Before you buy stock in AGNC Investment Corp., consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and AGNC Investment Corp. wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Matthew DiLallo has positions in Energy Transfer. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
While there's reason to be optimistic that the mortgage REIT can maintain its big-time payout in 2024, its long-term sustainability remains a big question mark, given its history. He went on to point out that the company's dividend yield has increased considerably over the past couple of years, due to the decline in its share price. However, the CEO noted, "We continuously evaluate our dividend as market conditions, expected returns, and risk management considerations are always changing."
|
Since it switched to paying monthly dividends in 2014, AGNC has cut its dividend four times, steadily reducing its monthly payment from $0.22 per share to the current rate of $0.12 per share. The company expects to invest about $2 billion to $3 billion on growth projects each year (27% to 40% of its cash flow), including around $2 billion in 2023. Before you buy stock in AGNC Investment Corp., consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and AGNC Investment Corp. wasn't one of them.
|
Since it switched to paying monthly dividends in 2014, AGNC has cut its dividend four times, steadily reducing its monthly payment from $0.22 per share to the current rate of $0.12 per share. CEO Peter Federico stated: "We do not provide forward guidance for our dividends, but I do want to share some thoughts on the dividend in the current environment...one of the primary factors that we evaluate in setting our dividend is the economic return that we expect to earn on our portfolio at current MBS valuation levels." Before you buy stock in AGNC Investment Corp., consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and AGNC Investment Corp. wasn't one of them.
|
AGNC Investments (NASDAQ: AGNC) offers one whopper of a dividend. A more sustainable income stream AGNC Investments' big-time dividend could see another cut in the future. Before you buy stock in AGNC Investment Corp., consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and AGNC Investment Corp. wasn't one of them.
|
31a8e0a0-b643-471f-bb18-83c3ccc37565
|
713630.0
|
2023-12-11 00:00:00 UTC
|
Chevron (CVX) Signs a 20-Year Agreement With Baker Hughes
|
DCOMP
|
https://www.nasdaq.com/articles/chevron-cvx-signs-a-20-year-agreement-with-baker-hughes
|
nan
|
nan
|
Chevron Corporation’s CVX Australian unit and Baker Hughes BKR have entered into a 20-year framework agreement. This strategic partnership marks a significant commitment to innovation and efficiency, aimed at unlocking new energy resources while minimizing environmental impact.
Let's delve deeper into the key aspects of this long-term partnership.
Details of the Agreement
The agreement focuses on the deployment of Baker Hughes' advanced Aptara Subsea production systems across Chevron Australia's future offshore projects. Aptara boasts a suite of innovative subsea equipment, including lightweight and compact subsea trees, wellheads and control systems, designed to optimize performance, reduce costs and enhance environmental sustainability.
Key Benefits
This partnership promises a multitude of benefits for both Chevron and Baker Hughes, as well as the broader energy sector.
Enhanced Efficiency and Cost Reduction: Aptara's innovative design minimizes project complexity and streamlines operations, leading to significant cost savings for Chevron.
Environmental Sustainability: The lightweight and compact nature of Aptara systems reduces the environmental footprint of offshore developments, contributing to Chevron's broader sustainability goals.
Technological Advancement: The agreement fosters collaboration and knowledge sharing between the two industry leaders, accelerating the development of even more advanced subsea technologies.
Local Economic Development: The agreement prioritizes the Australian industry’s participation, ensuring that local businesses and workforce benefit from the partnership.
Conclusion
The Chevron-Baker Hughes agreement marks a milestone in the evolution of offshore energy exploration. This long-term partnership paves the way for the development of sustainable, efficient and cost-effective solutions, ensuring access to vital natural gas resources for Australia and beyond.
As both companies leverage their combined expertise and technological prowess, this collaboration holds immense potential to shape the future of the energy landscape.
Zacks Rank and Key Picks
Currently, both CVX and BKR carry a Zacks Rank #3 (Hold).
Investors interested in the energy sector might look at some better-ranked stocks like The Williams Companies WMB, sporting a Zacks Rank #1 (Strong Buy), and Liberty Energy Inc. LBRT, carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Williams Companies is valued at $41.86 billion. The company currently pays a dividend of $1.79 per share, or 5.20%, on an annual basis.
WMB, the U.S.-based energy infrastructure company, operates through Transmission & Gulf of Mexico, Northeast G&P, West and Gas & NGL Marketing Services segments.
Liberty Energy is valued at $2.99 billion. LBRT currently pays a dividend of 28 cents per share, or 1.58%, on an annual basis.
LBRT is a leading provider of hydraulic fracturing and other auxiliary services to the North American onshore exploration and production companies.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Williams Companies, Inc. (The) (WMB) : Free Stock Analysis Report
Chevron Corporation (CVX) : Free Stock Analysis Report
Baker Hughes Company (BKR) : Free Stock Analysis Report
Liberty Energy Inc. (LBRT) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This long-term partnership paves the way for the development of sustainable, efficient and cost-effective solutions, ensuring access to vital natural gas resources for Australia and beyond. WMB, the U.S.-based energy infrastructure company, operates through Transmission & Gulf of Mexico, Northeast G&P, West and Gas & NGL Marketing Services segments. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Details of the Agreement The agreement focuses on the deployment of Baker Hughes' advanced Aptara Subsea production systems across Chevron Australia's future offshore projects. Investors interested in the energy sector might look at some better-ranked stocks like The Williams Companies WMB, sporting a Zacks Rank #1 (Strong Buy), and Liberty Energy Inc. LBRT, carrying a Zacks Rank #2 (Buy) at present. Click to get this free report Williams Companies, Inc. (The) (WMB) : Free Stock Analysis Report Chevron Corporation (CVX) : Free Stock Analysis Report Baker Hughes Company (BKR) : Free Stock Analysis Report Liberty Energy Inc. (LBRT) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Details of the Agreement The agreement focuses on the deployment of Baker Hughes' advanced Aptara Subsea production systems across Chevron Australia's future offshore projects. Investors interested in the energy sector might look at some better-ranked stocks like The Williams Companies WMB, sporting a Zacks Rank #1 (Strong Buy), and Liberty Energy Inc. LBRT, carrying a Zacks Rank #2 (Buy) at present. Click to get this free report Williams Companies, Inc. (The) (WMB) : Free Stock Analysis Report Chevron Corporation (CVX) : Free Stock Analysis Report Baker Hughes Company (BKR) : Free Stock Analysis Report Liberty Energy Inc. (LBRT) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Chevron Corporation’s CVX Australian unit and Baker Hughes BKR have entered into a 20-year framework agreement. Details of the Agreement The agreement focuses on the deployment of Baker Hughes' advanced Aptara Subsea production systems across Chevron Australia's future offshore projects. Investors interested in the energy sector might look at some better-ranked stocks like The Williams Companies WMB, sporting a Zacks Rank #1 (Strong Buy), and Liberty Energy Inc. LBRT, carrying a Zacks Rank #2 (Buy) at present.
|
67cd4e34-2569-4f00-8a02-55e594d8bc63
|
713631.0
|
2023-12-11 00:00:00 UTC
|
Want Decades of Passive Income? 2 Stocks to Buy Now
|
DCOMP
|
https://www.nasdaq.com/articles/want-decades-of-passive-income-2-stocks-to-buy-now-0
|
nan
|
nan
|
If you are trying to build a portfolio around passive income stocks, you are probably looking for high-yield opportunities. Enbridge (NYSE: ENB) and Enterprise Products Partners (NYSE: EPD) will be attractive, given their 7.7% and 7.6% respective yields. The interesting thing here is that these yields aren't a symptom of high risk, because these are two of the most boring and reliable income investments you can find. Here's what you need to know.
A toll-taker business model
Enbridge and Enterprise both own energy infrastructure. These are the assets that help to move oil and natural gas around the world, including pipelines, storage, processing, and transportation infrastructure. It would be hard, if not impossible, to replace the assets these companies own. In fact, they are two of the largest midstream companies in North America.
Image source: Getty Images.
The key fact here, however, is that Enbridge and Enterprise largely charge fees for the use of their assets. In this way, they are toll takers, and the often volatile prices of oil and natural gas aren't really all that important to their top and bottom lines. Energy demand is the key driver, and demand tends to remain resilient regardless of energy prices. Thus, these midstream giants produce fairly consistent cash flows over time.
The best example of this is found in their quarterly disbursements. Enbridge has increased its dividend annually for 28 consecutive years. Master limited partnership Enterprise has increased its distribution for 25 consecutive years. To be fair, dividend growth is likely to be modest over time, which is a key factor in the high yields. So expect that the yield is going to represent the lion's share of return here.
Rock-solid infrastructure owners
Stepping a little deeper into these two businesses, the story only gets better. For example, both Enbridge and Enterprise have investment-grade-rated balance sheets. In other words, they are financially strong and have the ability to withstand a little adversity. Their long streaks of annual disbursement increases proves this, but it is nice to see that credit rating agencies recognize this as well.
Then there's the distributable cash flow payout ratio, which is roughly 60% for Enterprise and 65% for Enbridge. And while Enbridge's distributable cash flow payout ratio is higher, it is right in the middle of the company's target range of 60% to 70%, so there's no particular reason for investors to be worried about the difference between the two payout ratios.
That said, some investors might be worried about the future of carbon fuels, given that the future of these two midstream players is effectively tied to oil and natural gas. The Energy Information Administration (EIA) and the International Energy Agency (IEA), two of the world's most notable industry watchers, both agree that oil and natural gas will remain vital to the global energy ecosystem for decades into the future -- basically for as far as their current outlooks examine, which is to 2050. That should keep the cash flows going and the disbursements flowing for Enterprise and Enbridge.
For income lovers, though not for everyone
As already noted, the yield you collect from Enbridge and Enterprise will likely represent most of your total return here. So these two midstream operators are best suited to investors looking to maximize the income their portfolios generate. Anyone looking for growth will probably end up disappointed. But if decades of passive income is what you're after, now is a great time to look at adding this pair of high yielders to your portfolio.
Should you invest $1,000 in Enterprise Products Partners right now?
Before you buy stock in Enterprise Products Partners, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Enterprise Products Partners wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Reuben Gregg Brewer has positions in Enbridge. The Motley Fool has positions in and recommends Enbridge. The Motley Fool recommends Enterprise Products Partners. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The interesting thing here is that these yields aren't a symptom of high risk, because these are two of the most boring and reliable income investments you can find. These are the assets that help to move oil and natural gas around the world, including pipelines, storage, processing, and transportation infrastructure. In this way, they are toll takers, and the often volatile prices of oil and natural gas aren't really all that important to their top and bottom lines.
|
And while Enbridge's distributable cash flow payout ratio is higher, it is right in the middle of the company's target range of 60% to 70%, so there's no particular reason for investors to be worried about the difference between the two payout ratios. Before you buy stock in Enterprise Products Partners, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Enterprise Products Partners wasn't one of them. The Motley Fool recommends Enterprise Products Partners.
|
That should keep the cash flows going and the disbursements flowing for Enterprise and Enbridge. For income lovers, though not for everyone As already noted, the yield you collect from Enbridge and Enterprise will likely represent most of your total return here. Before you buy stock in Enterprise Products Partners, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Enterprise Products Partners wasn't one of them.
|
To be fair, dividend growth is likely to be modest over time, which is a key factor in the high yields. That should keep the cash flows going and the disbursements flowing for Enterprise and Enbridge. Before you buy stock in Enterprise Products Partners, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Enterprise Products Partners wasn't one of them.
|
de095a02-19a9-4814-958d-7dbaa4b34418
|
713632.0
|
2023-12-11 00:00:00 UTC
|
Siemens Mobility Reports Largest Mireo Order As Part Of MDSB 2025+ Project With Leipzig Hub
|
DCOMP
|
https://www.nasdaq.com/articles/siemens-mobility-reports-largest-mireo-order-as-part-of-mdsb-2025-project-with-leipzig-hub
|
nan
|
nan
|
(RTTNews) - Siemens Mobility said it has won an order for the delivery of 75 Mireo trains for the "Central German S-Bahn Network 2025+" project with an order volume of approximately 500 million euros. The order include: 41 three-car Mireo trains, 18 four-car Mireos, and 16 battery-powered Mireo Plus B trains. The trains will cover a total of 10.6 million train kilometers a year in the MDSB network, when operations start as planned in 2026.
Gerhard Greiter, CEO North East and Eastern Europe at Siemens Mobility, said: "The Leipzig transport hub is one of the most important in the Central German metropolitan region. With the delivery of the Mireo trains, we are enabling greater flexibility for public transport in Central Germany, higher capacity per train and more comfort for passengers."
Siemens Mobility noted that, to date, it has sold 22 Mireo fleets with a total of over 400 trains.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Siemens Mobility said it has won an order for the delivery of 75 Mireo trains for the "Central German S-Bahn Network 2025+" project with an order volume of approximately 500 million euros. Gerhard Greiter, CEO North East and Eastern Europe at Siemens Mobility, said: "The Leipzig transport hub is one of the most important in the Central German metropolitan region. Siemens Mobility noted that, to date, it has sold 22 Mireo fleets with a total of over 400 trains.
|
(RTTNews) - Siemens Mobility said it has won an order for the delivery of 75 Mireo trains for the "Central German S-Bahn Network 2025+" project with an order volume of approximately 500 million euros. The order include: 41 three-car Mireo trains, 18 four-car Mireos, and 16 battery-powered Mireo Plus B trains. The trains will cover a total of 10.6 million train kilometers a year in the MDSB network, when operations start as planned in 2026.
|
(RTTNews) - Siemens Mobility said it has won an order for the delivery of 75 Mireo trains for the "Central German S-Bahn Network 2025+" project with an order volume of approximately 500 million euros. The order include: 41 three-car Mireo trains, 18 four-car Mireos, and 16 battery-powered Mireo Plus B trains. With the delivery of the Mireo trains, we are enabling greater flexibility for public transport in Central Germany, higher capacity per train and more comfort for passengers."
|
(RTTNews) - Siemens Mobility said it has won an order for the delivery of 75 Mireo trains for the "Central German S-Bahn Network 2025+" project with an order volume of approximately 500 million euros. The order include: 41 three-car Mireo trains, 18 four-car Mireos, and 16 battery-powered Mireo Plus B trains. The trains will cover a total of 10.6 million train kilometers a year in the MDSB network, when operations start as planned in 2026.
|
8f39465b-6edb-481a-a803-5368801e1199
|
713633.0
|
2023-12-11 00:00:00 UTC
|
Hold On! SOFI Stock Could Break DOWN Before It Breaks OUT.
|
DCOMP
|
https://www.nasdaq.com/articles/hold-on-sofi-stock-could-break-down-before-it-breaks-out.
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Fintech firm SoFi Technologies (NASDAQ:SOFI) could represent the future of personal finance, but it’s taking forever for SOFI stock to have its big breakout moment. Ultimately, there’s nothing really wrong with investing in SoFi Technologies for the long term, but be prepared for a bumpy road in the coming months.
In SoFi Technologies, the company has a banking charter and seeks to establish itself as a legitimate financial institution. That’s fine, but SoFi could miss an exciting opportunity in the world of decentralized digital assets. So, consider both the positives and the negatives if you’re considering a share stake in SoFi Technologies.
SOFI Stock: Going Nowhere Since March
Momentum-focused stock traders, be forewarned. SOFI stock has been range-bound since March of this year. The stock has effectively gone nowhere. That’s frustrating, and SoFi Technologies doesn’t offer a consolation prize in the form of dividend payments.
This has occurred even though the major stock-market indexes are significantly higher since March. So, SoFi Technologies can’t use high interest rates or inflation as excuses for letting the shareholders down.
Don’t get the wrong idea. I still like SOFI stock as a bet on the future of neo-banking. Just be patient and don’t be in a hurry to add any shares now, as SoFi Technologies will still have to deal with the White House’s push for student loan forgiveness.
Remember, SoFi Technologies earns some of its revenue from helping its customers refinance their student loans. Hence, it’s a problem for the company when the Biden administration cancels people’s federal student loan debt.
The White House isn’t finished with this battle, as the Department of Education recently disclosed that it’s canceling nearly $5 billion worth of student-loan debt for over 80,000 borrowers. Investors might expect SoFi Technologies to face ongoing challenges with this segment of its business model.
Crypto Bulls: You Won’t Like What SoFi Technologies Just Did
As I alluded to earlier, SoFi Technologies is trying hard to present itself as a legitimate bank that people from all walks of like can trust. Should trust-building involve SoFi Technologies distancing itself from cryptocurrency, though?
That’s the pertinent question as SoFi Technologies plans to terminate its cryptocurrency-trading services on Dec. 19. SoFi Technologies’ current crypto-trading clients can migrate to another firm, Blockchain.com. I suspect that some of them will simply stop trading cryptocurrency altogether.
That’s a shame, as Bitcoin (BTC-USD) is really finding its footing in late 2023. Cryptocurrency and blockchain bulls will probably want to see SoFi Technologies leaning toward the pro-crypto movement, but it looks like the company is taking a big step back.
Maybe, SoFi Technologies’ management is worried about the scandals involving FTX and Binance. Yet, it’s entirely possible for a legitimate, established financial firm to have crypto connections. A great example would be BlackRock (NYSE:BLK), which seeks to get a spot Bitcoin exchange traded fund (ETF) approved for public trading.
Don’t Rush Into a Long Position With SOFI Stock
All in all, I still appreciate SoFi Technologies’ forward-looking spirit and the company’s drive to innovate. However, some folks might not like SoFi’s apparent move away from the world of cryptocurrency.
Therefore, if you’re a dyed-in-the-wool crypto bull, there’s no need to invest in SoFi Technologies right now. Besides, the White House’s efforts to forgive student-loan debt could persist for a while.
In the final analysis, it’s fine to hold SOFI stock if you already own it. Just don’t assume that a share-price breakout will happen anytime soon. Don’t be in a huge hurry to add to your SoFi Technologies share stake right now. Be patient, as you may get in at a lower price soon.
On the date of publication, David Moadel did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
David Moadel has provided compelling content – and crossed the occasional line – on behalf of Motley Fool, Crush the Street, Market Realist, TalkMarkets, TipRanks, Benzinga, and (of course) InvestorPlace.com. He also serves as the chief analyst and market researcher for Portfolio Wealth Global and hosts the popular financial YouTube channel Looking at the Markets.
More From InvestorPlace
The #1 AI Investment Might Be This Company You’ve Never Heard Of
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post Hold On! SOFI Stock Could Break DOWN Before It Breaks OUT. appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Just be patient and don’t be in a hurry to add any shares now, as SoFi Technologies will still have to deal with the White House’s push for student loan forgiveness. The White House isn’t finished with this battle, as the Department of Education recently disclosed that it’s canceling nearly $5 billion worth of student-loan debt for over 80,000 borrowers. David Moadel has provided compelling content – and crossed the occasional line – on behalf of Motley Fool, Crush the Street, Market Realist, TalkMarkets, TipRanks, Benzinga, and (of course) InvestorPlace.com.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fintech firm SoFi Technologies (NASDAQ:SOFI) could represent the future of personal finance, but it’s taking forever for SOFI stock to have its big breakout moment. In SoFi Technologies, the company has a banking charter and seeks to establish itself as a legitimate financial institution. Don’t be in a huge hurry to add to your SoFi Technologies share stake right now.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fintech firm SoFi Technologies (NASDAQ:SOFI) could represent the future of personal finance, but it’s taking forever for SOFI stock to have its big breakout moment. Crypto Bulls: You Won’t Like What SoFi Technologies Just Did As I alluded to earlier, SoFi Technologies is trying hard to present itself as a legitimate bank that people from all walks of like can trust. Don’t Rush Into a Long Position With SOFI Stock All in all, I still appreciate SoFi Technologies’ forward-looking spirit and the company’s drive to innovate.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fintech firm SoFi Technologies (NASDAQ:SOFI) could represent the future of personal finance, but it’s taking forever for SOFI stock to have its big breakout moment. SOFI Stock: Going Nowhere Since March Momentum-focused stock traders, be forewarned. Just be patient and don’t be in a hurry to add any shares now, as SoFi Technologies will still have to deal with the White House’s push for student loan forgiveness.
|
e5bd201c-0105-4d37-bf7d-011968d9b5e6
|
713634.0
|
2023-12-11 00:00:00 UTC
|
3 Short-Squeeze Stocks Ready for a Year-End Rally
|
DCOMP
|
https://www.nasdaq.com/articles/3-short-squeeze-stocks-ready-for-a-year-end-rally
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Investors with short stocks are less prevalent within the market compared to average investors taking long company positions. However, they still play a massive role in a company’s overall share price trajectory. A short squeeze is a situation in which investors flood a stock with orders to purchase shares, and those who have a short interest must exit their short position by buying shares to limit their losses.
Below are a few companies with above-average short interest and are poised to continue growing for the remainder of the year. This may lead short position holders to buy shares to exit their positions to stop their losses, increasing the corresponding stock price.
Sprouts Farmers Market (SFM)
Source: Ken Wolter / Shutterstock.com
Sprouts Farmers Market (NASDAQ:SFM), headquartered in Phoenix, Arizona, offers natural and organic food products in its grocery store locations. They own and operate over 400 retail locations throughout the U.S., with multiple stores planned to open at the beginning of 2024.
On Oct. 31, they released their earnings for the third quarter of 2023, which stated that their net sales rose by 8%, and their earnings per share were $0.61 per share, a 5% increase year-over-year. On the same day, they announced the appointment of a Curtis Valentine as Chief Financial Officer, who will take over on January 1, 2024.
Year-to-date, their share price has risen by 52% due to improved financial position, continued store expansion plan, and their new partnership with Uber. On Dec. 11, Sprouts announced that they would partner with Uber, and on-demand grocery delivery will be available for Sprouts customers through the Uber Eats app starting in Florida. On Dec. 12, Goldman Sachs (NYSE:GS) upgraded Sprouts Farmers Market from a Sell to a Buy rating due to better-than-anticipated execution. And their competitor Grocery Outlet Holdings (NASDAQ:GO) to a Sell from a Buy rating, citing slowing growth trends.
They also have an inflated short-interest position hovering around 17%. Still, with the recent spate of positive news surrounding the company, investors will be unlikely to drop Sprouts from their portfolio. This may lead to a short squeeze if their stock price keeps rising.
Abercrombie & Fitch (ANF)
Source: Paul McKinnon / Shutterstock.com
Abercrombie & Fitch (NYSE:ANF) is a retail company that produces apparel under their brands of Abercrombie & Fitch, Hollister, Social Tourist, and Gilly Hicks. It sells products through different methods, including its e-commerce platform, franchising, and wholesale.
Their share price has more than tripled year-to-date due to improved sales compared to their peers and robust management structure. On November 21, it reported earnings for the third quarter of 2023, in which it stated sales growth among its two flagship brands, Hollister and Abercrombie, of 11% and 30% compared to the previous year, respectively. In the third quarter of 2022, they reported a net loss of $700,000; in Q3 2023, they reported a net income of $97 million. The U.S. and other international regions all had double-digit sales growth year-over-year.
Abercrombie & Fitch has seen a record year in growth, even in a high-interest rate environment, which isn’t conducive to improved consumer spending. It will be interesting to see if their rally will continue with their reported short interest of 15%.
Ardelyx (ARDX)
Source: shutterstock.com/Champhei
Ardelyx (NASDAQ:ARDX), headquartered in Waltham, Massachusetts, is a biopharmaceutical company that produces various therapies for treating gastrointestinal diseases. Their flagship medication is Ibsrela, an oral medication for the treatment of irritable bowel syndrome, and Xphozah, their new oral medication that is supposed to lower a patient’s phosphorus levels and help treat chronic kidney disease (CKD) which, back in October, received FDA approval.
Their share price fell dramatically in 2021 following negative regulatory news from the FDA regarding their chronic kidney disease serum treatment. Since this event, the stock has seen consistent growth, and its share price has more than tripled. Currently, they have approximately 17% short interest in their company.
On Oct. 31, their earnings report for the third quarter stated that total revenue surged by 11-fold compared to the year before, which was fueled mainly by an increase in sales of Ibsrela, which is expected to see full-year 2023 revenue between $76 million to $78 million. Investors will be looking to see if their new medication, Xpozah, will be another revenue catalyst like Ibsrela.
As of this writing, Noah Bolton held a LONG position in ANF. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Noah has about a year of freelance writing experience. He’s worked with Investopedia dealing with topics such as the stock market andfinancial news
More From InvestorPlace
The #1 AI Investment Might Be This Company You’ve Never Heard Of
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post 3 Short-Squeeze Stocks Ready for a Year-End Rally appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
On Dec. 12, Goldman Sachs (NYSE:GS) upgraded Sprouts Farmers Market from a Sell to a Buy rating due to better-than-anticipated execution. He’s worked with Investopedia dealing with topics such as the stock market andfinancial news More From InvestorPlace The #1 AI Investment Might Be This Company You’ve Never Heard Of Musk’s “Project Omega” May Be Set to Mint New Millionaires. The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post 3 Short-Squeeze Stocks Ready for a Year-End Rally appeared first on InvestorPlace.
|
Sprouts Farmers Market (SFM) Source: Ken Wolter / Shutterstock.com Sprouts Farmers Market (NASDAQ:SFM), headquartered in Phoenix, Arizona, offers natural and organic food products in its grocery store locations. Abercrombie & Fitch (ANF) Source: Paul McKinnon / Shutterstock.com Abercrombie & Fitch (NYSE:ANF) is a retail company that produces apparel under their brands of Abercrombie & Fitch, Hollister, Social Tourist, and Gilly Hicks. Ardelyx (ARDX) Source: shutterstock.com/Champhei Ardelyx (NASDAQ:ARDX), headquartered in Waltham, Massachusetts, is a biopharmaceutical company that produces various therapies for treating gastrointestinal diseases.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors with short stocks are less prevalent within the market compared to average investors taking long company positions. A short squeeze is a situation in which investors flood a stock with orders to purchase shares, and those who have a short interest must exit their short position by buying shares to limit their losses. This may lead short position holders to buy shares to exit their positions to stop their losses, increasing the corresponding stock price.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Investors with short stocks are less prevalent within the market compared to average investors taking long company positions. This may lead short position holders to buy shares to exit their positions to stop their losses, increasing the corresponding stock price. On November 21, it reported earnings for the third quarter of 2023, in which it stated sales growth among its two flagship brands, Hollister and Abercrombie, of 11% and 30% compared to the previous year, respectively.
|
63af74ce-7173-468c-acac-aa148dc11b4c
|
713635.0
|
2023-12-11 00:00:00 UTC
|
Millionaires Know All About This "Boring" Stock. Do You?
|
DCOMP
|
https://www.nasdaq.com/articles/millionaires-know-all-about-this-boring-stock.-do-you
|
nan
|
nan
|
There are few businesses less exciting than self-storage real estate. After all, you're talking about a bunch of mostly pre-fabricated buildings that customers store things in and rarely go to.
Sometimes, however, boring businesses are the best businesses, and early investors in self-storage leader Public Storage (NYSE: PSA) know this very well. Over the past 30 years, Public Storage has generated a 5,870% total return for investors -- more than five times what the S&P 500 produced in the same period.
What does Public Storage do?
Public Storage is a real estate investment trust, or REIT (pronounced "reet"), specializing in self-storage properties. It owns just under 3,300 properties in 40 states with a total of 238 million rentable square feet.
Key advantages and growth potential
The company has some major advantages over its peers. As the largest self-storage owner in the U.S., it has scale advantages and the most recognizable brand name in the business. And the economics of the self-storage business are fantastic.
In a previous annual report, Public Storage said it could break even with just 35% of its space rented (it's typically over 90% occupied). The company has higher net operating income (NOI) margins than all of its publicly traded competitors and grows through a combination of acquisitions and development.
The company has an industry-leading technology platform that provides customer service, property access, and even rental agreements completely through the app, improving efficiency, as well as the customer experience. It also has unmatched financial flexibility to pursue growth opportunities as they arise. Public Storage has extremely low debt, A-rated credit, and $630 million in cash on its balance sheet.
One particularly interesting competitive advantage is that Public Storage's management has a long history of avoiding dilution and excessive debt. It's common practice for REITs to fund their growth with a combination of debt and equity (issuing new stock), but Public Storage doesn't.
On the equity side, fellow large-cap REITs Prologis and Digital Realty Trust have increased their outstanding share counts by 85% and 136%, respectively, over the past decade. Public Storage has 2% more shares than it did 10 years ago.
PSA Shares Outstanding data by YCharts.
On the debt side, the company spent years avoiding debt altogether, but finally decided to take some on during the extreme low-interest-rate environment in 2019-2021. Even so, $9.1 billion in debt (at an average 2.9% interest rate) is remarkably low for a REIT with a $48 billion market cap.
Instead, Public Storage prefers to fund its growth the old-fashioned way -- by paying what it has to in dividends and reinvesting the rest of its earnings into the business. This lack of dilution and interest expense has proven to be a winning combination for investors and is a particularly big advantage in the high-cost-of-capital environment we're currently in.
Finally, and perhaps most significant for long-term investors, only 18% of self-storage properties are owned by public REITs. Some are owned by private REITs, but a staggering 73% of self-storage properties are still owned by small operators. This should provide a steady stream of acquisition opportunities over the coming years.
The bottom line
One of the most important lessons long-term investors should learn is that an exciting product doesn't always make a great business (look at Peloton as an example). Conversely, a dull or boring product doesn't necessarily make a bad business. Many of the richest people I know got that way by owning and operating laundromats, vending machines, and various rental properties.
Public Storage is an excellent publicly traded example of a boring business that has certainly made some of its long-term investors millionaires. It could continue to deliver market-beating performance for decades to come.
Should you invest $1,000 in Public Storage right now?
Before you buy stock in Public Storage, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Public Storage wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Matthew Frankel, CFP® has positions in Digital Realty Trust and Public Storage. The Motley Fool has positions in and recommends Digital Realty Trust, Peloton Interactive, and Prologis. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The company has higher net operating income (NOI) margins than all of its publicly traded competitors and grows through a combination of acquisitions and development. On the equity side, fellow large-cap REITs Prologis and Digital Realty Trust have increased their outstanding share counts by 85% and 136%, respectively, over the past decade. The bottom line One of the most important lessons long-term investors should learn is that an exciting product doesn't always make a great business (look at Peloton as an example).
|
It's common practice for REITs to fund their growth with a combination of debt and equity (issuing new stock), but Public Storage doesn't. On the equity side, fellow large-cap REITs Prologis and Digital Realty Trust have increased their outstanding share counts by 85% and 136%, respectively, over the past decade. Before you buy stock in Public Storage, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Public Storage wasn't one of them.
|
Sometimes, however, boring businesses are the best businesses, and early investors in self-storage leader Public Storage (NYSE: PSA) know this very well. Public Storage is an excellent publicly traded example of a boring business that has certainly made some of its long-term investors millionaires. Before you buy stock in Public Storage, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Public Storage wasn't one of them.
|
What does Public Storage do? Public Storage is an excellent publicly traded example of a boring business that has certainly made some of its long-term investors millionaires. Before you buy stock in Public Storage, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Public Storage wasn't one of them.
|
c1780fe0-a264-4716-ad1e-91ba4b9625f8
|
713636.0
|
2023-12-11 00:00:00 UTC
|
AMD Updates on Its New AI Chip -- Is the Stock a Buy for 2024?
|
DCOMP
|
https://www.nasdaq.com/articles/amd-updates-on-its-new-ai-chip-is-the-stock-a-buy-for-2024
|
nan
|
nan
|
AMD (NASDAQ: AMD) stock has been in rally mode again. It has less to do with the Q3 2023 earnings update and more to do with AMD management palling around with other high-tech executives touting the merits of the upcoming MI300X chip system for AI. AMD stock has now more than doubled in value in 2023 in an AI-fueled rally, and it's homing back in on all-time highs after the MI300X event in early December.
But like all semiconductor stocks laying the groundwork for the AI movement, AMD trades for a high premium. Is it still a buy for 2024?
Move over, Nvidia -- AMD wants a seat at the AI table
The current hype surrounding generative AI infrastructure really got ignited by Nvidia and its explosive data center revenue earlier this year. At this point, the market for AI training -- where a company's data is used to customize an algorithm that can create new digital content on command -- is dominated by Nvidia. At the AI event on Dec. 6, AMD CEO Lisa Su claimed the MI300X has reached performance parity with comparable Nvidia systems in AI training.
However, the inference market -- when the trained AI algorithm is put into use -- is more open range. That's where AMD is talking up the performance of the MI300X. Su claims the chip system is capable of performing 1.4 times to 1.6 times better than the competition.
But why all the hoopla in the first place? The value of existing data centers worldwide has been estimated at roughly $1 trillion, and the computing infrastructure within it needs to be refreshed or replaced every four to five years. Generative AI infrastructure is now being layered in on that existing data center base, and it's been posited this new AI buildout could roughly double the value of the data center market by the end of this decade.
To wit, Su said that AMD believed that annual AI infrastructure spend would go from "something like $30 billion in 2023 to more than $150 billion in 2027." But after all that has unfolded in the last year, Su says AMD now thinks the data center AI market (AI accelerator systems like the MI300X) will reach "over 400 billion in 2027."
If that's even a remotely accurate estimate, AMD could have much to gain. And it explains why the tech industry at large is flocking to AMD (as well as Nvidia) AI events. Su and company were joined on stage by executives at Microsoft, Meta Platforms, Dell, and Super Micro Computer to sing the praises of the MI300X.
A premium is warranted, but how much?
All the hype aside, AMD's AI chip business is still far behind Nvidia's. No financial update was provided at the December AI event, but about a month prior, Su said on AMD's Q3 2023 earnings update that AI accelerator sales could "exceed $2 billion" in 2024, up from about $400 million in 2023.
It's a stellar growth outlook, but AMD is a broadly diversified company that's on pace to bring in nearly $23 billion in total sales this year. All on its own, the MI300X is no reason to buy AMD stock, which currently trades for a premium of 35 times Wall Street analysts' expectations for 2024 earnings per share.
I'm a happy AMD shareholder, but I'm taking a more cautious approach to the AI hype. That said, I think there are other reasons to be optimistic about AMD's 2024 prospects. It looks like the PC market is stabilizing, and robust profitability could make a comeback. That seems to be a forgotten part of the AMD story that could provide possible upside for the stock.
Nevertheless, until more clarity is provided on what's coming down the pike in 2024 as far as finances go, I think AMD stock is best bought in smaller batches right now, perhaps using a dollar-cost averaging plan.
Should you invest $1,000 in Advanced Micro Devices right now?
Before you buy stock in Advanced Micro Devices, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Advanced Micro Devices wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to Meta Platforms CEO Mark Zuckerberg, is a member of The Motley Fool's board of directors. Nicholas Rossolillo and his clients have positions in Advanced Micro Devices, Meta Platforms, and Nvidia. The Motley Fool has positions in and recommends Advanced Micro Devices, Meta Platforms, Microsoft, and Nvidia. The Motley Fool recommends Super Micro Computer. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
At this point, the market for AI training -- where a company's data is used to customize an algorithm that can create new digital content on command -- is dominated by Nvidia. Su and company were joined on stage by executives at Microsoft, Meta Platforms, Dell, and Super Micro Computer to sing the praises of the MI300X. All on its own, the MI300X is no reason to buy AMD stock, which currently trades for a premium of 35 times Wall Street analysts' expectations for 2024 earnings per share.
|
At the AI event on Dec. 6, AMD CEO Lisa Su claimed the MI300X has reached performance parity with comparable Nvidia systems in AI training. No financial update was provided at the December AI event, but about a month prior, Su said on AMD's Q3 2023 earnings update that AI accelerator sales could "exceed $2 billion" in 2024, up from about $400 million in 2023. The Motley Fool has positions in and recommends Advanced Micro Devices, Meta Platforms, Microsoft, and Nvidia.
|
Move over, Nvidia -- AMD wants a seat at the AI table The current hype surrounding generative AI infrastructure really got ignited by Nvidia and its explosive data center revenue earlier this year. But after all that has unfolded in the last year, Su says AMD now thinks the data center AI market (AI accelerator systems like the MI300X) will reach "over 400 billion in 2027." Before you buy stock in Advanced Micro Devices, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Advanced Micro Devices wasn't one of them.
|
At the AI event on Dec. 6, AMD CEO Lisa Su claimed the MI300X has reached performance parity with comparable Nvidia systems in AI training. All on its own, the MI300X is no reason to buy AMD stock, which currently trades for a premium of 35 times Wall Street analysts' expectations for 2024 earnings per share. Before you buy stock in Advanced Micro Devices, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Advanced Micro Devices wasn't one of them.
|
ce3ccec4-71f6-44d2-9f69-b9983602c473
|
713637.0
|
2023-12-11 00:00:00 UTC
|
3 Machine Learning Stocks to Turn $10,000 Into $1 Million: December 2023
|
DCOMP
|
https://www.nasdaq.com/articles/3-machine-learning-stocks-to-turn-%2410000-into-%241-million%3A-december-2023
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Machine learning stocks are rising in popularity. The interest in AI and machine learning has surged this year thanks to OpenAI’s release of ChatGPT. We’ve tasted what these technologies are capable of and are already thinking about what the future could hold.
Machine learning stocks, therefore, have much room to run and the ability to mint tomorrow’s millionaires.
These companies have applications ranging from helping doctors diagnose life-threatening diseases to stopping credit card fraud, chatbots, and prognosticated tech utilization like artificial general intelligence.
So, if you want to add three new machine learning stocks with tremendous upside potential, continue reading.
C3.ai (AI)
Source: Shutterstock
C3.ai (NYSE:AI) provides AI software for enterprises, but it’s most well-known for its advancements in machine learning capabilities. It allows companies to launch and manage their own AI applications that are stored in the cloud.
There are a few reasons to believe that C3.ai could be one of those machine learning stocks that will deliver multi-bagger returns. Although the company is currently unprofitable with a negative net income, this is par the course for tech startups, as their focus is on scaling revenue and reaching those important network effects first.
C3.ai has launched pilots with numerous marquee brands such as GSK (LON:GSK), Indorama (NSE:INDORAMA), First Business Bank (NASDAQ:FBIZ), and others. It also closed 62 agreements in total with various companies, which signals that its revenues could be scaling quickly.
Then there’s also the company’s valuation, which remains attractive. On a forward price-to-sales basis, it trades at just 11.17 times sales. Therefore, the company seems cheap relative to its progress in onboarding numerous blue-chip clients, making it one of those machine learning stocks with massive potential.
Appen (APXYY)
Source: Shutterstock
Appen (OTCMKTS:APXYY) An Australian company, Appen focuses on developing high-quality training data for machine learning and artificial intelligence. This is my ultra high-risk, high-reward play for one of those machine learning stocks to consider.
The company is a penny stock, trading around AUD 0.60 at the time of writing. This is an enormous decline from its AUD 35.43 peak share price recorded in August 2020. It also recently reported a massive 30% drop in revenue amid a reduction in spending by a few of Appen’s major tech customers and a capital raise that saw its shares diluted.
However, despite these problems, some brokers believe that Appen’s business remains structurally sound despite facing a downturn. The company is predicted to realize a small EBITDA profit next year, and thanks to being down 94.82% over the past five years, its share could very nearly be at the absolute bottom.
DataRobot (DR)
Source: Shutterstock
DataRobot (NASDAQ:DR) offers an enterprise AI platform that enables organizations to build and deploy machine learning models. Like the other machine learning stocks on this list, DR also has some powerful catalysts ahead of it.
For example, the company recently enhanced its partnership with SBI Holdings, a Japanese internet financial services leader, to advance generative AI in Japan. The partnership will see them develop chatbots for financial products and create summarization services for certain legal and financial documents. The big picture is that the initiative could deliver revenue within the next three years.
Also, on the enterprise front, DR launched a new console for clients to get a bird’s eye view of the health and performance of their enterprise models. Specifically, this console allows organizations to help monitor if their models generate toxic or misleading content and to take steps to correct it.
In summary, DR stock addresses the core risk of generative AI models for large enterprises, namely the problem of hallucinating and creating dubious content. If DR can successfully handle this issue, then one of the key issues that stop organizations from adopting the technology will be overcome, and its privacy and governance features are planned to keep the AI assets in a secure environment.
On the date of publication, Matthew Farley did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Matthew started writing coverage of the financial markets during the crypto boom of 2017 and was also a team member of several fintech startups. He then started writing about Australian and U.S. equities for various publications. His work has appeared in MarketBeat, FXStreet, Cryptoslate, Seeking Alpha, and the New Scientist magazine, among others.
More From InvestorPlace
ChatGPT IPO Could Shock the World, Make This Move Before the Announcement
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post 3 Machine Learning Stocks to Turn $10,000 Into $1 Million: December 2023 appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These companies have applications ranging from helping doctors diagnose life-threatening diseases to stopping credit card fraud, chatbots, and prognosticated tech utilization like artificial general intelligence. It also recently reported a massive 30% drop in revenue amid a reduction in spending by a few of Appen’s major tech customers and a capital raise that saw its shares diluted. In summary, DR stock addresses the core risk of generative AI models for large enterprises, namely the problem of hallucinating and creating dubious content.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Machine learning stocks are rising in popularity. Appen (APXYY) Source: Shutterstock Appen (OTCMKTS:APXYY) An Australian company, Appen focuses on developing high-quality training data for machine learning and artificial intelligence. DataRobot (DR) Source: Shutterstock DataRobot (NASDAQ:DR) offers an enterprise AI platform that enables organizations to build and deploy machine learning models.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Machine learning stocks are rising in popularity. Appen (APXYY) Source: Shutterstock Appen (OTCMKTS:APXYY) An Australian company, Appen focuses on developing high-quality training data for machine learning and artificial intelligence. DataRobot (DR) Source: Shutterstock DataRobot (NASDAQ:DR) offers an enterprise AI platform that enables organizations to build and deploy machine learning models.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Machine learning stocks are rising in popularity. C3.ai (AI) Source: Shutterstock C3.ai (NYSE:AI) provides AI software for enterprises, but it’s most well-known for its advancements in machine learning capabilities. The company is a penny stock, trading around AUD 0.60 at the time of writing.
|
6dbc9dec-6b48-4957-95ed-f55962dbfd8c
|
713638.0
|
2023-12-11 00:00:00 UTC
|
80% of Warren Buffett's $313 Billion Portfolio Is in Just 5 Stocks. Find Out What He Owns Now.
|
DCOMP
|
https://www.nasdaq.com/articles/80-of-warren-buffetts-%24313-billion-portfolio-is-in-just-5-stocks.-find-out-what-he-owns
|
nan
|
nan
|
Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) has a $313 billion investment portfolio that Warren Buffett has been in charge of for decades. And while he is known for buying companies for cheap and holding for decades, he's made some big moves in recent years. Tech stock Apple (NASDAQ: AAPL) has become over half of the portfolio.
In this video, Travis Hoium goes through the Apple position and the top five stocks, which make up 80% of this massive portfolio.
*Stock prices used were end-of-day prices of Dec. 12, 2023. The video was published on Dec. 13, 2023.
Should you invest $1,000 in Berkshire Hathaway right now?
Before you buy stock in Berkshire Hathaway, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Berkshire Hathaway wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Bank of America is an advertising partner of The Ascent, a Motley Fool company. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Wells Fargo is an advertising partner of The Ascent, a Motley Fool company. Travis Hoium has positions in Alphabet, Apple, and Berkshire Hathaway. The Motley Fool has positions in and recommends Alphabet, Apple, Bank of America, and Berkshire Hathaway. The Motley Fool recommends Chevron and Occidental Petroleum and recommends the following options: long January 2024 $47.50 calls on Coca-Cola. The Motley Fool has a disclosure policy. Travis Hoium is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
And while he is known for buying companies for cheap and holding for decades, he's made some big moves in recent years. In this video, Travis Hoium goes through the Apple position and the top five stocks, which make up 80% of this massive portfolio. The Motley Fool has positions in and recommends Alphabet, Apple, Bank of America, and Berkshire Hathaway.
|
Before you buy stock in Berkshire Hathaway, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Berkshire Hathaway wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Bank of America is an advertising partner of The Ascent, a Motley Fool company. The Motley Fool has positions in and recommends Alphabet, Apple, Bank of America, and Berkshire Hathaway.
|
Before you buy stock in Berkshire Hathaway, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Berkshire Hathaway wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Bank of America is an advertising partner of The Ascent, a Motley Fool company. The Motley Fool has positions in and recommends Alphabet, Apple, Bank of America, and Berkshire Hathaway.
|
Before you buy stock in Berkshire Hathaway, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Berkshire Hathaway wasn't one of them. Travis Hoium has positions in Alphabet, Apple, and Berkshire Hathaway. The Motley Fool has positions in and recommends Alphabet, Apple, Bank of America, and Berkshire Hathaway.
|
ed92fa08-07f7-4cae-b248-0c5b9d29467a
|
713639.0
|
2023-12-11 00:00:00 UTC
|
Orion Engineered Carbons S.A. Shares Approach 52-Week High - Market Mover
|
DCOMP
|
https://www.nasdaq.com/articles/orion-engineered-carbons-s.a.-shares-approach-52-week-high-market-mover
|
nan
|
nan
|
Orion Engineered Carbons S.A. (OEC) shares closed today at 1.3% below its 52 week high of $26.83, giving the company a market cap of $1B. The stock is currently up 45.7% year-to-date, up 37.7% over the past 12 months, and up 12.2% over the past five years. This week, the Dow Jones Industrial Average rose 2.9%, and the S&P 500 rose 3.5%.
Trading Activity
Trading volume this week was 87.8% higher than the 20-day average.
Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3.
Technical Indicators
The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
MACD, a trend-following momentum indicator, indicates an upward trend.
The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis
The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis
The company share price is the same as the performance of its peers in the Materials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis
Per Group Comparative Performance
The company's stock price performance year-to-date beats the peer average by 26772.8%
The company's stock price performance over the past 12 months beats the peer average by -1115.4%
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Orion Engineered Carbons S.A. (OEC) shares closed today at 1.3% below its 52 week high of $26.83, giving the company a market cap of $1B. Beta, a measure of the stock’s volatility relative to the overall market stands at 1.3. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 26772.8% The company's stock price performance over the past 12 months beats the peer average by -1115.4%
|
This week, the Dow Jones Industrial Average rose 2.9%, and the S&P 500 rose 3.5%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 26772.8% The company's stock price performance over the past 12 months beats the peer average by -1115.4%
|
Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 26772.8% The company's stock price performance over the past 12 months beats the peer average by -1115.4% This story was produced by the Kwhen Automated News Generator. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This week, the Dow Jones Industrial Average rose 2.9%, and the S&P 500 rose 3.5%. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Materials industry sector , beats it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 26772.8% The company's stock price performance over the past 12 months beats the peer average by -1115.4%
|
d21df664-61bb-45a6-b420-c3978381da1b
|
713640.0
|
2023-12-11 00:00:00 UTC
|
Is Microsoft Going to $600? 1 Wall Street Analyst Thinks So.
|
DCOMP
|
https://www.nasdaq.com/articles/is-microsoft-going-to-%24600-1-wall-street-analyst-thinks-so.
|
nan
|
nan
|
As a general rule, I ignore Wall Street's non-stop merry-go-round of upgrades and downgrades. However, while the prognostications about where a stock price is headed over the coming year are virtually meaningless to long-term investors, the logic behind the moves can yield valuable insight regarding a company's prospects. Such is the case here.
Truist Securities analyst Joel Fishbein initiated coverage of Microsoft (NASDAQ: MSFT) stock, issuing a buy rating and three-year price target of $600. That represents potential gains for investors of 60%, compared to the stock's closing price on Wednesday, even though it's moved 56% higher so far this year. Also, note the three-year time frame, which makes his view more valuable to long-term investors.
At first glance, the math doesn't appear to be a stretch as it suggests a compound annual growth rate of roughly 17%. Notwithstanding last year's historic downturn, Microsoft stock has gained 75% (or 21% annually) over the past three years, so the analyst isn't going out on a limb here.
But what Fishbein says about Microsoft's prospects is telling. And it won't surprise anyone who's been paying attention that he believes the biggest driver will be artificial intelligence (AI).
The analyst cites Microsoft's "early investments" in AI, which places them in a "leadership position in ... the fastest growing multi-billion-dollar market in technology." Perhaps more importantly, the upside will come over multiple years as an increasing number of companies adopt AI.
Microsoft was quick to roll out generative AI tools to its cloud infrastructure customers, and investors have already seen the early impact on the company's results. During its fiscal 2024 first quarter (ended Sept. 30), Microsoft took market share from its largest rivals, while attributing roughly three points of its cloud growth to increasing demand for AI services.
The company also has just started to roll out Microsoft Copilot, the generative AI assistant deeply integrated into its software products and services. Wall Street believes it could add billions of dollars in incremental revenue over the next few years.
Furthermore, most analysts who offer an opinion estimate the market opportunity from AI in the trillions of dollars. And the trend is just getting started.
Given the scope of the opportunity and Microsoft's unique place in the tech ecosystem, I suspect the analyst was a bit on the conservative side.
Should you invest $1,000 in Microsoft right now?
Before you buy stock in Microsoft, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Microsoft wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Danny Vena has positions in Microsoft. The Motley Fool has positions in and recommends Microsoft. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
However, while the prognostications about where a stock price is headed over the coming year are virtually meaningless to long-term investors, the logic behind the moves can yield valuable insight regarding a company's prospects. Truist Securities analyst Joel Fishbein initiated coverage of Microsoft (NASDAQ: MSFT) stock, issuing a buy rating and three-year price target of $600. During its fiscal 2024 first quarter (ended Sept. 30), Microsoft took market share from its largest rivals, while attributing roughly three points of its cloud growth to increasing demand for AI services.
|
Truist Securities analyst Joel Fishbein initiated coverage of Microsoft (NASDAQ: MSFT) stock, issuing a buy rating and three-year price target of $600. The analyst cites Microsoft's "early investments" in AI, which places them in a "leadership position in ... the fastest growing multi-billion-dollar market in technology." Before you buy stock in Microsoft, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Microsoft wasn't one of them.
|
Notwithstanding last year's historic downturn, Microsoft stock has gained 75% (or 21% annually) over the past three years, so the analyst isn't going out on a limb here. Before you buy stock in Microsoft, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Microsoft wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Danny Vena has positions in Microsoft.
|
However, while the prognostications about where a stock price is headed over the coming year are virtually meaningless to long-term investors, the logic behind the moves can yield valuable insight regarding a company's prospects. The analyst cites Microsoft's "early investments" in AI, which places them in a "leadership position in ... the fastest growing multi-billion-dollar market in technology." Before you buy stock in Microsoft, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Microsoft wasn't one of them.
|
fcfca0c9-9e5f-49da-8edb-99a7927172c5
|
713641.0
|
2023-12-11 00:00:00 UTC
|
1st Source (SRCE) Stock Jumps 5.1%: Will It Continue to Soar?
|
DCOMP
|
https://www.nasdaq.com/articles/1st-source-srce-stock-jumps-5.1%3A-will-it-continue-to-soar
|
nan
|
nan
|
1st Source SRCE shares rallied 5.1% in the last trading session to close at $53.57. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 2% gain over the past four weeks.
The Federal Reserve has signaled an end to the current rate hike cycle by keeping interest rates unchanged at the 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. The central bank has also indicated a 75 basis points cut in rates by 2024-end. The above-mentioned developments have attributed to bullish investor sentiments. Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This probably drove the SRCE stock higher in last day’s trading session.
This holding company for 1st Source Bank is expected to post quarterly earnings of $1.12 per share in its upcoming report, which represents a year-over-year change of -10.4%. Revenues are expected to be $91.2 million, down 3.7% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For 1st Source, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on SRCE going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
1st Source belongs to the Zacks Banks - Midwest industry. Another stock from the same industry, Macatawa Bank MCBC, closed the last trading session 3.4% higher at $10.76. Over the past month, MCBC has returned 4.2%.
Macatawa's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.32. Compared to the company's year-ago EPS, this represents a change of -8.6%. Macatawa currently boasts a Zacks Rank of #1 (Strong Buy).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
1st Source Corporation (SRCE) : Free Stock Analysis Report
Macatawa Bank Corporation (MCBC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This holding company for 1st Source Bank is expected to post quarterly earnings of $1.12 per share in its upcoming report, which represents a year-over-year change of -10.4%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> 1st Source belongs to the Zacks Banks - Midwest industry. Macatawa's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.32. Click to get this free report 1st Source Corporation (SRCE) : Free Stock Analysis Report Macatawa Bank Corporation (MCBC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> 1st Source belongs to the Zacks Banks - Midwest industry. Click to get this free report 1st Source Corporation (SRCE) : Free Stock Analysis Report Macatawa Bank Corporation (MCBC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This holding company for 1st Source Bank is expected to post quarterly earnings of $1.12 per share in its upcoming report, which represents a year-over-year change of -10.4%. Another stock from the same industry, Macatawa Bank MCBC, closed the last trading session 3.4% higher at $10.76.
|
0dbed0fc-33d8-4e73-b681-aa98d865da45
|
713642.0
|
2023-12-11 00:00:00 UTC
|
Alkermes To Sell Development And Manufacturing Facility In Athlone - Quick Facts
|
DCOMP
|
https://www.nasdaq.com/articles/alkermes-to-sell-development-and-manufacturing-facility-in-athlone-quick-facts
|
nan
|
nan
|
(RTTNews) - Alkermes plc (ALKS) has entered into a definitive agreement to sell its development and manufacturing facility in Athlone, Ireland to Novo Nordisk. Upon closing, Alkermes will be entitled to a one-time cash payment of $92.5 million for the facility and related assets. Alkermes said it will continue to retain all royalty revenues associated with products currently manufactured at the facility. Alkermes will continue to manufacture its commercial products, VIVITROL, ARISTADA, ARISTADA INITIO and LYBALVI, at its Wilmington, Ohio manufacturing facility.
The companies also plan to enter into subcontracting arrangements to continue certain work currently performed at the facility for a period of time after closing of the transaction, which may continue through the end of 2025.
For More Such Health News, visit rttnews.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Alkermes plc (ALKS) has entered into a definitive agreement to sell its development and manufacturing facility in Athlone, Ireland to Novo Nordisk. Upon closing, Alkermes will be entitled to a one-time cash payment of $92.5 million for the facility and related assets. Alkermes said it will continue to retain all royalty revenues associated with products currently manufactured at the facility.
|
(RTTNews) - Alkermes plc (ALKS) has entered into a definitive agreement to sell its development and manufacturing facility in Athlone, Ireland to Novo Nordisk. Upon closing, Alkermes will be entitled to a one-time cash payment of $92.5 million for the facility and related assets. Alkermes will continue to manufacture its commercial products, VIVITROL, ARISTADA, ARISTADA INITIO and LYBALVI, at its Wilmington, Ohio manufacturing facility.
|
Alkermes will continue to manufacture its commercial products, VIVITROL, ARISTADA, ARISTADA INITIO and LYBALVI, at its Wilmington, Ohio manufacturing facility. The companies also plan to enter into subcontracting arrangements to continue certain work currently performed at the facility for a period of time after closing of the transaction, which may continue through the end of 2025. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Alkermes plc (ALKS) has entered into a definitive agreement to sell its development and manufacturing facility in Athlone, Ireland to Novo Nordisk. Upon closing, Alkermes will be entitled to a one-time cash payment of $92.5 million for the facility and related assets. Alkermes said it will continue to retain all royalty revenues associated with products currently manufactured at the facility.
|
ef2a140f-1ef2-44cc-b96c-f50b73c49be1
|
713643.0
|
2023-12-11 00:00:00 UTC
|
New Strong Sell Stocks for December 14th
|
DCOMP
|
https://www.nasdaq.com/articles/new-strong-sell-stocks-for-december-14th-1
|
nan
|
nan
|
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
American Axle & Manufacturing Holdings, Inc. AXL is an automotive technology company. The Zacks Consensus Estimate for its current year earnings has been revised 154.6% downward over the last 60 days.
Babcock & Wilcox Enterprises, Inc. BW is an energy and emissions control solutions provider. The Zacks Consensus Estimate for its current year earnings has been revised 290% downward over the last 60 days.
Lazydays Holdings, Inc. LAZY is RV dealership operator. The Zacks Consensus Estimate for its current year earnings has been revised 1760% downward over the last 60 days.
View the entire Zacks Rank #5 List.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
American Axle & Manufacturing Holdings, Inc. (AXL) : Free Stock Analysis Report
Babcock (BW) : Free Stock Analysis Report
LAZYDAYS HOLDINGS, INC. (LAZY) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Babcock & Wilcox Enterprises, Inc. BW is an energy and emissions control solutions provider. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains. Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
|
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: American Axle & Manufacturing Holdings, Inc. AXL is an automotive technology company. The Zacks Consensus Estimate for its current year earnings has been revised 154.6% downward over the last 60 days. Click to get this free report American Axle & Manufacturing Holdings, Inc. (AXL) : Free Stock Analysis Report Babcock (BW) : Free Stock Analysis Report LAZYDAYS HOLDINGS, INC. (LAZY) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: American Axle & Manufacturing Holdings, Inc. AXL is an automotive technology company. The Zacks Consensus Estimate for its current year earnings has been revised 154.6% downward over the last 60 days. Click to get this free report American Axle & Manufacturing Holdings, Inc. (AXL) : Free Stock Analysis Report Babcock (BW) : Free Stock Analysis Report LAZYDAYS HOLDINGS, INC. (LAZY) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report American Axle & Manufacturing Holdings, Inc. (AXL) : Free Stock Analysis Report Babcock (BW) : Free Stock Analysis Report LAZYDAYS HOLDINGS, INC. (LAZY) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
c17ecaf7-26c6-4a2b-bcf6-32a869a4024a
|
713644.0
|
2023-12-11 00:00:00 UTC
|
Pfizer: From pandemic hero to investor jitters
|
DCOMP
|
https://www.nasdaq.com/articles/pfizer%3A-from-pandemic-hero-to-investor-jitters
|
nan
|
nan
|
Pfizer (NYSE: PFE) is the pharmaceutical giant synonymous with the lifesaving COVID-19 vaccine. Pfizer now faces a new reality: stagnant revenue and investor anxieties. The company raked in billions from its blockbuster Comirnaty vaccine and Paxlovid antiviral drug and was once considered a pandemic powerhouse of the pharmaceutical sector. Now, Pfizer has reported that it anticipates minimal to no revenue growth in 2024. This stark contrast to the boom years has sent shockwaves through the investment community. It has raised questions about Pfizer's future and has left investors wondering if the company can recapture its past glory.
The boom and bust
Pfizer's COVID-19 portfolio was once a market blockbuster, generating record-breaking revenue. Recently, however, it has fallen victim to market normalization. Comirnaty and Paxlovid, the company’s pandemic-era stars, have seen their demand wane as vaccination rates plateau and infection rates stabilize. This sharp decline in sales has plunged the company into a period of stagnant revenue growth. This new reality starkly contrasts the boom years of the pandemic. To secure future growth, Pfizer must navigate the company's new reality. The critical challenge will be diversifying its portfolio and mitigating dependence on pandemic-related products.
Investor jitters and the market reaction
Pfizer's 2024 outlook sent shockwaves through the market. The outlook was significantly below analyst estimates, and that news triggered a plunge of over 8% in Pfizer’s stock price. This sharp decline reflects investor concerns regarding the company's ability to sustain future growth post-pandemic. Income-oriented investors may find solace in Pfizer's robust dividend yield of approximately 6%, which provides a reliable income stream amid the current market turbulence. This dichotomy between growth anxieties and income stability presents a complex investment proposition for Pfizer.
Beyond the pandemic
Recognizing the limitations of its pandemic-dependent portfolio, Pfizer is actively pivoting toward sustainable growth through strategic diversification and R&D investments. The acquisition of Seagen (NASDAQ: SGEN), a leading oncology biotech, has been approved and is expected to be completed soon. This acquisition bolsters Pfizer's pipeline in a lucrative market and unlocks new growth avenues.
Simultaneously, the company's innovation engine continues to operate at full speed. The company has announced promising advancements like Marstacimab for hemophilia. Pfizer has also announced that its new drug ELREXFIO has received conditional marketing authorization for the treatment of multiple myeloma in the European market. This proactive approach toward therapeutic expansion and innovation signifies Pfizer's commitment to crafting a future beyond the COVID-19 boom-and-bust cycle.
Pfizer's playbook for the future
Pfizer has devised a multi-pronged strategy to help right the ship. The company actively pursues proactive acquisitions in high-growth areas like rare diseases and gene therapy. Seagen is merely the opening move as Pfizer seeks to bolster its pipeline and expertise in key therapeutic segments.
Recognizing the need for tighter operational efficiency, Pfizer is embarking on cost-optimization maneuvers. Streamlining internal processes and optimizing expenses are crucial to improving profitability in this challenging environment. The company has set an ambitious target of achieving at least $4 billion in cost savings by the end of 2024.
Pfizer remains committed to staying ahead of the curve through unwavering R&D investments. The company's robust $8.3 billion R&D budget for 2023 demonstrates its dedication to bringing innovative drugs to market and securing future growth. This three-pronged approach of strategic acquisitions, cost optimization, and R&D investment represents Pfizer's roadmap for navigating the challenges and opportunities of the post-pandemic era.
The road ahead: A cautious optimism
While the road ahead holds challenges, Pfizer's trajectory inspires cautious optimism. The company boasts a resilient track record because it has weathered market cycles throughout its history and emerged stronger.
Additionally, its strategic diversification beyond the COVID-19 crutch, with a focus on lucrative areas like oncology and rare diseases, presents significant avenues for future growth.
Furthermore, Pfizer's proactive approach, evident in its targeted strategic acquisitions, cost-optimization initiatives, and unwavering commitment to R&D, underscores its resolve to adapt and thrive in the evolving pharmaceutical landscape. These factors suggest that while the immediate future may be bumpy, Pfizer possesses the necessary tools and determination to navigate the challenges and emerge as a resilient player in the post-pandemic era.
Pfizer's current dip might present a compelling opportunity for patient investors seeking long-term potential and an excellent dividend. While immediate rebounds might be uncertain, the company's strong fundamentals, strategic initiatives, and promising pipeline offer a glimmer of hope for brighter days beyond the pandemic and well into the future.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Income-oriented investors may find solace in Pfizer's robust dividend yield of approximately 6%, which provides a reliable income stream amid the current market turbulence. Furthermore, Pfizer's proactive approach, evident in its targeted strategic acquisitions, cost-optimization initiatives, and unwavering commitment to R&D, underscores its resolve to adapt and thrive in the evolving pharmaceutical landscape. While immediate rebounds might be uncertain, the company's strong fundamentals, strategic initiatives, and promising pipeline offer a glimmer of hope for brighter days beyond the pandemic and well into the future.
|
This three-pronged approach of strategic acquisitions, cost optimization, and R&D investment represents Pfizer's roadmap for navigating the challenges and opportunities of the post-pandemic era. Additionally, its strategic diversification beyond the COVID-19 crutch, with a focus on lucrative areas like oncology and rare diseases, presents significant avenues for future growth. Furthermore, Pfizer's proactive approach, evident in its targeted strategic acquisitions, cost-optimization initiatives, and unwavering commitment to R&D, underscores its resolve to adapt and thrive in the evolving pharmaceutical landscape.
|
To secure future growth, Pfizer must navigate the company's new reality. Pfizer's playbook for the future Pfizer has devised a multi-pronged strategy to help right the ship. This three-pronged approach of strategic acquisitions, cost optimization, and R&D investment represents Pfizer's roadmap for navigating the challenges and opportunities of the post-pandemic era.
|
Pfizer now faces a new reality: stagnant revenue and investor anxieties. Investor jitters and the market reaction Pfizer's 2024 outlook sent shockwaves through the market. The company's robust $8.3 billion R&D budget for 2023 demonstrates its dedication to bringing innovative drugs to market and securing future growth.
|
07027968-d563-48c1-a34f-f42487a58faf
|
713645.0
|
2023-12-11 00:00:00 UTC
|
Fnality completes 'world's first' blockchain payments at Bank of England
|
DCOMP
|
https://www.nasdaq.com/articles/fnality-completes-worlds-first-blockchain-payments-at-bank-of-england
|
nan
|
nan
|
By Huw Jones
LONDON, Dec 14 (Reuters) - Fnality, a blockchain-based wholesale payments firm, said on Thursday that shareholders Lloyds Banking Group, Santander and UBS had completed the "world's first" live transactions that digitally represent funds held at a central bank.
Fnality seeks to bridge the gap between mainstream and digital finance to cut the time and cost of settling, managing collateral and making real-time wholesale payments for financial market transactions on a global scale.
"The creation of a new systemically important global payment system is a once in a generation event," said Hyder Jaffrey, managing director for principal investments and strategic ventures at UBS.
The inaugural live payments were made in sterling using an "Omnibus Account" at the Bank of England, introduced by the central bank in 2021 to spur innovation and competition in payments by allowing an operator to pool funds of participants.
Backing transactions with central bank money provides reassurance for institutions making payments.
Goldman Sachs, Barclays, BNP Paribas, BNY Mellon, CIBC, Commerzbank, DTCC, Euroclear, ING, KBC, Mizuho, MUFG Bank, Nasdaq Ventures, Nomura, Sumitomo Mitsui, State Street and WisdomTree are also shareholders in Fnality, signalling global backing to support Fnality's cross-border, round-the-clock ambitions.
"As we step into 2024, our focus sharpens on scaling up operations within a managed and approved framework as set out by the Bank of England, and steadily progressing towards unlocking new market use cases," Fnality UK CEO Angus Fletcher said in a statement.
The aim is to set up a series of regulated, blockchain based "institutional grade" payments systems for other core currencies, including the dollar and euro, overseen by their home central banks.
Fnality also plans to bring on board more participant banks, and roll out related services such as digital securities settlement, intraday repos, and intraday FX swaps.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Fnality seeks to bridge the gap between mainstream and digital finance to cut the time and cost of settling, managing collateral and making real-time wholesale payments for financial market transactions on a global scale. "As we step into 2024, our focus sharpens on scaling up operations within a managed and approved framework as set out by the Bank of England, and steadily progressing towards unlocking new market use cases," Fnality UK CEO Angus Fletcher said in a statement. The aim is to set up a series of regulated, blockchain based "institutional grade" payments systems for other core currencies, including the dollar and euro, overseen by their home central banks.
|
By Huw Jones LONDON, Dec 14 (Reuters) - Fnality, a blockchain-based wholesale payments firm, said on Thursday that shareholders Lloyds Banking Group, Santander and UBS had completed the "world's first" live transactions that digitally represent funds held at a central bank. Fnality seeks to bridge the gap between mainstream and digital finance to cut the time and cost of settling, managing collateral and making real-time wholesale payments for financial market transactions on a global scale. "The creation of a new systemically important global payment system is a once in a generation event," said Hyder Jaffrey, managing director for principal investments and strategic ventures at UBS.
|
By Huw Jones LONDON, Dec 14 (Reuters) - Fnality, a blockchain-based wholesale payments firm, said on Thursday that shareholders Lloyds Banking Group, Santander and UBS had completed the "world's first" live transactions that digitally represent funds held at a central bank. The inaugural live payments were made in sterling using an "Omnibus Account" at the Bank of England, introduced by the central bank in 2021 to spur innovation and competition in payments by allowing an operator to pool funds of participants. Goldman Sachs, Barclays, BNP Paribas, BNY Mellon, CIBC, Commerzbank, DTCC, Euroclear, ING, KBC, Mizuho, MUFG Bank, Nasdaq Ventures, Nomura, Sumitomo Mitsui, State Street and WisdomTree are also shareholders in Fnality, signalling global backing to support Fnality's cross-border, round-the-clock ambitions.
|
By Huw Jones LONDON, Dec 14 (Reuters) - Fnality, a blockchain-based wholesale payments firm, said on Thursday that shareholders Lloyds Banking Group, Santander and UBS had completed the "world's first" live transactions that digitally represent funds held at a central bank. "The creation of a new systemically important global payment system is a once in a generation event," said Hyder Jaffrey, managing director for principal investments and strategic ventures at UBS. Backing transactions with central bank money provides reassurance for institutions making payments.
|
00fe21a2-75f7-4ac4-b7f8-a3549d09b32f
|
713646.0
|
2023-12-11 00:00:00 UTC
|
3 Top Bargain Stocks Ready for a Bull Run
|
DCOMP
|
https://www.nasdaq.com/articles/3-top-bargain-stocks-ready-for-a-bull-run-5
|
nan
|
nan
|
Although the market has had a strong end to 2023, a few stocks haven't seen the enthusiasm. However, there's no good reason for these stocks to be left out of the rally, and they look like strong buys right now to take advantage of their inactivity. However, these picks aren't just for the next month; they're also solid investments for the foreseeable future.
On my list of stocks that are well set up for a bull run are Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), PayPal (NASDAQ: PYPL), and dLocal (NASDAQ: DLO). If you don't have any of these stocks, you may want to consider them.
1. Alphabet
Google parent Alphabet is only up about 5% compared to the Nasdaq-100's 10% rise since Nov. 1. However, within that time frame, Alphabet released the latest version of Gemini, its generative artificial intelligence (AI) model.
This groundbreaking innovation is the first to outperform human experts on massive multitask language understanding, a common benchmark for assessing AI models. It also outperforms its chief rival OpenAI's GPT-4 in nearly every benchmark. This is a huge win for Alphabet and will be something that helps power the company higher for years to come.
Additionally, in Alphabet's third quarter, it delivered 11% revenue growth, marking its return to market-beating growth. Earnings per share (EPS) also increased from $1.06 to $1.55, a 46% rise.
Alphabet is hitting its stride, yet its stock trades for 20 times 2024 earnings compared to its five-year average of about 27 times trailing earnings.
GOOGL PE Ratio (Forward 1y) data by YCharts
Should Alphabet hit analyst projections and end 2024 at its average valuation of 27 times earnings, the stock is slated to rise around 36% next year. That's a fantastic return for one of the world's most dominant and consistent companies.
Because of that, I think Alphabet is set up for a bull run soon.
2. PayPal
I only need to show one chart to get my point across about PayPal.
PYPL PE Ratio data by YCharts
The stock is ridiculously undervalued, trading at 12 times forward earnings. That's far cheaper than the S&P 500's 25 times trailing and 21 times forward earnings. However, PayPal is projected to grow revenue by around 8% in 2024 and earnings by about 12%.
Those are market-matching growth figures, yet PayPal trades at a substantial discount to the market in general. Couple that with a new CEO coming on board who is focused on improving PayPal's profits, and you have a recipe for a stock that is about to explode higher due to hardly any expectations going into 2024.
3. dLocal
dLocal is a company few have heard of, but once you know about it, it's hard to find a flaw. Its software allows its clients to easily sell to countries with less developed financial systems, as dLocal has done all the legwork to set up payment infrastructure in these locations. This allows giants like Amazon, Shopify, Spotify, and Nike to operate in countries including India, Turkey, and Morocco.
Instead of these businesses setting up a specific payment system for each company, they concede a bit of the revenue to dLocal and are given a whole new customer base.
dLocal's growth has been impressive, and Q3 was no different. Total processed volume rose 69% year over year to $4.6 billion, with revenue rising 47% to $164 million. While dLocal is still rapidly growing, it has already achieved full profitability, converting 25% of revenue into profits during Q3.
You'd think the stock would come with an ultra-premium price tag with all factors considered, but dLocal trades for a mere 22 times 2024 earnings.
This stock hasn't received much mainstream attention yet, but when it does, shareholders should be ready for an incredible run.
Should you invest $1,000 in Alphabet right now?
Before you buy stock in Alphabet, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Alphabet wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. Keithen Drury has positions in Alphabet, Amazon, DLocal, PayPal, and Shopify. The Motley Fool has positions in and recommends Alphabet, Amazon, Nike, PayPal, Shopify, and Spotify Technology. The Motley Fool recommends the following options: long January 2025 $47.50 calls on Nike and short December 2023 $67.50 puts on PayPal. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This groundbreaking innovation is the first to outperform human experts on massive multitask language understanding, a common benchmark for assessing AI models. GOOGL PE Ratio (Forward 1y) data by YCharts Should Alphabet hit analyst projections and end 2024 at its average valuation of 27 times earnings, the stock is slated to rise around 36% next year. Couple that with a new CEO coming on board who is focused on improving PayPal's profits, and you have a recipe for a stock that is about to explode higher due to hardly any expectations going into 2024.
|
On my list of stocks that are well set up for a bull run are Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), PayPal (NASDAQ: PYPL), and dLocal (NASDAQ: DLO). GOOGL PE Ratio (Forward 1y) data by YCharts Should Alphabet hit analyst projections and end 2024 at its average valuation of 27 times earnings, the stock is slated to rise around 36% next year. The Motley Fool has positions in and recommends Alphabet, Amazon, Nike, PayPal, Shopify, and Spotify Technology.
|
On my list of stocks that are well set up for a bull run are Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), PayPal (NASDAQ: PYPL), and dLocal (NASDAQ: DLO). Before you buy stock in Alphabet, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Alphabet wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors.
|
GOOGL PE Ratio (Forward 1y) data by YCharts Should Alphabet hit analyst projections and end 2024 at its average valuation of 27 times earnings, the stock is slated to rise around 36% next year. Before you buy stock in Alphabet, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Alphabet wasn't one of them. The Motley Fool has positions in and recommends Alphabet, Amazon, Nike, PayPal, Shopify, and Spotify Technology.
|
24c80b4f-7535-4aa2-8bd6-b15a7339ac99
|
713647.0
|
2023-12-11 00:00:00 UTC
|
Why You Should Retain PPG Industries (PPG) in Your Portfolio
|
DCOMP
|
https://www.nasdaq.com/articles/why-you-should-retain-ppg-industries-ppg-in-your-portfolio-1
|
nan
|
nan
|
PPG Industries, Inc. PPG is gaining from pricing actions, enhanced manufacturing efficiencies, cost discipline and acquisitions amid headwinds from demand weakness in Europe and China.
The company’s shares are up 11.1% over a year, compared with a 13% rise of its industry.
Image Source: Zacks Investment Research
Let’s find out why this Zacks Rank #3 (Hold) stock is worth retaining at the moment.
Cost & Pricing Actions, Acquisitions Drive PPG
PPG Industries is benefiting from higher pricing across its segments, manufacturing efficiencies, cost actions and efforts to grow its business through acquisitions.
The company is implementing a cost-cutting and restructuring strategy, as well as optimizing its working capital requirements. The cost savings generated by these restructuring initiatives will act as a tailwind for the company. PPG Industries has undertaken extensive restructuring efforts to reduce its cost structure, primarily focusing on regions and end markets with weak business conditions. The company achieved $15 million in incremental cost reductions through restructuring programs and acquisition synergies in the third quarter of 2023 and expects incremental savings of around $15 million in the fourth quarter.
PPG Industries is also raising selling prices across its business segments to offset the impact of raw material and other cost inflation and drive profitability. Significant progress has been made in increasing consolidated segment margins, which were about 15% in the third quarter of 2023, an increase of 260 basis points compared to the same quarter in 2022, aided by strong selling price realization. Pricing measures are likely to continue to support its margins in the fourth quarter.
The company is also undertaking measures to grow business inorganically through value-creating acquisitions. Contributions from the acquisitions are expected to get reflected in its performance. Acquisitions, including Tikkurila, Worwag and Cetelon, are likely to contribute to its top line.
PPG Industries also remains committed to boost shareholder returns with cash deployment. It has an impressive record of returning cash to shareholders through dividends and share buybacks. The company, in July 2023, raised its quarterly dividend by around 5% to 65 cents per share. PPG paid dividends worth $153 million in the third quarter and $445 million during the first nine months of 2023.
Weaker Demand Ails
The company remains exposed to soft demand conditions in Europe and China. Industrial production remains muted, mainly due to cautious consumer buying behavior in Europe and a slow recovery in China. Moreover, softening demand in certain end-use markets in the United States adds to the difficulties.
Global industrial production is expected to remain at lower levels in the fourth quarter. PPG anticipates overall organic sales in the Industrial Coatings segment to decrease by a low single-digit percentage in the quarter. Industrial production is expected to remain weak in end-use markets including industrial coatings and packaging coatings. The company sees industrial activities to remain be lower in most regions in industrial coatings in the fourth quarter.
PPG Industries, Inc. Price and Consensus
PPG Industries, Inc. price-consensus-chart | PPG Industries, Inc. Quote
Stocks to Consider
Better-ranked stocks worth a look in the basic materials space include Denison Mines Corp. DNN, Axalta Coating Systems Ltd. AXTA and Hawkins, Inc. HWKN.
Denison Mines has a projected earnings growth rate of 100% for the current year. DNN has a trailing four-quarter earnings surprise of roughly 225%, on average. The stock is up around 61% in a year. It currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
In the past 60 days, the Zacks Consensus Estimate for Axalta Coating Systems’ current-year earnings has been revised upward by 8.2%. AXTA, carrying a Zacks Rank #1, beat the Zacks Consensus Estimate in three of the last four quarters while missing in one quarter, with the average earnings surprise being 6.7%. The company’s shares have gained around 25% in the past year.
Hawkins has a projected earnings growth rate of 21% for the current year. It currently carries a Zacks Rank #2 (Buy). Hawkins has a trailing four-quarter earnings surprise of roughly 27.5%, on average. HWKN shares have rallied around 67% in a year.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
PPG Industries, Inc. (PPG) : Free Stock Analysis Report
Denison Mine Corp (DNN) : Free Stock Analysis Report
Axalta Coating Systems Ltd. (AXTA) : Free Stock Analysis Report
Hawkins, Inc. (HWKN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
PPG Industries has undertaken extensive restructuring efforts to reduce its cost structure, primarily focusing on regions and end markets with weak business conditions. PPG Industries is also raising selling prices across its business segments to offset the impact of raw material and other cost inflation and drive profitability. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
PPG Industries, Inc. PPG is gaining from pricing actions, enhanced manufacturing efficiencies, cost discipline and acquisitions amid headwinds from demand weakness in Europe and China. PPG Industries, Inc. Price and Consensus PPG Industries, Inc. price-consensus-chart | PPG Industries, Inc. Quote Stocks to Consider Better-ranked stocks worth a look in the basic materials space include Denison Mines Corp. DNN, Axalta Coating Systems Ltd. AXTA and Hawkins, Inc. HWKN. Click to get this free report PPG Industries, Inc. (PPG) : Free Stock Analysis Report Denison Mine Corp (DNN) : Free Stock Analysis Report Axalta Coating Systems Ltd. (AXTA) : Free Stock Analysis Report Hawkins, Inc. (HWKN) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Cost & Pricing Actions, Acquisitions Drive PPG PPG Industries is benefiting from higher pricing across its segments, manufacturing efficiencies, cost actions and efforts to grow its business through acquisitions. PPG Industries, Inc. Price and Consensus PPG Industries, Inc. price-consensus-chart | PPG Industries, Inc. Quote Stocks to Consider Better-ranked stocks worth a look in the basic materials space include Denison Mines Corp. DNN, Axalta Coating Systems Ltd. AXTA and Hawkins, Inc. HWKN. Click to get this free report PPG Industries, Inc. (PPG) : Free Stock Analysis Report Denison Mine Corp (DNN) : Free Stock Analysis Report Axalta Coating Systems Ltd. (AXTA) : Free Stock Analysis Report Hawkins, Inc. (HWKN) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
PPG Industries, Inc. Price and Consensus PPG Industries, Inc. price-consensus-chart | PPG Industries, Inc. Quote Stocks to Consider Better-ranked stocks worth a look in the basic materials space include Denison Mines Corp. DNN, Axalta Coating Systems Ltd. AXTA and Hawkins, Inc. HWKN. The stock is up around 61% in a year. The company’s shares have gained around 25% in the past year.
|
a398240f-2ad8-47c9-9ddb-5e67ced2cecd
|
713648.0
|
2023-12-11 00:00:00 UTC
|
Strength Seen in Take-Two (TTWO): Can Its 3.8% Jump Turn into More Strength?
|
DCOMP
|
https://www.nasdaq.com/articles/strength-seen-in-take-two-ttwo%3A-can-its-3.8-jump-turn-into-more-strength
|
nan
|
nan
|
Take-Two Interactive (TTWO) shares ended the last trading session 3.8% higher at $163.12. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 2.5% gain over the past four weeks.
The upswing in share price came after the announcement that Take-Two Interactive will join the Nasdaq-100 index, effective Dec 18 before market opens. It will replace Seagen as part of the index’s annual reconstitution.
This publisher of "Grand Theft Auto" and other video games is expected to post quarterly earnings of $0.87 per share in its upcoming report, which represents a year-over-year change of -6.5%. Revenues are expected to be $1.34 billion, down 3.4% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Take-Two, the consensus EPS estimate for the quarter has been revised 11.4% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on TTWO going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Take-Two belongs to the Zacks Toys - Games - Hobbies industry. Another stock from the same industry, Nintendo Co. (NTDOY), closed the last trading session 1.2% higher at $12.02. Over the past month, NTDOY has returned 1%.
For Nintendo Co., the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.17. This represents a change of -5.6% from what the company reported a year ago. Nintendo Co. currently has a Zacks Rank of #3 (Hold).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Take-Two Interactive Software, Inc. (TTWO) : Free Stock Analysis Report
Nintendo Co. (NTDOY) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The upswing in share price came after the announcement that Take-Two Interactive will join the Nasdaq-100 index, effective Dec 18 before market opens. This publisher of "Grand Theft Auto" and other video games is expected to post quarterly earnings of $0.87 per share in its upcoming report, which represents a year-over-year change of -6.5%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Take-Two Interactive (TTWO) shares ended the last trading session 3.8% higher at $163.12. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Take-Two belongs to the Zacks Toys - Games - Hobbies industry. Click to get this free report Take-Two Interactive Software, Inc. (TTWO) : Free Stock Analysis Report Nintendo Co. (NTDOY) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Take-Two belongs to the Zacks Toys - Games - Hobbies industry. Click to get this free report Take-Two Interactive Software, Inc. (TTWO) : Free Stock Analysis Report Nintendo Co. (NTDOY) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Take-Two Interactive (TTWO) shares ended the last trading session 3.8% higher at $163.12. This publisher of "Grand Theft Auto" and other video games is expected to post quarterly earnings of $0.87 per share in its upcoming report, which represents a year-over-year change of -6.5%. For Nintendo Co., the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.17.
|
bb2ead7a-3f43-4d33-b226-3a9a9f4ebba1
|
713649.0
|
2023-12-11 00:00:00 UTC
|
Independent Bank Group (IBTX) Surges 8.7%: Is This an Indication of Further Gains?
|
DCOMP
|
https://www.nasdaq.com/articles/independent-bank-group-ibtx-surges-8.7%3A-is-this-an-indication-of-further-gains
|
nan
|
nan
|
Independent Bank Group IBTX shares ended the last trading session 8.7% higher at $46.98. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 10.4% gain over the past four weeks.
The Federal Reserve has signaled an end to the current rate hike cycle by keeping interest rates unchanged at the 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. The central bank has also indicated a 75 basis points cut in rates by 2024-end. The above-mentioned developments have attributed to bullish investor sentiments. Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This probably drove the IBTX stock higher in last day’s trading session.
This bank holding company is expected to post quarterly earnings of $0.65 per share in its upcoming report, which represents a year-over-year change of -45.8%. Revenues are expected to be $122.2 million, down 20.1% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Independent Bank Group, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on IBTX going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Independent Bank Group belongs to the Zacks Banks - Southeast industry. Another stock from the same industry, City Holding CHCO, closed the last trading session 3.5% higher at $106.43. Over the past month, CHCO has returned 4.3%.
For City Holding, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.88. This represents a change of -8.3% from what the company reported a year ago. City Holding currently has a Zacks Rank of #3 (Hold).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Independent Bank Group, Inc (IBTX) : Free Stock Analysis Report
City Holding Company (CHCO) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This bank holding company is expected to post quarterly earnings of $0.65 per share in its upcoming report, which represents a year-over-year change of -45.8%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Independent Bank Group IBTX shares ended the last trading session 8.7% higher at $46.98. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Independent Bank Group belongs to the Zacks Banks - Southeast industry. Click to get this free report Independent Bank Group, Inc (IBTX) : Free Stock Analysis Report City Holding Company (CHCO) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Independent Bank Group belongs to the Zacks Banks - Southeast industry. Click to get this free report Independent Bank Group, Inc (IBTX) : Free Stock Analysis Report City Holding Company (CHCO) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Independent Bank Group IBTX shares ended the last trading session 8.7% higher at $46.98. This bank holding company is expected to post quarterly earnings of $0.65 per share in its upcoming report, which represents a year-over-year change of -45.8%. Another stock from the same industry, City Holding CHCO, closed the last trading session 3.5% higher at $106.43.
|
0fd8e726-82d1-4367-af74-c747c40c0492
|
713650.0
|
2023-12-11 00:00:00 UTC
|
1 Under The Radar Stock That Will Make You Look Like a Genius in 2024
|
DCOMP
|
https://www.nasdaq.com/articles/1-under-the-radar-stock-that-will-make-you-look-like-a-genius-in-2024
|
nan
|
nan
|
Everyone would love to find that one stock no one has heard about yet, and then tell their friends and family about it after it has skyrocketed. Toast (NYSE: TOST) is one of the stocks with that potential; the best part is it's right under everyone's nose. So, keep reading if you want to know more about this stock and why it has breakout potential from here.
Its subscription business is key
Toast is on the technological side of restaurants and provides hardware and software solutions for its clients. You may have seen a Toast point-of-sale (POS) system at your local restaurant, including the mini versions that waitstaff carry around so they don't have to take your card to an individual kiosk.
However, Toast is using these devices only as a way into a much more lucrative business: subscriptions. Toast offers its customers a full suite of products to help run a restaurant, including payment processing, payroll, gift cards, employee scheduling, and delivery services. By getting clients on board with the Toast ecosystem, it can gradually expand to improve a restaurant's operations.
These add-ons are quite popular, as 43% of Toast's clients use at least six additional products beyond the base functionality. In all, Toast's annual recurring run-rate on the subscription side is $587 million and $631 million on the payments side for a total of $1.22 billion, up 41% from last year. Additionally, the number of locations using Toast rose from 74,000 to 99,000.
But that's just scratching the surface. Toast believes its addressable market is around $15 billion. If Toast can break into even bigger chains, its market will be much larger.
Still, investors must understand Toast's margin picture to invest in it. Because Toast is in the payment processing business and sells hardware, its margins aren't like a standard software-as-a-service (SaaS) company. Although Toast's gross margin is rapidly improving, it will never be in the 80% range like many other SaaS companies.
TOST Gross Profit Margin (Quarterly) data by YCharts.
Toast's low gross margin caps its maximum profit margin, so the stock won't carry as high of a valuation as some of its peers. As for profits, Toast is inching closer. While Toast grew its revenue by 37%, operating expenses rose by only 21%, a sign that the company's breakeven point is getting closer.
Still, Toast's net loss for the quarter was $31 million. But with over $1 billion in cash and marketable securities on its balance sheet, investors don't have to worry about Toast going broke anytime soon.
The stock trades at a low valuation
Given that Toast is unprofitable, we need to examine the company from a price-to-sales standpoint. While many companies have seen their multiples expand in 2023, Toast's has contracted. But is 2.3 times sales a reasonable price to pay? After all, its margins won't ever reach the levels of other tech companies.
TOST PS Ratio data by YCharts. PS Ratio = price-to-sales ratio.
With a large part of Toast's gross margin consumed by transaction expenses, it's not unrealistic to assume it can achieve a profit margin similar to a company like PayPal, another payment processor. If we project Toast to achieve a 6% profit margin (PayPal's is 12%) over the long term, it gives us a conservative estimate of what Toast could be in a few years. So, if Toast could snap its fingers and become instantly profitable with a 6% margin, it would trade around 38 times earnings.
A company growing revenue at 37% and trading for 38 times earnings is a fairly reasonable price, making me confident that investors can take advantage of Toast's low stock price now and hold it for at least five years to watch the company grow, break even, and finally establish a healthy profit margin.
Should you invest $1,000 in Toast right now?
Before you buy stock in Toast, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Toast wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 7, 2023
Keithen Drury has no position in any of the stocks mentioned. The Motley Fool recommends Toast. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
You may have seen a Toast point-of-sale (POS) system at your local restaurant, including the mini versions that waitstaff carry around so they don't have to take your card to an individual kiosk. Toast offers its customers a full suite of products to help run a restaurant, including payment processing, payroll, gift cards, employee scheduling, and delivery services. But with over $1 billion in cash and marketable securities on its balance sheet, investors don't have to worry about Toast going broke anytime soon.
|
TOST Gross Profit Margin (Quarterly) data by YCharts. Toast's low gross margin caps its maximum profit margin, so the stock won't carry as high of a valuation as some of its peers. Before you buy stock in Toast, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Toast wasn't one of them.
|
Toast's low gross margin caps its maximum profit margin, so the stock won't carry as high of a valuation as some of its peers. A company growing revenue at 37% and trading for 38 times earnings is a fairly reasonable price, making me confident that investors can take advantage of Toast's low stock price now and hold it for at least five years to watch the company grow, break even, and finally establish a healthy profit margin. Before you buy stock in Toast, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Toast wasn't one of them.
|
TOST Gross Profit Margin (Quarterly) data by YCharts. Toast's low gross margin caps its maximum profit margin, so the stock won't carry as high of a valuation as some of its peers. With a large part of Toast's gross margin consumed by transaction expenses, it's not unrealistic to assume it can achieve a profit margin similar to a company like PayPal, another payment processor.
|
bd7df0af-a29b-4e78-a3e2-a9e1fa7d549e
|
713651.0
|
2023-12-11 00:00:00 UTC
|
Implied Volatility Surging for On Kingstone (KINS) Stock Options
|
DCOMP
|
https://www.nasdaq.com/articles/implied-volatility-surging-for-on-kingstone-kins-stock-options
|
nan
|
nan
|
Investors in Kingstone Companies, Inc. KINS need to pay close attention to the stock based on moves in the options market lately. That is because the Apr 19, 2024 $5.00 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?
Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?
Clearly, options traders are pricing in a big move for Kingstone shares, but what is the fundamental picture for the company? Currently, Kingstone is a Zacks Rank #4 (Sell) in the Insurance - Property and Casualty industry that ranks in the Top 13% of our Zacks Industry Rank. Over the last 30 days, no analysts have increased the earnings estimates for the current quarter, while one has revised the estimates downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from earnings of 5 cents per share to loss of 8 cents in that period.
Given the way analysts feel Kingstone right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
Looking to Trade Options?
Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.
Click to see the trades now >>
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Kingstone Companies, Inc (KINS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. Click to see the trades now >> The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. Click to get this free report Kingstone Companies, Inc (KINS) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. Given the way analysts feel Kingstone right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium.
|
Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. Over the last 30 days, no analysts have increased the earnings estimates for the current quarter, while one has revised the estimates downward. Looking to Trade Options?
|
ef2c644f-191f-4213-a68e-30d8341818e9
|
713652.0
|
2023-12-11 00:00:00 UTC
|
Chewy Stock: Bull vs. Bear
|
DCOMP
|
https://www.nasdaq.com/articles/chewy-stock%3A-bull-vs.-bear-0
|
nan
|
nan
|
Like other pandemic darlings, Chewy (NYSE: CHWY) has taken its shareholders on a wild roller-coaster ride in the past few years.
If you invested in this pet e-commerce stock at its IPO price of $22 in June 2019 and held until its all-time high in Feb. 2021, you would have seen a remarkable 440% gain. But as of this writing, the stock is down 84% from its peak, and it currently sits below that IPO price from more than four years ago.
Some investors might view the shares as too cheap to pass on right now, while others think it's best to avoid Chewy stock. To see who's right, let's review the bull and bear arguments.
What the bulls say
Bullish investors will talk about Chewy's growth potential. This business isn't posting the monster revenue gains it did in fiscal 2020 and 2021 (47% and 24%, respectively), but it's still expanding at a healthy clip. Last fiscal year (ended Jan. 29, 2023), sales jumped 14%, and in the latest quarter, revenue was up 8% year over year.
There are two major trends that should help Chewy continue growing over the long term. One is the ongoing rise of online shopping, which has been a change that has transformed the economy for more than two decades.
The other is pet ownership. In the U.S., 66% of households have a pet, a figure that has steadily climbed over time. And according to Chewy CEO Sumit Singh, the industry for pet products is estimated to be worth $130 billion in the U.S. alone, which should fuel Chewy's growth.
This company has done a fantastic job generating a recurring revenue stream. Chewy offers the Autoship program, a subscription-like service that delivers pet products on a scheduled basis. In the fiscal third quarter, 76.4% of overall revenue was derived from Autoship, a penetration rate that's up more than 3 percentage points from the year-ago period. This trend of higher recurring sales has occurred over the past few years.
From Chewy's perspective, having more customers signed up for the Autoship program helps drive customer stickiness and loyalty, while at the same time requiring less marketing spending. And it gives the management team greater visibility when making financial forecasts. It's encouraging to see sales in this area rising.
What the bears say
Bears won't hesitate to call out the fact that Chewy's user base is shrinking. The company currently has 20.3 million active customers, down from 20.5 million in Q3 2022. To its credit, average spending per active customer was up nearly 14% year over year.
However, the macroeconomic headwinds can't be ignored. Discretionary spending is under pressure. Inflationary concerns and higher interest rates could be affecting pet ownership too.
"Pet household formation is muted, and it's muted because of the high kind of pressures that consumers are seeing from every direction," Singh said on the latest earnings call.
Worries about the economic environment led management to cut its full-year guidance. Executives now expect revenue to increase just 3% in the current quarter, effectively bringing fiscal 2023's full-year growth down to 10%. There could be more troubles on the horizon for this business before things start to improve.
Chewy has successfully carved out a niche in a lucrative corner of the e-commerce market, but it has invited intense competition from other companies. Petco is one such business. There are also larger, well-known players in the space like Amazon and Walmart, two formidable opponents any e-commerce specialist has to deal with. They have the financial resources and distribution capabilities to be successful in the pet category.
As a result of this competition, it might become more expensive for Chewy to attract and retain customers in the years ahead, which could make it even more difficult to improve profitability. Chewy's quarterly operating margin has stalled near breakeven the past few years.
Chewy's shares are also trading at a price-to-sales multiple that's more than 5 times Petco's. To be fair, both stocks sell for less than a single year of sales, but relatively, the market has much higher hopes for Chewy.
What Chewy has accomplished up to this point is admirable, but I think the bear arguments outweigh the bullish ones. As a result, I'm not adding the stock to my portfolio.
Should you invest $1,000 in Chewy right now?
Before you buy stock in Chewy, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Chewy wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 7, 2023
John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Neil Patel and his clients have no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Amazon, Chewy, and Walmart. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
If you invested in this pet e-commerce stock at its IPO price of $22 in June 2019 and held until its all-time high in Feb. 2021, you would have seen a remarkable 440% gain. Chewy has successfully carved out a niche in a lucrative corner of the e-commerce market, but it has invited intense competition from other companies. As a result of this competition, it might become more expensive for Chewy to attract and retain customers in the years ahead, which could make it even more difficult to improve profitability.
|
If you invested in this pet e-commerce stock at its IPO price of $22 in June 2019 and held until its all-time high in Feb. 2021, you would have seen a remarkable 440% gain. Before you buy stock in Chewy, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Chewy wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 7, 2023 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors.
|
Last fiscal year (ended Jan. 29, 2023), sales jumped 14%, and in the latest quarter, revenue was up 8% year over year. To be fair, both stocks sell for less than a single year of sales, but relatively, the market has much higher hopes for Chewy. Before you buy stock in Chewy, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Chewy wasn't one of them.
|
Last fiscal year (ended Jan. 29, 2023), sales jumped 14%, and in the latest quarter, revenue was up 8% year over year. This trend of higher recurring sales has occurred over the past few years. The Motley Fool has positions in and recommends Amazon, Chewy, and Walmart.
|
98eadc16-aa7b-4373-8dc7-6f95f0469094
|
713653.0
|
2023-12-11 00:00:00 UTC
|
Do Options Traders Know Something About Johnson Controls (JCI) Stock We Don't?
|
DCOMP
|
https://www.nasdaq.com/articles/do-options-traders-know-something-about-johnson-controls-jci-stock-we-dont
|
nan
|
nan
|
Investors in Johnson Controls International plc JCI need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 19, 2024 $30.00 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?
Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?
Clearly, options traders are pricing in a big move for Johnson Controls shares, but what is the fundamental picture for the company? Currently, Johnson Controls is a Zacks Rank #4 (Sell) in the Security and Safety Services industry that ranks in the Top 18% of our Zacks Industry Rank. Over the last 30 days, no analysts have increased the earnings estimates for the current quarter, while two has revised the estimates downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from 68 cents per share to 66 cents in that period.
Given the way analysts feel Johnson Controls right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
Looking to Trade Options?
Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.
Click to see the trades now >>
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Johnson Controls International plc (JCI) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Investors in Johnson Controls International plc JCI need to pay close attention to the stock based on moves in the options market lately. Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. Click to see the trades now >> The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Investors in Johnson Controls International plc JCI need to pay close attention to the stock based on moves in the options market lately. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. Click to get this free report Johnson Controls International plc (JCI) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. Given the way analysts feel Johnson Controls right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium.
|
Over the last 30 days, no analysts have increased the earnings estimates for the current quarter, while two has revised the estimates downward. Given the way analysts feel Johnson Controls right now, this huge implied volatility could mean there’s a trade developing. Looking to Trade Options?
|
159853de-c052-4283-b19e-8c24015f31ea
|
713654.0
|
2023-12-11 00:00:00 UTC
|
First Bank (FRBA) Surges 5.1%: Is This an Indication of Further Gains?
|
DCOMP
|
https://www.nasdaq.com/articles/first-bank-frba-surges-5.1%3A-is-this-an-indication-of-further-gains
|
nan
|
nan
|
First Bank FRBA shares soared 5.1% in the last trading session to close at $14.25. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 7.5% gain over the past four weeks.
The Federal Reserve has signaled an end to the current rate hike cycle by keeping interest rates unchanged at the 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. The central bank has also indicated a 75 basis points cut in rates by 2024-end. The above-mentioned developments have attributed to bullish investor sentiments. Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This probably drove the FRBA stock higher, which touched a new 52-week high in last day’s trading session.
This company is expected to post quarterly earnings of $0.37 per share in its upcoming report, which represents a year-over-year change of -22.9%. Revenues are expected to be $30.95 million, up 22.8% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For First Bank, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on FRBA going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
First Bank is part of the Zacks Banks - Northeast industry. Meridian Bank MRBK, another stock in the same industry, closed the last trading session 1.2% higher at $13.14. MRBK has returned 6.1% in the past month.
Meridian Bank's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.30. Compared to the company's year-ago EPS, this represents a change of -23.1%. Meridian Bank currently boasts a Zacks Rank of #4 (Sell).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
First Bank (FRBA) : Free Stock Analysis Report
Meridian Bank (MRBK) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. Meridian Bank's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.30. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> First Bank is part of the Zacks Banks - Northeast industry. Meridian Bank's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.30. Click to get this free report First Bank (FRBA) : Free Stock Analysis Report Meridian Bank (MRBK) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> First Bank is part of the Zacks Banks - Northeast industry. Click to get this free report First Bank (FRBA) : Free Stock Analysis Report Meridian Bank (MRBK) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The Federal Reserve has signaled an end to the current rate hike cycle by keeping interest rates unchanged at the 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. Meridian Bank MRBK, another stock in the same industry, closed the last trading session 1.2% higher at $13.14. Meridian Bank's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.30.
|
b4b82f3c-9d5f-405c-b5f9-0a2334735ee5
|
713655.0
|
2023-12-11 00:00:00 UTC
|
Sage Therapeutics, Biogen Announce Availability Of ZURZUVAE In U.S. For PPD In Women
|
DCOMP
|
https://www.nasdaq.com/articles/sage-therapeutics-biogen-announce-availability-of-zurzuvae-in-u.s.-for-ppd-in-women
|
nan
|
nan
|
(RTTNews) - Sage Therapeutics, Inc. (SAGE) and Biogen Inc. (BIIB) announced Thursday the availability of ZURZUVAE (zuranolone) CIV, a prescription oral treatment for women with postpartum depression or PPD in the United States.
ZURZUVAE 50 mg (two 25 mg capsules per day) CIV is already there at specialty pharmacies and delivered to patients.
According to the companies, ZURZUVAE is the first and only oral, 14-day treatment course for adults with PPD that can provide rapid improvements in depressive symptoms at Day 15 and as early as Day 3.
Sage and Biogen said they are prioritizing access through active discussions with national, regional and government payors to advocate for broad and equitable access to ZURZUVAE for women with PPD with minimal restrictions. The companies also launched a patient support program, ZURZUVAE For You.
The companies are partnering with several specialty pharmacies and ZURZUVAE will be shipped directly to women with PPD who are prescribed the treatment.
Kristina Deligiannidis, a principal investigator in the ZURZUVAE clinical development program and Professor, The Feinstein Institutes for Medical Research in Manhasset, New York, said, "For women with PPD, delayed improvement in depressive symptoms can significantly worsen outcomes. Having an option like ZURZUVAE that can work at Day 15 and improve symptoms in as early as three days has the potential to make a profound difference in the lives of women with PPD."
For More Such Health News, visit rttnews.com
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Sage Therapeutics, Inc. (SAGE) and Biogen Inc. (BIIB) announced Thursday the availability of ZURZUVAE (zuranolone) CIV, a prescription oral treatment for women with postpartum depression or PPD in the United States. The companies are partnering with several specialty pharmacies and ZURZUVAE will be shipped directly to women with PPD who are prescribed the treatment. Kristina Deligiannidis, a principal investigator in the ZURZUVAE clinical development program and Professor, The Feinstein Institutes for Medical Research in Manhasset, New York, said, "For women with PPD, delayed improvement in depressive symptoms can significantly worsen outcomes.
|
(RTTNews) - Sage Therapeutics, Inc. (SAGE) and Biogen Inc. (BIIB) announced Thursday the availability of ZURZUVAE (zuranolone) CIV, a prescription oral treatment for women with postpartum depression or PPD in the United States. ZURZUVAE 50 mg (two 25 mg capsules per day) CIV is already there at specialty pharmacies and delivered to patients. According to the companies, ZURZUVAE is the first and only oral, 14-day treatment course for adults with PPD that can provide rapid improvements in depressive symptoms at Day 15 and as early as Day 3.
|
(RTTNews) - Sage Therapeutics, Inc. (SAGE) and Biogen Inc. (BIIB) announced Thursday the availability of ZURZUVAE (zuranolone) CIV, a prescription oral treatment for women with postpartum depression or PPD in the United States. According to the companies, ZURZUVAE is the first and only oral, 14-day treatment course for adults with PPD that can provide rapid improvements in depressive symptoms at Day 15 and as early as Day 3. Having an option like ZURZUVAE that can work at Day 15 and improve symptoms in as early as three days has the potential to make a profound difference in the lives of women with PPD."
|
(RTTNews) - Sage Therapeutics, Inc. (SAGE) and Biogen Inc. (BIIB) announced Thursday the availability of ZURZUVAE (zuranolone) CIV, a prescription oral treatment for women with postpartum depression or PPD in the United States. ZURZUVAE 50 mg (two 25 mg capsules per day) CIV is already there at specialty pharmacies and delivered to patients. According to the companies, ZURZUVAE is the first and only oral, 14-day treatment course for adults with PPD that can provide rapid improvements in depressive symptoms at Day 15 and as early as Day 3.
|
12a8652f-40dc-4e28-a27e-b4cc00735233
|
713656.0
|
2023-12-11 00:00:00 UTC
|
SurModics (SRDX) Soars 6.2%: Is Further Upside Left in the Stock?
|
DCOMP
|
https://www.nasdaq.com/articles/surmodics-srdx-soars-6.2%3A-is-further-upside-left-in-the-stock
|
nan
|
nan
|
SurModics SRDX shares rallied 6.2% in the last trading session to close at $36.73. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 0.1% loss over the past four weeks.
Surmodics recorded a price surge before its first-quarter fiscal 2024 earnings release with the latest Zacks Consensus Estimate showing significant upward revision for its quarterly revenues and earnings compared to the year-ago reported number. The company is expected to release its first-quarter fiscal 2024 earnings on Feb 5. Also, presentation of favorable 24-month data from the SWING Trial, a first-in-human study of the safety and performance of the Sundance Sirolimus Drug-Coated Balloon, at VEITH Symposium raises optimism.
This drug delivery technology company is expected to post quarterly loss of $0.35 per share in its upcoming report, which represents a year-over-year change of +30%. Revenues are expected to be $29.71 million, up 19.2% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For SurModics, the consensus EPS estimate for the quarter has been revised 4.5% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on SRDX going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
SurModics is a member of the Zacks Medical - Products industry. One other stock in the same industry, High Tide Inc. HITI, finished the last trading session 6.8% higher at $1.58. HITI has returned 14.7% over the past month.
High Tide Inc.'s consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.03. Compared to the company's year-ago EPS, this represents a change of +50%. High Tide Inc. currently boasts a Zacks Rank of #3 (Hold).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Surmodics, Inc. (SRDX) : Free Stock Analysis Report
High Tide Inc. (HITI) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Also, presentation of favorable 24-month data from the SWING Trial, a first-in-human study of the safety and performance of the Sundance Sirolimus Drug-Coated Balloon, at VEITH Symposium raises optimism. This drug delivery technology company is expected to post quarterly loss of $0.35 per share in its upcoming report, which represents a year-over-year change of +30%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Surmodics recorded a price surge before its first-quarter fiscal 2024 earnings release with the latest Zacks Consensus Estimate showing significant upward revision for its quarterly revenues and earnings compared to the year-ago reported number. Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. Click to get this free report Surmodics, Inc. (SRDX) : Free Stock Analysis Report High Tide Inc. (HITI) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Surmodics recorded a price surge before its first-quarter fiscal 2024 earnings release with the latest Zacks Consensus Estimate showing significant upward revision for its quarterly revenues and earnings compared to the year-ago reported number. Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. Click to get this free report Surmodics, Inc. (SRDX) : Free Stock Analysis Report High Tide Inc. (HITI) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Surmodics recorded a price surge before its first-quarter fiscal 2024 earnings release with the latest Zacks Consensus Estimate showing significant upward revision for its quarterly revenues and earnings compared to the year-ago reported number. One other stock in the same industry, High Tide Inc. HITI, finished the last trading session 6.8% higher at $1.58. High Tide Inc.'s consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.03.
|
edbbd553-8841-4914-812f-ebfc672e0d02
|
713657.0
|
2023-12-11 00:00:00 UTC
|
Jabil (JBL) Q1 Earnings Surpass Estimates, Top Line Falls Y/Y
|
DCOMP
|
https://www.nasdaq.com/articles/jabil-jbl-q1-earnings-surpass-estimates-top-line-falls-y-y
|
nan
|
nan
|
Jabil Inc. JBL reported healthy first-quarter fiscal 2024 results, with the top and the bottom line beating the respective Zacks Consensus Estimate. The company reported a revenue decline year over year due to sluggish demand trends in various end markets. Despite weak demand trends, management’s focus on innovation and efficiency boosted the core operating margin.
Net Income
Net income on a GAAP basis in the quarter was $194 million or $1.47 per share compared with $223 million or $1.61 per share in the prior-year quarter. The decline was primarily attributable to top-line contraction.
Non-GAAP net income in the reported quarter was $343 million or $2.60 per share compared with $319 million or $2.31 per share in the prior-year quarter. The bottom line surpassed the Zacks Consensus Estimate of $2.54.
Jabil, Inc. Price, Consensus and EPS Surprise
Jabil, Inc. price-consensus-eps-surprise-chart | Jabil, Inc. Quote
Revenues
Quarterly revenues decreased to $8,387 million from $9,635 million reported in the year-ago quarter. The top line beat the consensus estimate of $8,351 million. A shift in consumers’ demand schedule, owing to uncertainty in various end markets, impeded the top line.
Net sales from Diversified Manufacturing Services declined 6% year over year. Electronics Manufacturing Services were down 21% compared to the prior-year quarter.
Other Details
Gross profit stood at $775 million compared with $743 million in the year ago quarter. Non-GAAP operating income aggregated $499 million compared with $461 million in the year-ago period.
Cash Flow & Liquidity
In the first quarter of fiscal 2024, Jabil generated $448 million of net cash from operating activities compared with $166 million in the prior-year quarter. As of Nov 30, 2023, the company had $1,550 million in cash and cash equivalents, with $2,876 million of notes payable and long-term debt.
Outlook
For second-quarter fiscal 2024, revenues are expected to be in the range of $7.0-$7.6 billion. Non-GAAP operating income is projected in the $339-$399 million range. Management estimates non-GAAP earnings per share within the band of $1.73-$2.13.
For fiscal 2024, Jabil estimated net revenues to be $31 billion, with more than $9 in core earnings per share. The core operating margin is expected in the range of 5.3-5.5%.
Zacks Rank & Stocks to Consider
Jabil currently has a Zacks Rank #3 (Hold).
Model N Inc MODN, carrying a Zacks Rank #2 (Buy) at present, delivered an earnings surprise of 20.78%, on average, in the trailing four quarters. In the last reported quarter, it pulled off an earnings surprise of 3.33%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
MODN provides revenue management solutions for life sciences and technology companies, including applications for configuration, price, quote, rebate management and regulatory compliance.
NVIDIA Corporation NVDA, currently carrying a Zacks Rank #2, delivered an earnings surprise of 18.99%, on average, in the trailing four quarters. In the last reported quarter, it pulled off an earnings surprise of 19.64%.
NVIDIA is the worldwide leader in visual computing technologies and the inventor of the graphic processing unit. Over the years, the company’s focus evolved from PC graphics to AI-based solutions that support high-performance computing, gaming and virtual reality platforms.
Arista Networks, Inc. ANET, carrying a Zacks Rank #2, is likely to benefit from strong momentum and diversification across its top verticals and product lines. The company has a software-driven, data-centric approach to help customers build their cloud architecture and enhance their cloud experience. Arista delivered an earnings surprise of 12%, on average, in the trailing four quarters.
ANET holds a leadership position in 100-gigabit Ethernet switching share in port for the high-speed data center segment. Arista is gaining market traction in 200- and 400-gigabit high-performance switching products and is well-positioned for healthy growth in the data-driven cloud networking business with proactive platforms and predictive operations.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
NVIDIA Corporation (NVDA) : Free Stock Analysis Report
Jabil, Inc. (JBL) : Free Stock Analysis Report
Model N, Inc. (MODN) : Free Stock Analysis Report
Arista Networks, Inc. (ANET) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Jabil Inc. JBL reported healthy first-quarter fiscal 2024 results, with the top and the bottom line beating the respective Zacks Consensus Estimate. Arista is gaining market traction in 200- and 400-gigabit high-performance switching products and is well-positioned for healthy growth in the data-driven cloud networking business with proactive platforms and predictive operations. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Jabil Inc. JBL reported healthy first-quarter fiscal 2024 results, with the top and the bottom line beating the respective Zacks Consensus Estimate. Jabil, Inc. Price, Consensus and EPS Surprise Jabil, Inc. price-consensus-eps-surprise-chart | Jabil, Inc. Quote Revenues Quarterly revenues decreased to $8,387 million from $9,635 million reported in the year-ago quarter. Click to get this free report NVIDIA Corporation (NVDA) : Free Stock Analysis Report Jabil, Inc. (JBL) : Free Stock Analysis Report Model N, Inc. (MODN) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Non-GAAP net income in the reported quarter was $343 million or $2.60 per share compared with $319 million or $2.31 per share in the prior-year quarter. Jabil, Inc. Price, Consensus and EPS Surprise Jabil, Inc. price-consensus-eps-surprise-chart | Jabil, Inc. Quote Revenues Quarterly revenues decreased to $8,387 million from $9,635 million reported in the year-ago quarter. Click to get this free report NVIDIA Corporation (NVDA) : Free Stock Analysis Report Jabil, Inc. (JBL) : Free Stock Analysis Report Model N, Inc. (MODN) : Free Stock Analysis Report Arista Networks, Inc. (ANET) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Non-GAAP net income in the reported quarter was $343 million or $2.60 per share compared with $319 million or $2.31 per share in the prior-year quarter. Jabil, Inc. Price, Consensus and EPS Surprise Jabil, Inc. price-consensus-eps-surprise-chart | Jabil, Inc. Quote Revenues Quarterly revenues decreased to $8,387 million from $9,635 million reported in the year-ago quarter. Zacks Rank & Stocks to Consider Jabil currently has a Zacks Rank #3 (Hold).
|
1ead1d8c-e402-444b-9ddf-3fd6cc5cc5a7
|
713658.0
|
2023-12-11 00:00:00 UTC
|
Implied Volatility Surging for Integral Ad Science (IAS) Stock Options
|
DCOMP
|
https://www.nasdaq.com/articles/implied-volatility-surging-for-integral-ad-science-ias-stock-options-0
|
nan
|
nan
|
Investors in Integral Ad Science Holding Corp. IAS need to pay close attention to the stock based on moves in the options market lately. That is because the Jan 19, 2024 $7.5 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?
Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?
Clearly, options traders are pricing in a big move for Integral Ad Science shares, but what is the fundamental picture for the company? Currently, Integral Ad Science is a Zacks Rank #3 (Hold) in the Advertising and Marketing industry that ranks in the Bottom 43% of our Zacks Industry Rank. Over the last 60 days, five analysts have increased their earnings estimates for the current quarter, while one analyst has revised the estimate downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from 1 cent per share to 4 cents in that period.
Given the way analysts feel about Integral Ad Science right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
Looking to Trade Options?
Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk.
Click to see the trades now >>
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Integral Ad Science Holding Corp. (IAS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Investors in Integral Ad Science Holding Corp. IAS need to pay close attention to the stock based on moves in the options market lately. Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. Click to see the trades now >> The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Investors in Integral Ad Science Holding Corp. IAS need to pay close attention to the stock based on moves in the options market lately. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. Click to get this free report Integral Ad Science Holding Corp. (IAS) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. Currently, Integral Ad Science is a Zacks Rank #3 (Hold) in the Advertising and Marketing industry that ranks in the Bottom 43% of our Zacks Industry Rank. Given the way analysts feel about Integral Ad Science right now, this huge implied volatility could mean there’s a trade developing.
|
Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. Given the way analysts feel about Integral Ad Science right now, this huge implied volatility could mean there’s a trade developing. Looking to Trade Options?
|
dff6a28a-2303-4570-96d6-364cbaa3ac8f
|
713659.0
|
2023-12-11 00:00:00 UTC
|
Sportradar (SRAD) Secures Deal With ATP for Tennis Betting
|
DCOMP
|
https://www.nasdaq.com/articles/sportradar-srad-secures-deal-with-atp-for-tennis-betting
|
nan
|
nan
|
Sportradar Group AG SRAD has inked a groundbreaking multi-year agreement with ATP, gaining global data and streaming rights for betting, along with media data rights for all ATP Tour and ATP Challenger Tour events. The collaboration aims to propel commercial growth and enhance fan engagement by introducing innovative betting and media products.
Launching in December 2023, Sportradar's ATP Service+ introduces cutting-edge solutions for fan and bettor interaction, offering augmented streaming, expanded in-play betting markets, personalized betting products and more. These innovations aim to enhance fan engagement and drive commercial growth in the sports betting market.
The partnership extends beyond betting, as Sportradar will collaborate with Tennis Data Innovations (TDI) to create media products, including in-depth statistical analysis and insights. Additionally, Sportradar's Integrity Services will play a crucial role in safeguarding ATP events against betting-related match-fixing, ensuring the integrity of competitions.
Image Source: Zacks Investment Research
David Lampitt, CEO of TDI, emphasizes the strategic opportunity to elevate the fan experience through advanced technologies. The collaboration aims to position tennis as a technologically advanced sport, offering a more immersive and entertaining experience for fans.
With this groundbreaking agreement, Sportradar not only strengthens its position in the sports technology market but also taps into new revenue streams and fan engagement opportunities, setting the stage for continued growth and success in the dynamic world of sports betting and media. Shares of SRAD have gained 4.1% in the past year compared with the industry’s growth of 3.8%.
Zacks Rank & Key Picks
Sportradar currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Zacks Consumer Discretionary sector are:
Royal Caribbean Cruises Ltd. RCL currently sports a Zacks Rank #1 (Strong Buy). RCL has a trailing four-quarter earnings surprise of 28.3% on average. Shares of RCL have surged 115.9% in the past year. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for RCL’s 2023 sales and EPS indicates a rise of 57.7% and 187.9%, respectively, from the year-ago period’s levels.
Live Nation Entertainment, Inc. LYV sports a Zacks Rank #1 at present. The company has a trailing four-quarter earnings surprise of 37.5% on average. Shares of LYV have gained 17.4% in the past year.
The Zacks Consensus Estimate for LYV’s 2023 sales and EPS indicates a rise of 28.6% and 132.8%, respectively, from the year-ago period’s levels.
JAKKS Pacific, Inc. JAKK currently sports a Zacks Rank #1. The company has a trailing four-quarter earnings surprise of 61.8% on average. Shares of JAKK have increased 94.5% in the past year.
The Zacks Consensus Estimate for JAKK’s 2024 sales indicates an increase of 3.5% from the year-ago period’s levels.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Royal Caribbean Cruises Ltd. (RCL) : Free Stock Analysis Report
JAKKS Pacific, Inc. (JAKK) : Free Stock Analysis Report
Live Nation Entertainment, Inc. (LYV) : Free Stock Analysis Report
Sportradar Group AG (SRAD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The partnership extends beyond betting, as Sportradar will collaborate with Tennis Data Innovations (TDI) to create media products, including in-depth statistical analysis and insights. Image Source: Zacks Investment Research David Lampitt, CEO of TDI, emphasizes the strategic opportunity to elevate the fan experience through advanced technologies. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Sportradar Group AG SRAD has inked a groundbreaking multi-year agreement with ATP, gaining global data and streaming rights for betting, along with media data rights for all ATP Tour and ATP Challenger Tour events. The collaboration aims to propel commercial growth and enhance fan engagement by introducing innovative betting and media products. Click to get this free report Royal Caribbean Cruises Ltd. (RCL) : Free Stock Analysis Report JAKKS Pacific, Inc. (JAKK) : Free Stock Analysis Report Live Nation Entertainment, Inc. (LYV) : Free Stock Analysis Report Sportradar Group AG (SRAD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Sportradar Group AG SRAD has inked a groundbreaking multi-year agreement with ATP, gaining global data and streaming rights for betting, along with media data rights for all ATP Tour and ATP Challenger Tour events. With this groundbreaking agreement, Sportradar not only strengthens its position in the sports technology market but also taps into new revenue streams and fan engagement opportunities, setting the stage for continued growth and success in the dynamic world of sports betting and media. Click to get this free report Royal Caribbean Cruises Ltd. (RCL) : Free Stock Analysis Report JAKKS Pacific, Inc. (JAKK) : Free Stock Analysis Report Live Nation Entertainment, Inc. (LYV) : Free Stock Analysis Report Sportradar Group AG (SRAD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
You can see the complete list of today’s Zacks #1 Rank stocks here. Live Nation Entertainment, Inc. LYV sports a Zacks Rank #1 at present. Shares of JAKK have increased 94.5% in the past year.
|
94dd0cfe-b73b-4d4a-83ce-3ec9d0cf94af
|
713660.0
|
2023-12-11 00:00:00 UTC
|
Reasons to Add American States Water (AWR) to Your Portfolio Now
|
DCOMP
|
https://www.nasdaq.com/articles/reasons-to-add-american-states-water-awr-to-your-portfolio-now
|
nan
|
nan
|
American States Water’s AWR strategic investments in infrastructure upgrades will allow it to provide quality services to its expanding customer base. Given its growth opportunities, AWR makes for a solid investment option in the utility sector.
Let’s focus on the factors that make this Zacks Rank #2 (Buy) stock a strong investment option at the moment.
Growth Projections
The Zacks Consensus Estimate for AWR’s 2023 earnings per share (EPS) has moved north 0.7% to $2.98 in the past 60 days.
The Zacks Consensus Estimate for the company’s 2023 revenues is pinned at $603 million, implying a year-over-year increase of 22.7%.
AWR’s long-term (three to five years) earnings growth rate is 6.3%.
Return on Equity
Return on equity (ROE) indicates how efficiently a company has been utilizing the funds to generate higher returns. Currently, American States Water’s ROE is 13.6%, higher than the industry’s average of 9.58%. This indicates that the company has been utilizing the funds more constructively than its peers in the utility water supply industry.
Debt Position
At the end of third-quarter 2023, AWR’s total debt to capital was 52.41%, much better than the sector’s average of 58.48%.
The time to interest earned ratio at the end of third-quarter 2023 was 5.1. The ratio, being greater than one, reflects the company’s ability to meet future interest obligations without difficulties.
Dividend History
American States Water has been a steady dividend payer. It has paid dividends to shareholders every year since 1931. AWR’s objective is to hike its dividend rate and witness a CAGR of more than 7% over the long term.
In October 2023, the board of directors declared a quarterly dividend of 43 cents per share, which resulted in an annualized dividend of $1.72 per share. The company’s current dividend yield is 2.04%, better than the Zacks S&P 500 Composite’s yield of 1.41%.
Systematic Investments
Strategic capital investments are making AWR’s infrastructure stronger and more resilient. The regulated utilities invested $167.4 million in company-funded capital projects in 2022 and expect capital expenditures in the range of $140-$160 million for 2023. These systematic investments drove the rate base from $752.2 million in 2018 to $1,152.3 million in 2022.
Price Performance
In the past three months, the stock has returned 0.6% against the industry’s 36.3% decline.
Image Source: Zacks Investment Research
Other Stocks to Consider
A few other top-ranked stocks from the same industry are Global Water Resources GWRS, The York Water Company YORW and Consolidated Water Co. Ltd. CWCO, each holding a Zacks Rank #2 at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
GWRS’ long-term earnings growth rate is 15%. The company delivered an average earnings surprise of 27.1% in the last four quarters.
The Zacks Consensus Estimate for YORW’s 2023 EPS is pegged at $1.59, implying a year-over-year improvement of 13.6%. The company delivered an average earnings surprise of 6.7% in the last four quarters.
CWCO’s long-term earnings growth rate is 8%. The company delivered an average earnings surprise of 61.6% in the last four quarters.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The York Water Company (YORW) : Free Stock Analysis Report
American States Water Company (AWR) : Free Stock Analysis Report
Consolidated Water Co. Ltd. (CWCO) : Free Stock Analysis Report
Global Water Resources, Inc. (GWRS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
American States Water’s AWR strategic investments in infrastructure upgrades will allow it to provide quality services to its expanding customer base. Growth Projections The Zacks Consensus Estimate for AWR’s 2023 earnings per share (EPS) has moved north 0.7% to $2.98 in the past 60 days. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Let’s focus on the factors that make this Zacks Rank #2 (Buy) stock a strong investment option at the moment. Image Source: Zacks Investment Research Other Stocks to Consider A few other top-ranked stocks from the same industry are Global Water Resources GWRS, The York Water Company YORW and Consolidated Water Co. Ltd. CWCO, each holding a Zacks Rank #2 at present. Click to get this free report The York Water Company (YORW) : Free Stock Analysis Report American States Water Company (AWR) : Free Stock Analysis Report Consolidated Water Co. Ltd. (CWCO) : Free Stock Analysis Report Global Water Resources, Inc. (GWRS) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Growth Projections The Zacks Consensus Estimate for AWR’s 2023 earnings per share (EPS) has moved north 0.7% to $2.98 in the past 60 days. Image Source: Zacks Investment Research Other Stocks to Consider A few other top-ranked stocks from the same industry are Global Water Resources GWRS, The York Water Company YORW and Consolidated Water Co. Ltd. CWCO, each holding a Zacks Rank #2 at present. Click to get this free report The York Water Company (YORW) : Free Stock Analysis Report American States Water Company (AWR) : Free Stock Analysis Report Consolidated Water Co. Ltd. (CWCO) : Free Stock Analysis Report Global Water Resources, Inc. (GWRS) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Growth Projections The Zacks Consensus Estimate for AWR’s 2023 earnings per share (EPS) has moved north 0.7% to $2.98 in the past 60 days. Currently, American States Water’s ROE is 13.6%, higher than the industry’s average of 9.58%. Dividend History American States Water has been a steady dividend payer.
|
03e52ab6-96eb-4dc0-a734-751bebdd25ce
|
713661.0
|
2023-12-11 00:00:00 UTC
|
Strength Seen in First Financial Corp. (THFF): Can Its 5.7% Jump Turn into More Strength?
|
DCOMP
|
https://www.nasdaq.com/articles/strength-seen-in-first-financial-corp.-thff%3A-can-its-5.7-jump-turn-into-more-strength
|
nan
|
nan
|
First Financial Corp. (THFF) shares rallied 5.7% in the last trading session to close at $42.48. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 7.8% gain over the past four weeks.
After 11 interest rate hikes, the Fed's decision to pause rate hikes for the third month drove bullish sentiments across markets amid the optimism of easing inflation pressures. With this, the interest rates remain at a 22-year high of 5.25-5.5%. Further, the central bank indicated three interest rate cuts by 2024-end. These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. Hence, the THFF stock gained.
This holding company for First Financial Bank is expected to post quarterly earnings of $1.13 per share in its upcoming report, which represents a year-over-year change of -17.5%. Revenues are expected to be $51.1 million, down 5.8% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For First Financial Corp., the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on THFF going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
First Financial Corp. belongs to the Zacks Banks - Midwest industry. Another stock from the same industry, Commerce Bancshares (CBSH), closed the last trading session 5.5% higher at $54.26. Over the past month, CBSH has returned 10.6%.
Commerce's consensus EPS estimate for the upcoming report has changed +0.3% over the past month to $0.82. Compared to the company's year-ago EPS, this represents a change of -17.2%. Commerce currently boasts a Zacks Rank of #3 (Hold).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
First Financial Corporation Indiana (THFF) : Free Stock Analysis Report
Commerce Bancshares, Inc. (CBSH) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. This holding company for First Financial Bank is expected to post quarterly earnings of $1.13 per share in its upcoming report, which represents a year-over-year change of -17.5%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
This holding company for First Financial Bank is expected to post quarterly earnings of $1.13 per share in its upcoming report, which represents a year-over-year change of -17.5%. Another stock from the same industry, Commerce Bancshares (CBSH), closed the last trading session 5.5% higher at $54.26. Click to get this free report First Financial Corporation Indiana (THFF) : Free Stock Analysis Report Commerce Bancshares, Inc. (CBSH) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> First Financial Corp. belongs to the Zacks Banks - Midwest industry. Click to get this free report First Financial Corporation Indiana (THFF) : Free Stock Analysis Report Commerce Bancshares, Inc. (CBSH) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
With this, the interest rates remain at a 22-year high of 5.25-5.5%. Hence, the THFF stock gained. This holding company for First Financial Bank is expected to post quarterly earnings of $1.13 per share in its upcoming report, which represents a year-over-year change of -17.5%.
|
2e9c2d30-c205-442b-a66b-0a9e5dfe0930
|
713662.0
|
2023-12-11 00:00:00 UTC
|
German American Bancorp (GABC) Soars 5.9%: Is Further Upside Left in the Stock?
|
DCOMP
|
https://www.nasdaq.com/articles/german-american-bancorp-gabc-soars-5.9%3A-is-further-upside-left-in-the-stock
|
nan
|
nan
|
German American Bancorp (GABC) shares rallied 5.9% in the last trading session to close at $32.84. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 2.2% gain over the past four weeks.
After 11 interest rate hikes, the Fed's decision to pause rate hikes for the third month drove bullish sentiments across markets amid the optimism of easing inflation pressures. With this, the interest rates remain at a 22-year high of 5.25-5.5%. Further, the central bank indicated three interest rate cuts by 2024-end. These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. Hence, the GABC stock gained.
This financial services holding company is expected to post quarterly earnings of $0.67 per share in its upcoming report, which represents a year-over-year change of -19.3%. Revenues are expected to be $61.25 million, down 7.3% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For German American Bancorp, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on GABC going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
German American Bancorp belongs to the Zacks Banks - Midwest industry. Another stock from the same industry, Wintrust Financial (WTFC), closed the last trading session 4.4% higher at $93.99. Over the past month, WTFC has returned 8.4%.
For Wintrust, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $2.50. This represents a change of +12.1% from what the company reported a year ago. Wintrust currently has a Zacks Rank of #1 (Strong Buy).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
German American Bancorp, Inc. (GABC) : Free Stock Analysis Report
Wintrust Financial Corporation (WTFC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. This financial services holding company is expected to post quarterly earnings of $0.67 per share in its upcoming report, which represents a year-over-year change of -19.3%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> German American Bancorp belongs to the Zacks Banks - Midwest industry. For Wintrust, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $2.50. Click to get this free report German American Bancorp, Inc. (GABC) : Free Stock Analysis Report Wintrust Financial Corporation (WTFC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> German American Bancorp belongs to the Zacks Banks - Midwest industry. Click to get this free report German American Bancorp, Inc. (GABC) : Free Stock Analysis Report Wintrust Financial Corporation (WTFC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
With this, the interest rates remain at a 22-year high of 5.25-5.5%. Hence, the GABC stock gained. Click to get this free report German American Bancorp, Inc. (GABC) : Free Stock Analysis Report Wintrust Financial Corporation (WTFC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
6963caae-ba3f-4d9a-a00d-5a0c128cc66c
|
713663.0
|
2023-12-11 00:00:00 UTC
|
Pfizer Closes $43 Bln All-cash Acquisition Of Seagen
|
DCOMP
|
https://www.nasdaq.com/articles/pfizer-closes-%2443-bln-all-cash-acquisition-of-seagen
|
nan
|
nan
|
(RTTNews) - Pfizer Inc. (PFE) announced Thursday the successful completion of its acquisition of biotechnology company Seagen Inc. (SGEN). Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion.
With the addition of Seagen's four in-line medicines, ADCETRIS (brentuximab vedotin), PADCEV (enfortumab vedotin), TIVDAK (tisotumab vedotin) and TUKYSA (tucatinib), Pfizer's industry-leading Oncology portfolio now includes over 25 approved medicines and biosimilars across more than 40 indications, including nine medicines that are either blockbuster or have the potential to be blockbuster.
With the addition of Seagen, Pfizer's Oncology pipeline has doubled in size with 60 programs spanning multiple modalities, including ADCs, small molecules, bispecifics and other immunotherapies.
Moving forward, Pfizer will leverage its leading protein engineering and medicinal chemistry capabilities to advance Seagen's ADC technology, unlocking potential novel combinations and next-generation biologics.
As previously disclosed, to address U.S. Federal Trade Commission concerns, Pfizer has chosen to irrevocably donate the rights of royalties from sales of Bavencio (avelumab) in the U.S. to the American Association for Cancer Research (AACR).
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
With the addition of Seagen, Pfizer's Oncology pipeline has doubled in size with 60 programs spanning multiple modalities, including ADCs, small molecules, bispecifics and other immunotherapies. Moving forward, Pfizer will leverage its leading protein engineering and medicinal chemistry capabilities to advance Seagen's ADC technology, unlocking potential novel combinations and next-generation biologics. As previously disclosed, to address U.S. Federal Trade Commission concerns, Pfizer has chosen to irrevocably donate the rights of royalties from sales of Bavencio (avelumab) in the U.S. to the American Association for Cancer Research (AACR).
|
Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion. With the addition of Seagen's four in-line medicines, ADCETRIS (brentuximab vedotin), PADCEV (enfortumab vedotin), TIVDAK (tisotumab vedotin) and TUKYSA (tucatinib), Pfizer's industry-leading Oncology portfolio now includes over 25 approved medicines and biosimilars across more than 40 indications, including nine medicines that are either blockbuster or have the potential to be blockbuster. With the addition of Seagen, Pfizer's Oncology pipeline has doubled in size with 60 programs spanning multiple modalities, including ADCs, small molecules, bispecifics and other immunotherapies.
|
With the addition of Seagen's four in-line medicines, ADCETRIS (brentuximab vedotin), PADCEV (enfortumab vedotin), TIVDAK (tisotumab vedotin) and TUKYSA (tucatinib), Pfizer's industry-leading Oncology portfolio now includes over 25 approved medicines and biosimilars across more than 40 indications, including nine medicines that are either blockbuster or have the potential to be blockbuster. Moving forward, Pfizer will leverage its leading protein engineering and medicinal chemistry capabilities to advance Seagen's ADC technology, unlocking potential novel combinations and next-generation biologics. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
(RTTNews) - Pfizer Inc. (PFE) announced Thursday the successful completion of its acquisition of biotechnology company Seagen Inc. (SGEN). Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion. With the addition of Seagen's four in-line medicines, ADCETRIS (brentuximab vedotin), PADCEV (enfortumab vedotin), TIVDAK (tisotumab vedotin) and TUKYSA (tucatinib), Pfizer's industry-leading Oncology portfolio now includes over 25 approved medicines and biosimilars across more than 40 indications, including nine medicines that are either blockbuster or have the potential to be blockbuster.
|
178bbdfd-7167-40af-9f18-2222feeec860
|
713664.0
|
2023-12-11 00:00:00 UTC
|
Independent Bank (IBCP) Soars 6.1%: Is Further Upside Left in the Stock?
|
DCOMP
|
https://www.nasdaq.com/articles/independent-bank-ibcp-soars-6.1%3A-is-further-upside-left-in-the-stock
|
nan
|
nan
|
Independent Bank (IBCP) shares ended the last trading session 6.1% higher at $24.50. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 3.5% gain over the past four weeks.
After 11 interest rate hikes, the Fed's decision to pause rate hikes for the third month drove bullish sentiments across markets amid the optimism of easing inflation pressures. With this, the interest rates remain at a 22-year high of 5.25-5.5%. Further, the central bank indicated three interest rate cuts by 2024-end. These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. Hence, the IBCP stock gained.
This bank holding company is expected to post quarterly earnings of $0.71 per share in its upcoming report, which represents no change from the year-ago quarter. Revenues are expected to be $51.5 million, down 1.1% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Independent Bank, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on IBCP going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Independent Bank is part of the Zacks Banks - Midwest industry. Farmers National Banc (FMNB), another stock in the same industry, closed the last trading session 5.5% higher at $13.76. FMNB has returned 2% in the past month.
Farmers National's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.36. Compared to the company's year-ago EPS, this represents a change of -14.3%. Farmers National currently boasts a Zacks Rank of #4 (Sell).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Independent Bank Corporation (IBCP) : Free Stock Analysis Report
Farmers National Banc Corp. (FMNB) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. Farmers National's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.36. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Independent Bank is part of the Zacks Banks - Midwest industry. Farmers National's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.36. Click to get this free report Independent Bank Corporation (IBCP) : Free Stock Analysis Report Farmers National Banc Corp. (FMNB) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Independent Bank is part of the Zacks Banks - Midwest industry. Click to get this free report Independent Bank Corporation (IBCP) : Free Stock Analysis Report Farmers National Banc Corp. (FMNB) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
With this, the interest rates remain at a 22-year high of 5.25-5.5%. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Independent Bank is part of the Zacks Banks - Midwest industry. Farmers National's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.36.
|
9f56da2d-21c8-491d-9b34-bcf383264336
|
713665.0
|
2023-12-11 00:00:00 UTC
|
Oil Rides on a Tide of Bullish News, Settles Near $70
|
DCOMP
|
https://www.nasdaq.com/articles/oil-rides-on-a-tide-of-bullish-news-settles-near-%2470
|
nan
|
nan
|
U.S. oil prices recovered on Wednesday from the previous day’s more than five-month low after the Energy Information Administration ("EIA") said domestic crude inventories shrank more than 4 million barrels last week, significantly more than analysts' expectations. Also boosting oil prices, the Fed indicated that it would cut interest rates in 2024.
On the New York Mercantile Exchange, WTI crude futures gained 86 cents, or 1.3%, to close at $69.47 a barrel yesterday.
We believe that oil’s descent below $70 allows long-term-oriented market participants to buy shares in quality companies at attractive prices. Investors interested in the sector could benefit from having quality stocks like Murphy USA MUSA, Matador Resources MTDR and Liberty Energy LBRT in their portfolio.
Let's dig deep into EIA’s Weekly Petroleum Status Report for the week ending Dec 8.
Analyzing the Latest EIA Report
Crude Oil: The federal government’s EIA report revealed that crude inventories fell 4.3 million barrels compared to expectations of a 2.7 million-barrel decrease per the analysts surveyed by S&P Global Commodity Insights. The higher-than-expected stockpile drop with the world’s biggest oil consumer was largely thanks to lower imports, which more than offset continued high domestic production, which at 13.1 million barrels per day, is near all-time highs.
Total domestic stock now stands at 440.8 million barrels — 3.9% above the year-ago figure of 424.1 million barrels but 2% less than the five-year average.
However, on a slightly bearish note, the latest report showed that supplies at the Cushing terminal (the key delivery hub for U.S. crude futures traded on the New York Mercantile Exchange) gained 1.2 million barrels to 30.8 million barrels — the highest since August.
Meanwhile, the crude supply cover decreased from 28.2 days in the previous week to 27.6 days. In the year-ago period, the supply cover was 25.8 days.
Let’s turn to the products now.
Gasoline: Gasoline supplies increased for the fourth successive week. The 409,000-barrel rise was primarily attributable to higher production and imports even as demand strengthened. Analysts had forecast that gasoline inventories would gain 3.4 million barrels. At 224 million barrels, the current stock of the most widely used petroleum product is a mere 0.2% more than the year-earlier level, while it is 2% below the five-year average range.
Distillate: Distillate fuel supplies (including diesel and heating oil) rose for the third time in as many weeks. The 1.5 million-barrel increase mainly reflected a jump in imports and strong production. Meanwhile, the market looked for a supply build of 1.6 million barrels. Following last week’s addition, current inventories — at 113.5 million barrels — are 5.6% below the year-ago level and 12% lower than the five-year average.
Refinery Rates: Refinery utilization, at 90.2%, dropped 0.3% from the prior week.
3 Energy Stocks to Buy
Having gone through the Weekly Petroleum Status Report, investors interested in the energy space might consider the operators mentioned below. Each of these companies currently carries a Zacks Rank #2 (Buy).
You can see the complete list of today’s Zacks #1 Rank stocks here.
Murphy USA: Murphy USA beat the Zacks Consensus Estimate for earnings in two of the trailing four quarters and missed in the other two. It has a trailing four-quarter earnings surprise of 7%, on average.
Murphy USA is valued at around $7.6 billion. The company has seen its shares gain 28% in a year.
Matador Resources: MTDR beat the Zacks Consensus Estimate for earnings in each of the last four quarters. Matador Resources has a trailing four-quarter earnings surprise of 13.9%, on average.
MTDR is valued at around $6.4 billion. Matador Resources has seen its shares drop 9.6% in a year.
Liberty Energy: The 2023 Zacks Consensus Estimate for LBRT indicates 52.1% year-over-year earnings per share growth.
Liberty Energy is valued at around $3 billion. LBRT has seen its shares rise 12.9% in a year.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Murphy USA Inc. (MUSA) : Free Stock Analysis Report
Matador Resources Company (MTDR) : Free Stock Analysis Report
Liberty Energy Inc. (LBRT) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
U.S. oil prices recovered on Wednesday from the previous day’s more than five-month low after the Energy Information Administration ("EIA") said domestic crude inventories shrank more than 4 million barrels last week, significantly more than analysts' expectations. Investors interested in the sector could benefit from having quality stocks like Murphy USA MUSA, Matador Resources MTDR and Liberty Energy LBRT in their portfolio. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Investors interested in the sector could benefit from having quality stocks like Murphy USA MUSA, Matador Resources MTDR and Liberty Energy LBRT in their portfolio. Murphy USA: Murphy USA beat the Zacks Consensus Estimate for earnings in two of the trailing four quarters and missed in the other two. Click to get this free report Murphy USA Inc. (MUSA) : Free Stock Analysis Report Matador Resources Company (MTDR) : Free Stock Analysis Report Liberty Energy Inc. (LBRT) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Analyzing the Latest EIA Report Crude Oil: The federal government’s EIA report revealed that crude inventories fell 4.3 million barrels compared to expectations of a 2.7 million-barrel decrease per the analysts surveyed by S&P Global Commodity Insights. However, on a slightly bearish note, the latest report showed that supplies at the Cushing terminal (the key delivery hub for U.S. crude futures traded on the New York Mercantile Exchange) gained 1.2 million barrels to 30.8 million barrels — the highest since August. Click to get this free report Murphy USA Inc. (MUSA) : Free Stock Analysis Report Matador Resources Company (MTDR) : Free Stock Analysis Report Liberty Energy Inc. (LBRT) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
U.S. oil prices recovered on Wednesday from the previous day’s more than five-month low after the Energy Information Administration ("EIA") said domestic crude inventories shrank more than 4 million barrels last week, significantly more than analysts' expectations. Investors interested in the sector could benefit from having quality stocks like Murphy USA MUSA, Matador Resources MTDR and Liberty Energy LBRT in their portfolio. Analysts had forecast that gasoline inventories would gain 3.4 million barrels.
|
c1d93872-36a0-452a-aff4-c6adede597fe
|
713666.0
|
2023-12-11 00:00:00 UTC
|
MidWestOne (MOFG) Moves 7.9% Higher: Will This Strength Last?
|
DCOMP
|
https://www.nasdaq.com/articles/midwestone-mofg-moves-7.9-higher%3A-will-this-strength-last
|
nan
|
nan
|
MidWestOne (MOFG) shares ended the last trading session 7.9% higher at $25.34. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 4.5% gain over the past four weeks.
After 11 interest rate hikes, the Fed's decision to pause rate hikes for the third month drove bullish sentiments across markets amid the optimism of easing inflation pressures. With this, the interest rates remain at a 22-year high of 5.25-5.5%. Further, the central bank indicated three interest rate cuts by 2024-end. These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. Hence, the MOFG stock gained.
This holding company for MidWestOne Bank is expected to post quarterly earnings of $0.47 per share in its upcoming report, which represents a year-over-year change of -53.9%. Revenues are expected to be $43.4 million, down 20.4% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For MidWestOne, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on MOFG going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
MidWestOne is part of the Zacks Banks - Midwest industry. First Western (MYFW), another stock in the same industry, closed the last trading session 16.4% higher at $19.63. MYFW has returned -1.3% in the past month.
First Western's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.33. Compared to the company's year-ago EPS, this represents a change of -43.1%. First Western currently boasts a Zacks Rank of #5 (Strong Sell).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
MidWestOne Financial Group, Inc. (MOFG) : Free Stock Analysis Report
First Western Financial, Inc. (MYFW) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. This holding company for MidWestOne Bank is expected to post quarterly earnings of $0.47 per share in its upcoming report, which represents a year-over-year change of -53.9%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
This holding company for MidWestOne Bank is expected to post quarterly earnings of $0.47 per share in its upcoming report, which represents a year-over-year change of -53.9%. First Western's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.33. Click to get this free report MidWestOne Financial Group, Inc. (MOFG) : Free Stock Analysis Report First Western Financial, Inc. (MYFW) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> MidWestOne is part of the Zacks Banks - Midwest industry. Click to get this free report MidWestOne Financial Group, Inc. (MOFG) : Free Stock Analysis Report First Western Financial, Inc. (MYFW) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
With this, the interest rates remain at a 22-year high of 5.25-5.5%. Hence, the MOFG stock gained. This holding company for MidWestOne Bank is expected to post quarterly earnings of $0.47 per share in its upcoming report, which represents a year-over-year change of -53.9%.
|
fbe4aad6-7900-49b3-a9d1-9429a5f7ca6c
|
713667.0
|
2023-12-11 00:00:00 UTC
|
HarborOne Bancorp (HONE) Stock Jumps 5.7%: Will It Continue to Soar?
|
DCOMP
|
https://www.nasdaq.com/articles/harborone-bancorp-hone-stock-jumps-5.7%3A-will-it-continue-to-soar
|
nan
|
nan
|
HarborOne Bancorp (HONE) shares ended the last trading session 5.7% higher at $11.88. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 1.5% gain over the past four weeks.
After 11 interest rate hikes, the Fed's decision to pause rate hikes for the third month drove bullish sentiments across markets amid the optimism of easing inflation pressures. With this, the interest rates remain at a 22-year high of 5.25-5.5%. Further, the central bank indicated three interest rate cuts by 2024-end. These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. Hence, the HONE stock gained.
This bank holding company is expected to post quarterly earnings of $0.16 per share in its upcoming report, which represents a year-over-year change of -23.8%. Revenues are expected to be $41.24 million, down 16% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For HarborOne Bancorp, the consensus EPS estimate for the quarter has been revised 3.3% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on HONE going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
HarborOne Bancorp belongs to the Zacks Banks - Northeast industry. Another stock from the same industry, Citizens Financial Services (CZFS), closed the last trading session 4.6% higher at $64.05. Over the past month, CZFS has returned 11.3%.
Citizens Financial Services' consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.62. Compared to the company's year-ago EPS, this represents a change of -17.8%. Citizens Financial Services currently boasts a Zacks Rank of #3 (Hold).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
HarborOne Bancorp, Inc. (HONE) : Free Stock Analysis Report
Citizens Financial Services Inc. (CZFS) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. This bank holding company is expected to post quarterly earnings of $0.16 per share in its upcoming report, which represents a year-over-year change of -23.8%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> HarborOne Bancorp belongs to the Zacks Banks - Northeast industry. Citizens Financial Services' consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.62. Click to get this free report HarborOne Bancorp, Inc. (HONE) : Free Stock Analysis Report Citizens Financial Services Inc. (CZFS) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> HarborOne Bancorp belongs to the Zacks Banks - Northeast industry. Click to get this free report HarborOne Bancorp, Inc. (HONE) : Free Stock Analysis Report Citizens Financial Services Inc. (CZFS) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
With this, the interest rates remain at a 22-year high of 5.25-5.5%. Hence, the HONE stock gained. Citizens Financial Services' consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.62.
|
7ca1f452-3d98-48e1-8cac-022a4b81dd2b
|
713668.0
|
2023-12-11 00:00:00 UTC
|
CANADA STOCKS- TSX eyes higher open on Fed rate cut hopes
|
DCOMP
|
https://www.nasdaq.com/articles/canada-stocks-tsx-eyes-higher-open-on-fed-rate-cut-hopes
|
nan
|
nan
|
Dec 14 (Reuters) - Futures tied to Canada's main stock index gained on Thursday as risk-on sentiment dominated the market a day after the U.S. Federal Reserve indicated that its historic policy tightening run is nearing its end and rate cuts may start next year.
December futures on the S&P/TSX index SXFc1 were up 0.6% at 7:13 a.m. ET (1213 GMT), mirroring gains in their U.S. counterparts. .N
The Fed left interest rates unchanged on Wednesday and U.S. central bank chief Jerome Powell said the historic tightening of monetary policy is likely over as inflation falls faster than expected and with a discussion of cuts in borrowing costs coming "into view."
17 of 19 Fed policymakers seeing rates lower by the end of 2024, and none seeing them higher.
Joining in on the cheer, most base metals and gold prices rallied, while crude oil prices advanced on a bigger-than-expected weekly withdrawal from U.S. crude storage and a weaker dollar. GOL/MET/LO/R
The Toronto Stock Exchange's S&P/TSX composite index .GSPTSE ended at its highest level in three months on Wednesday, with real estate and the utilities leading gains.
Among individual stocks to look out for, exchange operator TMX GroupX.TO said it had acquired an around 78% stake in U.S. data analytics company VettaFi Holdings for $848 million (C$1.14 billion).
Pembina PipelinePPL.TO said it would buy Enbridge's ENB.TO interests in the Alliance Pipeline, Aux Sable and NRGreen joint ventures for C$3.1 billion ($2.30 billion).
Canadian Natural ResourcesCNQ.TOexpects production to increase in 2024, while Cenovus EnergyCVE.TO forecast higher capital expenditure in 2024.
COMMODITIES AT 7:13 a.m. ET
Gold futures GCc2: $2,040.7; +2.7% GOL/
US crude CLc1: $70.67; +1.7% O/R
Brent crude LCOc1: $75.57; +1.8% O/R
($1= C$1.3446)
(Reporting by Shashwat Chauhan in Bengaluru;Editing by Ravi Prakash Kumar)
((Shashwat.Chauhan@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Dec 14 (Reuters) - Futures tied to Canada's main stock index gained on Thursday as risk-on sentiment dominated the market a day after the U.S. Federal Reserve indicated that its historic policy tightening run is nearing its end and rate cuts may start next year. .N The Fed left interest rates unchanged on Wednesday and U.S. central bank chief Jerome Powell said the historic tightening of monetary policy is likely over as inflation falls faster than expected and with a discussion of cuts in borrowing costs coming "into view." GOL/MET/LO/R The Toronto Stock Exchange's S&P/TSX composite index .GSPTSE ended at its highest level in three months on Wednesday, with real estate and the utilities leading gains.
|
Dec 14 (Reuters) - Futures tied to Canada's main stock index gained on Thursday as risk-on sentiment dominated the market a day after the U.S. Federal Reserve indicated that its historic policy tightening run is nearing its end and rate cuts may start next year. GOL/MET/LO/R The Toronto Stock Exchange's S&P/TSX composite index .GSPTSE ended at its highest level in three months on Wednesday, with real estate and the utilities leading gains. ET Gold futures GCc2: $2,040.7; +2.7% GOL/ US crude CLc1: $70.67; +1.7% O/R Brent crude LCOc1: $75.57; +1.8% O/R
|
Dec 14 (Reuters) - Futures tied to Canada's main stock index gained on Thursday as risk-on sentiment dominated the market a day after the U.S. Federal Reserve indicated that its historic policy tightening run is nearing its end and rate cuts may start next year. .N The Fed left interest rates unchanged on Wednesday and U.S. central bank chief Jerome Powell said the historic tightening of monetary policy is likely over as inflation falls faster than expected and with a discussion of cuts in borrowing costs coming "into view." GOL/MET/LO/R The Toronto Stock Exchange's S&P/TSX composite index .GSPTSE ended at its highest level in three months on Wednesday, with real estate and the utilities leading gains.
|
Dec 14 (Reuters) - Futures tied to Canada's main stock index gained on Thursday as risk-on sentiment dominated the market a day after the U.S. Federal Reserve indicated that its historic policy tightening run is nearing its end and rate cuts may start next year. .N The Fed left interest rates unchanged on Wednesday and U.S. central bank chief Jerome Powell said the historic tightening of monetary policy is likely over as inflation falls faster than expected and with a discussion of cuts in borrowing costs coming "into view." ET Gold futures GCc2: $2,040.7; +2.7% GOL/ US crude CLc1: $70.67; +1.7% O/R Brent crude LCOc1: $75.57; +1.8% O/R
|
efd28c52-e479-4fbe-8e98-d77554ac6d61
|
713669.0
|
2023-12-11 00:00:00 UTC
|
Are These 3 Cheap Dividend Stocks With High Yields Too Good to Be True?
|
DCOMP
|
https://www.nasdaq.com/articles/are-these-3-cheap-dividend-stocks-with-high-yields-too-good-to-be-true
|
nan
|
nan
|
When dividend stocks crash in value, that sends their yields up in the opposite direction. But there can be danger for investors who load up on a stock just because its yield is high.
Before buying shares of a high-yielding company, investors should take a quick look to see why the stock is underperforming, and why the yield is so high. That can avoid a lot of headaches and regrets later on.
Three dividend stocks that look cheap right now are Pfizer (NYSE: PFE), Enbridge (NYSE: ENB), and AT&T (NYSE: T). They have all been struggling this year, and their yields are now well above 5%. Let's look at why these payouts are so high and whether you should consider investing in any of these stocks today.
1. Pfizer: 5.7% yield
It's not typical for a top healthcare company to lose more than 40% of its value in a single year. But that's exactly the situation Pfizer is in right now. Investors are concerned about a decline in revenue from its COVID vaccine and product; plus, issues relating to its long-term growth are exacerbating worries about the business. The stock is down more than 43% year to date.
Due to the sharp sell-off, Pfizer's yield is now an incredibly high 5.7%. Since its dividend has remained the same ($0.41 per quarter), investors are now collecting the same dividend at a lower price, resulting in a higher yield.
There is good reason for the concern as Pfizer incurred a third-quarter loss of just under $2.4 billion, for the period ended Oct. 1. A big 42% drop in revenue wasn't accompanied with a big decline in expenses, leading to a disastrous performance for the company.
But the company is planning to shed $3.5 billion in costs from its books as it adapts to low demand for COVID products, which should lead to better results. There's some risk with Pfizer's business today, but investors shouldn't push the panic button just yet. The company is in the midst of a transition as it loads up on acquisitions and lessens its exposure to COVID products.
Although its payout ratio is around 90%, which isn't great, I would expect that to get better as the company trims costs and reduces the size of its COVID business. Pfizer would need to endure more difficult quarters and prove this is a troubling pattern before I would start to worry about the safety of the dividend.
For long-term investors, Pfizer can make for an attractive contrarian buy as it trades at just nine times its estimated future earnings.
2. Enbridge: 7.7% yield
Over the years, Enbridge has normally offered a high dividend yield. This year, it has gone even higher to 7.7%. Shares of the Canadian pipeline and energy company have declined 11% year to date as investors have grown less optimistic about the oil and gas industry. And since it's a top pipeline company, it has struggled right along with similar stocks.
But not only is the company not worried, it also recently increased its dividend. In November, Enbridge announced it would be raising its payout by 3%. This means that it has now raised its dividend for 29 consecutive years.
Enbridge benefits from locking in long-term contracts, which provide it with good stability. The company projects that its distributable cash flow, a key metric when it comes to evaluating a dividend's safety within the industry, will grow by 3% next year.
Earlier this year, Enbridge caught investors and analysts off-guard with plans to acquire three companies from Dominion Energy for $14 billion. Enbridge called the move a "once in a generation" opportunity to expand its operations in the U.S.
Analysts, however, grew concerned about rising debt levels. But Enbridge says that just 10% of its debt portfolio is vulnerable to possible changes in interest rates. And by 2025, in the first full year that it owns the new assets, they will already be accretive to its per-share metrics.
Overall, Enbridge isn't in bad shape, and it could look even better due to the acquisition of these businesses. The stock's incredibly high yield might not be too good to be true. Income investors may want to buy shares sooner rather than later as they are trading within just a few dollars of their 52-week lows.
3. AT&T: 6.6% yield
There has been no shortage of naysayers surrounding AT&T's dividend. The business has a high debt load, and concerns about it having to potentially spend billions to clean up lead-covered cables resulted in a steep decline for the stock.
While investors shouldn't ignore concerns about a large cleanup cost, that's a situation that could play out over the course of years. Any payout, assuming one is necessary, would likely span years as well. The end result is that it's too early to know how big of a problem it may be, but even if it is big, AT&T likely won't need to make a big outflow of cash all at once to address the issue.
In recent months, fears have begun to subside, and the stock has been rallying. Year to date, AT&T stock is now down just 8%. While that isn't great, it's better than earlier when it was looking like it may be on track to finish the year down around 30%.
Things looked a whole lot better in October, when the company posted its most recent quarterly results. While revenue of $30.4 billion for the period ended Sept. 30 grew at only 1%, the big takeaway for investors was that not only was AT&T still on track to hit its goal of $16 billion in free cash flow for the year, but it was also raising that target to $16.5 billion.
Given its strong results, AT&T isn't a stock whose yield looks to be in trouble. And with the stock rallying in recent months, investors may want to buy the shares before they rise even more and the yield shrinks. At just seven times its estimated future earnings, the stock looks like a steal of a deal.
Should you invest $1,000 in Pfizer right now?
Before you buy stock in Pfizer, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Pfizer wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
David Jagielski has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Enbridge and Pfizer. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Shares of the Canadian pipeline and energy company have declined 11% year to date as investors have grown less optimistic about the oil and gas industry. The company projects that its distributable cash flow, a key metric when it comes to evaluating a dividend's safety within the industry, will grow by 3% next year. The business has a high debt load, and concerns about it having to potentially spend billions to clean up lead-covered cables resulted in a steep decline for the stock.
|
Shares of the Canadian pipeline and energy company have declined 11% year to date as investors have grown less optimistic about the oil and gas industry. And with the stock rallying in recent months, investors may want to buy the shares before they rise even more and the yield shrinks. Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Pfizer wasn't one of them.
|
Enbridge: 7.7% yield Over the years, Enbridge has normally offered a high dividend yield. Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Pfizer wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 David Jagielski has no position in any of the stocks mentioned.
|
Enbridge: 7.7% yield Over the years, Enbridge has normally offered a high dividend yield. While revenue of $30.4 billion for the period ended Sept. 30 grew at only 1%, the big takeaway for investors was that not only was AT&T still on track to hit its goal of $16 billion in free cash flow for the year, but it was also raising that target to $16.5 billion. Before you buy stock in Pfizer, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Pfizer wasn't one of them.
|
dd9f4349-51e8-416f-84f6-c9b6f2fb221a
|
713670.0
|
2023-12-11 00:00:00 UTC
|
The 7 Most Undervalued Cannabis Stocks to Buy in December
|
DCOMP
|
https://www.nasdaq.com/articles/the-7-most-undervalued-cannabis-stocks-to-buy-in-december
|
nan
|
nan
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Given that cannabis legalization is considered a growth trend, you may assume that there are few (if any) undervalued cannabis stocks. However, whether we’re talking about undervalued in the traditional sense of the term, or undervalued using other metrics, there are plenty of names in the space that fit within this category.
There are companies either directly in the cannabis space, or in adjacent industries, that trade at low price-to-earnings multiples, or at a discount to book value. In addition, there are cannabis stocks to buy based upon the fact that they are undervalued relative to future potential.
What makes these types of cannabis stocks appealing is the fact that, given their under-appreciation by the market, small positive developments could drive big gains, given the potential for shares to surge both on improving fundamentals and price discovery.
This could especially prove to be the case if and when the U.S. federal marijuana laws are relaxed/reformed. With this in mind, let’s dive in and take a look at the seven most undervalued cannabis stocks currently out there.
Green Thumb Industries (GTBIF)
Source: Shutterstock
Green Thumb Industries (OTCMKTS:GTBIF) is a leading multi-state operator. MSOs are companies that own and operate regulated cannabis operations across multiple U.S. states. On a P/E and price-to-book basis, this cannabis purveyor does not appear undervalued.
GTBIF stock currently has a forward earnings multiple of 55.8, and trades at a 52% premium to book value. However, as analysts at Zuanic & Associates (a cannabis stock research firm) argued last month, this “blue chip among the larger MSOs,” strong growth potential, irrespective of whenever federal marijuana law reforms ever happen.
Green Thumb shares have performed solidly in 2023, surging by nearly 20%. A revenue and earning beat last quarter may suggest strong operating performance will continue in the quarters ahead. The company’s existing large presence would also likely give it a big first mover advantage if cannabis became fully legal on the U.S. federal level.
Innovative Industrial Properties (IIPR)
Source: Shutterstock
Innovative Industrial Properties (NYSE:IIPR) is not directly in the cannabis business. Rather, this real estate investment trust owns and leases out commercial property to state-licensed cannabis operators.
Using traditional metrics, IIPR stock is one of the undervalued cannabis stocks. This REIT trades at a price-to-funds from operations ratio of just 10.7, a discounted multiple compared to other industrial REITs. Admittedly, industry risks help to explain this valuation discrepancy.
However, if the Federal Reserve pivots on interest rates next year, IIPR, like other REITs, is likely to benefit from a re-expansion of its multiple. Revenue (up nearly 10% last quarter) and FFO (up 7.5% last quarter) also continue to grow at a steady clip. Potential upside from growth and lower interest rates, coupled with IIPR’s 8.13% dividend, could be the recipe for some strong long-term total returns.
Cannara Biotech (LOVFF)
Source: Shutterstock
Cannara Biotech (OTCMKTS:LOVFF) is a cannabis stock that I’ve previously noted as being undervalued and under-the-radar. Shares in this Canada-based vertically-integrated cannabis firm trade for only 11.4 times trailing twelve month earnings.
LOVFF stock sports this low multiple, although the company’s revenue increased by 93% last fiscal year (ending August 2023), with net income surging threefold during this same time frame. That’s not to say, of course, that the current fiscal year will bring similar growth.
But even if Cannara’s growth decelerates from here, greater awareness of this low-priced pot stock could result in outsized gains for shares. Keep in mind that Cannara is relatively less liquid than other names in the space. That may present challenges if you’re looking to enter/exit a position. However, if you are aware of the risks, it’s one of the top cannabis stocks to consider.
WM Technology (MAPS)
Source: Shutterstock
WM Technology (NASDAQ:MAPS) is one of the more unique cannabis stocks. This company’s shares make it a SaaS stock and a cannabis stock play.
After experiencing a big run-up in growth from the late-2010s through 2022, WM Technology has experienced a bit of a growth slump.
Yet despite entering a near-term rough patch, as InvestorPlace’s Jeremy Flint pointed out in October, long-term growth potential with MAPS stock remains high. According to Flint, the cannabis industry is expected to keep growing at a 25% annualized clip through the start of the next decade.
Such growth could be even stronger if federal cannabis law reforms arrive far sooner than currently anticipated. That’s not all. Operational strategy changes discussed on WM’s most recentearnings conference callcould result in better-than-expected results in the quarters ahead.
Marimed (MRMD)
Source: Shutterstock
Marimed (OTCMKTS:MRMD) is another cannabis stock that I’ve previously noted as being undervalued in the traditional sense. However, since last discussing this particular MSO, the company has gone from reporting positive earnings to reporting net quarterly losses.
So, why do I consider it still one of the undervalued names in the space? As Zuanic & Associates noted in the aforementioned research report, Marimed’s swing to quarterly losses has to do with its ramping up of growth-related capital expenditures.
By keeping its foot on the growth gas pedal, Marimed could quickly scale into one of the top MSOs. Once the company is ready to take its foot off the pedal, this could result in a dramatic increase in profits. This in turn could result in a big jump for MRMD shares. As also noted before, Marimed could be an ideal acquisition candidate, whenever federal cannabis laws finally change.
Newlake Capital Partners (NLCP)
Source: Shutterstock
Just like IIPR, Newlake Capital Partners (OTCMKTS:NLCP) is a cannabis REIT, owning and leasing out space to state-licensed cannabis producers. If IIPR is one of the undervalued cannabis stocks, one could say that Newlake is one of the deep value cannabis stocks.
Yes, NLCP stock trades at a discount, because of perceptions that it is a riskier cannabis REIT. However, as a Seeking Alpha commentator recently argued, this valuation discrepancy may more than cover the increased risks.
Based on valuation metrics, it’s easy to agree with this commentator’s take. NLCP trades at a P/FFO ratio of 7.9, well below that of IIPR. This REIT also trades at a 30% discount to book value, and sports a double-digit dividend yield (11.22%). The reporting of “less bad” results, lower interest rates, and cannabis law reforms are all catalysts that could drive an eventual big comeback for NLCP.
Turning Point Brands (TPB)
Source: Shutterstock
Back in April, I called Turning Point Brands (NYSE:TPB) one of the top cannabis stocks. Even as TPB has delivered a mixed price performance since then, I still consider it one of the cannabis stocks to buy. This is not a cannabis pure play.
Turning Point is primarily a tobacco company, with Stoker’s smokeless tobacco its most prominent brand. However, as the U.S. distributor/marketer of Zig Zag rolling papers, it has high exposure (pun intended) to the cannabis sector. Zig Zag sales have entered a slump recently, and the main play with TPB stock now has more to do with the continued growth of Stoker’s.
Still, if Turning Points pulls off a turnaround of the Zig Zag segment, low-priced TPB (trading for just 8.8 times earnings) could surge substantially, thanks to both profitability growth and multiple expansion.
On the date of publication, Thomas Niel did not hold (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
Thomas Niel, contributor for InvestorPlace.com, has been writing single-stock analysis for web-based publications since 2016.
More From InvestorPlace
Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
The #1 AI Investment Might Be This Company You’ve Never Heard Of
The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors
The post The 7 Most Undervalued Cannabis Stocks to Buy in December appeared first on InvestorPlace.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
What makes these types of cannabis stocks appealing is the fact that, given their under-appreciation by the market, small positive developments could drive big gains, given the potential for shares to surge both on improving fundamentals and price discovery. However, as analysts at Zuanic & Associates (a cannabis stock research firm) argued last month, this “blue chip among the larger MSOs,” strong growth potential, irrespective of whenever federal marijuana law reforms ever happen. The #1 AI Investment Might Be This Company You’ve Never Heard Of The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors The post The 7 Most Undervalued Cannabis Stocks to Buy in December appeared first on InvestorPlace.
|
Green Thumb Industries (GTBIF) Source: Shutterstock Green Thumb Industries (OTCMKTS:GTBIF) is a leading multi-state operator. Cannara Biotech (LOVFF) Source: Shutterstock Cannara Biotech (OTCMKTS:LOVFF) is a cannabis stock that I’ve previously noted as being undervalued and under-the-radar. Newlake Capital Partners (NLCP) Source: Shutterstock Just like IIPR, Newlake Capital Partners (OTCMKTS:NLCP) is a cannabis REIT, owning and leasing out space to state-licensed cannabis producers.
|
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Given that cannabis legalization is considered a growth trend, you may assume that there are few (if any) undervalued cannabis stocks. Using traditional metrics, IIPR stock is one of the undervalued cannabis stocks. If IIPR is one of the undervalued cannabis stocks, one could say that Newlake is one of the deep value cannabis stocks.
|
Using traditional metrics, IIPR stock is one of the undervalued cannabis stocks. Zig Zag sales have entered a slump recently, and the main play with TPB stock now has more to do with the continued growth of Stoker’s. Still, if Turning Points pulls off a turnaround of the Zig Zag segment, low-priced TPB (trading for just 8.8 times earnings) could surge substantially, thanks to both profitability growth and multiple expansion.
|
320d108a-de89-4d5f-a0d5-a42ccf95a240
|
713671.0
|
2023-12-11 00:00:00 UTC
|
Horizon Bancorp (HBNC) Surges 15.1%: Is This an Indication of Further Gains?
|
DCOMP
|
https://www.nasdaq.com/articles/horizon-bancorp-hbnc-surges-15.1%3A-is-this-an-indication-of-further-gains
|
nan
|
nan
|
Horizon Bancorp HBNC shares soared 15.1% in the last trading session to close at $13.81. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 8.3% gain over the past four weeks.
The Federal Reserve has signaled an end to the current rate hike cycle by keeping interest rates unchanged at the 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. The central bank has also indicated a 75 basis points cut in rates by 2024-end. The above-mentioned developments have attributed to bullish investor sentiments. Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This probably drove the HBNC stock higher in last day’s trading session.
This bank holding company is expected to post quarterly earnings of $0.29 per share in its upcoming report, which represents a year-over-year change of -39.6%. Revenues are expected to be $51.17 million, down 14% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Horizon Bancorp, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on HBNC going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Horizon Bancorp is part of the Zacks Banks - Northeast industry. SB Financial Group, Inc. SBFG, another stock in the same industry, closed the last trading session 0.5% lower at $14.21. SBFG has returned 5.1% in the past month.
For SB Financial Group, Inc., the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.35. This represents a change of -28.6% from what the company reported a year ago. SB Financial Group, Inc. currently has a Zacks Rank of #3 (Hold).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Horizon Bancorp (IN) (HBNC) : Free Stock Analysis Report
SB Financial Group, Inc. (SBFG) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This bank holding company is expected to post quarterly earnings of $0.29 per share in its upcoming report, which represents a year-over-year change of -39.6%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
This bank holding company is expected to post quarterly earnings of $0.29 per share in its upcoming report, which represents a year-over-year change of -39.6%. For SB Financial Group, Inc., the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.35. Click to get this free report Horizon Bancorp (IN) (HBNC) : Free Stock Analysis Report SB Financial Group, Inc. (SBFG) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Horizon Bancorp is part of the Zacks Banks - Northeast industry. Click to get this free report Horizon Bancorp (IN) (HBNC) : Free Stock Analysis Report SB Financial Group, Inc. (SBFG) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Horizon Bancorp HBNC shares soared 15.1% in the last trading session to close at $13.81. This bank holding company is expected to post quarterly earnings of $0.29 per share in its upcoming report, which represents a year-over-year change of -39.6%. For SB Financial Group, Inc., the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.35.
|
1589fb16-5b9c-4cfd-9296-5e48818e3ad8
|
713672.0
|
2023-12-11 00:00:00 UTC
|
Salesforce (CRM) & ADP Tie Up to Enhance Client Experience
|
DCOMP
|
https://www.nasdaq.com/articles/salesforce-crm-adp-tie-up-to-enhance-client-experience
|
nan
|
nan
|
Salesforce CRM and Automatic Data Processing ADP have announced an ambitious collaboration to reshape the landscape of client experiences. Leveraging Salesforce's Customer 360 platform, ADP aims to revolutionize its service delivery for more than 1 million clients globally.
The expanded alliance between the companies signifies a strategic merging of ADP's extensive human capital management (HCM) expertise and Salesforce's AI prowess. This synergy seeks to empower ADP's service teams by unifying data insights and enabling lightning-fast responses to client queries.
Maria Black, ADP's president and CEO, emphasized the significance of this collaboration in meeting client demands swiftly and effectively. "This expanded partnership furthers our ability to quickly translate client data into actionable insights," she stated. ADP's two-decade-long collaboration with Salesforce has continuously propelled them toward the forefront of client experience delivery.
Salesforce Inc. Price and Consensus
Salesforce Inc. price-consensus-chart | Salesforce Inc. Quote
Marc Benioff, chair and CEO of Salesforce, echoed this sentiment, highlighting the transformative power of AI in reshaping customer experiences. He emphasized ADP's leadership in harnessing AI, the Data Cloud and collaboration tools to redefine the client experience.
ADP's proactive stance in embracing technological advancements isn't new; having previously partnered with Salesforce to digitize its global sales team, they are now embarking on a new journey to revamp human capital management experiences. This collaboration promises a tailored approach, integrating ADP's data-driven insights with Salesforce's cutting-edge technology to furnish personalized, actionable insights for each client.
AI-powered analytics can provide deeper insights into workforce trends, enabling ADP's clients to make more informed decisions about talent management, resource allocation and strategic planning. Integrating AI into HCM services can streamline and automate various HR processes such as payroll management, talent acquisition and employee benefits administration, thereby reducing manual efforts and errors.
Salesforce Banks on GenAI for Growth
Salesforce is currently focusing on incorporating generative AI tools across its products as it looks to keep its business ahead of rivals. The company forayed into the generative AI space with the launch of Einstein GPT in March 2023. Einstein GPT is the world’s first generative AI CRM technology, which delivers AI-created content across every sales, services, marketing, commerce and IT interaction at hyperscale. With Einstein GPT, the company will transform customer experience with generative AI.
Upping its ante in the space, CRM launched its AI Cloud service in June 2023, which is the company’s one-stop AI-powered solution for enterprises looking to enhance productivity. In March 2023, CRM raised its venture capital fund for generative AI to $500 million from $250 million. With this enhanced fund, Salesforce Ventures, the company’s global investment arm, will support the generative AI ecosystem and promote the development of responsible and trusted technology.
In September 2023, Salesforce announced that it entered into a definitive agreement to acquire Airkit.ai, a startup that develops AI-powered customer service applications. Founded in 2017, Airkit.ai is a low-code platform that helps e-commerce companies build AI-powered customer engagement applications that can be deployed across multiple channels, including web, mobile and messaging apps.
This Zacks Rank #3 (Hold) company has been benefiting from the resilient demand for its cloud and business software offerings in an uncertain macroeconomic environment as customers continue their major digital transformation. Moreover, its bottom-line results are benefiting from ongoing cost-restructuring initiatives, which include the trimming of the workforce and a reduction in office spaces.
In third-quarter fiscal 2024, its revenues and non-GAAP earnings per share soared 11% and 51%, respectively, on a year-over-year basis.
Stocks to Consider
Some better-ranked stocks from the broader technology sector are Intel Corporation INTC and Aspen Technology, Inc. AZPN each carrying a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Intel’s fourth-quarter 2023 earnings has moved up 11 cents to 44 cents per share in the past 60 days. The consensus estimate for 2023 earnings has increased 55.7% to 95 cents in the past 60 days.
Intel's earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, delivering an average surprise of 136.3%. Shares of INTC have risen 69.1% year to date (YTD).
The Zacks Consensus Estimate for Aspen's second-quarter fiscal 2024 earnings has moved north 14 cents to $1.49 per share in the past 60 days. The consensus estimate for fiscal 2024 earnings has increased 5 cents to $6.63 per share in the past 60 days.
Aspen's earnings missed the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average negative surprise of 32.3%. Shares of AZPN have lost 1.5% YTD.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Intel Corporation (INTC) : Free Stock Analysis Report
Salesforce Inc. (CRM) : Free Stock Analysis Report
Automatic Data Processing, Inc. (ADP) : Free Stock Analysis Report
Aspen Technology, Inc. (AZPN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
ADP's proactive stance in embracing technological advancements isn't new; having previously partnered with Salesforce to digitize its global sales team, they are now embarking on a new journey to revamp human capital management experiences. AI-powered analytics can provide deeper insights into workforce trends, enabling ADP's clients to make more informed decisions about talent management, resource allocation and strategic planning. Integrating AI into HCM services can streamline and automate various HR processes such as payroll management, talent acquisition and employee benefits administration, thereby reducing manual efforts and errors.
|
Salesforce CRM and Automatic Data Processing ADP have announced an ambitious collaboration to reshape the landscape of client experiences. The Zacks Consensus Estimate for Aspen's second-quarter fiscal 2024 earnings has moved north 14 cents to $1.49 per share in the past 60 days. Click to get this free report Intel Corporation (INTC) : Free Stock Analysis Report Salesforce Inc. (CRM) : Free Stock Analysis Report Automatic Data Processing, Inc. (ADP) : Free Stock Analysis Report Aspen Technology, Inc. (AZPN) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Salesforce Inc. Price and Consensus Salesforce Inc. price-consensus-chart | Salesforce Inc. Quote Marc Benioff, chair and CEO of Salesforce, echoed this sentiment, highlighting the transformative power of AI in reshaping customer experiences. The Zacks Consensus Estimate for Intel’s fourth-quarter 2023 earnings has moved up 11 cents to 44 cents per share in the past 60 days. Click to get this free report Intel Corporation (INTC) : Free Stock Analysis Report Salesforce Inc. (CRM) : Free Stock Analysis Report Automatic Data Processing, Inc. (ADP) : Free Stock Analysis Report Aspen Technology, Inc. (AZPN) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
With Einstein GPT, the company will transform customer experience with generative AI. The consensus estimate for fiscal 2024 earnings has increased 5 cents to $6.63 per share in the past 60 days. Today, you can download 7 Best Stocks for the Next 30 Days.
|
81574189-1d48-4d6e-baec-2a29501c9ac6
|
713673.0
|
2023-12-11 00:00:00 UTC
|
Analysts Predict 25% Gains Ahead For VDE
|
DCOMP
|
https://www.nasdaq.com/articles/analysts-predict-25-gains-ahead-for-vde
|
nan
|
nan
|
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Vanguard Energy ETF (Symbol: VDE), we found that the implied analyst target price for the ETF based upon its underlying holdings is $144.11 per unit.
With VDE trading at a recent price near $114.94 per unit, that means that analysts see 25.37% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of VDE's underlying holdings with notable upside to their analyst target prices are Vertex Energy Inc. (Symbol: VTNR), NextDecade Corp (Symbol: NEXT), and Expro Group Holdings NV (Symbol: XPRO). Although VTNR has traded at a recent price of $3.37/share, the average analyst target is 98.81% higher at $6.70/share. Similarly, NEXT has 97.42% upside from the recent share price of $4.66 if the average analyst target price of $9.20/share is reached, and analysts on average are expecting XPRO to reach a target price of $23.20/share, which is 49.77% above the recent price of $15.49. Below is a twelve month price history chart comparing the stock performance of VTNR, NEXT, and XPRO:
Below is a summary table of the current analyst target prices discussed above:
NAME SYMBOL RECENT PRICE AVG. ANALYST 12-MO. TARGET % UPSIDE TO TARGET
Vanguard Energy ETF VDE $114.94 $144.11 25.37%
Vertex Energy Inc. VTNR $3.37 $6.70 98.81%
NextDecade Corp NEXT $4.66 $9.20 97.42%
Expro Group Holdings NV XPRO $15.49 $23.20 49.77%
Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.
10 ETFs With Most Upside To Analyst Targets »
Also see:
Dividend Stock Screener
AXS Dividend Growth Rate
WAIR Options Chain
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Vanguard Energy ETF VDE $114.94 $144.11 25.37% Vertex Energy Inc. VTNR $3.37 $6.70 98.81% NextDecade Corp NEXT $4.66 $9.20 97.42% Expro Group Holdings NV XPRO $15.49 $23.20 49.77% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? 10 ETFs With Most Upside To Analyst Targets » Also see: Dividend Stock Screener AXS Dividend Growth Rate WAIR Options Chain The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Three of VDE's underlying holdings with notable upside to their analyst target prices are Vertex Energy Inc. (Symbol: VTNR), NextDecade Corp (Symbol: NEXT), and Expro Group Holdings NV (Symbol: XPRO). Similarly, NEXT has 97.42% upside from the recent share price of $4.66 if the average analyst target price of $9.20/share is reached, and analysts on average are expecting XPRO to reach a target price of $23.20/share, which is 49.77% above the recent price of $15.49. Vanguard Energy ETF VDE $114.94 $144.11 25.37% Vertex Energy Inc. VTNR $3.37 $6.70 98.81% NextDecade Corp NEXT $4.66 $9.20 97.42% Expro Group Holdings NV XPRO $15.49 $23.20 49.77% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now?
|
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. Similarly, NEXT has 97.42% upside from the recent share price of $4.66 if the average analyst target price of $9.20/share is reached, and analysts on average are expecting XPRO to reach a target price of $23.20/share, which is 49.77% above the recent price of $15.49. A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past.
|
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. With VDE trading at a recent price near $114.94 per unit, that means that analysts see 25.37% upside for this ETF looking through to the average analyst targets of the underlying holdings. Vanguard Energy ETF VDE $114.94 $144.11 25.37% Vertex Energy Inc. VTNR $3.37 $6.70 98.81% NextDecade Corp NEXT $4.66 $9.20 97.42% Expro Group Holdings NV XPRO $15.49 $23.20 49.77% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now?
|
ce84fba5-481f-4811-b138-b3af4c94534d
|
713674.0
|
2023-12-11 00:00:00 UTC
|
Analysts Predict 10% Upside For The Holdings of XSD
|
DCOMP
|
https://www.nasdaq.com/articles/analysts-predict-10-upside-for-the-holdings-of-xsd
|
nan
|
nan
|
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR S&P Semiconductor ETF (Symbol: XSD), we found that the implied analyst target price for the ETF based upon its underlying holdings is $236.88 per unit.
With XSD trading at a recent price near $215.12 per unit, that means that analysts see 10.11% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of XSD's underlying holdings with notable upside to their analyst target prices are NVIDIA Corp (Symbol: NVDA), Marvell Technology Inc (Symbol: MRVL), and Credo Technology Group Holding Ltd (Symbol: CRDO). Although NVDA has traded at a recent price of $480.88/share, the average analyst target is 34.88% higher at $648.63/share. Similarly, MRVL has 19.67% upside from the recent share price of $57.21 if the average analyst target price of $68.46/share is reached, and analysts on average are expecting CRDO to reach a target price of $21.89/share, which is 17.87% above the recent price of $18.57. Below is a twelve month price history chart comparing the stock performance of NVDA, MRVL, and CRDO:
Combined, NVDA, MRVL, and CRDO represent 8.38% of the SPDR S&P Semiconductor ETF. Below is a summary table of the current analyst target prices discussed above:
NAME SYMBOL RECENT PRICE AVG. ANALYST 12-MO. TARGET % UPSIDE TO TARGET
SPDR S&P Semiconductor ETF XSD $215.12 $236.88 10.11%
NVIDIA Corp NVDA $480.88 $648.63 34.88%
Marvell Technology Inc MRVL $57.21 $68.46 19.67%
Credo Technology Group Holding Ltd CRDO $18.57 $21.89 17.87%
Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.
10 ETFs With Most Upside To Analyst Targets »
Also see:
Communications Services Dividend Stocks
AXAS Split History
Institutional Holders of Duke Energy
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
SPDR S&P Semiconductor ETF XSD $215.12 $236.88 10.11% NVIDIA Corp NVDA $480.88 $648.63 34.88% Marvell Technology Inc MRVL $57.21 $68.46 19.67% Credo Technology Group Holding Ltd CRDO $18.57 $21.89 17.87% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? 10 ETFs With Most Upside To Analyst Targets » Also see: Communications Services Dividend Stocks AXAS Split History Institutional Holders of Duke Energy The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Three of XSD's underlying holdings with notable upside to their analyst target prices are NVIDIA Corp (Symbol: NVDA), Marvell Technology Inc (Symbol: MRVL), and Credo Technology Group Holding Ltd (Symbol: CRDO). Below is a twelve month price history chart comparing the stock performance of NVDA, MRVL, and CRDO: Combined, NVDA, MRVL, and CRDO represent 8.38% of the SPDR S&P Semiconductor ETF. SPDR S&P Semiconductor ETF XSD $215.12 $236.88 10.11% NVIDIA Corp NVDA $480.88 $648.63 34.88% Marvell Technology Inc MRVL $57.21 $68.46 19.67% Credo Technology Group Holding Ltd CRDO $18.57 $21.89 17.87% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now?
|
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. Similarly, MRVL has 19.67% upside from the recent share price of $57.21 if the average analyst target price of $68.46/share is reached, and analysts on average are expecting CRDO to reach a target price of $21.89/share, which is 17.87% above the recent price of $18.57. A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past.
|
For the SPDR S&P Semiconductor ETF (Symbol: XSD), we found that the implied analyst target price for the ETF based upon its underlying holdings is $236.88 per unit. With XSD trading at a recent price near $215.12 per unit, that means that analysts see 10.11% upside for this ETF looking through to the average analyst targets of the underlying holdings. Below is a twelve month price history chart comparing the stock performance of NVDA, MRVL, and CRDO: Combined, NVDA, MRVL, and CRDO represent 8.38% of the SPDR S&P Semiconductor ETF.
|
c10130ab-9d6e-4296-8a31-a686894dedaf
|
713675.0
|
2023-12-11 00:00:00 UTC
|
Sandy Spring Bancorp (SASR) Stock Jumps 9.3%: Will It Continue to Soar?
|
DCOMP
|
https://www.nasdaq.com/articles/sandy-spring-bancorp-sasr-stock-jumps-9.3%3A-will-it-continue-to-soar
|
nan
|
nan
|
Sandy Spring Bancorp SASR shares soared 9.3% in the last trading session to close at $25.55. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 1% gain over the past four weeks.
The Federal Reserve has signaled an end to the current rate hike cycle by keeping interest rates unchanged at the 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. The central bank has also indicated a 75 basis points cut in rates by 2024-end. The above-mentioned developments have attributed to bullish investor sentiments. Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This probably drove the SASR stock higher in last day’s trading session.
This holding company for Sandy Spring Bank is expected to post quarterly earnings of $0.53 per share in its upcoming report, which represents a year-over-year change of -32.9%. Revenues are expected to be $101.53 million, down 16.1% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For Sandy Spring Bancorp, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on SASR going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Sandy Spring Bancorp is part of the Zacks Banks - Northeast industry. Territorial Bancorp TBNK, another stock in the same industry, closed the last trading session 5.2% higher at $9.60. TBNK has returned 23.1% in the past month.
For Territorial Bancorp, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.07. This represents a change of -82.1% from what the company reported a year ago. Territorial Bancorp currently has a Zacks Rank of #4 (Sell).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Sandy Spring Bancorp, Inc. (SASR) : Free Stock Analysis Report
Territorial Bancorp Inc. (TBNK) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This holding company for Sandy Spring Bank is expected to post quarterly earnings of $0.53 per share in its upcoming report, which represents a year-over-year change of -32.9%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
This holding company for Sandy Spring Bank is expected to post quarterly earnings of $0.53 per share in its upcoming report, which represents a year-over-year change of -32.9%. For Territorial Bancorp, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.07. Click to get this free report Sandy Spring Bancorp, Inc. (SASR) : Free Stock Analysis Report Territorial Bancorp Inc. (TBNK) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Sandy Spring Bancorp is part of the Zacks Banks - Northeast industry. Click to get this free report Sandy Spring Bancorp, Inc. (SASR) : Free Stock Analysis Report Territorial Bancorp Inc. (TBNK) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
This holding company for Sandy Spring Bank is expected to post quarterly earnings of $0.53 per share in its upcoming report, which represents a year-over-year change of -32.9%. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Sandy Spring Bancorp is part of the Zacks Banks - Northeast industry. Territorial Bancorp TBNK, another stock in the same industry, closed the last trading session 5.2% higher at $9.60.
|
202c17cc-0023-4aa6-917e-049387c0ea85
|
713676.0
|
2023-12-11 00:00:00 UTC
|
Analysts Predict 13% Gains Ahead For The Holdings of FXH
|
DCOMP
|
https://www.nasdaq.com/articles/analysts-predict-13-gains-ahead-for-the-holdings-of-fxh
|
nan
|
nan
|
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the First Trust Health Care AlphaDEX Fund ETF (Symbol: FXH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $115.05 per unit.
With FXH trading at a recent price near $101.95 per unit, that means that analysts see 12.85% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of FXH's underlying holdings with notable upside to their analyst target prices are Encompass Health Corp (Symbol: EHC), Becton, Dickinson & Co (Symbol: BDX), and Natera Inc (Symbol: NTRA). Although EHC has traded at a recent price of $66.97/share, the average analyst target is 17.81% higher at $78.90/share. Similarly, BDX has 16.20% upside from the recent share price of $240.47 if the average analyst target price of $279.42/share is reached, and analysts on average are expecting NTRA to reach a target price of $68.18/share, which is 13.48% above the recent price of $60.08. Below is a twelve month price history chart comparing the stock performance of EHC, BDX, and NTRA:
Below is a summary table of the current analyst target prices discussed above:
NAME SYMBOL RECENT PRICE AVG. ANALYST 12-MO. TARGET % UPSIDE TO TARGET
First Trust Health Care AlphaDEX Fund ETF FXH $101.95 $115.05 12.85%
Encompass Health Corp EHC $66.97 $78.90 17.81%
Becton, Dickinson & Co BDX $240.47 $279.42 16.20%
Natera Inc NTRA $60.08 $68.18 13.48%
Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.
10 ETFs With Most Upside To Analyst Targets »
Also see:
WEST shares outstanding history
SDPI Videos
VSAT Price Target
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
First Trust Health Care AlphaDEX Fund ETF FXH $101.95 $115.05 12.85% Encompass Health Corp EHC $66.97 $78.90 17.81% Becton, Dickinson & Co BDX $240.47 $279.42 16.20% Natera Inc NTRA $60.08 $68.18 13.48% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? 10 ETFs With Most Upside To Analyst Targets » Also see: WEST shares outstanding history SDPI Videos VSAT Price Target The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Three of FXH's underlying holdings with notable upside to their analyst target prices are Encompass Health Corp (Symbol: EHC), Becton, Dickinson & Co (Symbol: BDX), and Natera Inc (Symbol: NTRA). Similarly, BDX has 16.20% upside from the recent share price of $240.47 if the average analyst target price of $279.42/share is reached, and analysts on average are expecting NTRA to reach a target price of $68.18/share, which is 13.48% above the recent price of $60.08. First Trust Health Care AlphaDEX Fund ETF FXH $101.95 $115.05 12.85% Encompass Health Corp EHC $66.97 $78.90 17.81% Becton, Dickinson & Co BDX $240.47 $279.42 16.20% Natera Inc NTRA $60.08 $68.18 13.48% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now?
|
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. Similarly, BDX has 16.20% upside from the recent share price of $240.47 if the average analyst target price of $279.42/share is reached, and analysts on average are expecting NTRA to reach a target price of $68.18/share, which is 13.48% above the recent price of $60.08. A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past.
|
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. With FXH trading at a recent price near $101.95 per unit, that means that analysts see 12.85% upside for this ETF looking through to the average analyst targets of the underlying holdings. First Trust Health Care AlphaDEX Fund ETF FXH $101.95 $115.05 12.85% Encompass Health Corp EHC $66.97 $78.90 17.81% Becton, Dickinson & Co BDX $240.47 $279.42 16.20% Natera Inc NTRA $60.08 $68.18 13.48% Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now?
|
5d02a2c0-aa6c-4ff6-83a9-bce96b48d6c2
|
713677.0
|
2023-12-11 00:00:00 UTC
|
A Bull Market Is Coming: 1 Super Artificial Intelligence (AI) Stock to Buy Hand Over Fist and Hold Forever
|
DCOMP
|
https://www.nasdaq.com/articles/a-bull-market-is-coming%3A-1-super-artificial-intelligence-ai-stock-to-buy-hand-over-fist
|
nan
|
nan
|
The benchmark S&P 500 stock market index plunged into bear territory during 2022. But it has soared 29% from its low point set in October of that year, prompting some Wall Street analysts to call the beginning of a new bull market.
Not everyone agrees with that classification. Other experts think the S&P 500 has to reclaim its all-time high before the bear officially returns to hibernation. But here's the good news: After Wednesday's close, the index has to climb less than 2% to get there, so a new bull market could be right around the corner (by every definition). Therefore, now might be a great time for investors to buy quality stocks.
One to consider now is Oracle (NYSE: ORCL). The massive database software company just reported financial results for its fiscal 2024 second quarter (ended Nov. 30), and investors immediately sent its stock plunging by 9%. But that isn't the whole story. Here's why Oracle stock might represent one of the best long-term buying opportunities available right now.
In the midst of an incredible transition
Oracle is one of America's oldest technology companies. Founded in 1977 -- within a couple of years of both Apple and Microsoft -- its relational database management software was a smash hit in the 1980s. And in the 1990s, the company helped its customers prepare for the age of the internet.
That evolved into cloud services in the 2010s, and Oracle Cloud Infrastructure was officially launched in 2016 to deliver powerful computing power to customers through centralized data centers. Today, almost every organization in the world relies on the cloud in some capacity to run their operations online.
But we just entered the age of artificial intelligence (AI), and it could be Oracle's largest opportunity ever. AI is currently developed, trained, and deployed in the cloud, and it requires substantial amounts of computing power, which can only be delivered by specialized chips from providers like Nvidia. They can sell for over $40,000 each, so it's far too expensive for most businesses to build their own infrastructure.
Therefore, it's left to experienced data center operators like Oracle who can build and manage the infrastructure at scale. In fact, Oracle's latest second-generation data centers -- called Gen2 Cloud -- are constructed with automation at their core. Oracle Chairman Larry Ellison says this infrastructure is very cost efficient; in fact, he said there is no difference in costs between managing 10 data centers and 100 data centers thanks to autonomous technologies.
The result is a cheap and efficient experience for the end user. Earlier this year, Ellison said Oracle's Gen2 Cloud has become the No. 1 choice for running generative AI workloads because its proprietary GPU cluster technology has the highest performance, and the lowest cost, in the world.
The challenge of meeting demand
Demand is so great that Oracle now has a supply problem. Ellison said the company is in the process of expanding 66 of its existing data centers while building 100 more, because it has billions of dollars in contracted demand that it currently can't supply. Nvidia's advanced AI data center chips are one of the constraints. Oracle simply can't get its hands on enough of them.
Ellison said demand for the company's cloud infrastructure and generative AI services is increasing at an "astronomical rate." It showed up in the numbers; even while Oracle's total revenue grew by a modest 5% year over year (which disappointed investors), Oracle Cloud Infrastructure revenue soared 52% in the second quarter of Oracle's fiscal 2024.
It only accounted for $1.6 billion of the company's $12.9 billion in total sales, but Ellison said he expects the segment to grow above 50% for years to come, and at that pace it won't be long before it's the driving force behind Oracle overall.
Data source: Oracle. Infographic by The Motley Fool.
Oracle did, however, deliver a whopping 44% gain in net income (profit). As I touched on earlier, Gen2 infrastructure is incredibly cost efficient, so strong increases in the company's bottom line should continue especially once it completes construction of its latest data centers and brings them online. As Oracle Cloud Infrastructure becomes a larger part of Oracle's business, it will likely boost the company's profitability overall.
Why Oracle stock is a screaming buy
Oracle has attracted some of the leading developers of AI, including Adept AI, Cohere, and even Elon Musk's xAI, which just launched its large language model called Grok. These start-ups have already committed to spending billions of dollars on Gen2 Cloud capacity, and in the case of xAI, Musk already wants significantly more GPUs than Oracle can possibly provide right now. Ellison wasn't kidding when he said demand was astronomical.
With that in mind, Oracle stock looks extremely attractive right now. The company has generated $3.62 in trailing-12-month earnings per share, and based on its current stock price of $105, it trades at a price-to-earnings (P/E) ratio of 29.
By comparison, Microsoft, another cloud-focused AI stock, trades at a much higher P/E ratio of 35.9. Oracle stock would have to gain 24% from here just to catch up, which makes it seem like a bargain at the current price especially considering the company's rapid earnings growth.
Longer-term, AI is going to be one of the greatest financial opportunities in the tech sector's history. A report by research and consulting firm McKinsey & Company suggests 70% of companies will use AI by 2030, adding $13 trillion to global economic output. Considering Oracle's Gen2 Cloud is the top choice for generative AI workloads, its stock will likely be a great place for your money, especially at this price.
Should you invest $1,000 in Oracle right now?
Before you buy stock in Oracle, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Oracle wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Anthony Di Pizio has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Apple, Microsoft, Nvidia, and Oracle. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
AI is currently developed, trained, and deployed in the cloud, and it requires substantial amounts of computing power, which can only be delivered by specialized chips from providers like Nvidia. Ellison said the company is in the process of expanding 66 of its existing data centers while building 100 more, because it has billions of dollars in contracted demand that it currently can't supply. As I touched on earlier, Gen2 infrastructure is incredibly cost efficient, so strong increases in the company's bottom line should continue especially once it completes construction of its latest data centers and brings them online.
|
The massive database software company just reported financial results for its fiscal 2024 second quarter (ended Nov. 30), and investors immediately sent its stock plunging by 9%. That evolved into cloud services in the 2010s, and Oracle Cloud Infrastructure was officially launched in 2016 to deliver powerful computing power to customers through centralized data centers. It showed up in the numbers; even while Oracle's total revenue grew by a modest 5% year over year (which disappointed investors), Oracle Cloud Infrastructure revenue soared 52% in the second quarter of Oracle's fiscal 2024.
|
It showed up in the numbers; even while Oracle's total revenue grew by a modest 5% year over year (which disappointed investors), Oracle Cloud Infrastructure revenue soared 52% in the second quarter of Oracle's fiscal 2024. Why Oracle stock is a screaming buy Oracle has attracted some of the leading developers of AI, including Adept AI, Cohere, and even Elon Musk's xAI, which just launched its large language model called Grok. Before you buy stock in Oracle, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Oracle wasn't one of them.
|
The massive database software company just reported financial results for its fiscal 2024 second quarter (ended Nov. 30), and investors immediately sent its stock plunging by 9%. Before you buy stock in Oracle, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Oracle wasn't one of them. The Motley Fool has positions in and recommends Apple, Microsoft, Nvidia, and Oracle.
|
465a03ff-1161-40ac-a4dc-8771d86b3138
|
713678.0
|
2023-12-11 00:00:00 UTC
|
Shore Bancshares (SHBI) Soars 7.3%: Is Further Upside Left in the Stock?
|
DCOMP
|
https://www.nasdaq.com/articles/shore-bancshares-shbi-soars-7.3%3A-is-further-upside-left-in-the-stock
|
nan
|
nan
|
Shore Bancshares (SHBI) shares soared 7.3% in the last trading session to close at $13.80. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 6.2% gain over the past four weeks.
After 11 interest rate hikes, the Fed's decision to pause rate hikes for the third month drove bullish sentiments across markets amid the optimism of easing inflation pressures. With this, the interest rates remain at a 22-year high of 5.25-5.5%. Further, the central bank indicated three interest rate cuts by 2024-end. These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. Hence, the SHBI stock gained.
This bank holding company is expected to post quarterly earnings of $0.38 per share in its upcoming report, which represents a year-over-year change of -17.4%. Revenues are expected to be $51.17 million, up 55.8% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Shore Bancshares, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on SHBI going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Shore Bancshares is part of the Zacks Banks - Northeast industry. Midland States Bancorp (MSBI), another stock in the same industry, closed the last trading session 4.8% higher at $26.16. MSBI has returned 3.2% in the past month.
For Midland States Bancorp, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.79. This represents a change of -7.1% from what the company reported a year ago. Midland States Bancorp currently has a Zacks Rank of #3 (Hold).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Shore Bancshares Inc (SHBI) : Free Stock Analysis Report
Midland States Bancorp, Inc. (MSBI) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. This bank holding company is expected to post quarterly earnings of $0.38 per share in its upcoming report, which represents a year-over-year change of -17.4%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Midland States Bancorp (MSBI), another stock in the same industry, closed the last trading session 4.8% higher at $26.16. For Midland States Bancorp, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.79. Click to get this free report Shore Bancshares Inc (SHBI) : Free Stock Analysis Report Midland States Bancorp, Inc. (MSBI) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Shore Bancshares is part of the Zacks Banks - Northeast industry. Click to get this free report Shore Bancshares Inc (SHBI) : Free Stock Analysis Report Midland States Bancorp, Inc. (MSBI) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
With this, the interest rates remain at a 22-year high of 5.25-5.5%. Hence, the SHBI stock gained. This bank holding company is expected to post quarterly earnings of $0.38 per share in its upcoming report, which represents a year-over-year change of -17.4%.
|
c71cf290-2b2f-4155-9db3-f01f7d1f7dd6
|
713679.0
|
2023-12-11 00:00:00 UTC
|
Vertex (VRTX) Hits Record High on Non-Opioid Pain Drug Data
|
DCOMP
|
https://www.nasdaq.com/articles/vertex-vrtx-hits-record-high-on-non-opioid-pain-drug-data
|
nan
|
nan
|
Vertex Pharmaceuticals Incorporated VRTX announced encouraging data from a phase II study that demonstrated a promising safety and efficacy profile of its investigational non-opioid pain medicine, VX-548, for treating painful diabetic peripheralneuropathy (DPN) across all doses. DPN is a type of neuropathic pain (damage to nerves) caused by diabetes.
The data from the phase II dose-ranging study showed that VX-548, a novel first-in-class NaV1.8 inhibitor, led to a statistically significant and clinically meaningful reduction in the primary endpoint of change from baseline in the Numeric Pain Rating Scale (NPRS), a measure of pain intensity in adults.
The mean change in NPRS at Week 12 was -2.26, -2.11 and -2.18 at the 69 mg, 46 mg and 23 mg doses, respectively. In the active reference arm of pregabalin (neuropathic pain relief tablets), the mean change from baseline in NPRS at Week 12 was -2.09. In all the dose arms, sustained mean reductions in pain were observed from baseline starting at Week 1. The pain intensity continued to decrease until Week 5 and was then maintained throughout the treatment period of 12 weeks. More than 30% of patients treated with VX-548 achieved more than 50% reduction in pain in all dose groups, while more than 20% of patients reported a 70% decline in pain in 69 mg and 46 mg dose arms. VX-548 was generally well tolerated in the study, with no serious adverse events.
Based on the positive data from the phase II study, Vertex plans to move VX-548 to pivotal development for DPN.
Vertex also initiated the second phase study of VX-548 in patients with painful lumbosacral radiculopathy, another form of peripheral neuropathic pain (caused by damage to nerves).
Investors are paying a lot of attention to VX-548, which, they believe, has blockbuster potential. It can change the standard of care for neuropathic pain, an area with limited treatment options, mostly highly addictive opioid-based medications. Following the positive data, shares of Vertex were up 13.2% on Wednesday, hitting a 52-week high price of $405.36.
So far this year, the stock has risen 40.7% against the industry’s 19.2% decline.
Image Source: Zacks Investment Research
VX-548 is also being evaluated in two pivotal phase III acute pain studies, one following bunionectomy surgery and the other following abdominoplasty surgery. Data from the pivotal studies are expected in first-quarter 2024.
Though Vertex enjoys a dominant position in the cystic fibrosis (CF) market, it has seen success in its non-CF pipeline candidates’ development lately.
Last week, the FDA approved Vertex and partner CRISPR Therapeutics’ CRSP Casgevy (exagamglogene autotemcel) for the treatment of sickle cell disease (SCD) for patients aged 12 years and older with recurrent vaso-occlusive crises. Casgevy became the first CRISPR-based gene-editing therapy to be approved in the United States.
CRISPR and Vertex have also developed Cagevy for the treatment of transfusion-dependent beta thalassemia (TDT) in the United States. A regulatory filing for the use of Casgevy for this indication is currently under review. A decision from the FDA is expected on Mar 30, 2024. Last month, Casgevy was approved in the United Kingdom for treating both SCD and TDT indications.
This week, Vertex also struck a non-exclusive licensing deal with Editas Medicine EDIT for using the latter’s Cas9 gene-editing technology for developing Casgevy. Editas’Cas9 gene editing tool uses an enzyme called Cas9 to target genetic defects that cause specific diseases, thus providing a precise and targeted approach to gene editing medicines.
Zacks Rank and Stock to Consider
Vertex currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Vertex Pharmaceuticals Incorporated Price and Consensus
Vertex Pharmaceuticals Incorporated price-consensus-chart | Vertex Pharmaceuticals Incorporated Quote
A better-ranked biotech stock is Dynavax Technologies Corporation DVAX, carrying a Zacks Rank of 2 (Buy).
In the past 60 days, estimates for Dynavax Technologies’ 2023 loss per share have narrowed from 23 cents to 12 cents. During the same period, earnings per share estimates for 2024 have improved from 3 cents to 18 cents. Year to date, shares of DVAX have rallied 26.4%.
DVAX’s earnings beat estimates in two of the trailing four quarters and missed the mark in the other two, delivering an average surprise of 293.21%.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Dynavax Technologies Corporation (DVAX) : Free Stock Analysis Report
Vertex Pharmaceuticals Incorporated (VRTX) : Free Stock Analysis Report
Editas Medicine, Inc. (EDIT) : Free Stock Analysis Report
CRISPR Therapeutics AG (CRSP) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
It can change the standard of care for neuropathic pain, an area with limited treatment options, mostly highly addictive opioid-based medications. Last week, the FDA approved Vertex and partner CRISPR Therapeutics’ CRSP Casgevy (exagamglogene autotemcel) for the treatment of sickle cell disease (SCD) for patients aged 12 years and older with recurrent vaso-occlusive crises. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Last week, the FDA approved Vertex and partner CRISPR Therapeutics’ CRSP Casgevy (exagamglogene autotemcel) for the treatment of sickle cell disease (SCD) for patients aged 12 years and older with recurrent vaso-occlusive crises. Vertex Pharmaceuticals Incorporated Price and Consensus Vertex Pharmaceuticals Incorporated price-consensus-chart | Vertex Pharmaceuticals Incorporated Quote A better-ranked biotech stock is Dynavax Technologies Corporation DVAX, carrying a Zacks Rank of 2 (Buy). Click to get this free report Dynavax Technologies Corporation (DVAX) : Free Stock Analysis Report Vertex Pharmaceuticals Incorporated (VRTX) : Free Stock Analysis Report Editas Medicine, Inc. (EDIT) : Free Stock Analysis Report CRISPR Therapeutics AG (CRSP) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Vertex Pharmaceuticals Incorporated VRTX announced encouraging data from a phase II study that demonstrated a promising safety and efficacy profile of its investigational non-opioid pain medicine, VX-548, for treating painful diabetic peripheralneuropathy (DPN) across all doses. Vertex Pharmaceuticals Incorporated Price and Consensus Vertex Pharmaceuticals Incorporated price-consensus-chart | Vertex Pharmaceuticals Incorporated Quote A better-ranked biotech stock is Dynavax Technologies Corporation DVAX, carrying a Zacks Rank of 2 (Buy). Click to get this free report Dynavax Technologies Corporation (DVAX) : Free Stock Analysis Report Vertex Pharmaceuticals Incorporated (VRTX) : Free Stock Analysis Report Editas Medicine, Inc. (EDIT) : Free Stock Analysis Report CRISPR Therapeutics AG (CRSP) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
In the active reference arm of pregabalin (neuropathic pain relief tablets), the mean change from baseline in NPRS at Week 12 was -2.09. Based on the positive data from the phase II study, Vertex plans to move VX-548 to pivotal development for DPN. Last month, Casgevy was approved in the United Kingdom for treating both SCD and TDT indications.
|
9f3ae246-5fee-40e0-80d6-99ea8f80227e
|
713680.0
|
2023-12-11 00:00:00 UTC
|
Benefits of Moderna and Merck melanoma vaccine plus Keytruda extend to three years
|
DCOMP
|
https://www.nasdaq.com/articles/benefits-of-moderna-and-merck-melanoma-vaccine-plus-keytruda-extend-to-three-years
|
nan
|
nan
|
By Michael Erman and Patrick Wingrove
Dec 14 (Reuters) - An experimental messenger RNA cancer vaccine developed by Moderna MRNA.O and Merck & Co MRK.N paired with Merck's Keytruda cut the chance of recurrence or death from melanoma by half after three years, showing that benefits demonstrated a year ago have held up over time.
Moderna shares rose 11% in morning trading after having fallen 50% this year due to waning demand for COVID vaccines and questions about how well its mRNA influenza shot works compared to the current standard and whether the cancer vaccine will be successful. Two analysts said this data was a positive but incremental step.
Merck shares fell by 0.6% to $105.70 in morning trading.
The combination of the personalized cancer vaccine and Merck's blockbuster immunotherapy cut the risk of recurrence or death of the most deadly skin cancer by 49% compared with Keytruda alone in the midstage trial, the companies said.
The results come at a median point of three years into the study involving 157 patients with stage III/IV melanoma whose tumors were surgically removed before being treated with either the drug/vaccine combination or Keytruda alone with the aim of delaying disease recurrence.
A year earlier, the study had shown a 44% reduction of recurrence or death.
"The durability of the responses is really strong, they're essentially rock solid through this time," Moderna President Stephen Hoge said in an interview. "This is a pretty significant improvement, a pretty dramatic improvement over standard of care with just Keytruda alone."
Morningstar analyst Karen Andersen said the new results could help Moderna and Merck make a case to the U.S. Food and Drug Administration for accelerated approval based on its midstage data.
The combination treatment has won U.S. breakthrough therapy and European Medicines Agency PRIME scheme designations, regulatory programs that aim to speed development of innovative treatments. Still, Hoge said that even with the new data it would be some time before the companies can file for approval of the treatment.
The vaccine is custom-built based on an analysis of a patient's tumors after surgical removal. The vaccines are designed to train the immune system to recognize and attack specific mutations in cancer cells.
Moderna is currently building a dedicated facility in Massachusetts to produce the vaccine at commercial scale, which it hopes to finish sometime next year.
"We need to make sure that we have that near completion before we could even contemplate asking for approval," Hoge said.
He said the companies are engaging with regulators globally on the pathway for approval for the product.
They have already begun a confirmatory late-stage trial for the combination in melanoma, as well as one in non-small cell lung cancer that is already enrolling patients.
(Reporting by Michael Erman; Editing by Bill Berkrot and Mark Porter)
((michael.erman@thomsonreuters.com;))
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
The results come at a median point of three years into the study involving 157 patients with stage III/IV melanoma whose tumors were surgically removed before being treated with either the drug/vaccine combination or Keytruda alone with the aim of delaying disease recurrence. Morningstar analyst Karen Andersen said the new results could help Moderna and Merck make a case to the U.S. Food and Drug Administration for accelerated approval based on its midstage data. Moderna is currently building a dedicated facility in Massachusetts to produce the vaccine at commercial scale, which it hopes to finish sometime next year.
|
By Michael Erman and Patrick Wingrove Dec 14 (Reuters) - An experimental messenger RNA cancer vaccine developed by Moderna MRNA.O and Merck & Co MRK.N paired with Merck's Keytruda cut the chance of recurrence or death from melanoma by half after three years, showing that benefits demonstrated a year ago have held up over time. The results come at a median point of three years into the study involving 157 patients with stage III/IV melanoma whose tumors were surgically removed before being treated with either the drug/vaccine combination or Keytruda alone with the aim of delaying disease recurrence. The vaccine is custom-built based on an analysis of a patient's tumors after surgical removal.
|
By Michael Erman and Patrick Wingrove Dec 14 (Reuters) - An experimental messenger RNA cancer vaccine developed by Moderna MRNA.O and Merck & Co MRK.N paired with Merck's Keytruda cut the chance of recurrence or death from melanoma by half after three years, showing that benefits demonstrated a year ago have held up over time. Moderna shares rose 11% in morning trading after having fallen 50% this year due to waning demand for COVID vaccines and questions about how well its mRNA influenza shot works compared to the current standard and whether the cancer vaccine will be successful. The combination of the personalized cancer vaccine and Merck's blockbuster immunotherapy cut the risk of recurrence or death of the most deadly skin cancer by 49% compared with Keytruda alone in the midstage trial, the companies said.
|
The combination of the personalized cancer vaccine and Merck's blockbuster immunotherapy cut the risk of recurrence or death of the most deadly skin cancer by 49% compared with Keytruda alone in the midstage trial, the companies said. The results come at a median point of three years into the study involving 157 patients with stage III/IV melanoma whose tumors were surgically removed before being treated with either the drug/vaccine combination or Keytruda alone with the aim of delaying disease recurrence. Still, Hoge said that even with the new data it would be some time before the companies can file for approval of the treatment.
|
a5fded60-b1bd-438a-abd3-7053eb86dd98
|
713681.0
|
2023-12-11 00:00:00 UTC
|
Energy Sector Update for 12/14/2023: SDRL, BP, SHEL, XLE, USO, UNG
|
DCOMP
|
https://www.nasdaq.com/articles/energy-sector-update-for-12-14-2023%3A-sdrl-bp-shel-xle-uso-ung
|
nan
|
nan
|
Energy stocks were gaining pre-bell Thursday, as the Energy Select Sector SPDR Fund (XLE) was up 1.4% recently.
The United States Oil Fund (USO) was 2.6% higher, and the United States Natural Gas Fund (UNG) was up 0.8%.
Front-month US West Texas Intermediate crude oil was up almost 3% at $71.52 per barrel at the New York Mercantile Exchange. Global benchmark Brent gained 2.9% to $76.38 per barrel, and natural gas futures were 1.8% higher at $2.38 per 1 million BTU.
Seadrill (SDRL) was advancing by more than 6% after saying it has completed a $250 million share-buyback program.
BP (BP) was more than 2% higher after saying in a regulatory filing it will compel former Chief Executive Bernard Looney to return part of his remuneration, with the total affected reaching about 32.4 million pounds ($41.2 million).
Shell (SHEL) has agreed to sell its 30% stake in the Linnorm gas discovery in the Norwegian Sea to Equinor (EQNR), the companies said. Shell was up more than 1% in recent premarket activity.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Front-month US West Texas Intermediate crude oil was up almost 3% at $71.52 per barrel at the New York Mercantile Exchange. Global benchmark Brent gained 2.9% to $76.38 per barrel, and natural gas futures were 1.8% higher at $2.38 per 1 million BTU. Shell (SHEL) has agreed to sell its 30% stake in the Linnorm gas discovery in the Norwegian Sea to Equinor (EQNR), the companies said.
|
The United States Oil Fund (USO) was 2.6% higher, and the United States Natural Gas Fund (UNG) was up 0.8%. Global benchmark Brent gained 2.9% to $76.38 per barrel, and natural gas futures were 1.8% higher at $2.38 per 1 million BTU. BP (BP) was more than 2% higher after saying in a regulatory filing it will compel former Chief Executive Bernard Looney to return part of his remuneration, with the total affected reaching about 32.4 million pounds ($41.2 million).
|
The United States Oil Fund (USO) was 2.6% higher, and the United States Natural Gas Fund (UNG) was up 0.8%. Global benchmark Brent gained 2.9% to $76.38 per barrel, and natural gas futures were 1.8% higher at $2.38 per 1 million BTU. BP (BP) was more than 2% higher after saying in a regulatory filing it will compel former Chief Executive Bernard Looney to return part of his remuneration, with the total affected reaching about 32.4 million pounds ($41.2 million).
|
Energy stocks were gaining pre-bell Thursday, as the Energy Select Sector SPDR Fund (XLE) was up 1.4% recently. The United States Oil Fund (USO) was 2.6% higher, and the United States Natural Gas Fund (UNG) was up 0.8%. Front-month US West Texas Intermediate crude oil was up almost 3% at $71.52 per barrel at the New York Mercantile Exchange.
|
9a2a0ae9-5f1c-4c0e-8d4e-17f39521f299
|
713682.0
|
2023-12-11 00:00:00 UTC
|
General Mills (GIS) Q2 Earnings Coming Up: Factors to Note
|
DCOMP
|
https://www.nasdaq.com/articles/general-mills-gis-q2-earnings-coming-up%3A-factors-to-note
|
nan
|
nan
|
General Mills, Inc. GIS is likely to register top-line and bottom-line growth when it reports second-quarter fiscal 2024 earnings on Dec 20. The Zacks Consensus Estimate for revenues is pegged at $5.4 billion, suggesting an increase of 2.6% from the prior-year quarter’s reported figure.
The consensus mark for quarterly earnings has remained unchanged in the past 30 days at $1.16 per share. This indicates a rise of 5.5% from the year-ago quarter’s reported figure. GIS has a trailing four-quarter earnings surprise of 4.5%, on average.
Factors to Note
General Mills’ commitment toward its three priorities as part of its Accelerate strategy is likely to have aided in the quarter under review. These include competing efficiently through brand building and innovation; enhancing the supply chain by boosting Holistic Margin Management cost savings and curtailing costs and undertaking efficient capital allocation; rewarding shareholders and staying committed to reshaping the portfolio via strategic acquisitions and divestitures.
General Mills, Inc. Price, Consensus and EPS Surprise
General Mills, Inc. price-consensus-eps-surprise-chart | General Mills, Inc. Quote
The company has been gaining from favorable net price realization. For fiscal 2024, management expects organic net sales growth to be driven by robust marketing, innovation and in-store support. Also, gains from net price realization through the company’s Strategic Revenue Management initiative are likely to have aided. These upsides bode well for the quarter under review. Our model suggests price/mix to be up 3.8% in the second quarter.
Notably, General Mills’ North America Foodservice business has been performing well, gaining from high consumer traffic in hospitality, travel, education, and other non-restaurant away-from-home food channels. We expect segment sales to increase 3.5% year over year in the to-be-reported quarter.
That said, the company’s Pet segment retail sales in the first quarter of fiscal 2024 were somewhat affected by pet parents’ shift toward value products and channels, along with smaller pack sizes. Additionally, the company has been witnessing challenges in the wet food and treats categories, with pet parents spending more time at work or away from home. Management expects the difficult category dynamics to persist in the Pet segment throughout fiscal 2024 as it does not see any major change in economic viewpoint for pet parents in the near term. This raises concerns about the quarter under review as well.
Apart from this, General Mills input cost inflation has been moderating. On its first-quarterearnings call management stated that the biggest factors impacting its performance in fiscal 2024 are likely to be consumers’ economic status, the moderating rate of cost inflation and the rising stability of supply-chain status. However, continued brand investments may have escalated the SG&A expenses in the second quarter.
What the Zacks Model Unveils
Our proven model does not conclusively predict an earnings beat for General Mills this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is the case here.
General Mills has an Earnings ESP of -0.86% and carries a Zacks Rank #4 (Sell). You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks With the Favorable Combination
Here are three companies worth considering as our model shows that these also have the correct combination to beat on earnings this time:
Lamb Weston LW has an Earnings ESP of +0.71% and a Zacks Rank #2. The company is likely to witness top-and-bottom-line growth when it reports second-quarter fiscal 2024 results. The Zacks Consensus Estimate for Lamb Weston’s quarterly revenues is pegged at $1.7 billion, which suggests a rise of 32.6% from the figure reported in the prior-year quarter. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Lamb Weston’s quarterly EPS has remained unchanged in the past 30 days at $1.40, which suggests an increase of 9.4% from the year-ago quarter’s level. LW has a trailing four-quarter earnings surprise of 46.2%, on average.
Mondelez International MDLZ currently has an Earnings ESP of +1.86% and a Zacks Rank #3. The company is likely to register top-and-bottom-line growth when it reports fourth-quarter 2023 numbers. The Zacks Consensus Estimate for Mondelez’s quarterly revenues is pegged at $9.2 billion, indicating a rise of 5.9% from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for Mondelez’s quarterly earnings of 76 cents suggests an increase of 4.1% from the year-ago quarter’s levels. MDLZ has a trailing four-quarter earnings surprise of 7.3%, on average.
Colgate-Palmolive CL currently has an Earnings ESP of +0.95% and a Zacks Rank of 3. The company is likely to register top-line and bottom-line increases when it reports fourth-quarter 2023 numbers. The Zacks Consensus Estimate for Colgate’s quarterly revenues is pegged at $4.9 billion, indicating a rise of 5.3% from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for Colgate’s quarterly earnings of 85 cents suggests an increase of 10.4% from the year-ago quarter’s levels. CL has a trailing four-quarter earnings surprise of 3.6%, on average.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
General Mills, Inc. (GIS) : Free Stock Analysis Report
Colgate-Palmolive Company (CL) : Free Stock Analysis Report
Mondelez International, Inc. (MDLZ) : Free Stock Analysis Report
Lamb Weston (LW) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Notably, General Mills’ North America Foodservice business has been performing well, gaining from high consumer traffic in hospitality, travel, education, and other non-restaurant away-from-home food channels. Additionally, the company has been witnessing challenges in the wet food and treats categories, with pet parents spending more time at work or away from home. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
The Zacks Consensus Estimate for Lamb Weston’s quarterly revenues is pegged at $1.7 billion, which suggests a rise of 32.6% from the figure reported in the prior-year quarter. The Zacks Consensus Estimate for Lamb Weston’s quarterly EPS has remained unchanged in the past 30 days at $1.40, which suggests an increase of 9.4% from the year-ago quarter’s level. Click to get this free report General Mills, Inc. (GIS) : Free Stock Analysis Report Colgate-Palmolive Company (CL) : Free Stock Analysis Report Mondelez International, Inc. (MDLZ) : Free Stock Analysis Report Lamb Weston (LW) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The Zacks Consensus Estimate for Lamb Weston’s quarterly revenues is pegged at $1.7 billion, which suggests a rise of 32.6% from the figure reported in the prior-year quarter. The Zacks Consensus Estimate for Mondelez’s quarterly earnings of 76 cents suggests an increase of 4.1% from the year-ago quarter’s levels. Click to get this free report General Mills, Inc. (GIS) : Free Stock Analysis Report Colgate-Palmolive Company (CL) : Free Stock Analysis Report Mondelez International, Inc. (MDLZ) : Free Stock Analysis Report Lamb Weston (LW) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
General Mills, Inc. GIS is likely to register top-line and bottom-line growth when it reports second-quarter fiscal 2024 earnings on Dec 20. General Mills, Inc. Price, Consensus and EPS Surprise General Mills, Inc. price-consensus-eps-surprise-chart | General Mills, Inc. Quote The company has been gaining from favorable net price realization.
|
305d47ad-612e-49d4-9709-239dff6caaf4
|
713683.0
|
2023-12-11 00:00:00 UTC
|
Flowers Foods (FLO) Strategic Priorities Aid Amid High Costs
|
DCOMP
|
https://www.nasdaq.com/articles/flowers-foods-flo-strategic-priorities-aid-amid-high-costs
|
nan
|
nan
|
Flowers Foods, Inc. FLO has been benefiting from its key strategic priorities, encompassing team development, brand emphasis, margin prioritization, and engagement in mergers and acquisitions. The focus on innovation in leading brands like Dave Killer Bread is worth noting.
However, high selling, distribution and administrative (SD&A) expenses have been a concern. Input cost inflation has also been a hurdle for the company, though the impact is showing signs of moderation.
Strategic Priorities on Track
Flowers Foods has been shifting focus toward becoming a more brand-focused company. The company expects its optimized portfolio to drive market share gains through innovation. Management is focused on undertaking innovation in its leading brands. To this end, the rollout of Dave’s Killer Bread Snack Bars is in full swing, and the company is prepping for countrywide launches of DKB protein bars and DKB snack bites in spring and the second half of 2024, respectively.
Moving to margins, the company is undertaking pricing and saving measures and efforts to enhance business efficiency. The company has been focused on transitioning a larger part of its sales to higher-margin branded retail products (which increased 3% year over year and formed 64.3% of sales in the third quarter of 2023).
Apart from this, the company is on track with digital transformation and supply-chain efforts. Flowers Foods is ahead of track with its savings plan and now expects to achieve savings of $30-$35 million in 2023, up from the earlier view of $20-$30 million.
Gains from acquisitions have been another driver. Flowers Foods has been undertaking acquisitions to strengthen its product portfolio and expand in untapped markets. In February 2023, the company acquired Papa Pita Bakery, which boosted sales by 1.3% in the third quarter of 2023. In December 2018, the company completed the acquisition of Canyon Bakehouse, which has helped Flowers Foods expand into the growing gluten-free bakery space.
Image Source: Zacks Investment Research
High SD&A Costs & More
Flowers Foods’ SD&A expenses have been expanding as a percentage of sales on a year-over-year basis. In the third quarter, adjusted SD&A expenses expanded 200 bps to 38.4% of sales. Flowers Foods’ increased focus on marketing and innovation behind brands is likely to increase its cost burden in the near term, though it is expected to drive long-term growth.
The company expects costs related to upgrading its ERP system to be nearly $70-$80 million in 2023 (out of which $25-$35 million is anticipated to be capitalized).
Considering the third-quarter results, management now expects 2023 sales and adjusted EBITDA in the range of $5.085-$5.104 billion and $495-$515 million, respectively. Earlier, sales and adjusted EBITDA were expected to be $5.095-$5.141 billion and $503-$528 million bands, respectively.
Wrapping Up
Flowers Foods looks well placed on the back of its impressive pricing and portfolio strategies, along with enhanced efficiencies. These are likely to help the Zacks Rank #3 (Hold) company combat the inflationary challenges.
Shares of FLO have lost 6.3% in the past three months compared with the industry’s decline of 7.1%.
3 Appetizing Picks
The Kraft Heinz Company KHC, a food and beverage product company, currently carries a Zacks Rank #2 (Buy). KHC has a trailing four-quarter earnings surprise of 9.9%, on average. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Kraft Heinz’s current financial-year sales and earnings suggests growth of 1.1% and 6.5%, respectively, from the year-ago reported numbers.
Celsius Holdings, Inc. CELH, which develops, processes, markets, distributes and sells functional drinks and liquid supplements, holds a Zacks Rank #2. CELH has a trailing four-quarter earnings surprise of 110.9%, on average.
The Zacks Consensus Estimate for Celsius Holdings’ current financial-year sales and earnings suggests growth of 98.5% and 184.1%, respectively, from the year-ago reported numbers.
Vital Farms Inc. VITL offers a range of produced pasture-raised foods. It currently has a Zacks Rank #2. VITL has a trailing four-quarter earnings surprise of 145%, on average.
The Zacks Consensus Estimate for Vital Farms’ current financial-year sales suggests growth of 29.4% from the year-ago reported figure.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Flowers Foods, Inc. (FLO) : Free Stock Analysis Report
Kraft Heinz Company (KHC) : Free Stock Analysis Report
Celsius Holdings Inc. (CELH) : Free Stock Analysis Report
Vital Farms, Inc. (VITL) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Flowers Foods, Inc. FLO has been benefiting from its key strategic priorities, encompassing team development, brand emphasis, margin prioritization, and engagement in mergers and acquisitions. In December 2018, the company completed the acquisition of Canyon Bakehouse, which has helped Flowers Foods expand into the growing gluten-free bakery space. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
The Zacks Consensus Estimate for Celsius Holdings’ current financial-year sales and earnings suggests growth of 98.5% and 184.1%, respectively, from the year-ago reported numbers. The Zacks Consensus Estimate for Vital Farms’ current financial-year sales suggests growth of 29.4% from the year-ago reported figure. Click to get this free report Flowers Foods, Inc. (FLO) : Free Stock Analysis Report Kraft Heinz Company (KHC) : Free Stock Analysis Report Celsius Holdings Inc. (CELH) : Free Stock Analysis Report Vital Farms, Inc. (VITL) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Image Source: Zacks Investment Research High SD&A Costs & More Flowers Foods’ SD&A expenses have been expanding as a percentage of sales on a year-over-year basis. 3 Appetizing Picks The Kraft Heinz Company KHC, a food and beverage product company, currently carries a Zacks Rank #2 (Buy). Click to get this free report Flowers Foods, Inc. (FLO) : Free Stock Analysis Report Kraft Heinz Company (KHC) : Free Stock Analysis Report Celsius Holdings Inc. (CELH) : Free Stock Analysis Report Vital Farms, Inc. (VITL) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The company expects its optimized portfolio to drive market share gains through innovation. Flowers Foods has been undertaking acquisitions to strengthen its product portfolio and expand in untapped markets. Click to get this free report Flowers Foods, Inc. (FLO) : Free Stock Analysis Report Kraft Heinz Company (KHC) : Free Stock Analysis Report Celsius Holdings Inc. (CELH) : Free Stock Analysis Report Vital Farms, Inc. (VITL) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
4dc4dad9-1287-49f6-b436-02fb53bada44
|
713684.0
|
2023-12-11 00:00:00 UTC
|
3 Stocks to Watch From Leisure & Recreation Services Industry
|
DCOMP
|
https://www.nasdaq.com/articles/3-stocks-to-watch-from-leisure-recreation-services-industry
|
nan
|
nan
|
The Zacks Leisure and Recreation Services industry is benefiting from optimizing business processes, consistent strategic partnerships and digital initiatives. The robust demand for concerts, improving bookings for cruise operators and higher per capita spending at theme parks are supporting the industry. Industry players like Royal Caribbean Cruises Ltd. RCL, Live Nation Entertainment, Inc. LYV and AMC Entertainment Holdings, Inc. AMC are likely to gain in their respective fields owing to the factors mentioned above.
Industry Description
The Zacks Leisure and Recreation Services industry comprises various recreation providers, such as cruise, entertainment and media owners, golf-related leisure and entertainment venue businesses, theme park makers, resort operators and event organizers. Some industry players have ski and sports businesses, while some operate health and wellness centers onboard cruise ships and at destination resorts. Many companies are engaged in hospitality and related businesses. A few of the industry participants also provide weight management products and services. These companies primarily thrive on overall economic growth, which fuels consumer demand for products. Demand, highly dependent on business cycles, is driven by a healthy labor market, rising wages and a growing disposable income.
3 Trends Shaping the Leisure & Recreation Services Industry's Future
U.S. Economy Gradually Getting Back on Track: The Federal Reserve decided to keep interest rates unchanged, and Jerome Powell, the head of the U.S. central bank, mentioned that the unprecedented shift toward tighter monetary policy is probably finished. This comes as inflation is decreasing more rapidly than anticipated and the possibility of considering reductions in borrowing costs coming “into view.”
Robust Demand Aids Cruise Operators: The cruise industry is benefiting from strong demand for cruising and accelerating booking volumes. The industry is benefiting from solid bookings concerning North American and European sailings. Also, strong pricing (on closer-in-demand) and solid onboard spending bode well for the industry. However, the cruise operators’ operations are likely to be influenced by the uncertainties related to the Russian invasion of Ukraine. Geopolitical developments have pushed fuel curves higher.
Theme Park Operators & Live Entertainment Companies Bouncing Back: The theme park industry has been benefiting from robust demand. Theme park operators have been gaining from improving visitation. Consumer spending at theme parks continues to rise. Live entertainment firms have benefited from pent-up live event demand and robust ticket sales.
Zacks Industry Rank Indicates Bright Prospects
The Zacks Leisure and Recreation Services industry is grouped within the broader Zacks Consumer Discretionary sector. It carries a Zacks Industry Rank #90, which places it in the top 36% of 251 Zacks industries.
The group’s Zacks Industry Rank, which is the average of the Zacks Rank of all the member stocks, indicates bright near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than two to one.
The industry’s position in the top 50% of the Zacks-ranked industries results from a positive earnings outlook for the constituent companies in aggregate. Looking at the aggregate earnings estimate revisions, it appears that analysts are gradually gaining confidence in the group’s earnings growth potential. Since Sep 30, 2023, the industry's earnings estimates for 2023 have increased 11.1%.
Before we present a few stocks that investors can consider, let’s analyze the industry’s recent stock-market performance and valuation picture.
Industry Underperforms the S&P 500
The Zacks Leisure and Recreation Services industry has underperformed the Zacks S&P 500 composite but has outperformed its sector in the past year. Stocks in the industry have gained 14.9% in the past year compared with the broader sector’s increase of 13.5%. The S&P 500 has risen 19.7% in the said time frame.
One-Year Price Performance
Valuation
On the basis of the forward 12-month EV/EBITDA (Enterprise Value/Earnings before Interest Tax Depreciation and Amortization), which is a commonly used multiple for valuing debt-laden leisure service stocks, the industry trades at 54.43X compared with the S&P 500’s 19.8X and the sector’s 13.09X. In the past five years, the industry has traded as high as 59.36X and as low as 6.20X, with the median being 9.48X, as the charts below show.
EV/EBITDA Ratio (F12M) Compared With S&P
3 Leisure and Recreation Services Stocks to Keep an Eye On
Royal Caribbean Cruises: Based in Miami and incorporated in 1985, Royal Caribbean Cruises is a cruise company. It has been benefiting from solid demand for cruising and acceleration in booking volumes. Also, the emphasis on strong pricing (on closer-in-demand) bodes well. The company stated that the momentum has continued into 2024, with booked load factors and rates surpassing those of all previous years. Given the full fleet resumption and load factors at high prices, it expects customer deposits to return to typical seasonality in the upcoming periods.
Shares of this Zacks Rank #1 (Strong Buy) company have surged 120.4% in the past year. In 2023, its sales and earnings are expected to witness growth of 57.7% and 187.9%, respectively, from the prior year’s reported levels. You can see the complete list of today’s Zacks #1 Rank stocks here.
Price and Consensus: RCL
Live Nation Entertainment: The company has been benefiting from pent-up demand for live events, robust ticket sales and the sponsorship and advertising business. Also, the emphasis on new client and venue additions bodes well. Given the strength in consumer demand and confirmed sponsorship activity (fully committed) at more than $1 billion in revenues, the momentum is likely to persist in the upcoming periods.
Shares of this Zacks Rank #1 company have gained 25.4% in the past year. For 2023, its sales and earnings are expected to grow 28.6% and 132.8%, respectively, from the prior year’s reported levels.
Price and Consensus: LYV
AMC Entertainment: AMC Entertainment is benefiting from attendance growth. As the number and quality of movie titles from the company’s studio partners are notably increasing, movie theatres are seen captivating audiences and driving attendance back to AMC theatres.
Shares of this Zacks Rank #3 (Hold) company have declined 87.8% in the past year. In fiscal 2023, its sales and earnings are expected to witness growth of 23% and 76%, year over year, respectively.
Price and Consensus: AMC
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Royal Caribbean Cruises Ltd. (RCL) : Free Stock Analysis Report
Live Nation Entertainment, Inc. (LYV) : Free Stock Analysis Report
AMC Entertainment Holdings, Inc. (AMC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
3 Trends Shaping the Leisure & Recreation Services Industry's Future U.S. Economy Gradually Getting Back on Track: The Federal Reserve decided to keep interest rates unchanged, and Jerome Powell, the head of the U.S. central bank, mentioned that the unprecedented shift toward tighter monetary policy is probably finished. One-Year Price Performance Valuation On the basis of the forward 12-month EV/EBITDA (Enterprise Value/Earnings before Interest Tax Depreciation and Amortization), which is a commonly used multiple for valuing debt-laden leisure service stocks, the industry trades at 54.43X compared with the S&P 500’s 19.8X and the sector’s 13.09X. Price and Consensus: AMC The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Industry players like Royal Caribbean Cruises Ltd. RCL, Live Nation Entertainment, Inc. LYV and AMC Entertainment Holdings, Inc. AMC are likely to gain in their respective fields owing to the factors mentioned above. Price and Consensus: RCL Live Nation Entertainment: The company has been benefiting from pent-up demand for live events, robust ticket sales and the sponsorship and advertising business. Click to get this free report Royal Caribbean Cruises Ltd. (RCL) : Free Stock Analysis Report Live Nation Entertainment, Inc. (LYV) : Free Stock Analysis Report AMC Entertainment Holdings, Inc. (AMC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Industry Description The Zacks Leisure and Recreation Services industry comprises various recreation providers, such as cruise, entertainment and media owners, golf-related leisure and entertainment venue businesses, theme park makers, resort operators and event organizers. Zacks Industry Rank Indicates Bright Prospects The Zacks Leisure and Recreation Services industry is grouped within the broader Zacks Consumer Discretionary sector. Click to get this free report Royal Caribbean Cruises Ltd. (RCL) : Free Stock Analysis Report Live Nation Entertainment, Inc. (LYV) : Free Stock Analysis Report AMC Entertainment Holdings, Inc. (AMC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Industry Description The Zacks Leisure and Recreation Services industry comprises various recreation providers, such as cruise, entertainment and media owners, golf-related leisure and entertainment venue businesses, theme park makers, resort operators and event organizers. Robust Demand Aids Cruise Operators: The cruise industry is benefiting from strong demand for cruising and accelerating booking volumes. Price and Consensus: LYV AMC Entertainment: AMC Entertainment is benefiting from attendance growth.
|
db67b0e4-290f-4a84-a473-596fa7e6157a
|
713685.0
|
2023-12-11 00:00:00 UTC
|
2 Big Stocks Making Big Moves Thursday
|
DCOMP
|
https://www.nasdaq.com/articles/2-big-stocks-making-big-moves-thursday
|
nan
|
nan
|
Stock markets pushed upward to their best levels of the year on Wednesday, reacting positively to news that the Federal Reserve did not raise interest rates at its December meeting and largely sees its monetary policy as neutral at present. Early Thursday morning, it appeared that markets would continue to gain ground. Stock index futures were up as much as half a percent in premarket trading.
Even with the overarching support from the Fed, company-specific news continued to affect various individual stocks in different ways. Adobe (NASDAQ: ADBE) reported its latest financial results and saw its share price drop. However, Moderna (NASDAQ: MRNA) announced a potential victory that gave shareholders some new confidence that the biotech company could prosper even as its importance as a COVID-19 vaccine stock diminishes.
Adobe can't keep shareholders satisfied
Shares of Adobe were down 4% in premarket trading early Thursday. The creative software company got negative feedback from shareholders even as its fiscal fourth-quarter financial results for the period ended Dec. 1 were better than most of them had expected.
Adobe posted solid growth in its latest quarter. Revenue of $5.05 billion was up 12% year over year. Net income climbed 26% from year-ago levels to $1.48 billion, producing earnings of $3.23 per share. Adobe got balanced growth from just about all of its segments, with sales of its creative software products, its document cloud platform, and its digital experience products all climbing double-digit percentages from where they were 12 months earlier.
However, investors didn't seem to like Adobe's guidance. The company sees fiscal first-quarter sales of between $5.1 billion and $5.15 billion, which would be just 1% to 2% sequential growth. Similarly, full-year revenue projections for $21.3 billion to $21.5 billion imply full-year sales gains of just 10% to 11%, which would be consistent with fiscal 2023's 10% gains.
Adobe has largely flown under the radar with its efforts to integrate artificial intelligence (AI) into its product offerings. But AI represents a key long-term growth prospect, and Adobe just needs to make it clearer to shareholders that it's playing to win when it comes to technological innovation.
Moderna looks beyond COVID
Meanwhile, shares of Moderna soared 12% in premarket trading. The biotech company announced favorable results in a clinical study, showing shareholders a potential view of the path it could take to start a new phase of growth after its COVID-19 vaccine success in recent years.
Moderna and partner Merck released follow-up data from its Keynote-942 clinical trial evaluating Moderna's investigational individualized neoantigen therapy mRNA-4157 (V940). The trial involved patients with a form of high-risk melanoma, administering the therapy in conjunction with Merck's Keytruda therapy.
The trial has been going on for a while now, and after three years, the study showed that the combination treatment remained effective in improving recurrence-free and metastasis-free survival rates compared to using Keytruda by itself.
Moderna was pleased to see the investigational mRNA cancer treatment show benefits when used in combination with established treatments, and it sees immuno-oncology as an area that it can pursue further. For its part, Merck already has considerable experience in that subspecialty, which could open the door to further collaboration.
For Moderna, the news shows again that the company isn't going to be a one-hit wonder. With solid prospects in several key areas, Moderna's technology could have applications across the field of medicine.
Should you invest $1,000 in Adobe right now?
Before you buy stock in Adobe, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Adobe wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Dan Caplinger has positions in Moderna. The Motley Fool has positions in and recommends Adobe and Merck. The Motley Fool recommends Moderna and recommends the following options: long January 2024 $420 calls on Adobe and short January 2024 $430 calls on Adobe. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Stock markets pushed upward to their best levels of the year on Wednesday, reacting positively to news that the Federal Reserve did not raise interest rates at its December meeting and largely sees its monetary policy as neutral at present. However, Moderna (NASDAQ: MRNA) announced a potential victory that gave shareholders some new confidence that the biotech company could prosper even as its importance as a COVID-19 vaccine stock diminishes. The biotech company announced favorable results in a clinical study, showing shareholders a potential view of the path it could take to start a new phase of growth after its COVID-19 vaccine success in recent years.
|
Adobe can't keep shareholders satisfied Shares of Adobe were down 4% in premarket trading early Thursday. The biotech company announced favorable results in a clinical study, showing shareholders a potential view of the path it could take to start a new phase of growth after its COVID-19 vaccine success in recent years. Before you buy stock in Adobe, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Adobe wasn't one of them.
|
Adobe can't keep shareholders satisfied Shares of Adobe were down 4% in premarket trading early Thursday. Before you buy stock in Adobe, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Adobe wasn't one of them. The Motley Fool recommends Moderna and recommends the following options: long January 2024 $420 calls on Adobe and short January 2024 $430 calls on Adobe.
|
Adobe can't keep shareholders satisfied Shares of Adobe were down 4% in premarket trading early Thursday. The biotech company announced favorable results in a clinical study, showing shareholders a potential view of the path it could take to start a new phase of growth after its COVID-19 vaccine success in recent years. For Moderna, the news shows again that the company isn't going to be a one-hit wonder.
|
0b5bd3a8-ec2f-4d50-9ef3-f2c42ee2a68a
|
713686.0
|
2023-12-11 00:00:00 UTC
|
4 Solid Stocks to Buy as Inflation Continues to Cool
|
DCOMP
|
https://www.nasdaq.com/articles/4-solid-stocks-to-buy-as-inflation-continues-to-cool
|
nan
|
nan
|
Markets rallied in November and the upbeat sentiment has continued into December as investors sentiment remains upbeat on signs of cooling inflation. The Bureau of Labor Statistics reported on Dec 12 that inflation eased further in November.
Also, the Federal Reserve kept interest rates unaltered in its December policy meeting on Wednesday and hinted at implementing rate cuts in 2024. Given this situation, investing in consumer discretionary stocks like Virco Mfg. Corporation VIRC, Comcast Corporation CMCSA, Warner Music Group Corp. WMG and The RealReal, Inc. REAL would be an ideal choice.
Inflation Cools Further
The Consumer Price Index (CPI) rose 3.1% year over year in November, lower than October’s jump of 3.2% and in line with economists’ expectations, the Bureau of Labor Statistics reported on Dec 12.
On a month-over-month basis, CPI increased 0.1% in November. Core CPI, which excludes the volatile food and energy prices, increased 0.3% month over month in November. Core CPI rose 4% year over year.
The decline in November inflation can be attributed to a 2.3% drop in energy prices, as gasoline prices dipped 6%, while oil prices fell 2.7%.
Also, the producer price index (PPI) for final demand increased just 0.9% in November compared to a jump of 1.2% in October.
Year over year, Core PPI rose 2% in November, lower than October’s reading of a rise of 2.4% and economists’ expectations of 2.2%. Month over month, the Core PPI remained unchanged for the second straight month.
Although inflation is still higher than the Federal Reserve’s target of 2%, it has continued to move in the preferred direction for the Fed.
This came as the Fed on Dec 13 kept its benchmark policy rate unchanged in the range of 5.25-5.5% for the third straight time after hiking rates by 525 basis points since March 2022.
Fed Chair Jerome Powell said that he believes that the central bank’s benchmark policy rate is now at its peak and it doesn’t plan to keep interest rates high for too long.
Although the Fed didn’t give a specific time for the first rate cut, market participants believe that it could happen as early as May. The Fed had earlier revised its rate cut forecast to two from four in 2024, with the first cut not coming before September.
Lower borrowing costs definitely bode well for the economy and the present situation indicates a softer landing for the economy. The positive data comes during the peak of the holiday season when people tend to spend lavishly.
Our Choices
Therefore, from an investment perspective, we have identified four stocks from the consumer discretionary sector that are likely to capitalize on reduced inflationary pressure. Each of these stocks carries a Zacks Rank #1 (Strong Buy) or 2 (Buy).
Virco Mfg. Corporation designs, produces and distributes quality furniture for the contract and education markets worldwide. Examples of facilities served by VIRC include public and private schools, colleges and universities, convention centers, federal and state institutions, churches and other businesses. Virco Mfg also sells to wholesalers, distributors, retailers and catalog retailers.
Virco Mfg’s expected earnings growth rate for the current year is 32.4%. The Zacks Consensus Estimate for current-year earnings has improved 20.5% over the past 60 days. VIRC currently sports a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
Comcast Corporation is a global media and technology company with three primary businesses: Comcast Cable, NBCUniversal and Sky. Beginning first-quarter 2023, CMCSA changed its presentation of segment operating results around its two primary businesses, Connectivity & Platforms and Content & Experiences.
Comcast Corporation’s expected earnings growth rate for the current year is 8%. The Zacks Consensus Estimate for current-year earnings has improved 3.1% over the past 60 days. CMCSA presently carries a Zacks Rank #2.
Warner Music Group Corp. is a music-based content company. WMG’s operating segments consist of Recorded Music and Music Publishing. The Recorded Music segment is involved in the discovery and development of recording artists. The Music Publishing segment owns and acquires rights. Warner Music Groupoperates principally in the United States, the United Kingdom and internationally.
Warner Music Group’s expected earnings growth rate for the current year is 23.8%. The Zacks Consensus Estimate for current-year earnings has improved 5.7% over the past 60 days. WMG presently has a Zacks Rank #2.
The RealReal, Inc. operates an online marketplace for consigned luxury goods. REAL offers resale product categories, including women's, men's, kids', jewelry and watches, as well as home and art products.
The RealReal’s expected earnings growth rate for the current year is 39.9%. The Zacks Consensus Estimate for current-year earnings has improved 17.1% over the past 60 days. REAL currently has a Zacks Rank #2.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Comcast Corporation (CMCSA) : Free Stock Analysis Report
Virco Manufacturing Corporation (VIRC) : Free Stock Analysis Report
The RealReal, Inc. (REAL) : Free Stock Analysis Report
Warner Music Group Corp. (WMG) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Examples of facilities served by VIRC include public and private schools, colleges and universities, convention centers, federal and state institutions, churches and other businesses. Beginning first-quarter 2023, CMCSA changed its presentation of segment operating results around its two primary businesses, Connectivity & Platforms and Content & Experiences. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Corporation VIRC, Comcast Corporation CMCSA, Warner Music Group Corp. WMG and The RealReal, Inc. REAL would be an ideal choice. Inflation Cools Further The Consumer Price Index (CPI) rose 3.1% year over year in November, lower than October’s jump of 3.2% and in line with economists’ expectations, the Bureau of Labor Statistics reported on Dec 12. Click to get this free report Comcast Corporation (CMCSA) : Free Stock Analysis Report Virco Manufacturing Corporation (VIRC) : Free Stock Analysis Report The RealReal, Inc. (REAL) : Free Stock Analysis Report Warner Music Group Corp. (WMG) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Inflation Cools Further The Consumer Price Index (CPI) rose 3.1% year over year in November, lower than October’s jump of 3.2% and in line with economists’ expectations, the Bureau of Labor Statistics reported on Dec 12. Warner Music Group’s expected earnings growth rate for the current year is 23.8%. Click to get this free report Comcast Corporation (CMCSA) : Free Stock Analysis Report Virco Manufacturing Corporation (VIRC) : Free Stock Analysis Report The RealReal, Inc. (REAL) : Free Stock Analysis Report Warner Music Group Corp. (WMG) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Given this situation, investing in consumer discretionary stocks like Virco Mfg. Corporation VIRC, Comcast Corporation CMCSA, Warner Music Group Corp. WMG and The RealReal, Inc. REAL would be an ideal choice. Inflation Cools Further The Consumer Price Index (CPI) rose 3.1% year over year in November, lower than October’s jump of 3.2% and in line with economists’ expectations, the Bureau of Labor Statistics reported on Dec 12.
|
80640b6b-9190-4c31-ba16-38cb3d2eea9f
|
713687.0
|
2023-12-11 00:00:00 UTC
|
Acadia (ACAD) Rises 35% on Positive Patent Ruling for Nuplazid
|
DCOMP
|
https://www.nasdaq.com/articles/acadia-acad-rises-35-on-positive-patent-ruling-for-nuplazid
|
nan
|
nan
|
Acadia Pharmaceuticals Inc. ACAD announced that the U.S. District Court in Delaware passed a judgment strongly in favor of the company in its litigation against MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals, Inc. and other abbreviated new drug application filers.
The court granted summary judgment to Acadia confirming the validity of the '740 composition of matter patent for its lead drug for Nuplazid (pimavanserin).
The ruling prevents generic drug manufacturers, like MSN Laboratories, from making low-cost generic versions of Acadia’s lead-marketed drug, Nuplazid.
The ‘740 composition of matter patent protects Nuplazid exclusivity into 2030.
Acadia’s stock surged 34.5% in the last trading session as investors expect Nuplazid sales to maintain its growth trajectory in the absence of any generic alternatives available in the market. Year to date, the shares of Acadia have surged 78.8% against the industry’s 19.2% loss.
Image Source: Zacks Investment Research
Acadia believes that the favorable judgment from the court reaffirms its innovation in developing new treatments for disorders with high unmet needs.
Nuplazid is a selective serotonin inverse agonist and antagonist preferentially targeting 5-HT2A receptors. It is the first and the only FDA-approved treatment for hallucinations and delusions associated with Parkinson’s disease psychosis.
The drug was launched in May 2016 in the U.S. market and has shown strong uptake since. In the nine months ended Sep 30, 2023, revenues generated from Nuplazid sales, accounting for 82% of Acadia’s total revenues, were recorded at $405 million, representing a 6% increase over the year-ago figure.
Acadia markets two forms of Nuplazid, a 34mg capsule and a 10mg tablet, which are also protected by issued patents. The 34mg capsule is protected by multiple issued formulation patents until 2038, while the 10mg tablet is protected by an issued method of use patent until 2037.
Notably, Acadia is also evaluating Nuplazid in schizophrenia-negative symptoms. Label expansion of the drug, subject to successful development and commercialization, will further boost revenues for the company.
In a separate press release, Acadia announced a second positive ruling from the U.S. District Court in Delaware. The court has also issued a claim construction order in favor of the company regarding its ‘721 formulation patent for Nuplazid.
A claim construction order is a process in which courts interpret the meaning and scope of a patent’s claims. Per the outcomes of the proceedings, the court ruled in favor of Acadia on all the disputed claim construction points, adopting the company’s interpretation of key disputed terms of the patent.
Acadia also reported that, following the recent proceedings, a pre-scheduled claims construction hearing had been canceled by the court. The next hearing date is scheduled for December 2024.
Acadia also currently markets another drug, Daybue (trofinetide), in the United States, which was approved by the FDA in May 2023 to treat Rett syndrome in adult and pediatric patients two years of age and older.
ACADIA Pharmaceuticals Inc. Price and Consensus
ACADIA Pharmaceuticals Inc. price-consensus-chart | ACADIA Pharmaceuticals Inc. Quote
Zacks Rank and Other Stocks to Consider
Acadia currently carries a Zacks Rank #2 (Buy).
Some other top-ranked stocks worth mentioning are Puma Biotechnology, Inc. PBYI, ADMA Biologics ADMA and Agenus AGEN. While PBYI sports a Zacks Rank #1 (Strong Buy), ADMA and AGEN carry a Zacks Rank #2 each at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
In the past 30 days, the Zacks Consensus Estimate for Puma Biotech’s 2023 earnings per share (EPS) has remained constant at 72 cents. During the same time frame, the consensus estimate for Puma Biotech’s 2024 EPS has increased from 62 cents to 64 cents. In the year so far, shares of PBYI have lost 5.4%.
PBYI’s earnings beat estimates in three of the last four quarters while missing on one occasion, delivering a four-quarter average earnings surprise of 76.55%.
In the past 30 days, the Zacks Consensus Estimate for ADMA Biologics’ 2023 loss per share has remained constant at 3 cents. The consensus estimate for ADMA Biologics’ 2024 EPS is pegged at 16 cents. In the year so far, shares of ADMA have gained 3.4%.
ADMA beat estimates in three of the trailing four quarters and matched in one, delivering an average earnings surprise of 63.57%.
In the past 30 days, the Zacks Consensus Estimate for Agenus’ 2023 loss per share has remained constant at 63 cents. During the same time frame, the consensus estimate for Agenus’ 2024 loss per share has remained constant at 45 cents. In the year so far, shares of AGEN have plunged 65.7%.
AGEN beat estimates in one of the trailing four quarters, matching in one and missing the mark on the other two occasions, delivering an average earnings surprise of 0.49%.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Agenus Inc. (AGEN) : Free Stock Analysis Report
Puma Biotechnology, Inc. (PBYI) : Free Stock Analysis Report
ADMA Biologics Inc (ADMA) : Free Stock Analysis Report
ACADIA Pharmaceuticals Inc. (ACAD) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Acadia Pharmaceuticals Inc. ACAD announced that the U.S. District Court in Delaware passed a judgment strongly in favor of the company in its litigation against MSN Laboratories Pvt. Image Source: Zacks Investment Research Acadia believes that the favorable judgment from the court reaffirms its innovation in developing new treatments for disorders with high unmet needs. Acadia also currently markets another drug, Daybue (trofinetide), in the United States, which was approved by the FDA in May 2023 to treat Rett syndrome in adult and pediatric patients two years of age and older.
|
ACADIA Pharmaceuticals Inc. Price and Consensus ACADIA Pharmaceuticals Inc. price-consensus-chart | ACADIA Pharmaceuticals Inc. Quote Zacks Rank and Other Stocks to Consider Acadia currently carries a Zacks Rank #2 (Buy). In the past 30 days, the Zacks Consensus Estimate for Puma Biotech’s 2023 earnings per share (EPS) has remained constant at 72 cents. Click to get this free report Agenus Inc. (AGEN) : Free Stock Analysis Report Puma Biotechnology, Inc. (PBYI) : Free Stock Analysis Report ADMA Biologics Inc (ADMA) : Free Stock Analysis Report ACADIA Pharmaceuticals Inc. (ACAD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
ACADIA Pharmaceuticals Inc. Price and Consensus ACADIA Pharmaceuticals Inc. price-consensus-chart | ACADIA Pharmaceuticals Inc. Quote Zacks Rank and Other Stocks to Consider Acadia currently carries a Zacks Rank #2 (Buy). In the past 30 days, the Zacks Consensus Estimate for ADMA Biologics’ 2023 loss per share has remained constant at 3 cents. Click to get this free report Agenus Inc. (AGEN) : Free Stock Analysis Report Puma Biotechnology, Inc. (PBYI) : Free Stock Analysis Report ADMA Biologics Inc (ADMA) : Free Stock Analysis Report ACADIA Pharmaceuticals Inc. (ACAD) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Acadia Pharmaceuticals Inc. ACAD announced that the U.S. District Court in Delaware passed a judgment strongly in favor of the company in its litigation against MSN Laboratories Pvt. The court has also issued a claim construction order in favor of the company regarding its ‘721 formulation patent for Nuplazid. In the past 30 days, the Zacks Consensus Estimate for ADMA Biologics’ 2023 loss per share has remained constant at 3 cents.
|
e336a351-8af9-4ff3-b7fb-3a88980f563a
|
713688.0
|
2023-12-11 00:00:00 UTC
|
Jabil (JBL) Q1 Earnings and Revenues Surpass Estimates
|
DCOMP
|
https://www.nasdaq.com/articles/jabil-jbl-q1-earnings-and-revenues-surpass-estimates-0
|
nan
|
nan
|
Jabil (JBL) came out with quarterly earnings of $2.60 per share, beating the Zacks Consensus Estimate of $2.54 per share. This compares to earnings of $2.31 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 2.36%. A quarter ago, it was expected that this electronics manufacturer would post earnings of $2.31 per share when it actually produced earnings of $2.45, delivering a surprise of 6.06%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.
Jabil, which belongs to the Zacks Electronics - Manufacturing Services industry, posted revenues of $8.39 billion for the quarter ended November 2023, surpassing the Zacks Consensus Estimate by 0.43%. This compares to year-ago revenues of $9.64 billion. The company has topped consensus revenue estimates three times over the last four quarters.
The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.
Jabil shares have added about 76.8% since the beginning of the year versus the S&P 500's gain of 22.6%.
What's Next for Jabil?
While Jabil has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?
There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.
Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.
Ahead of this earnings release, the estimate revisions trend for Jabil: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $1.99 on $7.36 billion in revenues for the coming quarter and $9.09 on $31.17 billion in revenues for the current fiscal year.
Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Electronics - Manufacturing Services is currently in the top 15% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.
Another stock from the broader Zacks Computer and Technology sector, Micron (MU), has yet to report results for the quarter ended November 2023. The results are expected to be released on December 20.
This chipmaker is expected to post quarterly loss of $1 per share in its upcoming report, which represents a year-over-year change of -2400%. The consensus EPS estimate for the quarter has been revised 16.9% higher over the last 30 days to the current level.
Micron's revenues are expected to be $4.6 billion, up 12.6% from the year-ago quarter.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Jabil, Inc. (JBL) : Free Stock Analysis Report
Micron Technology, Inc. (MU) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. Another stock from the broader Zacks Computer and Technology sector, Micron (MU), has yet to report results for the quarter ended November 2023. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Jabil, which belongs to the Zacks Electronics - Manufacturing Services industry, posted revenues of $8.39 billion for the quarter ended November 2023, surpassing the Zacks Consensus Estimate by 0.43%. The current consensus EPS estimate is $1.99 on $7.36 billion in revenues for the coming quarter and $9.09 on $31.17 billion in revenues for the current fiscal year. Click to get this free report Jabil, Inc. (JBL) : Free Stock Analysis Report Micron Technology, Inc. (MU) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Jabil (JBL) came out with quarterly earnings of $2.60 per share, beating the Zacks Consensus Estimate of $2.54 per share. Jabil, which belongs to the Zacks Electronics - Manufacturing Services industry, posted revenues of $8.39 billion for the quarter ended November 2023, surpassing the Zacks Consensus Estimate by 0.43%. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock.
|
Jabil (JBL) came out with quarterly earnings of $2.60 per share, beating the Zacks Consensus Estimate of $2.54 per share. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock.
|
47275267-97a5-45b6-8ef4-8a002650c198
|
713689.0
|
2023-12-11 00:00:00 UTC
|
S&T Bancorp (STBA) Soars 5.6%: Is Further Upside Left in the Stock?
|
DCOMP
|
https://www.nasdaq.com/articles/st-bancorp-stba-soars-5.6%3A-is-further-upside-left-in-the-stock
|
nan
|
nan
|
S&T Bancorp (STBA) shares rallied 5.6% in the last trading session to close at $31.48. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 2.1% gain over the past four weeks.
After 11 interest rate hikes, the Fed's decision to pause rate hikes for the third month drove bullish sentiments across markets amid the optimism of easing inflation pressures. With this, the interest rates remain at a 22-year high of 5.25-5.5%. Further, the central bank indicated three interest rate cuts by 2024-end. These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. Hence, the STBA stock gained.
This holding company for S&T Bank is expected to post quarterly earnings of $0.86 per share in its upcoming report, which represents a year-over-year change of -16.5%. Revenues are expected to be $100.1 million, down 4.4% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For S&T Bancorp, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on STBA going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
S&T Bancorp is part of the Zacks Banks - Northeast industry. Pathward Financial (CASH), another stock in the same industry, closed the last trading session 0.6% higher at $52.54. CASH has returned 5.2% in the past month.
For Pathward, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.24. This represents a change of +53.1% from what the company reported a year ago. Pathward currently has a Zacks Rank of #2 (Buy).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
S&T Bancorp, Inc. (STBA) : Free Stock Analysis Report
Pathward Financial, Inc. (CASH) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. This holding company for S&T Bank is expected to post quarterly earnings of $0.86 per share in its upcoming report, which represents a year-over-year change of -16.5%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. For Pathward, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.24. Click to get this free report S&T Bancorp, Inc. (STBA) : Free Stock Analysis Report Pathward Financial, Inc. (CASH) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> S&T Bancorp is part of the Zacks Banks - Northeast industry. Click to get this free report S&T Bancorp, Inc. (STBA) : Free Stock Analysis Report Pathward Financial, Inc. (CASH) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
With this, the interest rates remain at a 22-year high of 5.25-5.5%. Hence, the STBA stock gained. For Pathward, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.24.
|
be013da1-99b0-4974-aaaa-0557d2b0a300
|
713690.0
|
2023-12-11 00:00:00 UTC
|
Stratasys (SSYS) Enhances Tumor Surgery With 3D-Printed Guides
|
DCOMP
|
https://www.nasdaq.com/articles/stratasys-ssys-enhances-tumor-surgery-with-3d-printed-guides
|
nan
|
nan
|
Stratasys SSYS has announced that the University Hospital Birmingham in England has achieved enhanced results for head and neck cancer patients. The hospital has reported a reduction in surgery times by up to three hours, attributed to the implementation of customized, 3D-printed cutting guides.
The implementation of tailored, 3D-printed surgical guides at University Hospital Birmingham is enhancing patient outcomes and reducing surgery times. The success is credited to the adoption of a Stratasys J5 MediJet 3D printer, thus allowing the hospital to create precise, patient-specific cutting guides before surgeries.
This approach revolutionizes the removal of tumors in head and neck cancer patients, replacing the previous manual method involving cutting and bending metal during surgery. The new process, with a resolution of within 150 microns, utilizes patient scans to produce accurate devices in Biocompatible Clear MED610, which is a rigid, transparent resin suitable for prolonged contact with intact skin and limited contact with tissue, bone or mucosal membranes, thereby enhancing surgical success.
Stratasys' GrabCAD Print Software, which operates in conjunction with this printer, has demonstrated additional advantages. The software's capability to automatically construct support material plays a role in the overall time-saving aspect facilitated by the 3D printing workflow.
Stratasys, Ltd. Price and Consensus
Stratasys, Ltd. price-consensus-chart | Stratasys, Ltd. Quote
Stratasys Recent Partnerships to Aid Top-Line Growth
Stratasys has entered into partnerships with Siemens SIEGY, Toyota TM and the National Occupational Competency Testing Institute. These notable partnerships are set to boost Stratasys’s top-line performance in the upcoming quarters and establish a dominant position in the market.
The Zacks Consensus Estimate for SSYS’s 2023 revenues is pegged at $625.47 million, indicating a year-over-year decline of 3.99%. The consensus estimate for earnings is pegged at 15 cents per share, indicating flat year-over-year growth.
Stratasys recently collaborated with Siemens Healthineers for a groundbreaking research initiative aimed at creating innovative solutions to advance medical imaging phantoms for computed tomography (CT) imaging. CT phantoms, which are crucial tools in medical imaging and widely utilized in hospitals globally, are specialized devices employed to assess and verify the performance of CT scanners.
Stratasys has entered into an agreement with Toyota to become the inaugural customer to acquire the state-of-the-art Stratasys F3300 3D printer. Toyota intends to employ the F3300 for various purposes, including new production support for parts and fixtures, as well as prototyping applications to expedite the introduction of new products to the market. The F3300 possesses the capability to produce intricate, high-precision parts vital to vehicle design and usage, spanning from prototypes to end-use components.
Stratasys recently announced the attainment of third-party validation from the National Occupational Competency Testing Institute (NOCTI) for its groundbreaking Fused Deposition Modeling Process Certification. The collaboration marks a crucial moment for individuals, be they students or professionals, aspiring to pursue a career in additive manufacturing. The NOCTI certification ensures that both traditional and non-traditional students acquire industry-endorsed skills.
Shares of SSYS, which currently carries a Zacks Rank #3 (Hold), have gained 4% year to date compared with the Zacks Computer and Technology sector’s 47.8% increase due to tough competition in the 3D printing market from a dominant player like Altair Engineering ALTR.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Altair Engineering has become a prominent player in the realm of 3D printing with its array of simulation tools exerting a substantial influence on the additive manufacturing process. The Inspire Print3D product, a part of its suite, effectively optimizes product development and diminishes manufacturing expenses. The integration of Gen3D, a company specializing in design software and consulting, has bolstered Altair's capabilities in the field of 3D printing.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Toyota Motor Corporation (TM) : Free Stock Analysis Report
Altair Engineering Inc. (ALTR) : Free Stock Analysis Report
Stratasys, Ltd. (SSYS) : Free Stock Analysis Report
Siemens AG (SIEGY) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
This approach revolutionizes the removal of tumors in head and neck cancer patients, replacing the previous manual method involving cutting and bending metal during surgery. Stratasys recently announced the attainment of third-party validation from the National Occupational Competency Testing Institute (NOCTI) for its groundbreaking Fused Deposition Modeling Process Certification. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Stratasys, Ltd. Price and Consensus Stratasys, Ltd. price-consensus-chart | Stratasys, Ltd. Quote Stratasys Recent Partnerships to Aid Top-Line Growth Stratasys has entered into partnerships with Siemens SIEGY, Toyota TM and the National Occupational Competency Testing Institute. CT phantoms, which are crucial tools in medical imaging and widely utilized in hospitals globally, are specialized devices employed to assess and verify the performance of CT scanners. Click to get this free report Toyota Motor Corporation (TM) : Free Stock Analysis Report Altair Engineering Inc. (ALTR) : Free Stock Analysis Report Stratasys, Ltd. (SSYS) : Free Stock Analysis Report Siemens AG (SIEGY) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Stratasys, Ltd. Price and Consensus Stratasys, Ltd. price-consensus-chart | Stratasys, Ltd. Quote Stratasys Recent Partnerships to Aid Top-Line Growth Stratasys has entered into partnerships with Siemens SIEGY, Toyota TM and the National Occupational Competency Testing Institute. Shares of SSYS, which currently carries a Zacks Rank #3 (Hold), have gained 4% year to date compared with the Zacks Computer and Technology sector’s 47.8% increase due to tough competition in the 3D printing market from a dominant player like Altair Engineering ALTR. Click to get this free report Toyota Motor Corporation (TM) : Free Stock Analysis Report Altair Engineering Inc. (ALTR) : Free Stock Analysis Report Stratasys, Ltd. (SSYS) : Free Stock Analysis Report Siemens AG (SIEGY) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The implementation of tailored, 3D-printed surgical guides at University Hospital Birmingham is enhancing patient outcomes and reducing surgery times. Stratasys' GrabCAD Print Software, which operates in conjunction with this printer, has demonstrated additional advantages. Stratasys, Ltd. Price and Consensus Stratasys, Ltd. price-consensus-chart | Stratasys, Ltd. Quote Stratasys Recent Partnerships to Aid Top-Line Growth Stratasys has entered into partnerships with Siemens SIEGY, Toyota TM and the National Occupational Competency Testing Institute.
|
94acfb34-112d-4ef6-8754-d4d7d4bed1e6
|
713691.0
|
2023-12-11 00:00:00 UTC
|
Reasons to Retain Baxter International (BAX) in Your Portfolio
|
DCOMP
|
https://www.nasdaq.com/articles/reasons-to-retain-baxter-international-bax-in-your-portfolio-0
|
nan
|
nan
|
Baxter International BAX is poised for growth, given the demand for its medically essential products, coupled with transformational actions. However, inflationary pressure remains a concern.
Shares of this Zacks Rank #3 (Hold) company have lost 28% year to date compared with the industry's 6.3% decline. The S&P 500 Index has increased 16.6% in the same time frame.
BAX, with a market capitalization of $18.61 billion, is a global medical technology company providing items such as kidney-dialysis equipment, infusion pumps and intravenous solutions. The company has an earnings yield of 7.1% compared with the industry's (1.8%). It anticipates earnings to improve 5.2% over the next five years.
Image Source: Zacks Investment Research
What's Driving the Performance?
Baxter Internationalended third-quarter 2023 with an improvement in both earnings and revenues. Sales across all product categories were strong except for a decline in the Care & Connectivity Solutions category, led by lower rental revenues and hospital capital spending.
The company expects the demand for its medically essential products to continue amid stabilizing macroeconomic conditions and the healthcare marketplace. BAX stated that the ongoing transformational actions, announced earlier this year, will likely boost its performance going forward.
The transformational actions, which include realigning its businesses and operations into four vertically integrated global business segments, are likely to be completed by July 2024. Baxter Internationalis also progressing with the proposed spin-off of its Kidney Care segment, comprising of Renal Care and Acute Therapies product categories, into an independent, publicly traded company. This is also a part of BAX’s transformational actions.
On its third-quarterearnings call Baxter Internationalannounced that it completed the divestment of its BioPharma Solutions (BPS) business at the end of the third quarter. In May, it had signed an agreement to divest the business for $4.25 billion. As part of its transformation, BAX established its new operating model, integrating the prior matrixed structure of its nine businesses operating across three geographic regions into the aforementioned four verticalized global segments. The company started reporting under a new model, beginning third-quarter 2023.
Revenues from continued operations totaled $3.71 billion in the third quarter, up 3% on a reported basis and 4% organically.
Notable Developments
In June, Baxter Internationalannounced the U.S. launch of its new Hillrom Progressa+ bed for the intensive care unit. Progressa+, which offers new technology and features, has been designed to make it easier for nurses to care for patients and support patient recovery.
What's Weighing on the Stock?
Although recovering, the company continues to face pressure for services related to hospital admissions and procedural volumes. Supply-chain disruptions continue to hurt growth albeit slowly compared with the last few quarters. Lower rental revenues and reduced hospital capital spending continue to impact top-line growth. A decline in sales in China due to the implementation of value-based procurement initiatives is likely to continue in the country.
Although gross profit improved 1%, operating profit declined 4.9% year over year in the third quarter, reflecting inflationary pressure. Both gross and operating margins contracted during the same time frame.
Estimates Trend
The Zacks Consensus Estimate for 2023 revenues is pegged at $14.75 billion, indicating a 2.4% decline from the previous year’s level. However, revenues are likely to witness an estimated growth rate of 4% in 2024.
The consensus mark for adjusted EPS is pinned at $2.60, indicating a 25.7% decrease from the year-ago reported number. The consensus estimate for adjusted EPS has improved 1.2% in the past 30 days. However, EPS is likely to witness an estimated growth rate of 14.5% in 2024.
Baxter International Inc. Price
Baxter International Inc. price | Baxter International Inc. Quote
Stocks to Consider
Some better-ranked stocks in the broader medical space are DexCom DXCM, HealthEquity, Inc. HQY and Biodesix BDSX.
DexCom, carrying a Zacks Rank #2 (Buy) at present, has an estimated long-term growth rate of 33.6%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
DXCM’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 36.43%. The company’s shares have risen 4.2% year to date compared with the industry’s 3.8% growth.
HealthEquity, carrying a Zacks Rank #2 at present, has an estimated long-term growth rate of 26.8%. HQY’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 16.5%.
The company’s shares have rallied 15% year to date against the industry’s 9.9% decline.
Biodesix, carrying a Zacks Rank #2 at present, has an estimated growth rate of 32.3% for 2024. BDSX’s earnings surpassed estimates in three of the trailing four quarters and missed once, delivering an average surprise of 9.76%.
The stock has fallen 30.9% year to date compared with the industry’s 9.9% decline.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Baxter International Inc. (BAX) : Free Stock Analysis Report
DexCom, Inc. (DXCM) : Free Stock Analysis Report
HealthEquity, Inc. (HQY) : Free Stock Analysis Report
Biodesix, Inc. (BDSX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
BAX, with a market capitalization of $18.61 billion, is a global medical technology company providing items such as kidney-dialysis equipment, infusion pumps and intravenous solutions. The company expects the demand for its medically essential products to continue amid stabilizing macroeconomic conditions and the healthcare marketplace. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Although gross profit improved 1%, operating profit declined 4.9% year over year in the third quarter, reflecting inflationary pressure. Baxter International Inc. Price Baxter International Inc. price | Baxter International Inc. Quote Stocks to Consider Some better-ranked stocks in the broader medical space are DexCom DXCM, HealthEquity, Inc. HQY and Biodesix BDSX. Click to get this free report Baxter International Inc. (BAX) : Free Stock Analysis Report DexCom, Inc. (DXCM) : Free Stock Analysis Report HealthEquity, Inc. (HQY) : Free Stock Analysis Report Biodesix, Inc. (BDSX) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Estimates Trend The Zacks Consensus Estimate for 2023 revenues is pegged at $14.75 billion, indicating a 2.4% decline from the previous year’s level. Baxter International Inc. Price Baxter International Inc. price | Baxter International Inc. Quote Stocks to Consider Some better-ranked stocks in the broader medical space are DexCom DXCM, HealthEquity, Inc. HQY and Biodesix BDSX. Click to get this free report Baxter International Inc. (BAX) : Free Stock Analysis Report DexCom, Inc. (DXCM) : Free Stock Analysis Report HealthEquity, Inc. (HQY) : Free Stock Analysis Report Biodesix, Inc. (BDSX) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
The company has an earnings yield of 7.1% compared with the industry's (1.8%). It anticipates earnings to improve 5.2% over the next five years. Estimates Trend The Zacks Consensus Estimate for 2023 revenues is pegged at $14.75 billion, indicating a 2.4% decline from the previous year’s level.
|
c9bd5115-21e6-4f1f-bf82-94fbc4f7f235
|
713692.0
|
2023-12-11 00:00:00 UTC
|
First Merchants (FRME) Moves 7.1% Higher: Will This Strength Last?
|
DCOMP
|
https://www.nasdaq.com/articles/first-merchants-frme-moves-7.1-higher%3A-will-this-strength-last
|
nan
|
nan
|
First Merchants (FRME) shares rallied 7.1% in the last trading session to close at $36.59. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 9.3% gain over the past four weeks.
After 11 interest rate hikes, the Fed's decision to pause rate hikes for the third month drove bullish sentiments across markets amid the optimism of easing inflation pressures. With this, the interest rates remain at a 22-year high of 5.25-5.5%. Further, the central bank indicated three interest rate cuts by 2024-end. These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. Hence, the FRME stock gained.
This bank is expected to post quarterly earnings of $0.87 per share in its upcoming report, which represents a year-over-year change of -26.9%. Revenues are expected to be $158.5 million, down 8.4% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For First Merchants, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on FRME going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
First Merchants is part of the Zacks Banks - Midwest industry. Enterprise Financial Services (EFSC), another stock in the same industry, closed the last trading session 6% higher at $44.30. EFSC has returned 6.5% in the past month.
For Enterprise Financial Services, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.19. This represents a change of -24.7% from what the company reported a year ago. Enterprise Financial Services currently has a Zacks Rank of #4 (Sell).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
First Merchants Corporation (FRME) : Free Stock Analysis Report
Enterprise Financial Services Corporation (EFSC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
These developments turned investor sentiment bullish on bank stocks, as high funding costs faced by the industry players are expected to decline in the next year, supporting spread income and margins. For Enterprise Financial Services, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.19. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
Enterprise Financial Services (EFSC), another stock in the same industry, closed the last trading session 6% higher at $44.30. For Enterprise Financial Services, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.19. Click to get this free report First Merchants Corporation (FRME) : Free Stock Analysis Report Enterprise Financial Services Corporation (EFSC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> First Merchants is part of the Zacks Banks - Midwest industry. Click to get this free report First Merchants Corporation (FRME) : Free Stock Analysis Report Enterprise Financial Services Corporation (EFSC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
With this, the interest rates remain at a 22-year high of 5.25-5.5%. Hence, the FRME stock gained. For Enterprise Financial Services, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $1.19.
|
9b799aa4-545e-4254-961f-69d36533d400
|
713693.0
|
2023-12-11 00:00:00 UTC
|
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
|
DCOMP
|
https://www.nasdaq.com/articles/heres-why-you-should-retain-glaukos-gkos-stock-for-now-1
|
nan
|
nan
|
Glaukos Corporation GKOS is well-poised for growth, backed by favorable clinical trial results and a robust product pipeline. However, stiff competition is a concern.
Shares of this Zacks Rank #3 (Hold) company have rallied 36.6% year to date against the industry’s 5.4% decline. The S&P 500 Index has also increased 16.6% in the same time frame.
Glaukos, with a market capitalization of $3.05 billion, is a leading ophthalmic medical technology and pharmaceutical company. It projects earnings growth of 8.3% for 2024 and anticipates to maintain its strong performance in terms of revenues.
The company has an average four-quarter earnings surprise of 5.72%.
Image Source: Zacks Investment Research
Key Catalysts
Glaukos’ sales returned to growth following a declining trend in 2022, reflecting an improving macro environment coupled with the launch of several new products in the past few quarters. Continued strong demand across international Glaucoma and Corneal Health franchises will be the key top-line in 2024.
Moreover, the commercial launch of iStent infinite in 2023 is boosting the U.S. glaucoma franchise, which will drive growth in the upcoming few quarters. The company’s raised outlook for revenues on its third-quarterearnings calllooks promising.
Meanwhile, the new local coverage determinations proposed in June 2023 are likely to remove certain ophthalmic goniotomy and canaloplasty procedures from coverage. This will likely have a positive impact on the iStent business.
GKOS has launched several products like iPrime, iAccess and iStent in the past few quarters, which are aiding its revenue growth. The company has been focused on delivering improved outcomes for patients suffering from chronic eye diseases. It does so by continuing to develop a pipeline of novel, dropless platform technologies designed to meaningfully advance the standard of care.
One of the advanced pipeline candidates, iDose TR, has been successfully tested in a phase III study. Glaukos filed a new drug application with the FDA in February and a decision regarding the same is expected later this year. The company stated that the targeted population is 3 million in the United States every year. A potential approval for the candidate will substantially boost Glaukos’ revenues.
Per top-line data from two pivotal studies, GKOS announced that its targeted injectable implant candidate, iDose TR, for glaucoma patients,achieved excellent tolerability and a favorable safety profile last year. The candidate achieved non-inferior reductions in intraocular pressure in three months from its baseline compared with the timolol ophthalmic solution.
What’s Hurting GKOS?
Glaukos’ competitors include medical companies, academic and research institutions, as well as others that develop new drugs, therapies, medical devices or surgical procedures to treat glaucoma. Thus, intense competition continues to weigh on the company’s overall performance.
Moreover, the U.S. Centers for Medicare & Medicaid Services significantly reduced physician payment rates in 2022, which led to lower U.S. Glaucoma sales volume in the year. With no significant change in payment rates in 2023, the impact continued through the year and will continue to adversely impact sales in the last quarter.
Estimate Trend
The bottom-line estimate for GKOS is pegged at a loss of $2.20 per share for 2023, 0.9% wider than the previous year’s reported loss of $2.18. The Zacks Consensus Estimate for 2023 revenues is pinned at $308.47 million, indicating growth of 9.1% from that recorded in the previous year.
Glaukos Corporation Price
Glaukos Corporation price | Glaukos Corporation Quote
Stocks to Consider
Some better-ranked stocks in the broader medical space are DexCom DXCM, HealthEquity, Inc. HQY and Biodesix BDSX.
DexCom, carrying a Zacks Rank #2 (Buy) at present, has an estimated long-term growth rate of 33.6%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
DXCM’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 36.43%. The company’s shares have risen 4.2% year to date compared with the industry’s 3.8% growth.
HealthEquity, carrying a Zacks Rank #2 at present, has an estimated long-term growth rate of 26.8%. HQY’s earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 16.5%.
The company’s shares have rallied 15% year to date against the industry’s 9.9% decline.
Biodesix, carrying a Zacks Rank #2 at present, has an estimated growth rate of 32.3% for 2024. BDSX’s earnings surpassed estimates in three of the trailing four quarters and missed once, delivering an average surprise of 9.76%.
The stock has fallen 30.9% year to date compared with the industry’s 9.9% decline.
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
DexCom, Inc. (DXCM) : Free Stock Analysis Report
HealthEquity, Inc. (HQY) : Free Stock Analysis Report
Glaukos Corporation (GKOS) : Free Stock Analysis Report
Biodesix, Inc. (BDSX) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Image Source: Zacks Investment Research Key Catalysts Glaukos’ sales returned to growth following a declining trend in 2022, reflecting an improving macro environment coupled with the launch of several new products in the past few quarters. Per top-line data from two pivotal studies, GKOS announced that its targeted injectable implant candidate, iDose TR, for glaucoma patients,achieved excellent tolerability and a favorable safety profile last year. Moreover, the U.S. Centers for Medicare & Medicaid Services significantly reduced physician payment rates in 2022, which led to lower U.S. Glaucoma sales volume in the year.
|
Glaukos Corporation Price Glaukos Corporation price | Glaukos Corporation Quote Stocks to Consider Some better-ranked stocks in the broader medical space are DexCom DXCM, HealthEquity, Inc. HQY and Biodesix BDSX. DexCom, carrying a Zacks Rank #2 (Buy) at present, has an estimated long-term growth rate of 33.6%. Click to get this free report DexCom, Inc. (DXCM) : Free Stock Analysis Report HealthEquity, Inc. (HQY) : Free Stock Analysis Report Glaukos Corporation (GKOS) : Free Stock Analysis Report Biodesix, Inc. (BDSX) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Image Source: Zacks Investment Research Key Catalysts Glaukos’ sales returned to growth following a declining trend in 2022, reflecting an improving macro environment coupled with the launch of several new products in the past few quarters. Glaukos Corporation Price Glaukos Corporation price | Glaukos Corporation Quote Stocks to Consider Some better-ranked stocks in the broader medical space are DexCom DXCM, HealthEquity, Inc. HQY and Biodesix BDSX. Click to get this free report DexCom, Inc. (DXCM) : Free Stock Analysis Report HealthEquity, Inc. (HQY) : Free Stock Analysis Report Glaukos Corporation (GKOS) : Free Stock Analysis Report Biodesix, Inc. (BDSX) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
With no significant change in payment rates in 2023, the impact continued through the year and will continue to adversely impact sales in the last quarter. The Zacks Consensus Estimate for 2023 revenues is pinned at $308.47 million, indicating growth of 9.1% from that recorded in the previous year. Millions of lithium batteries are being made & demand is expected to increase 889%.
|
ff35ed19-1714-493d-bd5d-0d40658d25bc
|
713694.0
|
2023-12-11 00:00:00 UTC
|
Can Nvidia Stock Top $600 in 2024?
|
DCOMP
|
https://www.nasdaq.com/articles/can-nvidia-stock-top-%24600-in-2024
|
nan
|
nan
|
Nvidia (NASDAQ: NVDA) has been one of the top stocks to own in 2023, rising from $142 to around $480 now -- about a 230% gain. I don't think anyone is expecting Nvidia stock to repeat its performance of last year and triple its size; if it did, it would become the world's largest company by market cap.
Still, many wonder if Nvidia can once again be a top stock in the market and reach $600 in 2024, which would be about a 25% return. That's still a phenomenal year by most standards, but is it realistic?
Nvidia posted astonishing growth rates in 2023
Nvidia's rise in 2023 resulted from one thing: the artificial intelligence (AI) arms race. Creating an AI model takes immense computing power, and Nvidia's GPUs (graphics processing units) are the hardware of choice for the job. While consumers may buy a single GPU to power their gaming computer, businesses creating a supercomputer or data center purchase thousands of these GPUs. By linking these devices together, an incredibly powerful computer can be created.
For example, Tesla's Dojo supercomputer, which it uses to train its full self-driving model, has 10,000 H100 GPUs connected. At about $30,000 a piece for a single H100, Tesla paid Nvidia about $300 million to outfit its supercomputer.
Tesla is just one customer; countless others are rushing to outfit their supercomputers and data centers to capitalize on the AI gold rush. As a result, Nvidia's revenue boomed throughout the year.
PERIOD REVENUE YOY GROWTH
Q1 FY 2024 $7.19 billion (13%)
Q2 FY 2024 $13.5 billion 102%
Q3 FY 2024 $18.1 billion 206%
Q4 FY 2024 $20 billion (projected) 231%
Data source: Nvidia. YOY = year over year.
Once the results for the fourth quarter of fiscal 2024 and Q1 FY 2025 are in, Nvidia will have lapped this GPU boom, and investors will be able to see how the company is truly valued. Right now, Nvidia trades at an expensive 63 times earnings. Should Nvidia meet its $20 billion guidance for Q4 and deliver a similar profit margin as in Q3, then repeat the quarter in Q1, Nvidia would have about $35.8 billion in net income.
If you divide its market cap by that figure, you'd get a forward earnings valuation of 33, which isn't so bad.
So, the stock should look reasonably priced once Nvidia completes a full year with this elevated business. But the question is, how long can it maintain its current business pace?
When will the demand boom for Nvidia's GPU end?
As mentioned above, Tesla spent $300 million on its supercomputer. But it has no plans to build a second computer to rival the original one. Because Nvidia is a hardware business and not a subscription one, customers don't necessarily have to return for more once they've made their initial purchase.
This is a brewing problem for Nvidia and its stock. This demand cycle has bitten Nvidia before, as it dealt with a supply glut created by the crypto fallout in 2019 and 2022.
NVDA Revenue (Quarterly) data by YCharts
The hardest thing to determine is the market size for Nvidia's top-end GPUs used by those constructing supercomputers or data centers. If we're nearing the limit, Nvidia could have a disaster in 2024 as the stock would plummet.
On the flip side, if it's five years before this demand slows, then not owning Nvidia stock would be a huge mistake.
As a result, I'm in a wait-and-see mode for Nvidia. I'd like to see the company lap one year of accelerated business before investing in the stock again, as I sold my shares earlier this year after a strong gain (a big mistake on my part). However, if Nvidia is an outsized part of your portfolio, I would consider trimming the stock a bit, as it could be a dramatic fall from grace if demand goes away in 2024.
So, could Nvidia hit $600 in 2024? I'd say yes. But it could also crash to $200 or $300 if demand disappears.
Should you invest $1,000 in Nvidia right now?
Before you buy stock in Nvidia, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Keithen Drury has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Nvidia. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
I don't think anyone is expecting Nvidia stock to repeat its performance of last year and triple its size; if it did, it would become the world's largest company by market cap. Creating an AI model takes immense computing power, and Nvidia's GPUs (graphics processing units) are the hardware of choice for the job. While consumers may buy a single GPU to power their gaming computer, businesses creating a supercomputer or data center purchase thousands of these GPUs.
|
While consumers may buy a single GPU to power their gaming computer, businesses creating a supercomputer or data center purchase thousands of these GPUs. Q1 FY 2024 $7.19 billion (13%) Q2 FY 2024 $13.5 billion 102% Q3 FY 2024 $18.1 billion 206% Q4 FY 2024 $20 billion (projected) 231% Data source: Nvidia. Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Nvidia wasn't one of them.
|
I don't think anyone is expecting Nvidia stock to repeat its performance of last year and triple its size; if it did, it would become the world's largest company by market cap. So, the stock should look reasonably priced once Nvidia completes a full year with this elevated business. Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Nvidia wasn't one of them.
|
While consumers may buy a single GPU to power their gaming computer, businesses creating a supercomputer or data center purchase thousands of these GPUs. YOY = year over year. I'd like to see the company lap one year of accelerated business before investing in the stock again, as I sold my shares earlier this year after a strong gain (a big mistake on my part).
|
634309f4-423a-46be-ba8f-cdea13e86ec8
|
713695.0
|
2023-12-11 00:00:00 UTC
|
Here's 1 Fantastic Dividend Stock to Buy in December
|
DCOMP
|
https://www.nasdaq.com/articles/heres-1-fantastic-dividend-stock-to-buy-in-december
|
nan
|
nan
|
One of the best ways to round out a diversified portfolio is to allocate some positions toward dividend stocks. While many blue chip companies pay dividends, investors looking for substantial passive income might be better served elsewhere. Real estate investment trusts (REITs) are structured such that at least 90% of taxable income is passed on to shareholders.
One of the leading retail REITs on the market is Realty Income (NYSE: O). But you might not realize that if you only looked at the stock's price action. At just $54 per share, Realty Income is trading dangerously close to a three-year low. Let's take a look at the stock and why investors have soured on it.
While there are some risks surrounding the real estate industry, you might find that the concerns around Realty Income look overdone. With a dividend yield of 5.7%, now could be a terrific opportunity to buy the dip.
Don't let the macro picture fool you
The overall state of the economy can be tough to interpret. While the Federal Reserve has worked hard to bring down the rate of inflation, purchasing power for consumers is not as robust at the moment. As a result, people have been forced to make tougher decisions while out shopping.
The side effect is that retail stores in particular have struggled to entice consumers to spend. On the surface, this dynamic wouldn't engender confidence for a retail REIT. However, a closer look at Realty Income's tenant roster might cause you to think again. Brick-and-mortar stores like Hobby Lobby, Dollar General, Dollar Tree, Walgreens, and Walmart are all among its renters.
Investors could argue that many of these retail outlets are a staple for cost-conscious shoppers. In the event of an economic slowdown, a contrarian might argue that these stores will witness a surge in demand, which would actually be a good thing for Realty Income.
Image Source: Getty Images
Another point that investors might be misinterpreting is Realty Income's acquisition of Spirit Reality. While the deal is an all-stock transaction, I wouldn't worry too much. The bigger picture is that Realty Income is augmenting its portfolio with a complementary business that could produce significant benefits down the road.
The company is forecasting the deal to contribute meaningful accretion to funds from operations (FFO), which may be getting overlooked given the current price action of the stock.
Dividend investors will love this
While REITs are attractive for their dividends, there is an extra reason to like Realty Income. The company actually pays its dividend monthly. And it has increased its dividend for over 100 consecutive quarters.
With the stock trading at a 5.7% dividend yield, it's hard to pass on the opportunity to scoop up shares near a three-year low. Furthermore, the long-term theme of consistently increasing its dividend for decades underscores the resiliency of Realty Income and its ability to navigate challenging economies.
O dividend yield data by YCharts.
Should you buy Realty Income stock?
I see two obvious benefits of buying shares in Realty Income right now. The first is that you would be opening a position at a historically low price, all while benefiting from some monthly dividend income.
The second is the potential of the Spirit Realty deal. The sell-off in the stock following the announcement of the deal appears overblown. Some investors might believe this was an attempt to try to distract from a more obvious concern: the state of the economy. I don't see it that way.
Moreover, investors shouldn't discount Realty Income's potential should there be a slowdown anyway. The company appears well-positioned to benefit in the long run, regardless of inflation. Now looks like an interesting time to consider buying shares in this retail REIT. Dividend investors in particular might come to appreciate the consistency of some monthly passive income.
Should you invest $1,000 in Realty Income right now?
Before you buy stock in Realty Income, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Realty Income wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Adam Spatacco has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Realty Income and Walmart. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
In the event of an economic slowdown, a contrarian might argue that these stores will witness a surge in demand, which would actually be a good thing for Realty Income. The company is forecasting the deal to contribute meaningful accretion to funds from operations (FFO), which may be getting overlooked given the current price action of the stock. Furthermore, the long-term theme of consistently increasing its dividend for decades underscores the resiliency of Realty Income and its ability to navigate challenging economies.
|
With the stock trading at a 5.7% dividend yield, it's hard to pass on the opportunity to scoop up shares near a three-year low. I see two obvious benefits of buying shares in Realty Income right now. Before you buy stock in Realty Income, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Realty Income wasn't one of them.
|
Dividend investors will love this While REITs are attractive for their dividends, there is an extra reason to like Realty Income. Should you buy Realty Income stock? Before you buy stock in Realty Income, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Realty Income wasn't one of them.
|
Should you buy Realty Income stock? I see two obvious benefits of buying shares in Realty Income right now. Before you buy stock in Realty Income, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Realty Income wasn't one of them.
|
635c7d95-8467-4cde-83ec-4bb420ff8034
|
713696.0
|
2023-12-11 00:00:00 UTC
|
Like Devon Energy's Dividend? You'll Love These Dynamic Dividend Stocks.
|
DCOMP
|
https://www.nasdaq.com/articles/like-devon-energys-dividend-youll-love-these-dynamic-dividend-stocks.
|
nan
|
nan
|
Devon Energy (NYSE: DVN) has become one of the more popular stocks in the oil patch, with its dividend a big reason it has grabbed investors' attention. The company's fixed-plus-variable dividend provides investors with a solid base income stream and upside potential based on earnings.
While Devon was the first oil company to popularize that payout framework, other companies also provide their investors with an income-driven dividend. Blackstone (NYSE: BX) and CME Group (NASDAQ: CME) are notable variable-dividend stocks. Here's why investors seeking some upside to their income stream should look at these dynamic dividend stocks.
An oil-fueled dividend
Devon Energy launched the oil industry's first fixed-plus-variable dividend framework in 2021 after closing its merger-of-equals transaction with WPX Energy. The combined company expected to produce more free cash flow, which it intended to return to shareholders. The bulk of that return would come from paying dividends. It aimed to pay a fixed base dividend and a variable dividend of at least 50% of its excess free cash flow.
That combined payout has ebbed and flowed with its oil-fueled cash flows over the years:
Data source: Devon Energy. Chart by the author.
As that chart shows, Devon's dividend rose with its oil-fueled cash flow during the early part of 2022 before falling with oil over the past several quarters, until bouncing back in the most recent period.
Devon's dividend will likely continue to ebb and flow. In the near term, it could head lower because it slightly adjusted its capital return strategy for 2024.
Given the decline in its share price (the stock currently sits about 35% below its 52-week high), "we expect to pursue buybacks at a level that will most likely result in our variable payout being below the 50% threshold in the near term to capture the incredible value our equity offers at these trading levels," CEO Rick Muncrief said on the third-quarter conference call. Because of that, its dividends won't have as much upside potential in 2024.
The dividend follows its earnings
Blackstone has paid a variable dividend for years. The leading alternative-asset manager returns nearly all its distributable earnings to investors each quarter via dividends and share repurchases.
There's a lot of variability in its profits due to the timing of when it realizes performance revenue from the funds it manages. Because of that, its dividend can swing wildly from year to year:
Data source: Blackstone. Chart by the author.
While Blackstone's dividend has ebbed and flowed over the years, the general trend has been higher. Even after a down year in 2023, the payout has surged more than 500% over the past decade.
The driver is its rapid earnings growth. Blackstone's distributable earnings have grown at a 20% annual rate over the last 10 years -- more than double the rate of the broader market -- enabling it to pay higher dividends.
The company expects to continue growing. CEO Steve Schwarzman said on the third-quarter call: "Blackstone is extremely well positioned to capture future opportunities for growth in the alternatives area, which remains early in its long-term development. ... We have led the industry's evolution, and I expect we will continue to lead it in the future."
The company sees many opportunities, including expanding its private credit platform, insurance solutions business, and offerings for individual investors. As its earnings grow, the dividend will follow.
An extra payment once a year
CME Group pays a fixed quarterly dividend that it increases each year. On top of that, it has paid an annual variable dividend every year since 2012. That extra payment is often more than its total fixed-dividend outlay for the year:
Data source: CME Group. Chart by the author.
The exchange operator started paying an annual variable dividend to return excess cash to shareholders. It increases or decreases that payment based on its operating results, potential investment activity, and other forms of capital return like share repurchases.
The total payment has more than doubled over the last decade as the company has increased its earnings. CME Group delivered its ninth consecutive quarter of double-digit adjusted earnings growth in the third quarter of 2023.
The company believes it's in an excellent position to continue growing, driven by its diverse businesses and growth initiatives. That positions it to continue increasing its base dividend (which it boosted by 10% in early 2023) and paying meaningful variable dividends at the end of each year.
Income with upside
Many investors prefer fixed dividend payments because they give them visibility into their annual income stream. However, some investors like the prospect of income upside potential that Devon Energy offers. Because of that, they would also like Blackstone and CME Group.
While their payouts vary year to year, they've generally headed higher over the long term. That makes them compelling options for those seeking a higher-upside income stream.
Should you invest $1,000 in Devon Energy right now?
Before you buy stock in Devon Energy, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Devon Energy wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Matthew DiLallo has positions in Blackstone and CME Group. The Motley Fool has positions in and recommends Blackstone. The Motley Fool recommends CME Group. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Devon Energy (NYSE: DVN) has become one of the more popular stocks in the oil patch, with its dividend a big reason it has grabbed investors' attention. As that chart shows, Devon's dividend rose with its oil-fueled cash flow during the early part of 2022 before falling with oil over the past several quarters, until bouncing back in the most recent period. CEO Steve Schwarzman said on the third-quarter call: "Blackstone is extremely well positioned to capture future opportunities for growth in the alternatives area, which remains early in its long-term development.
|
The company's fixed-plus-variable dividend provides investors with a solid base income stream and upside potential based on earnings. That combined payout has ebbed and flowed with its oil-fueled cash flows over the years: Data source: Devon Energy. An extra payment once a year CME Group pays a fixed quarterly dividend that it increases each year.
|
The dividend follows its earnings Blackstone has paid a variable dividend for years. That positions it to continue increasing its base dividend (which it boosted by 10% in early 2023) and paying meaningful variable dividends at the end of each year. Before you buy stock in Devon Energy, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Devon Energy wasn't one of them.
|
The dividend follows its earnings Blackstone has paid a variable dividend for years. An extra payment once a year CME Group pays a fixed quarterly dividend that it increases each year. Before you buy stock in Devon Energy, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Devon Energy wasn't one of them.
|
c856c2dd-c820-4297-9ee4-c33143a19c44
|
713697.0
|
2023-12-11 00:00:00 UTC
|
2 Artificial Intelligence (AI) Stocks Down 46.5% and 54% to Buy Now
|
DCOMP
|
https://www.nasdaq.com/articles/2-artificial-intelligence-ai-stocks-down-46.5-and-54-to-buy-now
|
nan
|
nan
|
No doubt about it, artificial intelligence (AI) is this year's hottest trend. But its impact is still just starting to be felt. Investors are still at the outset of a revolutionary technology shift, and some magnificent AI stocks continue to trade at big discounts despite the market's surging interest in the new tech movement.
Two Motley Fool contributors have identified AI stocks that look like great investments -- one that AI investors have almost certainly heard of, and another name that's flying under the radar. Read on to see why they believe investing in these artificial intelligence stocks would be a great move.
Palantir is on the cutting edge of artificial intelligence
Parkev Tatevosian: Despite the incredible popularity of artificial intelligence, Palantir Technologies (NYSE: PLTR), one of the leading companies in AI, is selling at a price that is 54% off its high. The company has done an excellent job growing revenue and progressing toward profitability on the bottom line. Admittedly, despite the price decrease, the valuation is not cheap, but it has earned a premium due to its performance.
Indeed, Palantir's revenue has increased from $595 million in 2018 to $1.9 billion in 2022. The company offers enterprises, institutions, and governments solutions, including artificial intelligence, to solve their most pressing needs. Its systems help humans make actionable sense of overwhelming volumes of data. Their solutions help users tackle critical challenges in diverse areas like fraud detection, cybersecurity, supply chain optimization, and national security. Unsurprisingly, the rising effectiveness of AI could increase demand for Palantir's services.
Impressively, Palantir's revenue growth is leading to profitability. In 2018, when the company generated $595 million in sales, it reported an operating loss of $623 million. In its most recent quarter, Palantir reported revenue of $558 million and operating income of $40 million. Of course, it must deliver profitability over several more quarters before investors can be confident it has turned the corner in this crucial metric. Still, the improvement is encouraging, to be sure.
PLTR PE Ratio (Forward 1y) data by YCharts
Palantir is trading at a forward price-to-earnings ratio of 60, which is not a cheap valuation. However, given its excellent prospects riding the tailwind of artificial intelligence and the growth in profitability, it could be an excellent option for investors looking to capitalize on the AI wave.
This overlooked stock could be explosive
Keith Noonan: Smartsheet (NYSE: SMAR) might not be a household name, but it's a stock that investors could look back on five years from now and regret missing out on. With shares still down 46.5% from their valuation peak, now could be a great time to build a position in this underappreciated artificial intelligence stock.
Smartsheet provides project management software for businesses and institutions, and it's recently rolled out a suite of AI tools to make handling daily operations and long-term projects easier for its customers. Customers were already loving the company's up-front, highly visible cost structure and getting huge value from its services prior to the artificial intelligence rollout, and early indicators suggest the new AI tools are on track to be a hit and help build its recurring revenue base.
The enterprise software specialist generates most of its revenue from subscription-based software, but it also has a smaller support services business. For context, subscription revenue increased 23% year over year in the period to reach $232.5 million in the third quarter, while professional services revenue was roughly flat at $13.4 million.
Overall revenue was up 23% year over year in Q3, and the company swung to generating positive free cash flow of $11.4 million in the period after having posted a cash outflow of $4.6 million in last year's quarter. The company's non-GAAP (adjusted) gross margin also climbed to 84%, its highest margin in the last five quarters.
Eighty-nine customers increased their spending with the company by more than $100,000 in Q3, while 256 increased spending by more than $50,000. In short, Smartsheet continues to expand its customer base, boost contract values, and improve margins at an encouraging pace.
The company's current valuation leaves room for long-term investors to see strong upside, and continued momentum for the business may power Smartsheet stock to become an explosive multi-bagger.
Should you invest $1,000 in Palantir Technologies right now?
Before you buy stock in Palantir Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month. The Stock Advisor service has more than tripled the return of S&P 500 since 2002*.
See the 10 stocks
*Stock Advisor returns as of December 11, 2023
Keith Noonan has no position in any of the stocks mentioned. Parkev Tatevosian, CFA has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Palantir Technologies and Smartsheet. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Investors are still at the outset of a revolutionary technology shift, and some magnificent AI stocks continue to trade at big discounts despite the market's surging interest in the new tech movement. Customers were already loving the company's up-front, highly visible cost structure and getting huge value from its services prior to the artificial intelligence rollout, and early indicators suggest the new AI tools are on track to be a hit and help build its recurring revenue base. The company's current valuation leaves room for long-term investors to see strong upside, and continued momentum for the business may power Smartsheet stock to become an explosive multi-bagger.
|
Palantir is on the cutting edge of artificial intelligence Parkev Tatevosian: Despite the incredible popularity of artificial intelligence, Palantir Technologies (NYSE: PLTR), one of the leading companies in AI, is selling at a price that is 54% off its high. In its most recent quarter, Palantir reported revenue of $558 million and operating income of $40 million. Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Palantir Technologies wasn't one of them.
|
Palantir is on the cutting edge of artificial intelligence Parkev Tatevosian: Despite the incredible popularity of artificial intelligence, Palantir Technologies (NYSE: PLTR), one of the leading companies in AI, is selling at a price that is 54% off its high. Overall revenue was up 23% year over year in Q3, and the company swung to generating positive free cash flow of $11.4 million in the period after having posted a cash outflow of $4.6 million in last year's quarter. Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Palantir Technologies wasn't one of them.
|
Palantir is on the cutting edge of artificial intelligence Parkev Tatevosian: Despite the incredible popularity of artificial intelligence, Palantir Technologies (NYSE: PLTR), one of the leading companies in AI, is selling at a price that is 54% off its high. Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Palantir Technologies wasn't one of them. See the 10 stocks *Stock Advisor returns as of December 11, 2023 Keith Noonan has no position in any of the stocks mentioned.
|
bd93ad1b-359b-4833-9a95-175c968990c1
|
713698.0
|
2023-12-11 00:00:00 UTC
|
HBT Financial (HBT) Soars 6.4%: Is Further Upside Left in the Stock?
|
DCOMP
|
https://www.nasdaq.com/articles/hbt-financial-hbt-soars-6.4%3A-is-further-upside-left-in-the-stock
|
nan
|
nan
|
HBT Financial HBT shares soared 6.4% in the last trading session to close at $21.16. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 1.1% gain over the past four weeks.
The Federal Reserve has signaled an end to the current rate hike cycle by keeping interest rates unchanged at the 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. The central bank has also indicated a 75 basis points cut in rates by 2024-end. The above-mentioned developments have attributed to bullish investor sentiments. Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This probably drove the HBT stock higher in last day’s trading session.
This bank holding company is expected to post quarterly earnings of $0.60 per share in its upcoming report, which represents a year-over-year change of -3.2%. Revenues are expected to be $57.81 million, up 15.5% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For HBT Financial, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on HBT going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
HBT Financial is part of the Zacks Banks - Northeast industry. Premier Financial PFC, another stock in the same industry, closed the last trading session 7.9% higher at $23.32. PFC has returned 6.6% in the past month.
For Premier Financial, the consensus EPS estimate for the upcoming report has changed +1.8% over the past month to $0.58. This represents a change of -18.3% from what the company reported a year ago. Premier Financial currently has a Zacks Rank of #2 (Buy).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
HBT Financial, Inc. (HBT) : Free Stock Analysis Report
Premier Financial Corp. (PFC) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This bank holding company is expected to post quarterly earnings of $0.60 per share in its upcoming report, which represents a year-over-year change of -3.2%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> HBT Financial is part of the Zacks Banks - Northeast industry. For Premier Financial, the consensus EPS estimate for the upcoming report has changed +1.8% over the past month to $0.58. Click to get this free report HBT Financial, Inc. (HBT) : Free Stock Analysis Report Premier Financial Corp. (PFC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> HBT Financial is part of the Zacks Banks - Northeast industry. Click to get this free report HBT Financial, Inc. (HBT) : Free Stock Analysis Report Premier Financial Corp. (PFC) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
HBT Financial HBT shares soared 6.4% in the last trading session to close at $21.16. Premier Financial PFC, another stock in the same industry, closed the last trading session 7.9% higher at $23.32. For Premier Financial, the consensus EPS estimate for the upcoming report has changed +1.8% over the past month to $0.58.
|
608d6074-2373-4afd-8f09-c2adb55590ea
|
713699.0
|
2023-12-11 00:00:00 UTC
|
First Mid Bancshares (FMBH) Stock Jumps 5.8%: Will It Continue to Soar?
|
DCOMP
|
https://www.nasdaq.com/articles/first-mid-bancshares-fmbh-stock-jumps-5.8%3A-will-it-continue-to-soar
|
nan
|
nan
|
First Mid Bancshares FMBH shares ended the last trading session 5.8% higher at $34.16. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 3.9% gain over the past four weeks.
The Federal Reserve has signaled an end to the current rate hike cycle by keeping interest rates unchanged at the 22-year high of 5.25-5.5% at the end of the two-day FOMC meeting. The central bank has also indicated a 75 basis points cut in rates by 2024-end. The above-mentioned developments have attributed to bullish investor sentiments. Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This probably drove the FMBH stock higher, which touched a new 52-week high in last day’s trading session.
This bank holding company is expected to post quarterly earnings of $0.83 per share in its upcoming report, which represents a year-over-year change of -17.8%. Revenues are expected to be $77.1 million, up 20.7% from the year-ago quarter.
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
For First Mid Bancshares, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on FMBH going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
First Mid Bancshares is part of the Zacks Banks - Northeast industry. Mid Penn Bancorp MPB, another stock in the same industry, closed the last trading session 3.2% higher at $23.72. MPB has returned 3.8% in the past month.
Mid Penn Bancorp's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.61. Compared to the company's year-ago EPS, this represents a change of -38.4%. Mid Penn Bancorp currently boasts a Zacks Rank of #4 (Sell).
The New Gold Rush: How Lithium Batteries Will Make Millionaires
As the electric vehicle revolution expands, investors have a chance to target huge gains. Millions of lithium batteries are being made & demand is expected to increase 889%.
Download the brand-new FREE report revealing 5 EV battery stocks set to soar.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
First Mid Bancshares, Inc. (FMBH) : Free Stock Analysis Report
Mid Penn Bancorp (MPB) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
|
Given the fall in rates, the higher funding costs being faced by banks will likely come down somewhat next year, thus supporting net interest income and margins. This bank holding company is expected to post quarterly earnings of $0.83 per share in its upcoming report, which represents a year-over-year change of -17.8%. The New Gold Rush: How Lithium Batteries Will Make Millionaires As the electric vehicle revolution expands, investors have a chance to target huge gains.
|
First Mid Bancshares FMBH shares ended the last trading session 5.8% higher at $34.16. Mid Penn Bancorp's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.61. Click to get this free report First Mid Bancshares, Inc. (FMBH) : Free Stock Analysis Report Mid Penn Bancorp (MPB) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> First Mid Bancshares is part of the Zacks Banks - Northeast industry. Click to get this free report First Mid Bancshares, Inc. (FMBH) : Free Stock Analysis Report Mid Penn Bancorp (MPB) : Free Stock Analysis Report To read this article on Zacks.com click here.
|
First Mid Bancshares FMBH shares ended the last trading session 5.8% higher at $34.16. Mid Penn Bancorp MPB, another stock in the same industry, closed the last trading session 3.2% higher at $23.72. Mid Penn Bancorp's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.61.
|
819099bc-d809-46a3-b1a5-b88d70320065
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.